{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pymedtermino\n",
    "pymedtermino.LANGUAGE = \"en\"\n",
    "pymedtermino.REMOVE_SUPPRESSED_CONCEPTS = True\n",
    "from pymedtermino.all import *\n",
    "from pymedtermino import *\n",
    "\n",
    "from pymedtermino.snomedct import *\n",
    "import wikipedia\n",
    "import spacy\n",
    "from wordcloud import WordCloud"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "sensitive_diseases=['AIDS','HIV','TB','CANCER','BIPOLAR','MENTAL-DISORDER','BRAIN TUMOR']\n",
    "sensitive_drugs = ['Abacavir','Didanosine','Emtricitabine','Lamivudine','Stavudine','Tenofovir','Zidovudine','Isoniazid','Rifampicin','Pyrazinamide','Ethambutol','RisPeridone','Olanzapine','Quetiapine','ziprasidone','paliperidone','lurasidone','afinitor','avastin','bevacizumab','bicnu','carmustine','everolinus','colozapine','AC-T']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Matplotlib is building the font cache; this may take a moment.\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "from wordcloud import WordCloud\n",
    "#convert list to string and generate\n",
    "unique_string=(\" \").join(sensitive_diseases)\n",
    "#maskArray = npy.array(Image.open(\"Downloads/shild.jpg\"))\n",
    "wordcloud = WordCloud(width = 1000, height = 500,background_color=\"white\").generate(unique_string)\n",
    "plt.figure(figsize=(15,8))\n",
    "plt.imshow(wordcloud)\n",
    "plt.axis(\"off\")\n",
    "plt.savefig(\"your_file_name\"+\".png\", bbox_inches='tight')\n",
    "plt.show()\n",
    "plt.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA1MAAAGwCAYAAABM9z+ZAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjMuMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8vihELAAAACXBIWXMAAAsTAAALEwEAmpwYAAEAAElEQVR4nOy9d3xc13mn/9w2fQZl0DsI9ip2UiTVq2XZKpbcSxKnOXayccpmS5LdxNn9pSeb4sS927Is2WpWpRpJib13EIUA0dv0dsv5/TEgSBAAgQHRSM7jDy3yzi1n7tx7znnP+77fVxJCkCVLlixZsmTJkiVLlixZMkOe7QZkyZIlS5YsWbJkyZIly/VI1pjKkiVLlixZsmTJkiVLlkmQNaayZMmSJUuWLFmyZMmSZRJkjaksWbJkyZIlS5YsWbJkmQRZYypLlixZsmTJkiVLlixZJoE6zuc3hNRfWrFQEDfjpKwklrBAAkVScSpObLJ91OMSZpy4GcOpuLDLDiRJmrY2Ro0IKSuJW/WM2Z4sNxeRQJRYOIE3343T7Zjt5mTJckNgWhaBeIK4oQ9t0xSFPKcTm6Jc07mFECQMg1AiiSksbIpKjsOOKsvTOn5kyZIlS5ZpZ8xOfDxj6oahMXKWd3peoyF6hqgRRpVU8m2FfKj8oyzPWTNifyEEu3rf5LXO59hWeA8PlT4xbW0TQvBM6/c4ETrMI+WfYHPBHdN2rSzXB8ISfO8rz/L6D3fy2T99nEe+cN9sNylLlhuCgXic//naG7xxrmFo27LiIr5y372sKCm+pnMnDZOv7d3HM8dPEEwkme/P5wubNnJn3byxR+EsWbJkyXJdc1MYUwG9n6dav0V/qo9F3mUUO8oQCBJmnHxbwZjHpawkpjBJWslpbZ9AELfiWMJCt1LTeq0s1wcCQTycwDItErHpff6mAksI+mMxWoNB2kNhgokEcV0nZVpIgE1RsKkKuQ4HeS4nhW435T4fLk3LrthnuWE42tXJf+7ZR8o0ATjS0ck/7NzFttqaa/Z6ZcmSJUuWuclNYUydCh6lO9nFPPdCHq/8DLlaPgJB0kxgV0YPn5IkiQ3526h21VHsKJvW9smSzAdLnyBQ0E+lq3ZCx0SMMHv7djDfu4SqCR6TZeYRQvDC17bjyXVx10dvnfBxsizzxO8/xLZH11O3qnoaW3htCOB4Zyev1zdwuKOD3miMgXicmJ5CNy10K21MqbKMKsu4NA2P3YbXbqfQ7WZefj7rK8rZUFmB154Nb81yfXOyqxvDsoZtO9fbR1zXs8ZUlixZstyg3BTGVFuiBRmJKlcNeTY/0mDAhUt1X/U4v70Qv71wJppIuauKcqomtK8QgoDez87e7eTZ/Fljag5j6hY//9dXWHP38oyMKYCqxWVULZ5eQ36yCCEYiCf4zoGDPHfyFL2xGEnDGH1fIGWapEyTmK7TG4sNfbaz+TzPHD9BqdfD59ev40NLl1xzuy4n6/XKMhrT9VS4bbYR25yaljWkrnOu7Fcuku1fskwlF5+zVFznxO6z7H31CE3HWwn1RTB0A7fPRV6xj5qlFSzfspg1dy27IZ/BaDDGd/7iZ5zYXc/q25fxxO9/gNxC32w366rc8MaUEIKEGQMk7IpryJC6nhEImiL1JMzYjaEQcgNz5mADgZ4Qlnnj/FKWEDT1D/DX77zL241NWGNMNCZCyjRJxeOosoQiX5u4qCUEDX19BBIJVFmhLj8PnyMr3JFlJNP1Nm6rqaHI46YnEsUSAruq8sSK5WhZY+q6xBQmcTNJbzJAc6SdiBnHJmuUOgsodxTi0VzYZG22mznlxKMJ4uHEmEbkRJFkmZwCL4qSFY6eKF0tffzbl7/LgTeOYZli5G8gwfsvHWLr2Q7W3LVsdho5zez8xT62/3gX0WCcvrYBapdXcM8nts52s67KdWFMWcIkrIcIGUGSZhwTCwUFh+Ikz5aPW/UO298UJh3xC6SsJCkrxUCqHwuL3mQXp0PHh/Zzq+4RYXUDqX66Eu3DtuXb/BTaS0ZdAYgYYdrjrRTbS/FoPvqTPYSNEIbQUSQVj+rFbytClYffakuk29Of6hvaJksShfYS8mz+Ue6BRcQIEdIDRI0IRwL7MIRBe7wFl3LJw2aTbZQ4ynCpnhH3MKQHCeoDJK0kEuBQXOTZ/LgVz4jvJoSgN9lFyAhS4ijDobgIpPoJ6gND382luCmwF6Ndw2AihEBPGvR1DBDqC5OIpRCWQLOr+PI9FFTkD1Oyi0cSNB1vBWDeyiocrpGhYZZlcf5kG8G+MJULS8kvyUWSJIQQxCMJ+joChAcipOI6SGB32sgt8lFQlo9mG/lKCCFIRJN0tfQSCUQxUiaKKmNz2PDme8gr9uFw2Yddo7u1j2gwxptPvYeeMuht7+fgm5eePUmWKK8roajSP+w6nc09dDR1X9pPkiibV0xx9ei5fd2tfbQ3dlG3shqH205ncw/B3jCGbqDZVPKKciiqKkDVpmYyJ4SgKxzh73fs5M2GxhGfu2028p1OPHYbNkVBliQsIdBNi7iuE0mlCCeTJK7wYlXk5LC+ouKa2jYQj/Onr73B/rZ28p1O/unhh7i1emLe3ixZpoJij5t/fvghfnbsBKFkklWlJTy5YjnKDbh6fKOTNFMcDpzh+bZ3OR48hyHMYZ8X2/N5oOxW7iraQIE9d3YaOU388ptv8b2vPEsiem35uj6/h3/b9ZfDxrksY5OIJfl/v/ttDrxxDCA9hhfn4M5xISsypmGSiqeIhuJsuP+W2W3sNBIOxjCNdLi0ntSv+TmcCea8MWUJi8OBvRwe2E9bvJmAPoBh6WiyjVxbPgu9y9hScBflzkuTpoQZ4+nW7xDQ+0mYMRJmAguLAwPvcSSwd2i/Bd5l/GbdHwy7XmP0DC+2/ZSklSRuxjCEzl1FH+CR8k+M2r7z0Qa+3fQvPFj6GG7Vw76+nbTFW0hYcWyynRJHOevzt7DJfzuafCkExBQGRwL72Nn7JikrQcyMIqPwWMUn2VZ474jr6JbO3r6dHArsZiDVR9SIYGGxvesl3u5+eWi/Qnspj1d8mvnexUPbkmaCM+Hj7OvfxfloAyEjiIxErs3PAs8SNhXcTo1r/giD6r2+t9nfv4tHKz6JIins7n2H5tg54mYMm2yn1r2AJyo/R4G9aIK/5kgM3eRn//xLju06Q8vpdoK9ISzTwuV1UrGwlK0fXs/dH99CXlHaxRvoCfGd//0zzp+6wP9++sssWjdvRLsT0RT/8NvfoL8zwJf++XNsfPCWdFhaV5Bn/+UVTu6pp+1cF+GBCJIk4fN7qF1exT0f38LWR9Zjcww3Dnsu9PPC197g4Jsn6GjqJhFNYLPb8OS5qFhQyr2f2sbtj29A1VSEENQfbub7X3mWrpY+BroC6EmDA28c59iO00PnVDSFz/35Ezz8G3cPbROWYN+rR3jmX14hEU0SCUSxTIvP/e8n+eiXHxr1/r33wgG++adP8Qf/8esE+8K8/fRuWk63kYgmcXod1K2s5v7P3Ma2R9aj2a99BdUSgqeOHuP1y5TQAJyayuaqKjZVVrKwsIBSrxeP3YYmy6QGDam+WIyOcJjWQJDG/n4a+vs519uHYVncWl1NkefqYbfjUd/bNyyEMEuWmUaSJNaWl7O2vHy2m5LlGjCFyeHAWb7e8HMCepiF3mqKHfnYZRumMAnoYRojbfyw+WW6Ev18tuaD+DTP+CfOkuUqHNt5hiPvnATA6bGz7ZENbHlkHcVVBWg2lVRcJzQQoae1j7X3rJjl1k4fi9fNo7S2iAv1HdSuqJrTeeMXmfPGFMCF2Hl6k10s9q2g2FGOXbYzkOpjb98O3ut9k6SZ4COVn8GpuACwyQ7uLfkQ1uBK0lvdr9AUreeW3A2syds4dF6POjIGc4FnKZ+s/g10obOn710OXWZ8XY29/TuIGhEWeZezJn8zEhJN0bMcHNhNb0c3Pi2XVbnrh/ZXJJU1eZupcc9Ht3Re7PgpnfH2Mc+vSgoLvUspcpRgCpPXu16gJ9HFloI7medZOLSfXXZQ4rw0kJvC4FToKL9o+zGG0FmTu4lyVzWmMGiMnOVwYB8tsUY+Wf0bVLhqRlw3ZSU5OLCbQKqffFsBdxd/EBmFvlQ3qqSiSdc+QT+26wxGyuCeT2yhtLYISYLGY61s//EufvK3L5BX5OP2j2xC1RT8pbnccvtSjr93ln2vHmH+LTUjvC5nDzTScLSFNXctY/6q6iGPUSKa5PS+Brx5Hj782ysprPCTjCc5tvMMu395iJZTbVQtKaNuZfWQgSaE4Cd/9wKv/2AHyzYt5N7/8SiePDfRUJz2xi4aj7YQGYgiDYaoSZJEWW0Rj33xAZDgrafe570XDrDq9iV88NfvHoovkmSJmqXDPTGSLLH5g2uoWVZBKqHz1D+8xIn3zk7oHj77r6/Q1zHApgdXc/+nt2GaFkfeOcWOX+yjvyOAvzSPVbddWz4SQFsoxA8PHxkWemBTFL5062YeWrSIUp8XeYxV+Nr8PCBtkIUSCdpDYRr7+znS2cmHliy65rad7e2lN5o1prJkyXJtxM0kr3W+T8xM8GTlfWz0Lyff5kOTNUxhEjHiXIh18e2m59nTd5xbchexrXD1bDd7yiidV8SG+28hlRipLiyE4Oi7p4gPeguql5RTXF2ILI/s911eJ3bnyDzCLKNz6K0TWGbaI1O3sprHf+9BqpeU35B5UVdj0bo6vvRPn6W/K0hxVQG1yytnu0njMueNKVmSuav4A2wtvAen4sIm25GQMIROtbuOr577Wy7EmulJdg0JMWiyxvKcSx3b4cA+zkcbKHaUsTJ33VWv59Ny8Gk5ADRF6pEnmGPVHm/lvuIPcWfxB3AO5matyl1PykxxOLCPI4H9rMxZN/RSyJI8TODi7Z5XgLGNKUVWqXLPo4p5GJbO7r53GZD7qHLXjfmdhBBEjQjbu39J3IzxWMUnWZmzDofiRCBYlbser5bDuz2v8UL7T/nNuj9ElobHNsfNGE2Reu4r+RCr8zbiVNxIgC50LGHhVJwTuj9joWoKX/7q55EkcPtcQx1vJBgjp8DLd//iGY6/d5aND96CJ9eNZtdYvKGO4uoCtj/1Hh/5Lx8YZkwJIXj9BzvQ7CrLNi0gvyQXSBs5RVV+/vhbv4Wmqbh8TjS7hrAs1t2zEsu0ePfZvRx5+xR1K6qHMtQTsRSH3jqB3Wnj43/8MEs3L0RVFUzTJBlPEY8kcLodQzHhkiRRWOGnsCId1lB/oBlZkSmuKuTWD6696r248tjtP3mPifahZw828Rv/9xPc96mtOL1OEIItH1pHsDfMid1nObrjNCu3Lb7mTvmthkYG4vFh2x5fvoxP3bIK1yjJ96MhSxK5Tie5TieLiwq5fV4tLu3ajPJYKkVDXz/RVLa0QJYsWa6NpKlzMtjIqrxF3FuykVzNO6zvdKtOiux5JK0Uf33qOzRG2m4oY2rNXctZsmEBjJIzZZoWf3T//yHe2AXA7Y9v5N5PbRs1RF6SJbx51xZxcDPR09o3dMtLaoooqvDfdIYUpMMbl21eOP6Oc4g5b0wBuFUvbhgmHmGT7Cz0LsOn5ZCyUsSM6Ow1EPCpuWwtvGdY/pFb9bAs5xYOBfYSTA1gCGNKPDmZ0B6/QHO0nlW561noXYZDcSJJEhISbtXD1oK7OTSwm+boOc5HG6j1LBh2vEBQ467jltwNeNWcoe+mMnXfo6Asb0SH4c1zs/zWhTg9DgI9IYxU2ssoSRLzb6mhdnkl7z1/gENvneDWhy8ZKX3tA+x+5TB5xTmsu28V8mWJr4qqUFieP/xaskJxdQHzVlbx/osH6b7Qh+CS2pfDaSO3wEtf+wCH3j5JzfJKXF4nqqbg9rlw+1xTdh+uhaJKPw/92p3DVgFzCrysv38Vh985yUBXANMwUbVre+V3nm8Z9m+bovDZNatxTtIYkiVpSiTRuyJRGvv7s4IsWSbEzTc9yZIJAkHMTFBkzyNHG5lTfJHF3hpMYZG8wepDOlz2UfORAUwjnTN8EafXSV6Rb0rCyG9mhBAkYknE4Cim2VXUUQzULHOT6+KXkpCImzGiRpikmcQQBhYWljBRJQ2BQAhr/BNNI2XOSmyybaRRoOYgARYWpjDQptAIGQ+BoDXWBECBrQiP6hvRPr+9EK+WQ9gI0RZvGWFMScj47UX4tNxpWSGRJAnLsgj2hokEoiRiKUzdwDIFF+o70WwqlmkNdTAAvnwPK7ct5vBbJ3jle++y8QOrhzxD7zyzh1Q8Rd3tS6lbWTXiWnrKINQXJhqMkUzomLo5dP10gqcFl5lTkizxqf/+KF/94x/y8397lb2vHua2xzayctsSSqoLyC30DTPYZotFa+aNKjKRV5wOZTUNC9OwUK/x8esKh4f9uy4/n1ync1ZXz4QQdEbCNA8EZq0NWbJkuXFQJIUSRwEJM4luGdiV0b3uA3oYh2LDb8uZ4RbeOAghiAZjBHvDxMIJDN1I1ya0a3hyXeQUeIcEnsbC0E3aGzoJD0Rxeh1ULSxDHZw7RAJRAj0hErEURspAVmTsLhvePA95Renxe6Lj18V0gWBviGgojp40EJZAtau4vE5yC724vOOPh/FIgvBAlFQ8RSqpo6cM4pEEgd7wUCrAQHeQk3vqR/X4+UvzKKoqGDW08nJMwyTcHyXYFyYZT2LqFrIioTls5OR78Pk9VzWCTcPk7IEmLMtKpzDUFZNT4J3w/Wpr6CTQHQLA5/dSUlM44vvoSZ2GYy2YujnaKdDsGmXzivDkTtzDKYQg2Bum7VwnkpwW8boorW5ZFtFAjIHuEPFIIr04oCnY7BruHCc+vxe7c+RcfjzmvDFlWDqN0XqOBw/SEmskrIe5JGwrCOh95GqzrxSTDu272qR6dtbME2Y6JEuTbajS6IpuTsWFQAztezmKJKdDK6dpshyPJHjvxQMcevME50+1ERuUY5UkSMZTRAKj58Csu2cFL339TU68f4YLZ9qpXlpBJBBjzyuHQZK45xNbhhk5Qgj6u4Lsem4/R3ec4kJ9J3pSRwiQJNIdW0If9Vpr7l7OH3/jN9nx7F5O7qnn6X98iWf/5RVuuX0pWz68jrV3L8/oRZ8OPDMUShFKDl+BddtsY+ZIzQRCCHTLoqG3n+5IZFbakDQMuiNRuqMReqMxoqkUKdPEFAKbLKMpCjkOBwVuF6U+H/lO56zesxsJIQS6adI0MEBbMMRAPE7CMJFlcGk2Ct1uavJyKfZ4hqT3JUm6IUNnLCFoDQS5EAzSF4sR1XUsy8Kmqrg0jQKXi/IcH6Ve7zWXIbiS/liclkCArkiEcDJJ0jCQJAm7qpLjcFDi8VCdl4vHlvkkZTZwKXa2Fa7maLCexsgFFvlqRoTAR4w4r3S8R5mzkFW511dI0lwhEoxxcnc9+147wtkDTXQ2dxMNxZFlGXeOi+ol5SzbvJCND66idnnVqIYFpOsSfeN/PsWelw9Tu7ySv3ruj/DkuDi4/Ri7Xz7M6X0N9LUPEA3Hsdk18otzqF1eyZq7lrP1kfUTqmFkpAxO7K7n4JvHObXnHG0NnYT70yJRnlwXJbVFLF5fx7p7VrBi22LsjrHD3o+8e4pXvvMOve39hPujhAcixCIJhHVpnrj7pUPsfunQqMc/9sX7+dW/eBJ5DENIWILuC30ceusER3ec5tzhZvo7AySiybRSst9L3apqVmxdxPp7V1I6r3hU+Xo9ZfD3v/11Ws90ICsyn//KR3n4N+/BNgEvpGlY/OvvfZeDb50ACR7+jXv47J89PuI3HOgJ8edP/OOQ0XUlpbVFfOmfPpux4MaB7cf5m1/7D1RN4Xf/5Ve471PbMA2Tg2+e4P2XDnJqzzm6zveQiKVwuO3k+L1ULChhy4fWcffHt4wQIhuPOW9MnQ2f5Pn2p+hLdbMhfxtV/nm4FBeqrCEh88Pz/znbTQTmbvE+h5qWFTdEClOYqNLIFyZhJpCQsCmju/Wn85s9/59v8Mz/exlvrps7ntxM5cJSnB4Hml2l9Uw73/2LZ0Y9rmxeMSu2LuL1H+7k7Z/t4bN/VsGpvedoP9dF+bwibrl96bD9TcPkh//n57zzzF5qllVw7ye3UlTpx+6yo9oUdj23n1e/t2PUa0mSxMI1tdQsq6CjsZvmExc4suMU7z67l+PvneFjf/QhHvzc7bMa5iArM/P8XZnbFNFT11RnKlMsIQgmErQGgrQGg7QEgpwPDHC0owvzsnZEUym+sW8/z588NaHzbq6u4qHFi1AzmGS2DATYe+ECRzo6OR8I0BuN0R+LEdN1UqaJJQTaoDHltdvJdzkp83pZWVrK/QsXUJs3vrdXCMGpnh6+d2D4oLqxspJHly8d46iJEUwkeOHUaY53dg1ty3M6+fDSJSwuGlms/IeHjnCss3Po336Xi8dXLGNefn5G100YBm+ea+DdpuahbV67nSdXrmBBwcQXxiwhOHChjedPneZ0Tw8d4TDBeIKEaSJL6WfV73JROSi7/9jypZR4vWiynNHvfCXn+vr4+YmT9E1Q7GRlaQkfXbnimgyYjlCYf9713tC/lxQV8pk1q4fEdc709PLimTMcae+gLRRmIB4nruuYg8aUU1XJd7ko9Xq4payUDy5exIKC0cstTBQBtIdCvF5/jr2tF2gNBOmJRomkUqQMAyQJu6Lgczgocrupzs9lS3U1DyxcMCWhvVOBEIJ9/SeGLXVKDJYpceRiDph8u+kFbslbSJmzELtswxAmfakgZ0PnORI4yydrHqTGPTeLq89l+joGeOFr23nzJ+/R1do7Yr05GU/R3xng+K4z7H31MB/5vQ+w5UNrxw1V7zzfQzKW5PXv7+CX33qLrpbeYZ8njCTtjd20N3ZzYPtxTu9r4PP/52PkFoxtUKUSKX7+b6/x+g930lbfgWUNb+xAd4iB7hCn9pxj9y8PcdeTm3n0iw+MmS/W3tjN4XdOEo8krvpdJoNlWTQcOc9P//GXHHjjGNHg8H5KTxnEwgk6m3s48MYx9r9+jI/+wQdZtmkBijp8wd3utHHnk5v53l8+i2VaHHzzOHc8uRn/YC761Th/6gJnDzUD4Mv3smTD/FHTIjSbSu2ySjo9PcRCcWKhOHrKGLHfZDF0k1gwhpEyefHr23nuP14fVn4GGLpuR1M35fNLhkRAMmFOG1MpK8mp0FHa4y3cWfQA95c8mvYADU5ATGFiCANFmtNfY1q4lD829kRWQqLCWQNAfzItp55jyxu2TyDVT1gPDoY1zKycb7A3zKvfewdDN/noHz7MbY9vGHKvCiFQFAVjDNevrMjc/fEtvP7DnRx66wQf/u17ObrjNIGeEB/67XtxuIcP1j0X+nn9R7soqy3ik3/yCCu2LkLVlKFrnd7TgLCu/gLZ7BrVS8qpWlTGmruXseauZfzfz/07e18+zPr7VlJaO4pE/ODPdK3FD+cKxR43Z3svDU7N/QOEkgn8rukP9fv5iZO8cOo0XeEIMV0f+pPQ9RFvQdI0h03Wx8OhqXxg0firy5YQnO3t5WfHjrOz+Ty90RjhZHKYIXdlO5KmSSSVoiMc5kRXN7vOt/DcyVP8xoZ1PLJs6bheKp/dwZsNjfRfJvxxuKODhxYvxKZOvu9rCQR46sgxTvX0DG27pbSEj64afQVwd0sLL5+tH/p3VU4Ot9XWZGxMGabF0c4ufnb8xNC2Qreb2+fVTtiYiqVS/PDwEZ46eozWQHDE/TcFhJMpwskUzQMBDrS1s72hgT+6bRury0qxX8N9645EeeVMPecDgQntH9d1nlixnGup9BZIJIbdr7r8fD6zZjW6afLK2Xq+sW8/53r7SJoj+8ukYZA0DAKJBI39/Rxoa+eNcw38zuZNPLBwwaS8pLppsqO5ma/v3c+p7h4iowm/CEHcMIhHInRFIhzv6mJn03leOn2G39uymdVls2+AWFj827mfYg1LE7g0usbNJDEzwblICw7FjizJCCFIWTpxM12v8fm2d0iaOo9W3DkL3+D6JNwf4dl/fZWXvrGdeCSJJEnULq9g9V3LKazIx9BNmk9cYM/LhwgPRDl7oIn/+K8/JKfAy6rbllx1rImHEzz19y+y49m9xMJxyuqKWXv3ckrnFYMQNJ+8wP7Xjw15at7+2R7yinP51b94YtTzmobFD/+/53nha28MGSZFlX7W3L2cygWlKKpMR3MPB7cf58K5Tjoau3n2X18lGorz2T97HJd3pEjX1kfWUbeqasSk/dt//jRn9qfrN254YBUf+s17UW0je46iCj/KKGH9Qgi6mnv56h/9kNP7GzB1E0mC5VsWs/zWheQUeElEk9QfamLfa0dJRJMcfOMYXed7+a/f/E3m31Iz4h7c9thGnv7HXxKPJDjx3ll6LvSRX5wz7ni/87n9JKJpY7FyYSkLVteMGpboy/fw+//2q6SSBqZuYhgGx3ed5bt/+Qyx0MhoqckQGojyy2+/xY//9nmCfWHyinwsXFdHcaUfZInu8z3UHz5PoDvIiq2LM/ZKwRw3pkxhkrDiCAT5tsIh8QQhBKYwORLcS8yIYLc5xj/ZDYWEU3GSNBNEjDCWMC8LMUzn+1x80MsclVS6aqmPnKIl1sQS1YsyGO5nCoO9/TsJG0GKHaXMcy8Y/XLTRDyaJBFNoqhy2ks0aEhZliAairHn1cMk42Mn9i7ZMJ+6lVX0XOjj3Wf30HjsPDaHjbue3Dxi30gwRiqewul14C/NHcovskyLjqZuTu9rGNVwM3UTXTdQVAVFkZFkCQaVBxfcUovdaSceTYwZIujyORFC0HOhDz2pDyWUCiGQkNLnu45YXV7GjubzQ/9OGAbPHD/B72/dgjrNxtSe1lZ2NDXPqshEQtf5/sFDPHv8JPoYxrfEcE/1lZ67mK5zrq+P//vWOyQNkydXLh/bayFJ5Luc3DW/jp8du1T0uT0U5v2WVm6fVzv6ceNgWhZnevo423epaLgmy6wsLaUqN3dS55wJhBDEdJ1v7T/AN/cdGHUSf/n9v3jvY7rOkY5O/vurr/E/7rwDh6oiMbng6/T5J/sNpoYLwbQXaN+FNv7vW+/QHR0uwCRf5flLGAZnenr5v2+9g2FZfHDxoowMqpRp8vMTJ/jbd3YSTCRG3MPL778Q4rKg/LRRuKv5PBeCQf7r7bdxV928KQ85zBRFUoaJW12OW3XiVq+YDEugyerQ9oSZImJkSzJMFNMwObD9OC987Q2SsRSaXeMzf/oYD//63ag2FVmWECI9Nrc1fIB//8Pvc2zHKfo7AvzzF7/N/9vxv/COE1b/2vd3oKgKD3z2dj713x9N5/kMPmeWadFw9Dxf/cMfcOZAI3pSZ+8rh7nnE1uoXjJ8QVkIwc7n9vH6D94lGoyhagpbPryOz/7ZRyisyEcePKewLCJ/HOPpf3iJF7/xJvFIgjd/8h7VSyu4/zO3jQihKyzPp7A8f0QH5Mv3cLFj8pfmsXLb4tFD6sZ4XfWkwff/z7Oc3F2PEILcQh9f/MfPsP7+VSiqMnhvBaZh0XyilX/78vc4e7CJ1jPt/L/f+y5//dKf4PIOn0/7S3NZe89ydv5iP/FokvdfOMD8VSNL0lxOJBDlwBvHMHQTRVWoW1VN+fySUfdVVIXi6kuREEIIQn0RVPValp+Gc+CNY3S39JFK6HzyTx7hoV+7E0+ue8i4s6x0LlzzyQtULSqb1LxsThtTdtlBkb0ETbaxo+d1/PYicrQ8EmacU6EjHAnsH+FpuRaSZpKwEcQUBpawCBtBBIKIEaIz0YYsyciSjFfNwS47Jr0SL4QgYcWJ6KFBIQ2LpJlAIAjqA3TELyBLCrIkk6vlo8nDXyZZkqnzLOZwYC/v9b6FTbJR4ixHt1JYwqLcWYVHS4tNeDQfdxc/xLMXfsDPLnyXbQX3UutZiCl0ToaOsqfvXRyKkw+XfxxVntkwtYLSXMrqSji1p57n//MNJFnC7XMy0B1i+493cWJ3/VVlVSVZ4gO/dhf/+l++y5s/eZ+BriBbH1mHzz9SfamstoiiKj/nT7Xx2vd3sPWRdaiaStu5Tt740S5azrRhG6UexpkDjXz7fz3NwjXzWLRuHgXleel45NY+XvnuOyTjKepWVVNQNvpzuGzTApxuB6f3N/Kjv36etfcsR5IkwgNRqhaXUTaveGjfWDhOoDuEaVpYhkkkGEMIGOgMcP5UG7Iio6gy/tI8bA5tVkJLt1VX8x+795K6bAX8+wcPs668nFurq65pxX88vDY7RZ6RhTGFEERSKWL6JYNWkiRyHQ5sysQ6ZJ99YgsyLpuNLdXVbG9oHKppdVGR0Ge347HZKPZ6yHM60WSZqJ4aDH+K0RONYlxmgA0kEnznwEHmF+Szrnz0WiIS4FBV7ltQxwunTpM00uEPScPg5TNn2VpTPanJaCiR5J3GJszL2uNz2Ll3ft2czucyLIvX6s/x7f0HhxlSEpDjcFDq81Lm81LgchNL6XRHI3SGI3RHI8R1g5ZAkH95bzdumw1Flof9HhPF73KxsbISv8tFXNfRLQvDtDAsi5Rp0jUDuXuGsHjm+EmeOX58yJCyKwpFHg+FbhclXi8eu52ErnMhFKQrHKUnGh323naEw3z/4CEW+v0sKiyYUH+imybPnTjJ/3r9zWGLCZosU+Tx4B8MJcx1OtFNk95ojLZwiN5ojNCg4SWA5oEA/7BzF167nfUV5bNmUCmSwrc2/PmsXPtmRAhBeCDKT//hRZKxFIoq87E//CCP/c79I5XrNIWapeV8+r8/yj99cYC2c510nu/h5W+/zZO/P3oR+4tYpsXGB1bxW3/7qZGqhJrCkg3z+eBv3E37f+si3B9loCdI/aGmEcbUQFeQt376Pn0dAZBg6cYF/NbffIr84isFRxTyinL4tb/8KLFwgpe/8zah/ghvPfUeK7csonxBybD3a+jvI145adhfJSmzBddTe8+x/cfpcGC3z8lv/92nufXhtSPC91QNFq6dx2//3Wf4xy98g/On2jh7sJEXv/YGT3z5oaH2SZKE3Wnj1ofX8f5LhzB1k3ee3csTX/4gnpyxlYyP7zpLb1s/kFYVXnfPilFzskZDkqT0atUUDkNn9jficNv5nb//NPd+atuofZ3dabumWpxz2piSJZlVuRvoS/VyKnSUbzf+C5IEmmyn0F7M/SWP0JPsYF//e+OfbAK0xBp4of2nRI0IKStJzIxiCpODA3s4Ez6BXbZjk+08WPo4y3NuQbqGwI0TwcO80fUiKStJ0kwSNUOYwuTt7lfZ27cTm2zHptj5dPVvU+IoG/4iIrEiZw3nYw2cCR3nJ63fwhImmmyjxj2fR8s/iUdLx/8qksJy32r0shR7+nawvftFYu1RJEnGo3qpcFazteBu5nuuvaBrpqg2lc/8z8f40d88x4n3z3LgjWNIsoTL62Tx+nn82l88yfafXP23XXfvSnKLfJw92ITDbWfLh9eNKifq9Dj41f/9JM999XVe/d47vPj17ciKTE6Bl7X3rGDbo+v56T++NOI4b74Hh8vOW0+/zwtfe4NUMj1hd7jsFJTncd+ntvHQr92Fe4yOZfH6Oj782/fyzs/28Oy/vMJP/vZ5FE0hp8DHF/7uU8OMqaPvnuJ7f/VzEtEkiViSUF8Y0zD55bffZscv9uFw2XC4HXzpnz7LonXzMrnVU8bykmI2VlYM807FdJ0/f307v7VpA3fOm0ex1zMtE/LHly/j1pqqEduThsELJ8/wav2lEDSPTeNX160ZNfdnNMp9vglP6G6trmJRQQGxVAfz/fksLixkRUkJy0uKqc3Lw20bbugmDIMDbW08e/wkbzU0Ekomhz5rCQR4q6GJZcXFY9bakiWJefn5rCwpZt+FNgBMITjS0UlLIEBthmF2F9UP97S2Dttem58/J0KvxkIIQWswyLf2Hxh2D2VJYmVJMR9ZsZy76uZR6HYP3f+UadLY389rZ8/xwqnTNA0McLyra6xLTIiFhQX81f33IoQgaZiEU0kiyRThZJL2UIjffeGlac8jNC3Bf+zZO1RXrSY3l3sXzOeBRQtZVFCAQ7vkAddNk6OdXTx7/ASv1tcTTFy6d8c6u9h1voXa/LxxF0IEsLP5PH/z7s5hhlSJ18N9C+bz4KKFLCksxHNZPpQlBB2hMO82NfHzE6c40tExFJJZ39vHN/ftpzo3lxLv2PLjWW4sTrx3loaj6RIbFQtLuf0jm0YNWYP0xHreikqWblpAW0Mnlmmx8+f7+PBv3XvVYsCaXePj//XDY8q7A6y+cxnePA/h/iiJSJLu1r4R+5w7cp5zh5vT57SpfPgL945iSF1C0RQ+9kcPs/P5/YT7I5w50Mi5o+cpnVc0wqCZDp7/zzeG/r72nhWs2LJwzOtevLebP7iGtnOdGLrJGz/ZxQOfuwOf/9KipaIq1K2oompRGU3HW+lo7ObEYO3P0dBTBsfeO5NWJgRKagpYumlmo55G4/bHN3LHE5umrZ+Z08YUQJGjhA+WPcGqnLUEjQCmZeBU3ZQ6KihylNKT6KTQXkqJc+xJwMb8bcxzL6TSdfWQmDxbARvzt2Fy9dXKInsJF83mUkcFj1Z8knxbATZ55Mtd4izjI5Wfxaflol5WY6rEUc6tBePHWHvUkSvxkiTh03L5UNlHacndQFAPDBlTeTb/UCHgi9gVB+vzt1Ljmk9Hoo2YGUFCwqv6KHNWkWfzj1AqAliZsxa/rZAKV/W47ZwsK7Yu4vcqf4WGIy2EB9IrurmFPhasrsGb5yGnwIueNHB5RsYdS5KEL9/DF/7u03S39uH0OFiyYf6Q6/1yZEVm26PrqVlWQcupdqKhWLruVEU+dauqkWUJh9tOfvFwUYCyeUX8+v/5OO2NXYT6I4MV4SWcbjuFlX5ql1WO6z178ssfZNXtS+hs7iUVT6FoCr58D4vX1w3bt6yumAc/d/todRKHkX9Z8ufK2xbzW3/zSSoXlg2FMVzOorXz+J1/+AxVi8uu6pafKKos8+sb1lPf10/nZTLp7eEwf/fuTnY2n+e+BfO5o24eOfapVYFcXFQ4qnEUTaU43N4xbJsmK6wqLeXW6pHG17WS63Tyq+vW0hONsrS4iHl5+UOT19FwqCq3VlUx3+/HpWk8e/zEUG6Lblkc6+ykKxyhNn9sL3uxx8OmqkoOtrUPTUa7IhHeO9+asTFlCcE7jc3DcrBkSeLDS5dc9XvMNgL4yZGjnOruGbZ9cWEhf3rXnSwvKR5hENsUhcWFhcz3+1lVVspfvfkWjf0DU9IeSZJwaCoOTaXQne4DynxeZEmaEVGWi4bUooICvnTrJu6qm4emKCNWwG2qyrqKcmryctEUhZ8dP07SSD9/hmXxdmMTH1y8iGLvyLHmcloCAb62dx+By56b6txcvrBpIx9csgjbFdeG9HNVnuPjo6tWsrK0lL/c/hb729qGPn+3qZmXz57lc2vXZGt/3SS89+KBob8v37yQ3MKrS227c1yU1xVjs2ukEjr93UHaGrqYt7xyzGOql5RTt+Lqfb+/JBfnYG61oRvEw8PFIAzdoPVsR9orBeQU+Fhz1/Lxvh6FFfms2raEnc/tIxlLcXL3OTY+cAtOz/QaU6H+CCd3pxcUNZvK4g1146oU2p02Fq2dR15xDj0X+unrCHD2YBPr7h2eN1tQkc+KrYtpOp5egHvt+++OaUx1t/RSf6gZI5VOj9j4wOpZL9ysOTRu/8hGVNv0RV/N3ZHzMjyqlyU5q0b9rMRZTonz6sIJi3zLWcT4L0GBvYiCwrszalu+vYAt9rvG/DzPVsC2wnuGbZMkiQpX9TUZKZIk4dVyWJZzy4T2VyRlQvfq8vPXehaMqDs11UiSRGlNEaU1o4g3kF49uhqqprDpAxOrPK9qadWY2mWjd8K3P75xxDZFVahaXEbV4smt2EuShM2hsWLLYlZsufq+VYvLqVqcmQjIvOVVzFs++qAhSRIVC0qpWFCa0TmvhiRJrCkv4/Pr1/LPu94nfJmHIJRM8sa5Bg60tfOjI0f5wKKF3LdgAWU+75Rdf66wpaYaWZJG5EeNhSRJFLndPLFiOQfa2jjbe2kVtHkgQE80elVjyqGqrCotpdTn5UIwLSEbTiY52N7OB5csIscx8bxRw7L4xRUqh7kOB/cvnP3Vw6vRH4vxzLETw7YpksSf3HEbK0tLrvo7KLLM1uoqvrR5E//9tdeJ61OnFjWb5DmdfHL1Ku6qmzeuGEmB283n1q3hnaZmLgSDQ9uPd3USSiYp8rjHvIeWELx65iwnu7qH0jzcNhsfv2UlDy1eNK5XS5YklhUX8Sd33MYnfvLToXBDUwi+e/AQjy9fltEzPFNEjTj14Ra6En0YYnQxJIBqdxnLc+rG/DzLJU68fymCoHReMU731X93SZLw5rmxOdLGlJHU6Wvvv6oxtXBt7bj1H2VFHlLgtUyBfkWfEI8kaW/oGhKJqFlWgdMz/jMqSRJLNtSx87l9ADQeayGV0Cd07LXQcrqN+KDggyfPTVFlwYS8YSU1heT4vfRc6EdP6DQcPT/CmHJ7nSzZUMc7P9tNsDfM8ffP0t7YTdm84fM2IQTNp9poPpE2uuxOjTue3DRF33DyFFX4KSzPH7cu17VwXRhTWbJkmTvYFYUnV6wgaZh8fe8+AolLK3qWEPTFYvTFYhzv7OJre/axpaaaj65cztKiYuyqMusJ51PBZKS1pcEJ5aLCAs719Q95LwbicaKp1GWlokc/dnlxEQsLCoaMKQGc6u7mXF8fa8rKJuwFPNDWTmN//7BtDy5aSO4cnMxezmv15wilksO23bNgPusqRs83u5yLctfrKirYVFnJW41N09jSmeOWslIeXDRxVcfq3Fw2VlbQFgwOGUVpxcMB6vz5Yz5/bcEQ77e0Er0sL3F5cTH3zK/DnkH40vKSYu6sm8erl6lCtgdDvNvUzMNLFk/4PNONEIIL8W6+1vAsJ4ONiMFoFTHsLU3/XZFkHizdkjWmJoCRMhnoumTIf/8rz/LU370w7nGppD4kRmWaFtHg1VXeCsvzJ5Rzc6nfGOlJ1lM6of5L0RfFVRMsJSBJFFVdUiUd6A5iGmMb4lNFf2cQYaa/h9PjuGpO0+V48zzYBz10pmkN+30uIskSC1bXUrGglGBvmGgwzvsvHuCxLz0wrO+NRxKc3nOO4GCI3+q7llFceW0lGKYCX74HbRq9UsBVq8xmyZIlywgkScKpqXx+/Vq+cv89LCkqxDHKZC5lmnRHo/z8xEk+/pOn+ezTz/DcyVO0h0JDQgo3G7Iss6CgYJgwRtIw0mF/44SG+V0u1paXDcutauwf4ERX95jS7FdiCcEzx08MC0OzKQqPLFsyp8OshBC8cqZ+2C2SgEeXLZ2wYStJEn63iw2VFXNaZGOiuG02bq2qysgIliWJW0pLR3z/nmh0zPINQgjqe3s5c1lJBJuisLK0hOrc8WulXY4iSdxVNzzfUwC7LsvBnAskrRSvdb7P4YHTuFQHdZ5KVuQsRAiocBaxyFtNni0Hh2zjo1X3cX/JSAXZLCOJhmLDnrNkPEV4IDrun2QsNWTvCEtgjONZTnuBru0dtwwrfd1BXON40C4iDV0/TSwUH1GXajqIRxJD91bVlDELHF+JZleHlPMsyyIWHt1QLa8rZsEt1aiagp7S2fPyYZKxS4tbQggGuoIceuckALIscf+nb5/eQqUTxObQpr0WZ9YzlSVLloyRJAlFknhg4UKWFRfz9NHj7Ghu5lxfP3F9pEy8EIJD7e0c6ehgRUkxH166hNtra6jIybkhPFUTRQLyna5hBoAgbVBdzTMF6Xu+rbaGp44eoyWQXj00LIvdLa3cv3ABxaMoHV5JeyjE+y0tw7atKy+jJi9vTgsAhJLJEXWdijxuFhb4MxqrbYpCVW4uuQ7HsJyx6xGv3caGyoqMf7diryetlnXZpDaUTI4pE69bFg39A/RcVqTYa7exvLhoUs/MksKReY+HOzoxLWvO9AUJM8WB/lNUuIr5ldoPsyZvMWEjyu8d/Fs+XH4Hd5dsoCF8gX8791NCepQ829VzU7KkGZbPLEHVojL8pZkpMru8jmF5w6MxFX2ZJEvD5LmNDBYALy+zotrUGSmloNqUS3UtLYE1QaVSy7KGjD0JacyiyLIis/aeFbzz7F4GuoJ0nu/h1L5GVt+xdOiaLafbaTqWHl/KF5TOCeGJmSJrTGXJkuWaqMzJ4Xe3bOaBhQvY03qBPa2t7G29MExx7SLWoApdfW8fbzU08sSKFdy3cP6kwuauVxyqMmJwFUKkVxXHGXUX+P2sKCnmQjA05F3af6GNtmCIIvfYOS8XeaO+gVBiuBLevQsW4LaNrYw1F2js7ydhDDfS6/x+nFrmJQL8Lhd+t+u6N6Y8Nhs1ebkZH+fStBEGaOIqK/3RVIrG/r5hHgWHqlGZM7aq2ZhIEj6HHU1R0C+TaQ8mEkRTOj7H2OprM4khTLqT/dxWuIblOXWocroWlSzJpCwdCYk6TwWPlN/BtxqfY0XOfDb4x8/Lvtlx+ZyomkIynp733/PJrdyZocKaJEt4cqZf0EDVFFy+S8JXF9XpxkMghsLcADy5rnHzt6YCX94lRcxUQicRG7tG5+XEI0n0QZViWZHw5I4dHrh080JKa4sY6Aoy0BXk2M7TrNy6CEVV0HWD9148MGRI3v74BhyuqRWhmstkjaksQ5jCoCdxjvORA/SnWkmYESRk3GouBY55zPNswqcV3zQvx1xjINXGgb6nCaTaJ3zM1qJfpcQ5/bkIqiyztLiIBQV+7l+4gNZAgLebmnjt7LkRHgVIy6nvaD5PfW8fzQMD/ObG9XNmVXq6SYdYTe4d0hSFhxcv5vX6hqEk/v54nF3N51lRUox2lbpakVSKd5ubh4VYVuflsqq0BG2O3/u2YBjdHL7SWu7zTbiO2OX4HOmaYNc7xR7vmHL6V2O0EMerBSHFdJ224PCJZF8sxl9sfxPnJK6fNMxh9c0gvcgSSibmjDElEKRMHbfqxKGkFxokJFRJIWFdWoxYnjOfqBmnPtw6J4wpISwGUm00RfbQl2wmNlgr06n48NurqPGsx2+vQZamX6Z7NBRVpnx+CWcPNiEEGCmDnALfVWXOZwuHy07RZXlSrWcmNu4KARfOXlKXLa0pHNPbM5VULCwdEpyIBKIEe0MTOi7QHRwK7VM1ldLa0cXAADw5LjZ9YDVn9jeQSujUH2qir2OAwgo/iXCSva8eAdI5SqvvXJ72lt0kZI2pLOl6KVaEnd3foj68A91KYAljKOlWQkEJqezr/Qlr/U+wOv+RWeuMb2Z0K05n/DQ9ycYJHxM3JtahThWaolDm81Lq9bCqtITPrF7Nu03NfO/QIRr6+kcUSe2MRPj63n24bBqfXbP6ujLUL67UW0JgWBZdkQinu3to6O+nLxZjIJ4gmEgQ13XiukHSMEgYBsFEgsgoXruJsq22hlKvd5iR+tKZM/zKujVXNaaOdXbSPDAwbOK8tqyMytycOX/fw8nkiLywfKdzUh5Np6ZNygiYS0hArnPyheMzIWWY9MViw7YlDIPDHZ1Tdg1LCKKpkeHBs4WMjFt1EjeTJC0dp2JHliRcqoOBVBhTmMjIaHL6fYsasXHOOP2YQmdP7485NvAiKSuOKfTLxnAZRVI50P8sS3PuYXPhp9Hka88rmgyrblvC2YNpAZiGoy1EgrFZK0J/NWxOG+Xzi3F67MQjSdrOddHZ3HNVYwPSBYMPvnVJdbTulhpsjunvb4qrCiiq8tN0LEY0HKflTAeJaBKHe+wFCiHSoXn9nQEgnVs0/5arq0zf+dHN/PhvniceSdB84gKtZzoorPBz+N2TBLrT841lmxdSUj2xQuA3CnN7OTLLjKCLOC+3/TXHAi+RMEOYIjXUCQMITAyRJGr2s7Pnm+zu+QGmNXcGvixzj3QNHo0Sr4cnVy7n6U9+nL+6/x4WFPhHyCiHUym+f/Awh66oFTWXsSzBQDzOntZWvvLW29z/re9wzze+zReee4G/37GL7xw4xHMnT/F2YxN7Wi9wtLOTM729nA8ECCQSV/UEjIdNUfjIiuElA8719XOwvWNMEQHTstjX2kZnODK0zWe3s66ifM6r+AFE9dSI7+bQtEkJSdgUZVIerbnGTIVmGpZJJDWxkKFrQYiJ5XjMBJqsUuUqoSPey0AqPUFUJYVKZwnnIq00RztImEnOhVsxLBO3OrIO4kyiW0ne7vwqe3t/RMwMYIjkFWO4hSFSxM0AB/p/xpsd/4phTf9vOhq3P7FpyBN1cPtxzh1qRkxQoGEoHHoGkCSJecurqB0sPZJKpHjle+9eVfxCCMHRHadpHCxKnFvoY9mmBTNiTMmKzAOfGRR8EHDorRO0NXRdVVgm0BPi6M7TRALpxYCaZZXMG6c+V2F5PuvuSUund1/oo/FEK3rK4N1n9wLp8MhVty8ht2gSYcDXMVlj6qZHcGzgl5yP7p/Q3pYwOBl8jQvxY9Pcriw3ApIkIUkSLk3jsWXL+O4Tj/OJW1bhdw2ffLSHQ7x85iyJ60DlL5JM8U5TE//jtdf57NPP8v2Dh4flMF0NWZKmREnuwYUL8dqHT6Z/duz4mEZaRzjMkc7OodBAgNr8vHHrM80VkoYx4v7aFGVS93KqfoPZRJKkGQvNtATD8psgrcqX73Sm88+m4E++yzmnwnztssYteYvoTQUI6GEEAk3WWJ23iHPhVr7T9Dw/OP9LvnruaTyaiyr31NXyyxxBY+R96sPvDjOgrsaZ8NvUh3dOb7NGQZIkqhaWcseTm5BlmXgkwbf/19McefcUiejY3nojZdDb3s+J3fWEByJj7jfVVCwsZe3dK3C47ZiGxfYf7WTfq0eHZNovxzRMGo628O0/fxohBIoqs+6+lVQtmnjZimvlzic3Uz1Yq/LcoWZe/vZb9FzoH2FQCSGIheK8/fQe9r2WDs1zehw89sX7J1Sb6t5PbUvngQk4teccbee6OLbjNABl84qZf0sNqnb9L1hlQjbM7yYnYUY4HXprwp0wQNQcoDmyjwrXShQp+whlmRiSJFHk8fClzRtxqirfPXiI6OCKt25aHO/qoi0Yos6fP8stHZuBeJyfHTvBt/cfoDsaHfG5S9Ooys2h0O0m1+nEbdNwaRo2RcWmKGiKwvGuLt5qaBxm2GSCJEkUez3cVlvLS6fPDG1/v6WFC8EgVbm5w/YXQtDQ18+pru6hbZoss6K4mJq8zJS0pgKBwMrQC6HK8ghtDktY1+ThyzIxRitMXeh288VbN42eszW4Mj7q3y/nsh/PpqoUTUCNcqawyRpbC1eTZ/NRbE/XDFJlhVW5C9ngX8b7vUc5OHAau6xxb8kmVuUunLW26laCpvAeEubEjQxTGJwKvsEC7zZUeWbzlWwOGx/+zXtpq+/i+HtnaDreyj9/8Vts/uBa6m6pxl+Si82pYRoW8XCCge60clzr6Q4aj7fwR1//DZZunJlC8JpN5Z5PbuHswUb2vnqE3rYBvvGnT3HXsRaWblpAfkkuiioT7A1Tf6iZt3+2m4ajaZn/yoVl3PepbeTNoIfGm+fmM3/6GP/+Bz+gr2OAl7/zNoHeMLc+tIaKhaW4vA70lEFXcw8H3zrBu8/uJdwfTXu1Pnc7a++eWN7fkg3zqVpcRvOJC9QfamLX8/uJReJIkkTtikqql5RP+jsIIbAMc0hsVAiBaVoIIeb0wl92JnyT05c8T9Toy+gYSxgMpC4QN4J4NP/4B2TJchk+h4NHli5hT2srB9ouJfW2h8J0hOeuMZUyTV6vP8fX9+4boQQ3Lz+PDyxaxJryMgrcLjw226ARlTagVFlGkWVkSeInR46ys/n8pI0pSHtlPrBoIa+drUcfzEMLJ1O8crae39iwfti+cV3nYHs7PZcZfz6Hndvn1c5KuJslBMkMi1i6NA35itn4aN6qiWBY1tA9yzI+siyNqCPnsmncPq+WUu/MTGpnGkmSqHAWUe4sGubF9Ntz+EzNw2zyrySYilDkyKPOU4lPm351ubEI6T0E9I6MFkRBEEx1EtK7yLdXTlvbRkOSJaqXVvC5//URvvu/f8aJ98/S0dzDL776Kt48D26fE0VTEZZFKmkQD8eJheOYhpX2dszwCkpJdSG/+pcfRU8ZHNx+nAtnO/jpP7xEfkkuLp8TWZaIRxP0dwSJhmMgoKSmkM/9+eMs3TgfSZ45A0BWZNbdu5JP/MmH+fHfPE9vWz87nt3LsR2nyS3yYbNrmKZFuD9Cb/sAlmmh2VUe+MztPPFfPoA6gdpUkiTh9NjZ9ugGmk9coLdtgDd/sgtDN3HnOFm+eSHevIm9D+cON3Ng+3FC/RFioTjxSGLwXgaGRDH6u4J87yvP8stvvonD7cDpufRn00OrqVtZNVxyf5aYMmPKsFIcGXieQ/2/mKpTDkeSUCUbmuxAk+yosh1NduJRC8jRSvBpxfi0EnJsxWiyE4nLFLMkBv+d5UrCejemyDz/KWmGSZjhrDGVZVJU5+WysKCAw+0dQ8ICoWRimGz3XEIIwYVgkO8cODTMkFJlmbvq5vF7W26lKjcnPemUpr+3kSWJhQUFLCkq4mhnWgjAsCzeONfAp1bfMuQxEEIQSCTY1Xx+2BykzOdjU9XMTqIuYgmRcTinyzYyPyqcTE24lsrlJA2D1HUQTjpX0GSFnCvy6gzLIpRI3LDGFAyGKA/+/WKYlIREkT2PQnsulrBQBoWYZnPVPG4GSZojveTjYYgkEaN3xo0pSOfVLN04ny9/9fM895+v8/K33yEVTxHsDQ+TFb+IJEmomsLK25ZQUD7zi23Vi8v4o6/9Bk//0y955bvvEA/HaW/suqKR6Tpaa+9Zwef+/CPULK2YlVA3u9PGfZ/aSmF5Ht//q5/TcLSFQE+IQM9wMSpJkvCX5vHYl+7nnk9sJafAO+FnWLWprLlrOc999TVCfRHaG7oRQpBXlMPqu5ZP+DxnDzXx8397lchAFMsSiMtqXl0kFU9Rf7CJetKGuCzLg/+VKCjLY97yyjmRsDSlnqmkFSFsdI+/45QjDf2/hEy+vYpS51LKnEsoci7AqeRik52okg1JmgN3fQ6RsuKTSvw1LB1TzE4Ca5brH0WWKXS70RQFc3Bim9ANEhl6LGYKSwgOt3dwtrd32PbFhQX8z7vuoNQ78YEorhvXnEQtSRLFHjdbaqo41tk5ZCi1BUPsb23jtnk1Q/u2BIIc67w08MuSxIeWLB7hbciUyX6DlDlSHW48itwe1CtqtbSHQ5Py7sVSOrFRCktnGR2npqYL/V4m3hfTdc4HAiwapQDvjcDFUNSYkSBp6VjCumpYqUt1kKPNTpiiKVJYk1gQtYRFyppcrbX80tyhvCGX1zFufbzRUFSF0nlF/Ob/9wke/Z372f3SIY6/f5au5h4igRiKJuPL91C+oIRFa+tYfecySqoLRq3ZJCsSuYU+iir9g21yTmhBK684h6IqP5Ik4ckd25siSRJ5xTl8/isf5cFfuYMdP9/Hid1n6b3Qj2VZ5BfnsuCWGjY/vIZF6+pQNWVSxnVuoY/iygKEEIN1ozI+RTqf0q6x4YFbWHXbUg5sP877Lx2k9Uw7kWAMp9tOUaWftXevYP39qygsz087HDKp9SVJFFf52fSB1Rx++ySQNiRX3baEigUlEz6PzaGRU+BFm4BHbKzjx8Lhsg89D7lFPuQJ5IJdCzdImJ8Y+n+BSW+yid5kE8cCLyGj4rdXU+1eR7l7GTlaKR61EJvsnNPxlzOFLMlMRh5VkuSsYZrl2rjisUsLA8xOU8ZDtyx2nW8Ztk2TZR5ZtpQyny+jc/XHYiPq7EwGl83G6rIyijweuiLpfImBeJzdrS3cWlOFKstD3qrLZcV9djsPLFyYcf93pUCAKawRcuUTIaEbtAaDGR0zLz8fmzJ8uGoZCJI0TQSZ9WD98Tj9seu7YO9M4rbZqM0fnlsXTaU429PHPfPnX/diHqNhWhZHg2d5oe1dzobPE9KjXC1D76GybXxh/hMz2MJLSOmZcObHSdKQZy0TFFXhb3753zI+bqw2SJJESXUhj3zhPh75wn2TOo83z8OXv/r5jI/785/83oT3lSQJRVWoWlTGJ//kwxlfayL84dd+fUrOc7Fvd7jtbPnQWrZ8aO2UnPdy/KV5/MF/XFt77/n4Vu75+NYpatElJEmatu89FjeIMTU2FgY9yQZ6kg0cGXDgd9RQ6lhMuXslFa6VOJXMJkI3Gg7FN6maUTbZiU0eu1J2lixXw7QseiPRYSphLpuGyzY5CdnRDIOplNC1LEFHaHj4iSLLrC0vy+g8KcOgeWBgynJ2lhQWsLiocMiYSpkmJ7q66QqHKc/JIWEYvHmuYdgxd9bVUuLNfBXdZdNQJGnIgIqldBJGZiviQgi6ImHag5nVPyv2eihwuYa+J0DzwAAdoTAlHs+EJ5OWEHSGwxl7xm5mnJrGQr8fj802JJGe0A2Od3XRF4tR6J69fKHpImrE+V7TS3Qmelnkq6HAnot6lXFyec78GWzdcDTZhSZlXuxYkVQcys0lX50ly3RxwxtTl6OLBJ3x03TFz1Af3kWho5b5ni3UejfhVmde1WoukGcrR5UyV/PxqH5cN+k9y3LtdITDNAcCwzwbBS43flfmBrosjUyQt4QgPoV5MQJB/IrQMAlG5JKMR31fH00DA5MSThiNIo+HNWWl7Gu9MBS61tQ/QH1fH+U5ORzp6BzmBVJkmY+smJhi05X47A4UWcYcNIDDySTdkSiGZU24eK5hWbzbfD7j30aVZbZUV3Gyu3vIP5A0Tbafa2BVaQnKBI2pcDLJ8a7ubJhfBlzMz5uXnz+UnyeA451dHGxr594FN553ShcGrbFONvpX8KmaD5CreQejOEZHmcUoDY+aj2MSi8J22U2ebfKqa1myZLnETRmnJRBEjB6aInt5t/trvHjhL2gIv4dhjSwMeaOTZ6sgL8MEVIfspdy1Ak2a+8U+s0wdFwsmXss7IoTAsCx2NbdwvHN4Am91Xi6VObkZn1ORJDxXFDBNmSatgcCUvc+SJOG5oq6TAAbiiQkdL4QgaRhsb2ikqX9gStoEaePo1upqCtyXjNDOSISzPX3opskrZ+uHBSetLClmYUHBpK5Vk5s7rOCyKQQHLrQTTiYndJ+FEHRHojx9dHI16j68bMmISftPjx2jNxqb8PXbQiHeamic1PVvZur8+awpLxtW26orEuFnx07QEQpP+j2bij5lOrDJKvM8FWiyild141Ts2GVtzD9X81pNN27VT4G9BjmDMiUSCjWe9djluSNHnyXL9cxNaUxdTtKK0h4/wUttf8Ubnf9IMNU+KXW76xVZUlmT9xiaPLEK7hIyJc7FLPBuy+ac3WTsab3Aa/Xn6IvFiaV0DMvKaBIkBlXc3m1q5qt79hBKXlLu89hsbKisoNCduWdKUxTKfb5hMt9xXef9ltYJT/THQ5Ekqq+o32RYFjuamsfNfxJCoJsmbzY08uPDR0legyT6aKwsKWZBgX8ob8gSgmNdXbSFQrzd2DS0nwQ8uGgRbpttUu/ukuIi3FfUFXr93DmOdnSO62kTQhBMJPiL7W/SN8l8pfl+PxsqK4ZtG4gn+N/btxNNXX0h7KKq4bf2H6AtlFmIYZa0FP+Hly6mOi93aJsA3m5s5B937qInGp1wHqAQAtOyiKV0OiOROfl7eFQ3n5/3CO3xbv6l/se83rWbw4EzHA82jPqnI9E7/kmnCVlSWOS7E59aNOFj8mxlrM57NDuGZ8kyRdxUYX5XwxQ6p4LbaYkeZkPBJ1jg3YpLyb0pOpsaz3rW5T/BkYEXiJljr5qrkp0y11LuLPkCDvXGlcTNMjqnunv4hx07yXE6ub22hnUV5dTk5ZHrcAwWp7VhU9M1lS7W6jRMi7ihE0om6Y3GeK2+np8ePUbwMgl0CVhVWsKDCxdM6n2TJIlSn5fqvFzqe9M10wRwsK2dHx4+yuPLl1Lgdo/wagghhmoejVZL53JUWWZDZSU/O34CY3DSaFgWPz9xknUV5dxSWopdU0cIIeimSUc4zDtNTXx19156otEhYYipQpFlHlq0mJ3N54fqN53u7uH1c+cIJS55zkq9XtZXlKNNsrbUkqJCFhT46YpEhrxdkVSKv9j+Jn92910sLykm1+EYEqoQgGVZBBMJGvsH+Ob+A0PG3eW5VxNFliS+uHkTp7p7CFz2vd5qbOb/vP0un1mzmupBefqLz5ElBJFUirZgiO8fOsQvTpy6JHc9qbvA0HkNy8KwLMzB/xqmRXc0OsKoixsG3ZEo9sF34+IfZfC/18MYI0kSK0pK+OQtq/iHne8RHlwIEcAvTp6iLRTic2vXsLCggHyXE6emDXmxzMG6XjFdJ5bSGYjHaQ0Geb+lhbcaGvnc2jX82vp1c6p4iSUswkYMSwje7z3Krt4jI+qcXc5DZdv4rfkfmcEWDqfUtYR1/o+yt+9HhPSuMfdTJA2/vYa7S343G6afJcsUkjWmriBq9LGz6+v0JhpYlfch/PbqSQk0XFdIsM7/JD5bMQ3h9+lLNhM1+tGtBBIyTtVHnq2SStdKluc+iEebXJhQlusfAXSGwzx19Bg/PXqMQrebytwcSrxeitxuvA47DlVFGzQYYrpObzRGazDIye7uUVXU5vv9/PamjZRmqIp3OdV5eawtL6exvx9zsE5FIJHgG/v2c6anh9XlZfidzkFDRpAyDeK6QTiVJJJMsb6inNvn1Y55flmSWFlazLKiIo50XtKIbg0G+Yvtb/GBxQtZVFhAnsOJIkskdIOBeJzzgSC7W1rZe6EV3bRwqCr3zK9jZ/P5YQbBtXJbbQ0lHi/nAwEA2kIhXj5dP0w6fGNlJWVe76QnrTZF4TNrVnOovWNIiADgfCDIH/3yFe6sm8eSokLynU4UWSZpGAQSCc709LKnpZW2UAgB+F0ulhUX8d75loyMyvSEvpgnViznuwcPDX033TR59vgJTnV3s7W6msrcHNw221AtpKaBAXadb6Gxrx+Amrw8XJrG6d7ejFQVo6kU2881EEgkSBoGCSP9DCUMffC/BsFEYoSX7nhXF3/11tu4NA2HpuJQNZyqOvh3FZuiUp7jY2NlBW5b5vmrM8mTK1fQHYny3YOHhuWd7bvQxrHOLpYXF7Og0E+hyz34XdLe6GgqRW80Rlc0QlPfAB2RyJDROcci/ACIGDG+2/QivckB1ucvo9jhx6ZoY747i301M9m8UVme+wAuNZezoXfpSTYQ0XvRB6XP7YqbXFs5Zc5lLM29D7+t6row4rNkuV7IGlOjoIsEJ4Ov059sZUPBx6hyr7mhDSoJCVW2sdh3N1WuNQT1DuJmENPSkSQJm+zGpxWTYytBySAuO8uNjQC6o1G6oyMLRl70TI3H6rJSfn/rFjZeEb6VKTl2O48sXcLBtjbODnqnAIKJBC+ePsOr9fV4bHYUWcKy0mF3CdNEN03sioJTU69qTEmSRJnXy8duWUnbjhC90bQanCUEZ3t7aXq/n3ynC5/djixJJE2TcDJJIB4f8sDYFYWHFi/ii5s3EUmmeLupaczrZUqu08GDixfyH7v3AhdV/bqGru2121hbUUau89ryHLdUV/PZtWv49/d3D/t9++Nxnjl+Ak2WcdtsKLJEyjSJ68Ywg8kmy/zaurXU5OdyuqeH7khmxUadmsbHVq2kNRjkjXMNw7yExzq7ON7ZhVPTcGoahmUR1/VhBqXf5eLXN6wjlEzS+v7wUNPxCCYS/POu97gQDGXkVeuORHmt/tyYn6uyzOaqShYXFsx5Y8quqvz6hvV47Da+uf8g/ZepIiYMg/1tbexva5vFFk4NpjDpSvSxLn8Jn619mAJ7HjLSnDZAJElinmcTZc5lBPQ24kYQ3Uov2NhkJx6tkFxbKZrsYDLlULJkyTI2sz4zzrWVIY2TumUJE0OkMKwEhkhiiumvXm8Knbb4cd7o+CfuKvkitZ5Nc7ojnQpkScaj+fFo/tluSpY5iCJLEy5nMt5U02Oz8eSK5XzslpXU5OVd87slSRKrSkv4g21b+V9vvElHeLiMuW5aDMSvrbaQTVV5cOEC+qIxvrZ337CJuG5adEUiw6S7L8euqnxk+TJ+a9MGij0ettZU8U5T0zWFml3J48uW8s19+9HNtIFx+YS/Ji+PlaUlI2pFZYqmyPzK2tWA4Jv7DpC4QpVPt6wxPW4OVeUPtm3hyZUraB4IUOzxZGxMSZJEZW4OX962BQmJN86dGyYzL0gXlB1Nrc9nt/Mnt9/GA4sWsP9CG26bLSNjyhrM+ZtMba2rYVgWScOYMoXH6cZrt/Hp1bdQm5/Hv723Z5jCYqZoikyea2L5ujOJQ7Gz3r8MS1jYZdtQiN/V8vLmwvxAkiScqg+nenOXfMmSZaaZVWNKkxw8UfX3OJSJKcpcLM2rW3HCeg8hvZNgqpPeZBOdibNEjX4sYWAKHcFU5CQIwkYPL7f/DfeVfpl53s1Zz0yWm5aPrVpJXX4+zxw/wd4LFwgnU5iWhSksLGvwjRNiaGIlMViUEYbyQ9w2jfsXLOSx5UtZXFSINoU5I5qicGfdPOb7/fzdjp3saj5P0kh7RqzL2yWll29kSUKRZVw2DbsysffabbPx+Q3rWFJUyD+/9z7netOqeeZg/tVFLp5bk2Uqcnx86dbN3D2/buj7bqutJW/33qGJuU1Rrvk+lPp83DN/Pu9dUVxYHjQ0F/ivfZFEkiRyHA5+a+MGlhUV8bW9+znX10fKNIcESS7eBVmSUGUZm6KwqrSEL926iVWlpaiyTIHbRW1eHi2BtGy7z26fsLy6LEnU5uXx1w/ex89PVvL1PfvojcWG8pdGu/6Gygr+6LZtzMvPQ5FlavJyKfF6howur92OOk7FaFmS8NntJIypFRAB8NjsV5UXV2RpmAy/LEk4tcnVZFNlmRyHY5jH8Gr5glciDV77nvnzWVNWxgunzvCTI0fpCIeHfgNrlH5AkSTkwXeiyOPmrro6Hl22lHn5eXPOT+JU7Hy4/HZ+dP5l/vr0d1jqm0e+zYdN1hjNq1PpKp4ToX5ZsmSZHaRxlK4mvOBkWCn29v2IPb0/mvDFNcnB5xf8EIdy7WIGljAJ6Z10xs/QHNlHd7KBmBEgYYamxLByKjlsK/p1FvpuG3STZ8kys3QnzvFa+9/Rk5y4tPMjFV+h1rthytsS13XO9fVxtreX9lCYznCEgXicxGAuiWlZODUNj81GntNJbX4eiwsLWFZcnHFtpslgWhZNAwO8f76FU9099ESjRFIpVFnGa7fjtdsp8XhYWFjAwoICqnJzhsl+TwTDstjT0sr+tjYa+/oZiCdImgYOVcXvcjMvP4/V5WWsKy+bEmNpLhLXdY52dnKgrZ1zvX0EEwliuj5kMC3w+9lUVcmy4uKM7+9EEEIQSem829TEwbZ2WgIBwskkqqzgdzlZVFjItprqtOE+SeGNLOOjmyaH2js43NFJY38f3ZEoMV1HAlyahs9hp8yXQ01eDsuKS1joz0edw79HbzLA7xz4vxjWxAznB0u38Pm6R6e5VVmyZJllxhzEbxhj6nKEsAgbPbTFjtMaPUx7/AQDqTauTb8JfFoJW4t+jfmeW1Hkya0KZskyWeaSMZUlS5YsNyoxI8EvO3ZOeP86TwWr8xZPY4uyZMkyBxjTmLohY9YkScanFePLKabWs5HeRCMtsUOcCm4npHeOf4IxCOmd7Ov9CV61gFLnEqRZrHqeJUuWLFmyZJl6XKqDj1TeM9vNyJIly3XCDWlMXY5D8VDuWkGxcyG1ng0c6v8558LvYYrU+AePQk+ykR3d3+Ch8v+BW/XfkKE7WbJkyZIly82KJSwiRmz8HQexyRoOxT6NLcqSJctc5oY3piCd/KpJDkoci7mn5PepcK1kd+8PiRp94x88AkF7/CRvd/0HD5b/CcrNcQuzZMmSJUuWm4L+VIjf2v9XE97/gdItfH7eI9PXoCxZssxpbipLQJIkNNnBityHyLNV8G7X1+hJNk5CoEJwLryTU4E3WJp7H3I23C9LlixZsmS5IZCRyNFGVxm2hCBl6YSNGCCocBZTaM+d0fZlyZJlbnFTGVNwqRZEhWsVD5b/N97t/k/ORw5gkZncrcBif/9TFDrqKHYumI6mZsmSJUuWLFlmGK/m5r8t/dWRHwhByjLoTQY4FqxnX/9JHi6/jXuLN858I7NkyTJnuOmMqYtIkkSerYJtRb+OItloDL+fsUEVTHVxqP/n3Fb8G7jU3OlpaJYsWbJkyZJlxtBklfmeyqvus8G/DE1Web7tHWrd5dk6U1my3MTc1PFpaYOqks0Fn6bctSLj4y0MzkcP0Bo7jLhG2fUsWbJkyZIly/WBXbZxT/FGuhP9HAuem+3mZMmSZRa5qY0pAFmS8durWe//KD6tJOPjY+YADaH3iOr9WYMqS5YsWbJkuUnI0TwkLZ2BVGi2m5IlS5ZZ5KY3piBdl6rKvYa1+Y+hSY6Mj2+K7qMrcQauXgA5S5YsWbJkyXKDcC5yAVmSUCVltpuSJUuWWeSmzZm6EkmSWJH7EG3xE5wNvZPRsSkrysnA65S7VmBXPEhjF0nOcoMghMAQSeJGkKQVIWFGMEQSUxhYwkAgkFGQJQVF0rApLhyyB4fixaH4BhUgJ/Oc3HjPlhACU+gkrQhJM0LKiqNbicH7qSOElc5nFOmFDwkJWVKQJRVVsqHKdjTJjk1xY5c92GQnSFL2PbwCISxSVpyEGSZpRUiZUXSRxBImljCwMEnftfRzq0o2NNmBJjtxKB4cSg6qZLspa+ulrBgJM33PUlaMlJXAEjoW5mXvuzr4vqtoshO77MauuHEoPlTJflPetyu52G8mzQhJK0rKimNYSUyRwhA6QpgILCxhIUkSEnL6f5KKIttQJQ1VsmOTXel7rLhQJceU31vDMmmNdY79uTAZSIX48flXcCkOypwFU3r9LLOLEAILg4QZJmFGBvvLWLqfFCYWl8Z4SVJQUNFkO5rsxCa7cKg52GX3Tav0bAmTpBVNv+eDfaYxYqyR0+M4Copswy670GTX4FjjRZbU62oMzxpTl6HIGhv9n6Ajdoqw0Z3Rsc3R/fQmmyh3rrgR57tZABAkzAi9yWZ6E030Jc8TNrqJG0FiZoCUFcO0dEyRSne0kooiaaiShkP14VJycal55Gql+O21FDrmkWsrR5Em9hqmO+7r/+ESQpCyogT0DgKpdgKpdqJGHzEjQNwMpCetVgx9cKKVnrCag4OXjCTJlwwpyY5NSQ9gTiUHh+LDreaTo5WSaysj31aJS81FukkHNSEEYaOb3kQTvckmAql2YubA4L0OoVtxTKFjCh1LGICEIqnIkoomObApbhyKB6eSi0f149OKKXDUUmCvxaP6b9j7agmTkN5FX/I8A6nWwWe0n4QZIm6GSZpRTJEavHcGDL3vKopkw664cSo5OBUfbtVPnq0Cv70Kv70Gt+q/qSZZhpUkkGqjP9VKINVBWO8iZgaJm8HBxZPY0OJJerKVNqgkJKSLky1JSy+ayHZskgu7cnFhyotb9eNVC/FqReTayvBoBRPuU8cibMT4l/qnxvxcFwa9iQEiRoxb8hZxS+6ia7pelrlB0ozQn2ylN9lEX+o8Eb138FkNkDDCQ32lKXQYWjBNv/M2xYVdduNQvHi0ArxqAXm2CgocdeTbKlEk7YYYv0fj4oLoxf6yP9VCUO8iPjjOJIbGGgPT0rEwBo0pdXDxyYFD8WFXvLiUHHxaETm2MvJtVRTYa3Gqvtn+iuOSNaauIN9exRr/47zT9dWMjjNEklPB7ZQ7lzMT1pQlLJoiezjc/4tpv9aVeLVCNhd+Fq9WOOPXng2EEMTNIPWhd2mM7CWgtxEzAqSs6FWPS0+2UqSAmBmgnxYgbRQ5FB9uLZ8i+3wW5dxBuXM5qmy/6vkU2YbM9RtOEjMGaIsd50LsGL3JRuJGkIQVJmGGBwen8Ul7qExMoaMTT280hu8jIQ8Nak41lyJHHVXuNVS516S9VnMES1i0Rg+xv++nV93vYhjyOv8TGZzbpDN+mtOht+iMnx4yVA2RGudIkd5HpEgRI2r2D/tUley41Fzcaj7FjoUs9N1BiXMhiqRNuG1zmaQZoSV6iMbIbnqTTcSNIHEzhCGS4x578X2HGHEzQIC2oc802YFTycGl5lPqXEyd51bKXcuRb+DwsP5kKw2RXbTHThLSu4ibQRJmZPAejY9AIISBhZH2ZlmRUfeTUQa90i7siheP6qfQMZ8K1wqKHQuxK+6M224Jk/ZEz5ifq5KM357DXcUbuK9kE8UOf8bXEELQlzrPO52ZzTWmAkXWuL34t8izVcz4tSdL0ozyWsffkzKvPu461VzuKP4CLjVnQudNj+8BzoZ20BTZQ0jvJGYESFgRGCcP3sTAFAa6SJCwhufNScg4FC8uNQ+fVsx87xbmeTbiUvMm1K7rAYEgrHfTHNlHU2QPwVTnoPEUxrpyYB5xbHrhJP1uR4kYfUOfSUjYZDdOxYdXK6bctYw6760U2GvnbJ+ZNaauQEKm1rOBU8HX6U5kptBTH3qXLYW/MkMy6YKI0UtL7NAMXGs4ebZKDCsx49edWQRCgC4SnAi8ysG+Z4ibQXSRZLwOdjwszLR3wBygL9HMufAuip0LubXgsxQ7FyIhj7qCpUo25GtccZ0phBAIBLoVpy1+jNPBN2mLnSBlRTGs1Lgd7TVdGyttpFlhAno7XfGznAq+iVcrYHnuB1jkux2XkgtIs7xSKIgafRN6hy0sVuc/etUV9/Q9N+lK1LO37yd0xE6SNKNTeq8NkSSkdxHSu+hK1HM6+CalriVsLvgMhY66MZ/duYoQAhDEzRCnQts5PvAyEaMX3UoiMiyVcTV0K4FuJQjpXXQn6jkZeJ38QeGjavfaod/1erp3lyMG84UtYdARP82RwHNciB0jZUYxBlfxpwsLk8Tg6jd6J92c43z0IIf7f4FTzaHCtZKFvtspdy5DlrRBj9fV73OezcdX1/63q+4jSzJ2WcMuTz70NWlGZmUMVyUbKTM249e9Fixh0BY7Sty8utiHLKlsKvgUTsV31d9FiPT4dHDgWU4GXidmDEzJ+D50fizigx7YvuR5LsSOcqDvZ6zIe4glOXfjkL3A9ffOXxzbI0Yvh/p/zrnwTuLG1MyNhq6BSIf9WxECejvt8RMcGXieavda1vqfpMBeM+fGmutjZjaDSJKEVy1ggfc2ehKNCKwJH5u0YpwOvcWa/EensYVZppuLcf0XYkfZ3fsDuuJnM3oOMsHCJGlFaIke5EL0CCvzHuKW/EfxacUjJs6a7ESRbNPSjqnCEgZJK0ZE7+FUcDtnw+8S1jMLmZ3yNmGQsgz6klHe6foqRwdeYL3/o9R4NuBScudUhzwWCSNERO8hx1Y66ueWsIgYvRwdeIEjAy+O6zWdCixhkBBhmiJ7aYkeZlnOfazxP06OVnxdGP1CWMTMIOfCOznU/wsGUq0zcl1LGCRFhI74CV5q+0sqXCtZ63+CUscSNHnq839mAkMk6U02cbDvGRojeybkyZs+xJCXMJmKEEi1cTzwMj6thEW+O1jg3YrPVoJddo85IZMlmTzb3A8tyjISSxj0JZvG9Lqlw8zjtMYO8n7P9+lNNjOdxv7gVdGtOP2pFt7p+g9OB7dza+FnKXetmJTo2WxhCoOY0c/xwMscGXhhXMN26q6bIm6mOB16i/rwThb57mRt/uODaRJzI3xy7o94s4Aq26lwrSDfVklf6nwGRwrOht5hZe5DqPLcnvRmGZ10jkkPpwKvcyTwAlGjf/yDpggLk8MDL9ARP80G/8eo8qxNT64Gw0Y12YEqz71wqnQ4jkkg1UFn4gyN4fc5H91PyorPdtNGZSB1gdc7/ok67ybW+Z+kyLHgmnMsppuUFSOkd41qTOlWgrbYcXb1fCtjb/pUYYoUxwK/pCfZyHr/k1S71w72gbM/yI1G0ozQET/Fof5f0BzdN2vtMIXO+egBuhL1LM99kCW+u8i3V183OVVCWAyk2jgbeptD/c+NCHWaS4T0Tvb1/YSjAy9S7VnHpoJPkm+rmu1mZZkGuhMNzPdu5cr+RwiLoN7J4YHnORF4dUYWnUYi6Eqc5cULX2Gt/yMsy7kXn614RFvnEhdTHVqiB9nf9zQ9yYZZa4spdE4GX6MzfoqVeQ+zwLsNt5o/6wbV3J5BzCJ+ezXFzkX0pVrIZNUimOqgP9VKkaNu+hqXZdroT57n/d7v0xjZM+HY/qkl3dG+0/01VqQ+wKq8D2GTnUhSWhjAJrtId7pzR4a/L9lMY3g356MH6YqfQRdzPwRUYHIuvIuBVBvr/E+w0Hv7nF4ASVpRgnonlVdsj5shTgff5GD/s4T0sdXHZgKBRUf8JO90/Sdr8h9nRe4D6bCqObBqeBEhBCG9k2OBlzkVfH1YnP5skjBD7O/7Ke2xE6zMe4j53q1o4+RQzjaGpXMhdoQD/c/QGj00bd77qSZpReiInSRhhsfcJ2XpHA82kKt5qHAVYxtjEUu3DHb0HKLE4WdpzrzpanKWDOlOnEMghpknQoh0CHTvj2mO7ptwnu50oYs4e3t/zECqlfX+j1Fgr51TfeVFhLDoT7VyqP8X6ZA+MzjbTQKgP9XKru5v0Rk/zdr8j1DknD+r7ckaU2Ngk92UOBbREH5vzMTX0dBFgrbYsawxdR3SGT/Dju6vcyF2jNk2VkJ6J/v7niJuBtha9KsopCf6DsWLjJwWYpgjtMWOs6f3R7Mc2jM5+pLNvN/zXUxLZ0nOPXPWoLromUo/l+kBN2XGOBF4lf19TxM3A7PZvGEE9Q529/4A3UpkJJox3Qgh6E+28F7vdzgfPYg+5zyngvb4cUJ6J6FUF6vyH8aheGe7UaNiCp3GyHu83/MDBlKt140hdZFy13JybeVjTl4jeox/q/8pXtXJQ2W3cXvRmlENqqSV4sctL7PZvyprTM0hehINXDmG9yQb2N7x/+hOnhvx2WxhYXAuvAvdSrCt6PPk2+eWpzRtgJ7l3e5v0Bk/NesG6JXoIsGZ0FsMpNrYUPAx5ntvZbY8fNdHLMEsIEkSZa6luNX8jI4zrAQd8ZNYYu5MdrNcHSEEXfGzvN311TlhSF0kaUU5OvAi73R9DcNKAQK77EOaY2o2te71MAdX1CZKSO9mb9+PaY0eRoi5OSm0hEFE7xkKnTSFQX14B3t7fzynDKmLxM0A+/ue4nTozSFxgtlECEFfspmX2r9CY3j3HDSkLhExetnX/xS7e75PzAjOift3OUJYtEQP8U7Xf9KfOn/dGVI22U25awUuZWy1N1NYdCZ6ORe5wDcaf87zbe9gWOaI30IIQcSIk7BmI4ohy1jEzABhPa3GeHER5Y2Of6Y7Wc9cGd8vYgqd5sg+9vX9lPgcet+FEDRH9/Fi21doix2bc4bURQSCrsQZdnR/g/rQLoSwZuUeZo2pq+C315JrKyMTS1cgCKY6B1eRp5d0Ls31O4mdC1wM+9nT+0M64ieZax2tIVKcCLzGvr6fYFg6LtU35+TRPVoRy3z3znYzromQ3sXu3u8T0NvnzGB2JRGjf2iwbY0e5s3Of83Iaz7TJKww7/d8j474yVm9p5aw6Ek28NyFP6MveX5OeXXHQrfiHBp4jj29PyBhhefQMynoS57n9fZ/IGL0znZjJkW+rZJy17Jxa6RpkspthatZ4KnkB82/5GsNzxA2YlP6W0hki4tPBwJBd6JhKAf67a7/pCtxdrabNSYWJieDr3Es8PKc6J9MYdAY2c1r7f8wKCA1V/qfsQmk2tjR/XUaIrtnZYEnG+Z3FWRJpsS5mPPRAxlZ5XEzSCDVPmiITQ8SErm2chZ4t5Ky4pcVkBz8YxnD/z3453pbRZxOhEjLbx7sf5bGyN5rPp8iaTgUHzbZhSbbkVGRJBmBhSVMTJFCtxIkzWhGk2BDJDgeeJUcW9mgco08p/o2CYnleQ9yJvQ2CWvsPISJnUtGkx3YZBeqbEeVbEPfWUZGILCEhSl0DJEkZUZJmJEpkf/uTJzhcP/zbCv6POocVE2MGv3EzCAWgre7/j3jsEoJGbviHnw+naiShoQyOKkUgzU/UuhWnIQZHvSCXduDFtK7ODTwHDm20oy9/FOBJUw64qd5q/NfpmSBS5Xs2BUPNtmJJjsGC2krQ9eyBmvO6GacpBWZQF2vqyE4PPAcSBIb/Z+YoZIbVydmBNje+c8j6o9lioSCTXYO9ZWKZEOR0v2lNPieC2FhYWJaqcHnMkHKil1TOLGMSolzIXm2K7MPR6fGXcbthWv5/vlf8nb3AQJ6hE9UP0ClqwRlCkRCnEouC7y3DX6v1Ijx2hLpcdywdKyL2+bAZHvuI+hOnqPavYbjgZdpix0l077s8nddlexDzydIiKExKEHCjJK0olhT4LnZ1/cU5a4VlLuWXfO5JktaFOcgO7u/Qewa33MZBbvixT44niuShiwpSEgIIdI15KwUukiSNMOkrBjiGsacoN7Bez3fwaF4KXeOv2AylWSNqXEodS5BltSMjKmEGR5yMU8X6UKeq6lyr8YSBikrgW7F0a04qcE/+ij/Tf9JpAf8wdonYb2L/hmSBZ5bCM6E3uF44NVJ15SRkPFpxRQ7F1FgryHPVoFbzcep+FAlO7KkDnYYOikrSswIEDF6CKTa6U+10JNoIGL0M15HHzF62N/3UzxqwZxzt0uSRI5WynzfVo4HXs7sWGS8agE+rQSvrQivWohb9eNR89OdsOIelITXUCRlyJC6OOGPGL0EU530p1roTpwjmOq4psnGyeBrzPdtodK1atLnmC6iRh9tsWN0xs8QSLVP+DifVkyhvY48eyW5tjI8aj5OJRe74k4PbqgILEyRImFGiBkBQnoXA6kL9CYb6U6cI2VNriaNwKIlepDmyD4W59w9o6qJF0P73u/5zqD88eTQZCcF9loK7DXk2srxacW41LzBdzxt7AsYnPQmiZsBosYAIb2LQKqN3mQTvcmmSb+3R/tfQEFlY8EnsCueSX+Pa8USBkcGXqAzPrkVfkWykW+rwG+vIUcrwasV4Vbz0gtQihttsL+UJWVwspo2JFJWlKQZHbqvEaOfiNFDWO8hlOrMyLBzKF7qvLdmVPiz2OnnN+seo8SRz+ude/h6w7N8tOp+lvquLUdKkiTy7OU8VPE/sISJbiUHx+fYsDH8ohGZGjF+x4fG8KjRR1+yZVrr911vtMdOcEZ9h5OBNyZsgNtkFwX2Wvz26kvvupKLU/UNGVQgpQv1WnESVnquF0i105c8T1fiDKFr8OSkrCjv9XyHD1X8+ay860JYdMXr2d3zg0nPCRXJRp6tnAJ7LXm2CnxaMR6tAIfixSa7Bg0qOb14Z6VIWlHiZpCw3k0g1UF/6jzdiXNEjQEmcx/7ks3s6v4295b+lxnNQcsaU+NQ5FiATXZlFGOfsmKEjR4sYc5ItWZZUnEoHhwTePkuekgMoQ+t+DWEd7Gj+5s3ndeqO9HA3t4fYUxSfc6l5LI89wNUu9eSZ6/AqeRMWNLYFDpRvY+BVBst0UOcDm0fV1msL9lM3zVMCqcTm+xkvncLjeH3iY2TwyNLKvm2KsqcSylxLiZHK8Gl5g5N8DN9Zy7WCwqlOmiLn+BE4DX6MyppcImUFeNA79OUV66Yc/LUCTPMof6fEzeDE3pX/fZqluTcQ6ljCTm2UlxqLoo0cWl93UoS1rvpSTRwOvQmLdGDk/K0JMwQZ0M7qHKvxqsVZXz8ZImZAxzsf5b2+MlJ9W022UWtZwN13lvx22vwqoXYFNeEw7KEsEhaUcJ6N33JZurDu2iO7MvYs2JhciLwKh7Vz6q8D6HMUnmEnmQTZ0M7Mp6wq5J9sHDubRTYa/FqRWkhnUmMjenVbJOEGSZuBImZAwRTnXQnztIeP8VAqvWqRqvfUUOpc2nG1/WoLj5SeQ/FjgKeaX2DrzU8w8eq7mdF7oKMzzUasqRgV1zYFRfgv+q+6THcGKqldVFVcUf3N+aM0tpcoDN+mkCqnYgx/sK2TXZR593MPM9m/PbqoXd9oljCHIxISo/nxwK/nHRZla74GerDO1me+8Ckjp8sQghiZoA9vT+kexIhkRLpBf753q0UORaQoxXjGKdw8hUtwBQGEb2PgN5OS/QAp4LbJ3Uf2+PH2dn9LR4s/xM0eWbqeGWNqXGwy27ybBVEM5DQFVhE9F5SVmzOqTHJkoIsOdFwcjH1xq0WcLPlXhlWip3d35h03H+1aw1bin6NPHsFmpR5oU1F0vDZSvBqxZQ6l7A45y729P6A+vDOSbVntpEkmUJ7HeWuldSH3x11H49awHzvFuZ5NpNvrxwMlXJecyVzSZJxq3m41TwKHXUs8G5jf//THB/45aS8VO3xk3TGT1PmynzSNZ0IrAk9rw7Fy8rch1iacy9erQhFsk3q/mqynfxBb1aFexVngm8N5vBknqfVGjtMV6Iet1owI0aqaemcCr7B2dA7k/IIFdrr2Fz4WcqcS7Ernkm1WZJkHIoXu+zBb6+lyr2Wttgx9vT+kJ5kE5msuiasMIcHnifHVs48z8YZl1AWwqIpvCdj+X2nksPmwk8z37sVp+IbDCu9lnddQkEdet+hBstlstDaRsqKEdA7OB85QH1oBwG9bfixyCzx3TWpyZUkSdhlG3cUrSXP5uXbTc/z7+ee5uGy25jpdLb0GK6gcUk6P5hqn5GF2+sJQyQnZEiVOBextfBXKXDUYZcn967LkoJbzcet5lPkWECtZyPv93yX5uj+jM+liwSngtup896KU5nJwtGC93u+T0v0YMahdjlaCZsLP0uVew0OxZPRot0lJBRJI8dWgk8rptS5mEXeO9jX9xT14Z0ZL4idjx7g8MDzrMt/Ykb6y6wxNQ6SJFFgr+VC7EhGx4WNHhJmeM4ZU1nSKzCnQ9vpSJzO+FhVsrEs9342F3wmw1WX0ZEkCZviokCu5YGyP6Fs4CV2935/TgsLjIVbzafGs46W6EGSVgQZBZviptixgGW5D1DjXjdYhPjajKerocp2fFoxtxX9On5bFe/3fC/jPC7dinM29DalziVzsu7H2Ejk2yrZVvzr1LjXXvPE9SKypOBScrkl/xEKHPN4pe3/yzhnxhQpzgbfodq9FkmyT2vSvRCC3mQze3p/nLEnTZFsLPHdzbbiz2OXPVNy/yQpLTLgVHKY791CsXMRu7q/RX14Z0a17IJ6B0cGnsNvryJHK53RZzNi9NEZP52RV82p5PJwxZ9R5lwK0vQJLaS9Oh7sihuPWki5czmbCj5FZ/wMp0LbOR89QNwI4FC8LPTePunrSJKEJqmszVuC35bDv597mqdaXkMX2dC66xFNcrAq70NsKvwk6iQWRMdClewUOxZyb+mXea/nu5wKbcfK8BkJpNpoix2nzrt5RgRKhBDUh3dyIvBKRguQsqQxz72RbcWfJ0crmbIcJUmS0HBS6JjP3aW/h99ew6H+n2c0lhsiybGBlyhzLqXMuWza+8usMTUB/PbqjI9JmMEhGeMsc4uI0cuJwGsZyyOrkp3luQ+yseDjONWxZXUngyRJqJKNlXkPYVMcvN/z/etOLUuSJCpdqyhzLSOsd1PhWsninLsodiyc0VXT9KTHwbLc+zFEkr29P8nIOLUw6UycJmFFcF43iyESZc6l3FnyOxQ5pr544UWDoNK1ivvL/pjXOv4u4+ezKbqPmBnAJxVPqyM8ZUXZ0f11UlY0o+OcSg6r8x9hbf4T01JvLD2YS/i0Iu4r+wPc3X6OB17O6NlsiR7ibOhd1uQ/hippzFREQTDVTkCfeJ6eJju5q+SLMzKJuYSEJKXFLWRJocK9ggr3csJ6L02RPYCEOsFCyKqsMN9bSb5tZD8vSRK1nnL+ZMmv8PXGZzkZbMStzEwoUZapwa34WV/wUZbnPjDlYWAXn3ePVsDmws+QsmKcC7+XUV52zBigLXaMWs/6SXp5MiOkd7Gn9wcZGVKa7GBJzr1s9H8cj1Yw5W26eB8dipe1/idQJJX9/U9ftdj2lYT0bk4GX6fAXotdcU95Gy8na0xNgAJ7TcbHJM0IhjW5XJws04clLBrC79GXzCynRkah1rORtfmP41Lzpql1oMo2FvruIGXG2NP3YxJmaNquNR34tBLW+z+KQ/GRb6ucVc+OJjtYlnM//akLnAq+kdHqYNQI0JNooMp9y/Q1cAopdy7n7tLfJd82vQm3kiRR4V7BhoKPsbP7WxkJU6SsKOcjB1iR+4Fpa59AcCLw6mC9uInjUHysyX+MVXkfmpHCzTIqmws/g012crD/GZITNPwEFocHfkGFawWlzqUzUt4tLS/dS1ifuPE8z7OJave6OeDZlfBqhazM+2BGR+VoHv7H0l/DoYxtfOXbfHxpwcc4EjhLkX3mlSqzTA6nksM6/xMsy71/2vNpvFohGws+OSjm0zTh4yxMepNNhPWeaVWFBtCtBIcHfsFAqm38nQeRUVjsu4uNBZ/Ao149x28q0GQ7t+Q/im4l2Nf31ISNPoFJa/QQHfGTg1ER0xdiPrcyrOcoOZN4mJNmFN2avIRrlukhavTREj2UcRhdrq2MDQUfx2crnqaWXcImO1mScy913s3I19l6hyRJlLuW47dXzYGJFDjVHFbnPYpHzWzlLGlGGLhOFC4L7fO4tfCzM2a8KpLKfO8WajzrMz62eQpKEFyNQKqNE8HXMloFViUbi3y3szz3wWlfvbzIRU/0qryHWZpzb0arz1Gjn719P5kxwSBLGET1vgkL9cgozPdumbHE7+lAlmTybD6cVzGmJEnCrTq5tWAV870Tk1rPMrsoksbSnPtYmnsvNtk5I9csdNSy3v9RMp1uB1LtM1KvtDN+hqbI3oxyS6vcq9lY8MkZMaQuosl21vgfp9azIaPjQnoXjZHdE16wmixZY2oCXKwpkglJK4ouEnOo2GKWi1LJHYlTGR4psb7gYxTaa6elXaPhVH2s8390Vmrz3Gj47dUs8d1NJiFRKStGMNWBEHNb4dIue1iZ9zClriUzWFNDwqXkMd+zBZeSmZe2PX7iGmsvjY0QgrOhdwikOjI6Ls9exdr8j0x56O54SJKEQ/GxMu+DlDiXZHRsa/Qw56MHZ2R8MdGJWRNXiXOpefi0ojmxmDLdCCGG/mSZ+xQ55rPO/8QM57JL1HlvTecOZkBE7yGsd0/rGKRbCZoj+whm0Ge6lFxuK/4NvFrhtLVrLOyyh02Fn8apTLyvFggaw3sI673T+p5mjakJICHjUnIzOkZgkTBDN53c+FxGt+K0RA8RMwYyOq7StYpF3jtmtAAcQJ5Wzpr8x7jZlBanGlmSWZH7gYwK8aaV8/pITrK+0swgUe1exwLv1hn3YEqSTJlrGYWOzGrtpKzEtHn8+lMtNEf2Z1TqQJXsbC74FD6tZEYSva9EkiTybJWsyH0QZwZjjCGSHOj7aUYCFpPFEiaGOfF7apfdaQXJm6DfEgguxLrpSlxbcdMs04+Mxp3Fv5PRRHyqUCU7t+R/iEzGcguTgN5+TUWqr0Z6cfk8TZE9Ew6bk5DZUPCJCRe9ng7ybBUsy70/o2PCRjfno/unteB11piaIJPJk0maESyRrVY+FxAIElaY1mhmqoyKpLHO/wTyDBYbvYgkSSzNvXdWVoBuNDyan3LXioyOSVkx9DlsTLnVfBb5bsep5syKF8CrFVDkmJ9RiJrAojcx8dyBCZ9XWHTET2WcC1nlXs08z+ZZ9aJIksR87xZKnYvJZLLVm2zmfPTg9DVsEIHAzKC2lMDKWFr5eiVhpvi3c0/xbNubs92ULOOwNOceCh11s/KuSxKUO5fhy7DOXjDVMW3pIqYwaI8dpy+DmowlzkXMz7Do9VSSDo+2U+fZjDvDEMMzobcwrOS0eaeyxtQEuBiOkSnpGNSbY1CZ84h0DHJfqjmjw8pdyylyLJi1yZZNdrM8J7NVmCyjIVHjWZvRESkzOmcVOSUkih0LqHKvntVWlDiXYJfHLxZ+ESEEA6kLU96ShBmmPXYyo1xITXay3v/klLdlMmiyg1vyPowmTTycPGlGaYrsxbCm1zslIaNksJgUN0Po1s0R4i4QxMxsbvRcx6nksiLvIaRZm/JKqLKTMufyjI4K693T5plKWREaIrsnvL8iaSz03Z6RB306kCQJn1ZCuXNZRsf1JBozCmfMlKwxNUEyGeQuYgj9plmhm+sITJoj+zNKspSQqfPcOmNJ6aO3QaLWuwmbPPFq7FlGp9ixOKP9dZHAmKMiMopkY5HvTmzK7D4XhfZatIwSuS3CUy75LwgZ3bTFjmZ0VKV7NYWO+TOiiDcRKtwrKXEunPD+FgbdifppF0qRJQWbPPE+MGGG6E+2TGtIzVxBIIgbWdXeuU6tZz25tpmtzXYlmmSn2LEgo2NiZgBzGuqYCSHoT7XSGZ94rc1cWwWlziWo8vRLtY+HU82h2Lkw46iIxgyMx0y5vqTCZg1pUlr/pkhljak5giUszkcPZHSMVyui0FE3q4p6kiThVQspdS6ekZCeGxmvVogmOdAnmFNjCXPOTgjdaj7zvBtnuxl4tUIciofgBNcoBIKY0TelbbBEOnQwqHdmcJTEEt+dKJKNuZKTqEgay3IfpDWDAvEDqTa6EvUUOuqmrV2qZMOdgdCIQHAm9CYLfFtR5nidNiEE7/YcpDPRx9aC1ZS70iHVcTPJG517xj0+aaUI6JkVBc8ys6iSnRr3uowWBKYDWVLJsZUio0x4XImboYwL/k4EgaA+tCMjr1eRvY48WwVzob9UJJU8WwUuJZew0TPh4xoju9lY8MlpaVPWmJogkzGmLMuAmyDU4XogYYbpSzZndEyhfd6cUKXSZAclzqVZY+oakCQJRVJxqrnoE5x0W8KYszmPNe51GXqEpgdZUvFpxXQl6ploSHPMCCKEmLL3yhAp2uPHMxL7ybdXUWCvnXMiCbWe9TiVHOLmxNTzUlaU3mQTKSs2bd5rCRm35scueyYcRnkhdoxTwe2synt41vIrJoKFxX82PEvCTKLJKo+57gIgasT4ZuMvQOKqz4hAoFtTP9nNMnXk2SrItVXM+jguSRJ2xYND8REzJyaClTSjmEKf0v4S0l6apgzKVNhkF0XO+RmFdE83Pq0Ut+bPyJgaSF0gYYZxqpmn7YxH1piaIMokXJsm2TC/uUJ7/ESGyooSefaKWY8PhvTKWpG9DkXSMgpTzDIcCTkdsjnBW2gJa85Ko8/3bZkzhoBbzUdCmnBfJ7Aw0VG59uK4QggMK0Fb7HhGx5U4FuFUZke442qokp0q9xrOhN6a8DE9iUaiRj822zQZU5KETyvCpxXTk5yYMSWw2NnzTdxqPrWe9XPC8B8NCYktBatoi3dT7Sod2i4EGMKk3FFEiXPsRHdDmJwINMxEU7NMkgJ7DT6tcE70l6pkw664J2xMgZgWxc7+ZGtGnnynkpNefJpD/aVHzcchZ2YUWcKgJ9lAlTr1ucZZY2qCTOZFlFDmxAucBdpjJzLa3y57yLOVo8rXPuG7ViRJwqXm4VULCejts92c6xYJCSWjCbxgLgrI2GUPRY6J59ZMN5nWbBHCSnvtlal5t0J6N4FU24T3l1AodMzDNou5kGMhSwpV7tUZGVN9yfNE9X5ytfJpm+zkaKXk2SvpSTYy0XfCsJK82fkvrMl/jIW+2/FpJcgzXF5iPGRJ5gvzn8BCoFzRNodi46GyLXyo/I4xj48YMX734N9McyuzTBZ5MBxsMgJi04EiaRnXLDWsqV9APR/ZRyZjm0Pxzaoc+mjYFQ9OxUc67HBi38USFj2JhmkRbppbPdscZjIeAUXSmDPZzTc53YnMVg+dqg+fVjr+jjOEQ/Hi0QpmuxnXPXNtMjcZihzzM6qZNd2okp1M4ugzldoej8746YwiAJyqjxzt/2fvvQPjuq47/899ZXpB7yBAFPZOSuxUl6xmW3JXXOPYcZzutN/G681uEm82uylOsZ24JXHvtmT1RomU2MTeKwgSvZfp88r9/TEgSAiFGBAghuR8XEjOvHLfnffuu+eec76nNC2FuuuFQKHAORc9jZC9mNXPgNE2ozUNXWqAcvcSnGnmncSsAfb0/JCt7V/mxMDLxK1wxqn8pUKAR48LutBwqxNPfAUCz1W2yTJ7uBQ/QUfpda8ROR6KUFDT9GHMRDRKc1piPQKvlod3CuWBZhJFqHi0HNQ0woglNn1pLLyl1Z4ZOepNiDkFV6sq9KxnKgOwpJG2R8el+PBrmWO8OFVf2nUVstycpKT6M2foVoWW/ig3jRPqzviZtLb3afl4tbxpO/90cimvIkcvSWu/nsTFGQ0BFkJQ419H0JH+ApNhx2iM7OWNzm/wdPNfcmpwK0krc+u3Abg1J4+Ub6bGVzHhdgJxVYMry+zhUv0E9OLZbsYwAgWRZg5hapFk+sZLw07Qk7w46e0VoZLrKM/I3EeX6k9LIEwiCU+7mmyKzFuay0jk1DxTik4mKJ/c6oSMbkw7PflaZ4Z5gpyKB08G5G9lmX1yHRUZtkgzm22RaXudvWpexhpTAA7FTY6jYiikbnL0JC5gSQOdmZvY+7VClgTfweuJC1PI45BErX6i0YO0x06S66xgWc6j1Pk34FR9Q5PMzLmnvaqb91Xed9VVb13ReHfFnfi0bOmKTMSheDJuEXK2x+4Bow0jjfmQgjqlRZTrga64UwuLk7Y1JRGzF1ta024cZs7yZoYzlcKIWc9UZjCQbE1L4jq12hgYCl/KDFThwKX6Z7HoYJZMIcdRmr0PhjBlMu0iwC7Nn3ae1/VEE860F3J6kxdmpB7NlQghWJL7IJWe5dd0HEPG6Yyf5eX2f+QHjb/Hnu7v05u8QNwazBj1TCEEDkUfM/zvSjShsiF/OcuC6dUPynJ9cKhuPFrObDcjo+hN04utCBVfhhmkl0jNsdN7F1rSIG5NfzmDrGdqEkgpSViTUzG6Ek04Mmq17VYlYvWmpcqmCC2lUJZBv50QApfqR1OcGHZstptz3ZAy5RW2ZBJLmljSHJIsN7GxUmIGWCnlPSxsefmzy99ZSGwSVnjSktOZiiZcuDJQhW62CJvdadVhESi41ACakjkLJW9HEw58aXrOwkZPqq7hNEsovx1VaNxR/BkiLT1pec7GY8BoY2f3dzjQ90vmetcyx7eKQmcNOY4yNOHM+Ps809t3ayNwKv60BR9udgaS7WmNmba06Iqfw8xAJeHO+Nm063BJac9ISHTWmJokkSkUmkzFc2ZenOmtRswcSCtBXUHNyDAgp+pDE04MbjZjSmJLi6g1QMToJWL2EDX7iNthElaEpB3BsOOYMoFpXzKsjGGDyhqqB3Xp3/YV/x7+DnPYqLqRcam+tBJub3bCRnrjsioceNScjI4YUISGWw2mVdzTxiRq9uPXima4dZDrKGdz8ad4o/NbaeerjUfcCnFi8GXOht4g31VNiWs+Ze5FlHoW4ddmv9ZflhsPBWVI7S3LlUSt3rQidUyZYGf3d2awRdcXSdaYmjUkkog52boAKVThGFI+yr4EZpuYNZjWJFoINSPDgDThzEgFsqlgSZOBZCud8XN0xc/Rk2gkZg9iWDGSdgxDxjDtlNF0oxtA04lT9aLcJPfAdBA2u9NaKFGFllGFJ8dCCIGuuNAUJ0l78kINIaOT4usgmS+EQoVnOZuLfoOdXf9Fa+wE05Ugb8g47bGTtMdOcTq0jaBeQql7IfX+LRS761MKudeBpG3wVu9xYmactflL8OujVQyllPyqdRumbXFX8RpyHdmJeyYhhJKR7/HZ1rKMmv0ZWz/xepDyTE1/7a7sW3kSGHYUQ6YpYKB40BVXdkUtA4hZA2nJ8QoUHGlKAF8PdOXGNKZSfS+RSLri5zgX3sWF8D4GjLZhL1O2GPHkcCiejFRVmi3CZm9a2ytCw6FmvliAJpxpG1MzpVI1FqrQqPAs497Sz/FG5zdoDO/Fnka5e5BEzT6iZh8d8TMcH3iJAudcFgcfoM6/cSh0S8zY+zVhGbzcvove5CBV3tIxjSmA1lgXe3qPUuouYH3BshlpS5apMVykPcOYzRmhLa20F5dvNiTMSG7mjTczmwUGjU7SXU9wqr6Mjsu/lUjlGKUR5ieUjJxwacKJcp1WZqcDKSWGjBM2urkQ2cvxgZfoijfc0gP5tZLySmUXaC5h2BHSe7ZVHIp75ho0TaiKI20BnPgU8nqvBUWo5DkqeaTiCxzqfYq9vT8lZg5Ms1EFtjSJWyGao4dpjh5hZ9e3WZLzILX+DQT0oiFFr+l9Jgxp0hBuoc5fSY5jfO/G4mANL7bv5GK0nfVkjalMQiCumyfzRsGwY5h2YrabMcukE8swebLG1CToSTSmvY9T8aKLbOJjJpBSuUrn8REZpeR3CUWoN4yKW8KK0BU/x/nIHk4NvEbI7JztJt0UKGgZne9zvUlXZVWg3BALEgpq2h7IqdRCvFaEEKjorMx7nArPcg72PcnFyH7CZs8MLZpIBs0OdnT/J4f7n6Y+sJla33rynVW4tenLhbOlTciMENC9ExblLXDkYkiLiHmz5bHeBAiRDYl+G5Y0s4uZM0T2TpsE3fHzae/j1oLoN8AK6K2ALc00TSkyMpRKCDXjw0ZtadERP8Opwa2cC+1g0OiY7SbdVChCyRpTV2DKZJrPtsjIZ/vtKEJJW7woteIsmQ3PpRCCIncddzg+Q1P0EOdCOzgf3kPM6p+xc4bNbg70/oLTg68zx7uaGt86Kr3Lcat+pqMPbClRmPh50xR1SHE0MyTds4wkKwA2EjtrTM0YWWNqEkxFAtanFWRk8uOtSCofJ70pVyZOuK72Yp9tElaEEwMvc7T/eXoSjWkpBmWZLJn7+88Glp1erp0Q4oaYYAnUVDHKNDDl7IfvOFUvtb71lLoXMj9wF6cGt9IQ2kncnv66LpeImL2cHHiZpsgBSt2LWJrzIJXeFdc0hitCIcfhpzc5QNiM4tHG9k5djLSjCRWvml04zUyy4+WVWNK8pcUnZpKsMXUVTDtBb6IprX0ECj6tAIeSeXk3tyL2FFZiMjGcLjW5yryXg5SShB1mR9d/cWLg5bSS5meGifpotrWUskwnUqT/e2beEzQ9ZMqdLYTAq+Xi8a6i1D2fFbmPcqT/WU4Pbidhz0xel0QSNrs5G3qD5ugh6vwbWV/4UTxqLilnfnq/ukPRqPNVcnywgXPhZvKdOamlrKHIACklSWnwbPub+DQ35Z6Zl6TPkuVasbGwM2akuLnIGlNXoSN+BkOmFw/tVL349cKMD8m6VVCHk/YnP4jMhNrLdJBpd5SUkqjVzwut/48LkX1M55QulTeioYihP1FQhIZT9eFWAzgVL07Vh2NIOVNX3OiKG4fiQlPcOETq75c+N+w4TzZ/gUiaCnBZMhdNONLaXiKxbgCPqcROewU53b6YaYQQOFUvRa553F1Sz+r893O8/wVODrxKzBrEkJfCEqcPiU3MGuBI/3NcjBxkU9GvM9d3e9oFgN2qizuKVrG/7yRfO/czQmaU1bkLUYWCRNIZ7+NHF1/g9OAFFgXmsjxn5iXps2S5VlLRLVlmgqwxdRVaokfTlm12Kn58euEMtShLuihp3+YSmaHGVKYxaLSztePLXIjsveZjqULHpQbwqDm41AA5jlJyHBUE9WICehFeLQ+3GkRVpjZpjJi9GelxzDJ1NOFIa5lEyhvj2ZbSTju3IWVMZdpUSSBEKlct11HOhsJPsDLvMU4PbqMxspfexAVCRve0KwCCZMBo5eW2L7Es92GW5T6CXyucdOikKhSWBut5sHQDL3Xs5p9Ofx+f5iFH95GwDfqSg1jSptpbxgeqHphQ8S9Llkzh0uJkOqhCp8hVP0Mtuv74tIKh0grTS9aYmgBbmrTHTg6pwU0etxogqJfMUKuypIsq9PQmXJD2b349SE2wMsdFHzZ62NX9XS6E91/TcfxaEUWuOgpdNeQ7q8l3ziGgl6YmylnvbpYJSNewltg3RE0zGytt77g+xUWG64kQAo+Wy4q8d7EgeA/tsVO0RI/QFjtOV+IccWt6c6sSdpj9vb9g0OhgXcGHyXVUTnpMyXH4ebziHopd+RzuP0N7vJu4lcSh6MwPVDPXW8aWwtUsDtZMa5uzZJkpVKGlvaDoUgI8WvE/ZqhF1x8FFac6/YXbs8bUBPQn2+g3WkknFEGgEHSU4NeynqlMIVVrYvLmlMTGTLNI8/XAkkbGhB8adpzjAy9xNrRjyqvKOY4K5vm3UOldQa6jHK+Wl5HCH1kyF6fiJZ1n25YWhp15z/bbMWUybalz/QbL0XWpPqp9q6n0Lmcw2U5P8iIt0SOcD++mP9k6bapjlkxyenAbUbOfe0v/gBxH2aT3zXcGebhsE+sLltGfDJG0DRSh4FXdFLpycd0ABmyWLJdQhJ62sI3ExqX6szW7rkLWmBoHKSWtsaNp51dowkGJawGqkr3xMgWX6kMg0ggFsknMuojCaCxpZISsqZSS7vh5jg+8RNKOpL2/LlzMD9zJ8rx3kesoQxOurAcqy5TwanlpbW9LMyOf7bdj2QnMNI2+dPsiU1CFRq6zghxHGXM8K1iR+06ao0c41v8CLbGjTEdelcSmOXqIre1f4YGyP8GtBiY95qhCpdCZS6Ez95rbkSXLbKIrrrSNIolN0o7jVrNz2onIGlPjYMg4rdFjxK3BtPbTFTflniUz1KosU8GlBlOrMZP06khsklbmTbhMmcyI8MOkHeXEwMv0JdNTuQRwq0HWF36MJcH7h1bJskZUlqnj1wrTWiixpUnSSn8B4HoipcSQibSlzm/0aAghFByqB111s0gvZn7gTjriZzjU9yQXIwdJWKFrKrcgkTRFD7K354dsKPxExgl2ZMky0yiouNUgAmXSC7MSm7g5MFS/Lct4ZI2pMZBIehMX6YyfS3tfn55HgXPuDLQqy1Rxa4G06jPZ0iJmDcxgi6ZG0o5ipRn6M91IKRk02jkd2pb2vl41jztLPsu8wJYZaNlkkGSOgHSW6cCnF5CO6IIpDaLWAFLKjDXkJRZxK5TmwonAq+fPWJuuJwIBQqAJB+WexZS6F9AZP8fxgRdpihxkwGif8jhoySRnQm9Q7llGjW/tVUOeTNsibEZJ2EmkHH/s8GguAvr052FkyTKdpMoW5CGEOmm1UFvahM0ecp0VM9y6G5usMTUGlm3QGjs2hZV3wVzfumyIX4bhUXPTSrq0pUXE7JnBFk2NpBXDtGfZmMLm9ODraRubLsXP+sKPUuffNEMtuzpSgpUhOWdZpgevlo+mOEnakzM8JKmFElMm0YVzhls3NUw7ScRIL7zcpfrRb9JwWUWolLjnUeyqpzN+lrOh7ZwP76EncWFKnqpBo5Mzg9spcS/Aq40fuhcyouzuOcLh/jP0GSn1vvFYl7+Ud5bfkXZbsmS53ni1PBSUSScMSGkRNrtmtE03A1ljahSSqNnL6cHX004A1oSDhYF7ZqhdWaZKquaXMmmnhI1FxOxFSjvtZM2ZJGGH074npxtbmpwafD3t/eYF7qA+sGWWJ3sSy04vdCpLZqMJB7mOCjripya9T8IKkbBC6EqGGlMyQdjsTmufXL18qJ7ezYsQgmJ3HfnOKmp86zkVep0TAy9NQQFQciGyl0WJe/FcCgF/G6ZtsqfnCP9x/in6jRBu1YlbddGXHMSjOpFAzErgUh2szF1AniMwLdeYJctME3SUogpt0mHENhZ9yZYZbtWNz809+k4BW9pcjBykI3Y67X2rvKsIOkpnoFVZroUcvRSFdFTiJHErRNwO4VaDM9audLCkScwamPUwv+5EI4NGR1r75OhlzAtswal40wq3nE6klFjSHCoUmuVmothVn5YxFTX7iFr9QyGCmYdhxxkw2tLaJ8855xZR2xJoioMS9wLynJVUepaztePLhIzOtI4Stfq5GDlAqXsRuhhdcyZmJXitcx9J2+ADcx5gQ8EykpbBXx//Bo9V3MVteYs51H+aH114gVW5C7gtL5snneXGIN9RldZYYUuT3sTFjA6NzgQyZ9k9Q4hZg7zV84MphA8IluS8I1sUNANxqQHcWk5a+8StECEjc1zbhh0lavbPdjNoihxMW1Gw1LOIAlfNrA/EYbMnI9QQs0wv6RaUDJs9hI0eMjF/TkpJ0o6mvRKc55yDcpN7pq5ECIFT9VHjW8u7Kv6SwBTqOjaG3yJpx8bMhUraJucizazKXcDDpRup9VZQ6i5EFxoBzUeVt5RHyjZzT8lanmndTkc8PU9iliyzRY6jLK06SxJJyOjKyDzyTCI7878CyzbY3f1d+tNcFQQoctZS4l4w6xPGLKMRQpDvmJPWPplmTMWtSNoy/TNBd/J8WtvripsiZx1udfbDYAan8FxnyXxK3PNR0giyiJr9hM0u7AkEBWYPyYDRnpaKrIJGrqPipg/zGwshFAqc1TxQ+scE9OK09u1ONBIbZ4FKYhMxYxQ4cwnqfoRI+dRVoZCwkwgECgr3l6yjM97Hgb7Je0azZJlNFKFSnOYCVMwaoDuR3rv/ViNrTA0hpeR85C1ODLyS9r6q0FmUcx8OxTsDLcsyHZS4F6S1fcwaTBWOnKTizUwTtwYIpRleNxP0JtITZXGrQfKclTPUmnSQdMTOzHYjskwzQgh8WgH5zqpJ72Nj0hVvmFKNtJnGkiYXIwfS2ifHUXY5L/QWRAiFYvc8luU8MmbI3nhIbDrjZ8c7KqpQkUP/AVCEwKk6CJnR4ZCnoO7Hkjbdyf5rv5AsWa4Tld6VpKOCGrP66Yo3TKhoeatza46+Y9AeP8Vb3T8gacfS3rfYNZ853tVZFb8MpsKzLK3tTRmnL9lEMgMKfEopiZh9s+4pk9ImavaltY9T8eDLgPo3EmiNHZ/tZmSZATTFQaV3eVr7tMdPE0uzhuD1wMbkYmR/WvsUuObiUW/tgrK64qLKtyYtoxqgL9nMWOGemlApcubSkxggZKbeAapQyXcEaY11MWhGkFISNiPY2LOWC5oly1So8q5OS800acfojJ/JyDEzU8gaU8BgsoN9PT8dWqVKz/LWhYta/3pyHKXZATWDyXPOwZVm0bmexAXCGSCRbskk3fEGDBmf1XaYMoGdprS4qjhxpRGfPVOEjA56Eo2z3YwsM4AqHJR5lqSVr9qTOE9/oiVjPM+X6Iidpj/ZOuntBQr5zmrcWmYI5cwmeY4KCl21pLPiPl7otEPRmR+o5mK0ja54ahtd0VgYmMvBvlM82/oGB/tP8Z3GZ9CESp5z9sOYs2SZLF4tL+1onc74GfqTzTPUohufW9qYkjKl2nao/ynOhXdMqWZFgWsuNb61t2S8+o2EpjgodS9Ka5+ueAMDybZZdW2nEtJjtMSOzlobLmHYSdJdbFBQURXHzDRokkgkDeGds66EmGVmEAhyHeUUuCZfLN2SBmdC27GkMYMtSw8pJUf7n09LJMWnFVDorElTrfTmRBUO/HoRmpj8eGPYYy9QuVQH6/KXEtC9KEJBItGFxpq8xThVBz+6+CJ/dewbvNl9iGJXPqtyF07XZWTJMuMIBHWBjWnt05tspiV6bNZrXWYqt6wxJaUkbofY2/NT9vX8HDutavMpnIqPRcH7yHVUks5qWJbrj0ClxrcurX0MGeNi5ADGFEI/p5Ow2ZMRIWrKlHIy7Flf/TfsGMcHXh3OfchycyGEwK8VU+lZnlZ0wNnQm4TN7ozJAxgw2jgf3p3WPnnOORS75mWFj0jdBy7Vl5bs83j9JhCszV/CF5f+DnW+yuFta3zlfLz6Uer8lRQ4gywIzOUTNe+k0p2e+EWWLLOLYK53bZoh+JKTg68waHRkzJiZSdyyxlTI6GRP9w/Y2/Mj5BQ8UiCY67udBcF7si+yGwCBoMy9KO26UefCOwjN4oRLIjk9+PqsG3QAmnCS7qKBJc0p5SFOFxLJudBOBtIIncpy4+FUPZS6F+HRJp87lLDD7O/9BZkgkW5Jk4O9vyQ5jqdkLDThpMy9CJ+eN4Mtu7GwpZXWoomuuMf8XAiBIhQ0RR1S8hND22tsKVrF/1ryGb649Hf44tLfZnXuwuwcIMsNhRACtxqg3r8prf26E+c5Nbh1SlFcNzu3nDFlS4vm6GG2dX6Ng71PTrnuTJ6jgnUFH8YxzmCcJbMQQuDRcijzpFdccdDo4PTAa7Pm1YiYPZwceHVWzv12VKHjUNO73y1pzKpqWsjo5OTgqxmp3JZleil1L6TQmV7OzOnB12iLnZy5Rk2S9thJGsK701rY82i51PjXk42KuIRMu7D5eCUbrlTxGwuv5qbQlYuuZMP7s9yY6IqLat+atMVrDvY9RUt09tMOMo1bypgy7DjH+1/i1fZ/5WzoTWzSD+2D1E24ofAT5DjKp7mFWWYSp+qnyrs67eKWh/p/RW/y4gy1amIO9z9DyOyclXO/nZQMdXrKfHErzOAsSbqbtsGZwe20Ro9nQ/xuAXxaPrX+DTjTKFERs0Ls7v7+rKpURc1+jvQ/S8iY/HMuENT41lGQpnrdzUzCijCQbE8rDy71Dh9tjIaMCF858xOO9J8laWdOXl2WLNOFEAqFrjrmeFemtV/cGmR759fTEsq5FbjpjSkpJba06Ek08lzL/2Frx1foSTRO2SOloLGu4MNU+26b5pZmmWkUVEpc8yhwVqe1X8wa4M3O/8C8ji9VKSVtsVMc63/+up1zMuQ4ytLaPmYN0Ju4eJ3DJCVSStpjJzjc93TWK3WLIITC/MAd5DrTWeSStMSOcLjvGawp5M1eC1JKLGlyLrSThtCutEJnHIqHVfnvSXth6GZFSklvspmexIW09htPSj1hG7zUvou/OvZ1vnDkq7zcsZuoFceSdjZfJMtNg0fNoc6/Ke1F0q74OV7v+DeiZn/2eRjipjWmpLRJWGG6E+fZ0fWf/OD873EuvAPzGuSlVaGzJPdBFgUfQBOObJz0DYYQgjxnFeXu9GSUAS5G9rO/92fXRclGSknU7GNX13fSrus006Qrp2rJJJ3xs+NKEM8EUkJPspE3ur5Jv5FdPbuVcCheVue9N63irYYd43Df05wZ3H7dDCopJRKb5sghdvd8j4QdnvS+AsGy3EcJaEUz2MIUqbFogKQVzeBJk8SUCS5E9tKdOD/pvQJaMQFtbOEIj+rigdIN5DkCnI+08KVT3+c33/prvt34NKfDFxlIhrGklcF9kiXL1RFCUOVbTYVnaVpzIolNY2Qv2zr/nZDROesiU2MhpcSwE8TMAazrsBB+0y1rGXackNFJb7KJC+G9nAvtJGJd+0ROQaXaexsrc9+NJ1vT44ZFV5zM9a2lIbybAaNt0vuZMsHh/qcJ6sXU+jegKZMveJcOUqbi/vf2/piW6OGMC08rdS1AQU1rFb0leoS22AlqtfUoYmYlnKW06YyfZVvn12mLnZjRc2XJPIQQ1Pk3cc6/i5ODr0x6v7DZxZ6eH6ApDub61qIIdUbrBkokTZGDbOv8WlrhfQCFrjqW5z46Qy0biSWT7Or+DrripNKzgnxnNT4tf2ghMTMWE20puRjZx9G+9GTlK7zL0BTnmIuiXs3NZ2rfQ1eij319JznYd5IL0Xaeanmd59t2sCynntvyFlPrK6fMVYhbm7zxniVLJuFQ3CzPfZSO+OmhItaTw5Ympwe3YUublXmPUeKah5iS4u/0YkubqNVHX6KZltgxImYPK3IfJT/NiKR0ueGNKSltYtYgA0Yb3YlGuuMNdCfO051oJD5tcfCCat9trCv4NfKcldN0zCyzRZlnMXO8qzjW/0JaeXMho5Nd3d/Dxqbev2naDarUKnAve3t/wvGBl2a9SO9Y5DjKyHVWplUAN2r1c7T/OYpcdQT04hnz6Jp2gvPht9jb8yPa46dm5BxZMh+BwtqCD9GVOJfWfdqTaGR75zeImH0sCt4zrtLbtZK0opwNvcGenh+mNXkBcKtBbst/P14t77pERkgk/clWLkT2cmLgVUpc8yl1L6DUvYhCVy1OdfL5aTOBLS3OhN5gd9d308ot1YSDKu8qdGV8I0gIQZErjwdLN3Bn0WrOhZs5NdjI8cEGTgyc562eY1R5S1kYmMvGguUszamfjkvKkuW6U+pZxOq897G141/Tyjm0pMGpwdfoT7ayOOcB6v0b01JUnS5S9TgjdMXP0RY7SWf8DO3xUwwaHZS45mPlzLz64A1jTKU6K0rE7B36Xw/9yVZ6EhcIm93ErRBRq4+4FWa6pW7nBbawsfAT5DhKp/W4WWYHXXGxIvedNIR3ETF70tq3N3mRNzu/RX+yldX5751WNce22Al2d3+XlujRjDSkABShUeffmNYkFeBi5ABvdn2Le0v+MG1FwKshkUTMXg71PjVUB6NrWo+f5cZCCEGOo5zb8z/I1vYvE7dDk963P9nCjq7/pCN2ilV576HAVcV0eWCklAwkW9nf9wvODG4naqUXwqugMi9wB5XelTPu4R2LiNnDufAOGiN78euF5DrKKXUvZo53JcWuuqE2XT9v1aDRyaG+pzg5sJWwmd4zX+iqo8hVP+naeW7VyZJgLQv81WwpXEVHopfToQvs7z3Byx270YSaNaay3LAIBAuCd9EZP8Ph/qfT3FvSET9Ff2crDaGdLAjezVzf7bhU/4y09crzxsxB2uOnaY4eoiN2mpDZRdjoxpSJGT73aGbVmDJlgqeb/3LMF4MkZfWadgLTTmDIJJZMIqWFjYUtLWxpYkljBkOhBIuC97Op6BND8pGZEdYwFcaO7ZZv+zON4yGviJMd3S+Znk+W76xiTd77eb3z30j3+kNmF3t7fsyFyD7WF3yUCu9SlKFHabLXfen3kEgGjDYO9T7F6dDrRMy+tNtzPREo1Ps3c7D3ybTyPGxMzgxuJ2GFubPks+ToZYCY8n2S6j+Jjc3ZwTfY2/sTehIX0pJFznLzIlCY61tLT94F9vX8NK3V1rg1yImBl2mJHWFR8D6W5DyIW80ZDvtL9xkHScKOcrz/RY70P8OA0Tal3Kwyz2KW574TlzLTk5SJsWSS/mQL/clWmiKHOND7M3x6IXO8q5jjWUmJez4OxTPUX+n12XhcHi9TkSgnB17h+MBL9CWb0/ptAVThoMa3jqBeSjrvdCklqlDIdwYRQnAu1ETYjJKwkhjXIdduonf4VOZAckRB9RvvHZ5letGEk9sLnmDQaKcxsjft/RN2iMbIXlpjx8hxlFPn30i9f9OwYubQSDC8/Xj318j7XI74/4Qdpjt+ntbYCVqjR+lJXiRpRTBlIu1xYLqZVWNKImmKHprNJoxDqqDZkpwHWZ3/XlyKP0MGFjmUuCyHB8JLRs3Iz6783B5SjTJI2FGSdpSkFSZhR0hYERJ2mI746bRizaNmP/t6f05AL8KpeHGo3pF/Ku6hnAMFgUAI5W1/F6l/j/H3a5lgp4MQCsvzHqEpepCG8C7SNWBMmaAtdpwnm79AqXshi4MPUOZZhEPxogr98vULMWLin1oEMDDsOJ3xM5wObediZD9x62qr54IC51x0xUVH7PSUZf2nA79eRH1gM0f7nyedfrOxaIzs5WcX/z9W572Hub61uNUcNMWBOglVMiltTJnEtJPErAEuRvZzuP/ZIS/Z1dvhUfOo9q2mIbQrLW9FlhsPIQQOxcOynEfpS7RwNvRmWjWcbCz6k63s6Pov9vf8nFr/Rur8G8h3zkVXnKhCQxHa8LgGDI/BtrRSC4EyQW+iiYbwLk4Nbr2mqIkcvZy1BR8mz1GZIe8iuCT8YFoJYtYgXfFz7Ov5KQ7FQ4FzLiWueZR45pPnqMKl+lGEhiJUFFSEUFBQYOgNgADk5T6UyCsWTE1iVj8d8dM0hvdyMXLgGhQ6BaXuBdT5N05aCVEiMWyTiBnjQqSNlzp2s7f3OHErgUd1Ue+fw7JJe6UkUg4ZMkPv5hF/Xvlef9vntrRI2lESdoSkFRnxDu+JN5K0opPuBUtaHOx7ihy9bJx3uAdV0SZ8V196v6Wegct/v17v8CzTS6r0ST6bij5Foj1Ce+zkFIz0VARZZ/wMnfEz7Oz6NrmOCkrcCyh21ZPjqMCvF6ArrqFxUxne79LTb9kGcTtEzOxn0OhkwGijP9lGb+ICg0bnUL525i043zBhftcPQZGrjhW572Re4E70GRIaSAcpbQaNTnqTFzDtJEk7hmFHSdqxob/H3/bvK/+MYtgxzGlcsU/YIY72PzvBFgJdONEVN7rixqG40RXXFX+//FnqT8/w3zXhwq8XUuCcO+MDsoLGxqKPMziUbzcVLGnQHD1Mc/QwTsVHoauGoF6GT8vHobhRFQe2tDBlgoQVImz2MpBspyd5AcOe/MvPrxWytuAJLGmwNfGvJOzZMaaEEDgVD/MCd3Ahsi/t5HlI5Z691vFVDvT+kirfaoqcdQQdJeiKZ3iSqqAMTyBMmRxS5emnJ3mBzvgZ2qIniduTz4l0qQE2FH6Ucs9SBox2WqJH0m53lhsLIQR+vYDbCz5EwgpxMXqQqbyE43aIYwPPc2zgedxqkDxnFQG9GJ+Wj1PxoAoHCIElkxhWjLDZw6DRQW+yaUjF8tpe/D4tdQ1zvCuu6TjXh1TuQmvsKK2xo9CX8hK61QB+vQivVoBbDeBS/ThVD6rQUYWOQMHGwpImhh0naUWIWv1EzB4Gku1EzJ60RG/Gw6vlsjTnIfKcFVzNK2VJmwEjTHusmxODDezoOcyZ0EVcipMSVz51/ko2FCxnWbAeh6pP3CtSErcGaY+fwpJJktbQ+1nGhv9++d/Ry+9wGcOwLv19+kK/JRYnBl6ecBtNON72Dr/09yve5cKNQx36bujvmnDh1XIpdNagKhP3S5bMQghBgbOKdQUf5s3O/6Ar0TDlMkKQWjToTV6kN3mR4wMvDn/uUNyowoEqHAgENqlFk1Q0WjzjhLcmQ9aYugKn4qfGv5blOY9S4l6QMasrtrQ4G3qD7Z3fuKYb+/ohMWQcw4pDmnkBAoX5gbt4oOyPEcxsXoAQglxHJesKPsIbndcuo52wwynDisPT1MIUunCxNPdB5vpupy/ZnJq8MXu1k4RQKHbNY55/C4f6fjXl+OQBo43Dfan4bIfixq3moitONOFEEdrQAGuQtKLErVBaYYVX4lID3J7/IRbn3E/SjpPnmJM1pm4hily1bCn+NNs6v87FyP5rOlbMGqAlepiWaWrb1fBrRawv/CiLgvdepzNOPxKbqNVP1OoHTs9aO1ThYEXuO6nzb+JqhlTcSvBS++6U2MTgeboT/RQ6c9lcsJJFwRoWB2upcBejKZN9R0k64md4qukvpsUovB6YMolppaIA0kNQ5V3NA2V/jFfJm5G2ZZk5hFCY410FRYKd3d+hfQZUcZN2DIhN+3Fnk6wxRSqpvsKzjKU5D1HhWZqKj88QQ+oSNtYNYkhdGylvxPWLfVWFRrXvNiJmL7u6v0fM6r9u554cgqW5D7Es5xF0xUWOXp5SoJrl97FL9bIk50E64mdojh7mWlffL3lVpxuXGuC2/A+wNOchBCpOxUOesxJNOKbVW5slsylw1nBH8Wd4o/ObnA/vnu3mTIqgXsqGwo9RH9jMjZyvmwkoQuW2/PezPPddaIrjqttHzBjfbnyapG1Q56vk4bLNLArMpcxdSFD3TVq44kpSgd43hiF1bcihd/iN513IkkIRKlXeVXi0INs6vpah6TiZxS1uTAn8WgFr8t9PnX8THi3nitydLLcKuuJicc4DmNJgV/d3MGZgUj9VluU8zLqCjwxLEOuKi1xHeVo1smYGQa6jnI2Fn+DZlv+dlizx9cKp+FiT9z6W5TycitEeqo2Tq1fg0XIZNDpmu4lZrhNCCPIdVdxZ/Fk8ag4nBl7O6IltvnMum4s+yRzvShS0jFvcu5HQhJPb8j/Airx341A8k9pHFSorcxdwb/Faan0V+HUPusj+DlluHYRQKHTWcX/ZH/NW9w85OvAC9nUqan4jcssZUwKBprjwa0UsyXkHC4P34lb9ZJMmb210xcXqvMdxql62d3yNxJQTnKcHTThZnPMONhZ+fMQEQAhBoauOxsg+ZnvlTwiFUvdCHir/bzzd/NdDxbEzYzXSq+Vxe/4HWZr7yFDC++VnO8dZjlfLzxpTtxhCCIJ6CVuKPoVbC3Ks/3li01aLcHpQhU6peyF3Fn92KG8Usl6pqSKG8s0+yKLgfWhi7AK9YxHUffzZwo8NiWRkle2y3JoIIfBrRWwu+jT5zir29vyUsNl9S0RJpcstY0w5FC9eLY88RyV1/o3U+jek5Fuzg2SWIYRQWBJ8B241wO7u79OTaJwFuU2BXytkee6jLM19eMyimEWu+kviV7OOEIJS9yIervg82zq+TmfizKyuXiloqQTawo9S61/HWBPRgFZEQC+mPXbihkx0zTJ1hBC4tAAbCj9OkbOW/b2/oCtxbtZldQUKAb2YeYEtrM5/L241OKvtuYzAqXoRiBvqWdGFi1L3Ilbnv4c53lVp1+USQqAO5exKJDErQdSMY0kLj+rCp0/Ow5Uly42OEAKH6mZZ7jvJd1ZzsPdJWmLHMjAlYjRuNUiuo2Ja64GOx01sTAlcqo9cRyX5jioKXTUUueopcFbjULMDYZaxEUJQ41tPQC/hcN/TnAvtSLu45lRRhMYc70oWBx9gru/2VG7UGBS5aiFjzKlUn5W5F3Fv6e9zsO9JzobeJD4LK/5erYA6/3qW5TxCvrOa8Vb0VUWnyFVLQ3hXRoV0Zrl+qEJjfvAuitzzONr/HOfDu+lNNKclnz5deLU85nhXsjB4L5WeFbNSkHc8VKGxJPgAmnDSHD1EyOjK6FVpTTgods1jrn8dCwJ349cLrul4ISPC0YFznBhsoCPRR9IyWF+wjPtL1iGlZH/fCZyKgwWBuWmIUWTJcuOhCIVK7wqKXPWcDb3JmdB22mInZuVdPxEKGjmOMkrc86nwLKfSsxy/XjTj571pjCmBMux5ynNWkeesJKAX49cKCejF6Io764XKMikUoVDorGFD4ceo9t3G8YEXaQjtmtFJRL6jiqW5DzHXt5agXjrhverXCvFouUTMnhlrT7oIoVDgnMvGwo9T4VnO8YEXuBg5yPUw+FThYK7vdhYG76HCswyn4rvqs17smo8u3Bg3maJQlvTI0ctYV/Bhan0bOB/ezcnBV69b+KdD8TLPv5la/0aK3fPwqEHEFIQNZhJFqMzxrqbIXU93vJHW2DEaw3toj5/ClpmTc6YKJxWeJdT6NlDhXUquo/Ka+7I/GeKpltd5uWMPvcmBYc9chefyxOy5th1EzBi/Vfc+5nhLrul8WbLcCDhVL4uC91LpXU5H7DQN4d00hHbOeu1Gr5pHuWcpld4VFDjnkuesxKVevwLnGW9MKehoigNNcaIJB5pw4lS9eLV8/Hohfq0Qv16EXy/ErfrRhAtdcaEpTlShcvPEm98s13FjIITAo+VQ41tHmXshHTkPcaz/eRoj+6bNmyFQyHPOYVnOw1R5V+PXi1I1V65iCAihUuicm1HGFFzqs1zmBbZQ6VlOU/QQR/ufozV6bEaKDLvUALW+DSwI3k2Bs3qoMOjkVoeLXHU4VS9Rq3f8ja7L4kt658iOAtOLEGIoJGwhBa65LArex4XIPk4MvkJHLL1i5pM6H4I85xzq/Vuo9W8YLnyeaUbUlQghcKtBKrzLKHEvYFHwPgaNTpoiB2iM7KUzfhZrlpQxc/Ry5vpupy6wkVxHBS4lVRz4WhdOTdtib99xnmp9nYDm4wNz7iffkcOXz/5oxHY1vgp+1fo6p0MXssbUCGZqpJr8cbNCYjOHEMpQrb1CKr3LWZX3OBciezk7+CYdidPXZaFFIPDrRZR7ljLXextF7nk4FR9O1TsqT/p6IKSccOV40svKqUrd1gx1onjbvwQIMfywpP4UQ/+9+R6gS1XQbxUlFSGUjFKwuvSM2JgMJNtpCO+iMbyHrkQDljSR0sKWQ9Xrhyp5p7h8hypCHXrAVbxqDnN8q6j1baDUvRBtqBr4ZK9XSomNiZRXn+gpQp+SjO+1kuoziSUNehIXORt+k/Oh3UMVzE1saSHH7DO4st9S94KCGOo/txakzL2YKu9K5nhX4VT9Uxo4pZRDeTITDXECVWgzNtGdynMtUKZlsjid2NJKc2wSk1o0mA1Sv0nq3uhLXqQhvIeLkf30Ji5iSSN1rVhDz558Wx6RGH4XKUIZ+q1S922ecw6VnuVU+VZT6KxFU5wIlIzsg6txaTyU2Ehpk7CjqULaseN0xRvoTV4kZg2+7Rm3h/v2cr+N9+yJy/8Z6sfUOKCiKS6KXXWUe5ZQ6VlBrrMSTeiIaZ48DRoR/ub4t+gzBvnd+g+yIFBNfzLMR3d/gccr7uaTNe9GSsnu3qP87Yn/5H2V9/FE1Tsm7DM5LBl+8zMT49Tkxuy3tUKoGRU2K6XElmZaizSK0NOaH8wGl99lFgNGOxcj+2mJHqUjfoqEFcYeGitGjp0w+re88tkXqWcfFSEUVKHh14ooctdR4ppPmWcxAb0YRWgpoZgrbIIZZNwTTJtnKnXhGorIeGfXDUeqbzNrULiVuDSIqejkOSvJc1ayOu+9RM0+uhMN9BmtDCTbiJp9JO0Yph3HxkZTHKmq8IqHgF5MrrOcPEcluY7KSdU6mag9KnpGuykuyZBrwkmxu55idz0bCj7GoNlBT/wCfckmwkY3EauXhBXFkklsaaEK7bIXWnHh1fKGPdA5jjJyHBVjGoe2bdPV3Et/5wBz5pfh8rkmfPkIIdDE1H+D6eBmea5nc8LS2jlAV2+YK1/KtXMK8bodk5p8JJMmZ5u68XudlBUGUdVUaQxFOCly1VPkqmddwa8RMXvpTVxkwGinP9lGxOwZftZNmUCgoClOdMWJQ/Hi0woI6EUEHSXkOapwq8GMngylw6XrEKggVDxKkGrfGqp9awCQ0iZmDRAyOgmbvUTNPqJWPwkrTNKOkrSjGHYcWxrYQxMsW9ooQkUVGqrQcShuXGoAlxrAq+US0EsI6iUEHCWo12GOYdgGDZFmNhWsZK63HFWoKGP8frl6ANM2iVoTRyuIoYmeIpwz1eSbnkwYs68VIVILSTcbV77L8p1zyHfOYWXeu7GlRV+ymYFkOyGzi5DRSdTqxbDjmHYCw05iS3PYWEo9+x6cqg+X6sOr5uHTC/HrhQT0kiEvfmaOo1nLJ0uWKSCEwKvn4dXzqJrtxtwgXJKmDuolwNppPXZ0MMZP/+FpXv3hm/zZf3yW296xYlqPnyUzee2tMzz16hGisSSDkTiJpMlX/+IDLJ9fPqn9zzZ184f/52fctmQOn/vY3eTljFbPhJRIhFfLo3I6G3+TIoSCR8vFo+VSPNuNmSISSFgGTtWBQ7naNOm6rIhnyXLDkTKuqsh33vyzpKwxlSVLloxBSsm2n+2mpKqQeWtqJr0KJYRAKAJVU9Ec2WHtVuHutfNYWFNM/2CMp7YeYdehxrT2V4RAEQJNVRFKdkKcJYUiFHIdfvqSg4TNGDmOsRPZz4WbcKo6eY5MkbLPkiXLbJCddWTJkiVj6OsY4Bf/8hybH7udeWtqJr2f2+/iA3/yTh76jXsonVs4gy3MkkmUFAQoKQgwGI6z58iFtPevrSzgy194P16Pk6Bv5muRZLkxcCo6i4O1HOw7xYH+U2wuWDnieyklfclBnm7dTo7uZ57/5l95z5Ily/hkjaksWbJkBFJKzh26QFdzL0YyPbEVRVHIL80lvzR3hlqX5WZE11VqKq+tFlGWmw+36uLe4rUc7j/Dv57+Ibu6D1PjqwCgJdrJz5tf5eWO3bTHe7ivZB0LAtWz2+AsWbLMKlljKkuWaUJKSTySoK9zgHg4jmXaKKqC7tTx53rx5/nQ9MuJ+tKWRMNxBntCxEIxTMNCURWcHgc5hUG8QTeKMlpsobOpm1BvhPK6ElRdpb9zgFBfBNOw0B0awQI/wQI/qqZimRYXT7USyPWhu3S6W3oRQlBUmY/T46S3vY/BnjAOl05JdSEO1+UE33OHLyCA0ppi3L6RBYSjoRjtjV043Q5KqgtRtZECBPFogt72fmLhOPZwP2j4cr34c33oQ6F4UkqMhElPWx/xSJx9Lx0m1Behu6WX0/saRhyzdlkVqj5Stau7pZeetpFFlSvmleHxjy1AERmI0nKug9K5Rbi9Trpbe4kMxLAtG92lk1PgJ1gYGHNfKSWxcJy+jgFi4ThSSpweJ7mFAXw53usWJialxLRsuvvChKNJLMtG1xQCPjf5OV6UK9ph25LG1h5sW1JSEMDnGZ0Ab9s2DU092FJSUZyDx+0Yca540qSnP0I0lsS2JU6HRm7ATcDnHnGuS/QNRunsCVFWFMTrdjAQjtM3GCWZtFBVgc/jpCDHh66PvGcs22YwHKd/MEYiaaIoAo/bQX7Qg8s5fep/0XiS9q5B4lcY7FcKUIzFmQtdqIqgujyPwUiCvoHocBt9Hid5Q228kp7+CJ09IYry/eQFPSPaL6Wkqa2PeNKkuMA/yitmWhYDoTgDoRhJw0II0DUVt0sn6Hfjnsb+yDIaRQgWBWv4SPXD/KJ5K3t6j/FG90EAdvce5a3eYwR0H5sKV/Cx6odRM1jaPkuWLDNP1pjKkmUakFLSeLSJ13+2m30vHaa1oYN4OI7DnTKMVt2zmA9//j3kFgeHt+9s6ubJr77IsR2naT3bTiySQFEFxXMKWHn3Eh759L1UzCsdZVD97J+e5bUf7eTP/vOzRENxnv/PrZx6q4HIYJRAno8HPnYH7/vcI/hyvERDMf7qg19i2ZaFBPL8PP+fryGE4NHfvJelmxbw47//FUffPEVeSQ4f/vzj3P2hjcOTtC+8+/8hhODz3/tdFq2bN6INDYcu8H8/+VWqF1fyJ9/8DP5c3/B33S29vPz9N9jx5Fu0nOsgGUvicOoECvzMX1PLo795L4s3zB/evvVcO9/87z+ivbGTzovdJKIJXvj2Nl778c4R5/zagf873H+XePPJt/jFv75AIpog3B8hGTf4P8/+N1bctXjM3+nknrP8j/f8PZ/9h4+iqAovfWcbF463kIwnCeT7WbZlIY/97juYt2pkiKG0JS3n2nnpO9vZ89wB2i90YZkWBWV5rLl/GQ987E6qF1eMMirHo2cgwsmmTvpCKRWwHJ+bBXOKyA94rjpJDkcSvLzrFC/vPElDUw/xhIHH7WRJfQmP3LGU25dV4RwyVi3L5t9/9CZHz7TyuY/dzd3r5o06fkvnAJ/725+jqgpf+m/vocqdl7pmKensCfHs9uNs33uWpvZ+TNMiN+hhzZI5PHLHEhbVlqC97Zq37T3LV36wnT/6+N2UFeXw85cOsu94E70DEVwOnRULy/njT9xDcX5geJ+kYXHgRBPPv3GCgyea6RuMoqkKc0pz2bKmjgc2LaKkwD8tBkRLez9f+8mbnLnQRSxhMBiOs2VNLX/+6QcI+scO9fvTv/8luqrwhd96kGdeP8qeIxfo6Y+iqYLaOYU8uHkR966fj997edHh+TeO8+Xvb+d3ntjMBx5ajfq2tv/9f77KuYtd/MFH7+LeDQuGP08kTd46eoHnth3j2Jk2+sNxAAI+FxXFOdy/cQEPbVmMQx/5+pZSMhCJs/XguTGvoaY0jyXVJeMajNNJfzjG6eYuuvrD2LYk4HVRX15ASV5gTAM8E3EoOncX38YcTwlv9R6nJdZJwk6ioJDrCLA4WMu6/KW41BtbYS5LlizXTtaYypJlGjh7sJFvfeFHHHr9OPPX1PDIp+4hkO8nHonTfKYd25K4fCO9ApGBKCd2n6W8rpiN71yDL9fLYE+IPc8d5Omvv4KRMPnU/3kCzxgTvGTC4LUf76S1oYOS6iLe/0ePYFs27Y1dFJTn4bzCA2EaFvteOsLaB1fywT9+lKe+9jJPfuUFTu09R0V9KUs2zOcn//gMT371Rdbcv4xgQWDU+SaLZVo8841X+Nk/PcvSTQt54n3rcXmdxEJxWs6103SyFcscWWMjkO/n3l/bBMDrP9nFrmf3s+HR1Wx455oR23mDnlHnW/fIaioXlBPui/D8f2xl38tHrtpG27J57ltbCfWGuf3Bldz1wY0kowneeuEQ2362m+6WXv7nTz43fD4pJf3dg3z9z77PiT1nWHn3Et7x63ehqgqn9zew9cc7aTnbwWf/8aOU1RRfdcJ/oaOPbzyzm7dONdEbigKQ63ezrKaMP3zPZsoKxk9mTyQNvv/MXn7ywgFqKgt44pE1+L0uOroHeW77cc5d3MpnPriZe4aMJlVVeMemhew42MDRs22sW16N923eqe37zhGOJdiypo7KksthktFYki//YBu7DjWyYmEFD2xahEPXaGjq4pVdp7nQ2scffPROFswd+5r3H2/iV68dxe3Uefc9y3BoKl19YZKGReAKT4wtJQdPNvOlb28laZjcdXs9laW5KQPreBM/em4/zR39/O6v3UHgKpL3k6GsOMgnHl/PQChKU3s///hfWye1X1dfhC9/fxu6rvLYvcvxeZw0tfXx4o6TfOtnOynI9bFh5VzUMbzJk0VKSXN7H1/+/jZsW3L/pkWUFQUwTZuuvjCnzncQjRuMVx6yvTfEX33npTG/+8CdK5hfWTTjxlR7b4jvvrSP1w830NkfxrZtgl43i6qK+e13b2ReRcEN41VThcr8QDXz/FXErWTKmBIKHtWFptzYJQ2yZMkyfWSNqSxZrpF4NMGz39zK4dePs+HR1fz6X32QvJIgulPHMi0ig6kwMvcVq9ZCCCrnl/En3/gMbr8Lf44XVVcxkyY1y6r42p99lx2/2sdHvvCeMY2peCTB0R2nePx3H2TTY7fjy/EOh6EpihgOowNAgsfv4o73rWPRunrisST/9T9/AsB7fv8hcoqDHNp2graGDtobu67JmIoMRDm55yzJuMGn//YJKupLUVQFy7SJhmKE+yIUVOSN6Ie8khzueO86AM4fvcie5w8yd0klW96z9qqTruI5BRTPKSAeiXPwtWOTbmfD4Yt85u8/wl3v34Avx4Nl2qy8dyl//cF/4syB85x86xyr7106vP1z39rKga1HufuDG/nI/3gPuUVBhCLY0L4ab9DDU199iR1P7ePdn70f3Tl+HRHbtvnJa4d4cd9pDPNygfOu/givHjhLnt/Df3vi7nH3f+voRZ7dfpzCPB+f//QDlBUH0VSVeNJgQU0xf/6lX/Hc9mMsriuhtDCIEDCvuoi55fkcOtlMV194hDEViSbYe/QiScPi4S2LR3gNnn/jONv2nmPtsmr+8GN3UZjrQ1EEg+E4hXk+vv6THWzdfZo5pXl43aNX519/6ywPblnMBx9cRU4gFbIaTxgkkibuK/rING2++bMdhMJxfv0963lg40I8bge2lGxaVcM3f7aTV3edZvn8ch65c8nVf9yr4HU7WVRbAkBpS8+k94snDBDwex++g+ryfDRVIRxNEAy4+dqP32T/8SZWL6ocESaZLlJKLrT10djSy8cfW8eHH12Dx+VISXUnDAbCcTxuBw49Myfyti159cAZntxxjEg8Ofx5byjKG0fP43Ro/O2nHuYGsaWGEULg1py4ydaJypIly2iygb5ZsoyDZdvEkyaxhDHqf/GkgRxaHm462crpfedQNZVPfvEJymqLcXldqJqKw+Ugtyg4pjCC7tQpqy0mtyiI5khVi9edOtWLK6mYV0Z/5wBG4vJ5RiKpnFfGvb+2iZzCAJquojs0Ank+fGPUyikoz6OwIh9FVahdXoVQBCVVhRRW5ONwpvKlTMMiMhC9pj5zepy4PCmjcf8rRzENC9uWqJpCIM9HWW0xjgmMjetF3coq1j20Cl9OKqxO01XmLqpkzoIybEvS1tAxvG3Kk/UqgXw/W967lrySHBRVQQhBbkkOK+9cTCDPx55nD5BMGBOet7M/wrELHSMMqUtIKdl2+ByxRHKMPVMT1Z0Hz9PTF+Zddy9jTlkuuqYiBLidOrctqaKmPJ+Gph4aW3qB1CQwN+hh3fJqTl/o4nxLL7Z92TN44nwHTe19VJbksGJhxfDnlmXzq9eOomsqD25eSHG+P1XQVggCPhe3La2iINfH3mNNhCLxMduragqfeGwtRfl+HLqGpir4PE7y33Z/nm7s4OiZNmrnFLJlTR1ejzPlVVMUyoqCbF5di8/r5KmtR7DtcVwyUySdo7mdOhtX1lA7p3Co31P5UovrSgn4XLR1DYz5u6aDEIKgz4WqKpy72EXfQAzLshGA2+WgpCBAwHvt3rmZYjAa5/iFjhGG1JVsP9JAOJ64zq2aOraUGLZJV6KXPT1HebXjLd7oOkhDuIWYGceS9tUPkiVLlpuerGcqS5Zx2Huqmf/9/Vdo6uwf9V1Rjo+nvvjrqdCl5h76OgaoXzWX/NKcSR9fSolpWIT7I8QjCcykiWXZhHrDWEOTMtsae7qnOXSqF1eMCOebCJfHidOdMmLcPheapuIJeIZFE3SHjpRyVAheujhcOg98bAstZ9v45ud/yNYf7eD+j97B0k3zKSjLwxNwZ8REsGphBW6fc0RbhCIIFgQQQDJ+2ShqOdvOQHeIvOIcbNPm/NGmEcca7AnjcDtoOdt+1f4LRePEk+MbXEnToi8cx+0c7d3oD8Xo6Alh2ZKAz8W5pu4R3xuGhd/norVrgIGhXCxIGQErFlTw9GtH2fbWGdYurcLjdmBZNkdOt9LZE+LT79uIdkX4V1v3IL0D0eEaTG8/V1dvGI9Lp71rgMQ4yovzq4vGFLx4OyfOtQNQmOcbZWgJISgvziHH7+bU+ZQRej1yfsbC6dCoqSxAufKeEQKnQ8PjcpA0LOzx4u/SoLo8nwc3LWLrntN85i9/yH3rF3D32nmUFQUJ+Fzok8zLmw1iCYNQdHxjybRsegaiBDyucbfJFAzb5MTgeX7RvJX9fScw5UhDucxVyLsr7mRL4Sr8+tjFnrNkyXJrkDWmsmSZiHHmRld+nIwbGAkzNRGfpJ0gpaSntY9dz+znwNZjtDV0YCRMbNvGMi36Owcn3F9RBB7/5A0ToSiIK3I5hCJQtLEmpZObDMpxNhVCsPbhVQQK/Lz0nW2c3neeb37+BwTyfax7aBWbH1/LwnX1szYhvoTH70aZqA1XTIrD/VGkhLbGTv7iff/AeD3uDXoYN5llCF1Tx1RovIQqBC597GE5kTRJGinD5W++/iJinJY4dBXrCu+TEIKq8jzmzy1m9+FGevojuF06nb1hjp9tw+N2sHFV7YhjRKIJbFsyGInz5196CsY5l8etj+M5Bf8kDf1wNIkiBB6XY8z72eXU0TUVy5ZE48lRqnnXQjpmvaKk2jg+6RlSY/WbEIK8oJdPf2AjNRX57DrcyMs7T/LkK4dZtaiSu9fNY+PKmmnJHZsJVFVBU8c39hQhRoR4ZiqWtDk6cJZ/P/czOuN9VHpKyHcE0BUdS9qEzSgtsU6+du7ntMa6eKLqQbxatk5Zliy3KlljKkuWa0TVVFRNIR6JX20uPYyZMPn2//opO57ex/w1tdzzxCbyS3Nxep3Ew3Ge+cYrHNl+cuKDpDOXmuZ5l2Va49aCEkKwcG09dSvm0nisiVN7z3Fg6zGe/8/XOLztBL/5fz88rtre9UIIMa4x8nacbh0B5Jfm8u7ffmCUTPwldIeOyzuxAVEQ9KYU+xh76j23NJ+gd+zja6oyLG7w4UdvozDHN+Z2iqqwuK50xGdFeX4W15Vy4EQzOw6e5/3vWElTex8nz3ewblk1BbneEZNzh64hBHjdDj76rtvxuce+Lk1TyQuOvSo/2cm+e8ggSyRNpGTUgkTSSHlsFSFGKdhdK+mYP0IIplOILjZOSKgQUJjr4wMPrebOtfWcPN/B4ZOt7DjYwL9893W6esN88KHVw4qNmYTf7aQkL5VbN1ZIZlVxLnnjKCZmEnErwQvtO+lPhni0bDPrC5ZT7MrDqTiwpEW/EeZcuIkfXHiB7V0HWBqsZ13B0qsfOEuWLDclmTca3+IMxuL8fO8x9p5vZkN9Fe+7fSn6BCt9NyoXuvv4/s6DtPQN8viaJdy9qPbqO6WBZdu8evwc39t5EIBfW7+SexfXzshqbrDQjy/HS8ORiyRiSRyuq6+8Np9p49Uf7aBuRRUf+5/vTdVQGgrf6Wzq5vWf7LzKEWYeTVcxEibxyMj8B2lLQn0RQn3hcfcVQuBw6cxbXUPt8irWP7KaJ7/yIj//l+d46bvbJzCmUr/PNERLTRulNcU4vU5cHidr7ltOzbI5Uz6W1+XgodsXcOhc66hwqKDXxaceXjuu1y7od5Eb9CAELJhbzB231U/6vLqmsmJBBc9vP85z247xzruXcrKhg1AkwcZVtbjfds+WFPjxuB0YpsWqRZUsqS9L/2InybyqQixb0tMfIRSJjVD6g1RIYSiaoLw4OK1eqZlGURQUIYjEkqOsNsO0aJuE97m0MEhJQYDbl1azYmE5X/vJm/zi5UO86+6lGWlMuRwam5fWsP3IeZq7BkZ853M5+NTD6zI6TPEScSvJkf4zLA3W82j5HeQ7giPeHX7dS4W7CCnhS6e/z5nwxawxlSXLLcy0xdrYUmJYFklz8v+zpRw3RORWpbl3gG+8/havnWjgH194k8i4AgQ3Nq+fPM/P9h7jtRMN/POLO0aEJU0HUkLHQJi3Gpp5q6GZjsHxJ/7XStXCcsrrSujvGuSXX34ey7SQdurellJiW6nQvSt/x4GeEEbCwJ/no6iyAEVVUtvaNq3nOjh/rHnG2jtZCivyiUcTXDjehG3bw9cTHohw4JUjGInRnilpSyzTwrbs4etVVIX80lwWrZ8HUtLX0T/uPe10O1BVha7mHqRk+JxyFscKt8/FhkdX09PWx45f7R0WBRn+fW17SGjDvmobhRDcs6qeL/76g6yZX0nQ6yLX5+bulXX8y+++m5V15ePue8kg8ntd/Pj5A8TixvAYKqXElhLLsrGssduxuL6U8pIczrf0cPBkM/uPN1FbWUBNRf6IPCBIhdZtXlVLLG7w/PYTQ16jK685VTh4Mtd8NRbWlFJVlkdDczeHT7ViX/HsRONJ9h9voqs3xL3rF4xq57Uyk4FyPo8Dt0vj2Nl2TMse0Xdv7DvH4BjCHVJKLPvyb3ipbz0unbo5hRTl+ekdiGLZMqMWHC4hhGDN/Er+4qP3c+fyWnJ9bgIeF+sWVfF/Pv0wdy6vufpBMgCJTdiMUeLOJ88xdhFvgGU5dVjSImbdOKIaWbJkmX6mbWnrTHs3f/SDZ2js6hv+TDLxy+rff/1xNtRNfZX3ZkQIgT6kmuXR9WkNK8kkVEVBFQIhBF6nPqOTmpkmkO/n/o9s4cLxZn74f5+ivbGLO967jtziIJGBGBdPttDW0MFjv/sgRZX5AFTMK8WX4+H8kYvseGovK+5chJRwel8DT/3bS4T7IrN8VbD58ds5secsz3zjVYIFAepXzSUWjvPy97az/ed7cHpG5480HLnAM994ldKaYhatqyenwI9tS5pPt/K9v/klulNn+R2Lxj3n3MWV+HO9vP6TnSzfspDa5dVIJJGBGHUrqtGukIROxpNEBmJYlkU8nCA2VNy0r3OQ7pZeFFVBd2h4Ap4R+02FJ/6/d3Ni1xme/MoL9LX3s+HdtxEs8DPYE6b1bDt7XzzM/R/bwtoHV161cK+uqWxcUs3GJdVptUEIwT3r5vHWkQts33eOP/5/v+Dd9yyjsiSXRNKgszfMgRPNOB0av/74uhEFZGHIa7C6lqOn23h++wmOnW3l0buWUlI4erIohODDj97GvmNNvPDmCcLRBPdtXEBhro9QOE5L1wBvHbnAbUureMemhdcUfud0aPzWBzfxv7/2Il/7yZuEYwkW1pSQMExefvMkv9p6hPqqIh69c+mIEMB4wiAaT2JZqdyu2JBoSO9AlM7eMKoi0DUVr8cxnMdj2zaRWJJE0sS2Jd1Dz1k8YdLVGyZpmCiKgtulXyU/6urUVhZSUZzLniONfPNnO7hvw0JURXD4dCvff/otPGN4sE3L5icvHKC1s5/bllZTWZKDrqqEonFefPMkR8+0sXpxJU6HlrHy4pqqsKq+nFX1Yy8MZGKu19tRhUqhMxfDNjGlhUOMve4cNmM4FZ1c3X+dW5glS5ZMYtqMKZeuUVuUh6ooGKZF0rKIJJIMxhLD3wfdLhyaikNT0VUV3xiKVbc6FXlBfuvudRxqamPTvGo8jrGTsm907lgwl95whI7BCI+tWTxhUn6mI4Rg/aOrSSYMnvnGK+x/+Qiv/2QnlmGhOTTcPhcL19WPmPzkFgb5tT9/nOf+Yyvf/PwPcLgc2LbEn+vljvetY+HtdTz1by/O3kUB9314C6f3nefwtuP8w2e+NmSc6FQtLOex33uQfS8fHrWPw+VgoHuQN5/cS3QwJbMuAV1XySvJ5b4Pb+ahT9497j29/M5F3PH+9Wz/+R7+7lP/DoAyJKv+1T1/M0L2/eiO0/z8n59jsCdENBSjpzW1kPONP/8egXw/Lq+L6kUVvP+PHqFsqK7QVBBCUFiZz+f+/dP86O9/xVsvHOKl724nmTCGjDU3+WV5uDzOST+rU32mvW4nf/DRuwj4XOw/3sTffuMlYgkDRRG4HDr5QQ93r5s/ZqigEIKNK2v43q/eYvves3g9DpbUlY5rNAT9br7w2Qf5j5/v5OjZVl7fe5ZE0kTXFNwuB4W5Xrasqbtmb5GiCNYuq+azH9rMk68c5h/+81WSRko5LeB1sWx+OR955+0U5o3M69p37CK/eOUwfQNRIrEk3UNhp1/69laCPjfuIW/Ohx5aTeVQaYLBcIIfPb+P/cebiMWNYVn3w6db+fN/+hVetwOv28EDmxby6J3XFrY1r6qQd969lF++bPPTFw/y/Wf24XJo5AY83HlbPQh4btvI2mgCcGgqOw808ty24xhDuWK2Lcnxu1laX8onHl83piGWSdzo7yy36mR9wXLOhZu4GGmjxleB8jaDKmYleKVjD8WufJbk1M1SS7NkyZIJTJsxVRL083v3byQUSxA3TKJJg4MXWvnmtr0ArK4u5z23LcHvcuLUNVy6RnXB6No7tzp+l5P3r13G+9cum+2mzCgVeUF+9/6Ns92MaUNRFe58/3oWrq3j9L7z9LT1YSQMHC6dQL6f6sWV5BbnDG+v6iqPfPpe5q2uofFYE7FwHKfbQdWiChbcVkfT6Vbyy3Lx545O7r/9wZUUlOWxeMP8q7bL6Xbw3j98mPzSnGFxhJKqQj7yhfew8PbLE4B1D6+kvL6E8vrLwgWegJvf+ruPcPTNU7Q3dmIaFv48L/NW11JUmU95XUlq8nfFZLx0bhEf/vzjXDjeQl/nAMm4gRDgC3opry9h4e11OCYoaur2ufi1P3+cZZsX0trQQTJu4HTp5JXmjJKBzykMsHzLQkxj/No+OYUBXFd4aMrqSvjY/3wf81bNRXeOHv42vmsNFfNKWbRh3ojPFUVh/m21/N4/f4LT+87TfqGLRCSB0+MgkO+ncn4Zc+aXDUvNzyR5QQ+//5E7OX6unYutvQxGEqiqwOd2Ul6cQ01l/riKaaWFQX7jvRvo6ouQF/SwbP74YYVCCOaW5/Env34vJxraae7oJxpL4tQ1Aj4Xc0pzqa7IH2W4Lawp4ePvXktFSc6kr8nl1Hloy2IW1ZZw6nwn/YMxNE2hpCDAotoSCvN8oybo+Tk+Vi2sJGmOLYQCkB/0jsgH03WF2srCCfONFCEoKwyO+OzXHlmDZUlK3vY5QHG+nyceXkPQ7xrR75qm8uidS6ivKuTMhS7C0QQup86c0lyWzSvnQmsvBbk+aucUDu+jqgr3rJ9PeXEOHd2DhGNJbNvG6dAozg+woKaYojz/iOLKWaaOlJIjA2cZmdSWEqep8pZwZOAM373wHKtzF1Dkysep6JjSYsAIcTrUxJvdB3m84m7qfZWzdQlZsmTJAMRV4t2nHJVtS8nrJxr4ne88BcAT65bzJw9vwaFlXtJslpsP07L54a5D/M3TrwHw3x69i19bvzytFdPdJy7yv7/3Ck1d/aO+K8zx8auhOlNZsmTJMttIKTnV1MUTX/zemN9/4M4V/P57NuPKQOGK2cKSFp/d+3+wuaKUAAwrfQ6aEQaNCB7VhU9zowoVG0ncShAyIgghmOev4t7itbyjdMMsXUWWLFmuE+NOILOjapYsWbJkyZLlliRkRkcYU2/nUkHemD1S1dSrewBoiXXSFu8etV+WLFluHTLemLJsm1jSJGEYGLaNLSUCUISCpio4NRWXrqNNogiolJKEmQpBNEwbS6bi0XVVwa3ruBz6hPH/saRBXySGEIKigDcVyy4l0YRB3DAxbRuQqIqCS9fwOByoipjQGxJNGgxE42MqYmmqQoHfm1ZOgi0lCcMkbpgYloVl20hSoSvaULvcDn24Xs14dIciJM3xw6fejqIIgm4XbsfY4UX90RjRceqquHSNPJ9n0ue6RMIwiSSTJIeU8hRFwaVpeJ0OEDd+3H6WLFmyZJk5FBS+s+6vrvk42TfNtSOlhZSDSBlDCA9CBKf1HZ6aY5nYVgcAQvEOnePGzdeeaa6lz6SMIe1+QCCUIEJkfn25ayFjjSkpJf3ROPsaW3jjdCNHmtpo6QsRSxoIIQi4nZQE/SwoLWRFVSlr5lZQkRcc0/CQUmJYNsdaOthx5gK7zl7kQk8/A9E4bqdOeU6A2+ZWsGXBXFbMKcXt0Md8iLedOs+f/vA5NFXh6c99DJ/Tya5zF3np2FkON7XRNRhBSkmez8OSimLuWVTHpnnV5HjGr1b/6vFzfPGpV4eFOq5kXkkB3/vMB/BMQqhDSklbf4iznT0cvNDKoYttnO/uoz8Sw7IlHqeDkqCPReVF3L2wlpXVZeR5xzdg/ugHz7D3fMtVz3uJPK+bz7/zbt6xbN6Y33/phTf5xd5jQwbnSO5dXMc/ffjRSZ/Lsm2aegd49fg5XjvRwNmOHuKGQcDtYnF5EfctrWdDXRW6lh0ks2TJkiXL2AghULOmUEZg2x1E+z+PkdyB5tiAP/dfAO/oKt7Xcg7zPP1ddwPg9DyBJ/DnCJEzbce/GRnZZx/CE/j8pPosEf0R0dA/Ajoe/+dweT40rb9lppGRxtQlQ+prW/fwq4Mn6IvEANAUBYemYlgWPeEoPeEox1o6eP7IaX73vvU8sX7FmD9W0rT42d6j/GDnIRq6eoHUIOrSVKKJJCfbujjZ1sWLx87w2OrFfHjDSnK941vRccOkoauPfeeb+cmeI/RGYqiKwKFpJE2Ltv4Qbf0hdpy5yLtXL+L379+Y8paMQXHQx/q6OXSHosSSBoPxBB0DIQwrvbpLlpR8f+dBfr7vGAPRy/VLHKqKriqE4wlOx+Kcbu/m5WNnef/ty/j45tXkj+MRKgr4qMwLIidIm5MSOgcjGNbVPVgLSgtZXz+HcDxJLGkM/352msVSLNvmaHMHX3llJ7vPNQ33k0NV6Y/GeO3keXaebeKdqxZSEvSjq+qk2pclS5YsWbJkGYm0IyTiz2JbrVPaX1XLcbgfv6o3Q9p9GMmdSBnBSGwd8lCNFmDKcmOQjL+KtFPzbTO5Fzwf5Gb24WakMWVLyYtHz/CTPYeJGSZLK0p4YOk8qgpy0FQF07LpCUc41dbN/gstJE2LeSWFY4auSSn58Z7D/Nuru+mPxsn3ebhnUS1r5lbgdzmJGwan2rt57vApLnb385/b9xFJJPn9+zeOG7IG8NWXd3GqvYuA28Wvb17N4opiPA4H4USCHWcu8tLRM4QTSX665wgLy4p4bPXiMY+zpLyYP35wC3HDIGlanO/u40svvElz78CY24+HAEpzAkQSSeqLC7itpoL5pYUU+NwoQmEgFmdPQxPPHT5FOJ7kF3uPUVOYx7tXLxrTa/bpO28nlEhcLhZ25Z9D7Gts4b+276cvGqPQ72VeScG47Xtw2Xw2zqsiYVgkTZPXTjbwnTcPjOmRm4jOwQjf2raXXWebMG2b+pICHl+9mMr8HJCSlv5Bnjt0iqcOnKDA58GW01sM+EbHtiWtPYOcb+uhpXuAzv4w/eE48aSBYVooQwsWXpeDoM9Fca6P8oIcasryyfd7rruKmGXbNLT2sOvERRpae4gmDHxuB5VFOdw2fw4LKgvHlAG/kt5QlN3HL3K0sZ2+UBQJ5PrczC3N4/b5lVSV5F2fi8mSZQJC0QQnLnZwurmL9t4QA+E4CdNEV1PPY1Guj5rSPBZXl1CY4xszCkPNqvxNCSklg9E4Jy92cb6th9beEAPhWKpYNSm5+oDXSWHQR1VxLgvmFFGc65u1kh6p9iY43dRJQ1svbb0hBiIxYgkD25Y4dRW/x0VB0EtVcS71FYWUFwSuGt4/9rnCJKLfS02Ip4DmWIvD/W5g4nMLJRfNsQ4juQuH8y6E8NzMc++bHofzLkzjEEK40J0bbmqvFGS4MRUzTOYW5vKH79jEiqpSHKqKEGKoSrwkbhiE40kiiSTleYFRx5FSsr+xle/vPER/NE6h38vvP7CRexfX4XU6hp/TzfPnsmleNf/rFy9zpqOHZw6eZF5JIY+NY2gAHLzYSnHQz1+/5z6WzynF5dCHbY31dXPI87r5zpsHSJgWP9h5iHetWjTmy8/t0EcYbbqm4p5CAUxFCB5aPp/K/AD1xQX4XU5cuj6cs2XZNncsqKEk6Oerr+6iLxpj/4UW7l5cS9DtGnW8+gkMIyklzX2DHLrYxkAsjtuh8QcPbKKqIGfcfYIeF0HP5fOc6+xFS3NgNy2bXecu8vrJ85i2zbySAv7hiUcozw2gDxXlNC2LuxfW8tdPvcrrJ8+ndfybjUt5eIZpcbq5m22Hz7H7xEW6BiLEkyaGaWGYqbw6W0ouOQkVIVAUgaoo6FrKuHI7derLC7lnVT33rKrHOVQEd6ox7a/sP8PXn9lNbCiPTlUEj6xfxCfecdvwMx6NG/x022F+tv0wvYNR4kaq0KqqCBy6xvdfOcDGJdX8/uObCXpHhtKmxgibN4828q3n3uJCRy/RhIFl2yBTEtROXSPH5+KB2xbw4XtXjTpGunz1qR28tO80ljU1EVQh4BPvuI13bVwy5TaMhWlZPLf7JN98bg9jOYI/eNdyHt+yDOc1FN69Gm09g/zN91/hQkf/qO90TeFvPvUw9eXjjzkAf/ntl9h/pnnUNXjdDv7sg3exvLZsWtpqS8m+U0389XdfGfP7J+5dyfvvSE8ZdCwuPZ/tvSGe2nmMV/afoXcwNrywYdkylSMsUjnCupa6Zz0unTXzKnjfHStYXF0MXH4OnbqOEIz5O18rP9t2mB+/foh4Ynwp+qvx2OYlfPT+Nddcm2wi/unn23n94Dks+3In5Pjc/PPvvIvAFc/4pf5v6hrgZ9sO8+bRRvrDURKGSdK0sSx7OHJCCJEqAq2qOHQVj1NnwZwiHtu0lPWLqlCukht9rVxqq2VLjp5v45ndJ9hz4iKRuEHCSI3lpm1j229vr4JD1/A4dWrK8nl47UI2L6vB4xw7lWF8BOlZNlfegNqk9lWUYnw5f4eUEYQSAOFJ85xZMgmn5wPornsBBUXN42b/LTPSmJISekKpgp9+l5M8r3vYkILUQKGpAp/qHDd8DlIDz7OHT9HaN4imKNy7pI53rlw4anXG7dBZMaeUz9yzjs//5AV6IzFeOnqGzfOrKfSP7WZWhOA37riNdXVzRgxKAsjxuLl7cR2vnzrP2Y4e2voHaekdSHlPZgghBDkeF5vnzR3+95WoikLA7eSjm1bxH9v3EkuatPWH6I/ExzSmxkNKSSie4Ic7D7Ht1HlUReEP7t/EpvnVM/qCBIgbBs8cPIlhWeiqwu/fv5GqgpwR59U1ldIcP7919zoOX2yj74qQx1sFW0oSSZP+cIwX3jrFs3tOcr69B9u+/FK+2v62JTEtm2HNkFCMlu5Bth1p4N+f3sUnH7yNu1fW4XNPvlDtlYTjSZq7+keIkpwb8jx5XQ5iCYOvPbOL77+yf8SkCFLPdSxhEEsYPLXjOA2tPXzxkw9SXhAcNsQM0+K5PSf5p5+/QX84Nur8pmVjWkki8STffnEvzV39/N7jmynN8095UtQbitLUOZAy2KbIYDQ9T+1kUBWFkvwApmXT2jM46vvn9pzi/tvm49DUGZkQSinZe7qZY40d9I3xW9RXFFJTmn/V43T1h7nY2T/qc7/bSTw5trjNVIkljTFLIgAMRq59TJFSEo4leGnfGb713B7aekPjPptSgiVtrKRNPGkyEInz9M4TvLL/LA+vW8iH71tNWX5gSJRJ4HE6iMSTYx7rWhiMJmjuGhheAJkKYz2L003vYJSLXf3DhgVAU1c/3YNRAkM152xbMhCJ8ePXD/OdF/cSSxoTGqBSSsyhMTGWNBiIxGnrDfHGkfPctmAOv/noOhZUFqGp6rQvwF8az860dPMfz7/FzuMXiKfVXnO4vTuPX2BuSR6/9c71rF1YNSmjSij5+HK/CnJyY5NlXSQ6+L+xjCMIEcTl+RDiKl4pACFUhFoATLyokuXGQCgeVCV9YbEblYw0poSA2qI8znR0c6ajh9dONuBx6pQG/aPc6hMNBC19A5xu78K0bXxOx5iG1JXHuXthLSVBP43dfTR09nCqrWtcY8rvdvLw8vljnl8IQXlOYDjvypKS3khsRo2pS+e9Gl6HTr7PQ3Pv4LDi32SRUmLaNi8cPs2P9xxGVRQeW72Y996+dMYNKSklkUSSgxfbgJQ4R11x/pjnFUJQHPSxfE4Zr51smNF2ZRqmZXOmpYtf7TjOC3tP0Rea3smLbUuau/r52x9u5dC5Vj7+wG1UFOVMy+/fMxilNxTF5dD4xRtH+e5L+65a6E5KyfELHfzrL9/kTz9wF3mB1OC988SFcQ2pt2NaNq/sP0NpXoDfeGgt3gmKCt+ICCGoLsllUVXxmMbU8YsdNLT2kjd/Zl588aTBgbMtDIxjhDy2cTG3UnSalJLW7kG+8dxuntpxfFILHKOOAUQTKc/tudZePv3IWlbVV6AoCn6Pc0aMqRud081d1JTmpcbI5i6+/OQOdp+4MGqxJh0My2bHsUaau/r5zUfWc9fKOpy6Nq0GVW8oyrO7T/Kdl/bSPRC9pmPZtuRcaw9/9rVneHjdQj5y3xqqinMnVEMWQkNVSyZ1fGmHSUR/jGWcAQRO96M43Y/e9CFeWbJkpDGlKgrvWrWIfY0tdIUi/PuruzlwoZWN9dUsrSimtjh/Qo/UJdr6Q5c9XG4n80sKJ9zeoamsqi6jsbuPrlCE9v7UauFYRsrCsiJ8bue4x3I5tOHQMyklcWPqoRHpEk8atPaH6BwMMxCLE0um8rFMyyZpWUSGVhZtKdMWgNh55iJfeXU3CcPkjoU1fPKONTivU+HaCz39xIZWoGuLJr4HPA4H1YW5cPK6NC1jMC2L1w+d46fbDmOmKWKSDvGkya92HieaMPjce7dQmOO7Zq9G72CE3sEofaEY33p+z6Qrhlu2ZM/JJrYfaeCRdYto6w3xL5M0pK48xlM7j7FxSTWr51XcdLL6+QEvy2pL2Xn8wqiJtm1Lnt51fOi6p//cje19nLrYOeZYUxD0snlZzfSfNIM509LNV57cwfYj56dkSF2JlLD/TDN/9+M4v/vujSyYU0TA46K9NzRNrb15OHGhg/vXzONUUyf/9PPt7D/dkvb7bzwudvbzr0++iaII7l1djzpNctsNrT189+V9/GrniWvyeL8dy5Y8s+skrd2D/Oaj61leW4qmXtt7XEoLI7mLROxnQBxNX4Xb/wcgsoXtb2xurnfhTJGRxpQiBLfVVPD7D2zkv97Yz9mObl4/eZ7d55qoys9hXmkB62rncOfCGoLu8fMcBmNxIsnUxKHQ751UTkBFXhCAhGnRF03Jimvq6OOX5QQmvMXEcA31FNf60pwMCcPkjdONbD3RQGN3H72RKJF4koRpDdecuhSHPxVOtnXxD89vp3MwzJKKYj65ZQ0lwamHRaVLx0B4+O95Ps+wsToWuqaQ45l8+OLNglPXWF5bTmneqXHDlN6Oqih4XTpup46UEIkniSaSV827sGzJqwfOUhDw8rn33XHNE/GeUJT23hCvHjjLQPiyF8OpawS8TsKxBLFx8jX6wzHePNrI2kVVfPulvTS09Y743jGUHxWJJcddte8LxXh290mW15ahT2GBYH5FIWsXzmEgHCMUSxCOJQnHEmnVa5spFCFYM6+SX+YeHdU3ANuPNNAzGKEwxzet57Vsm1PNXTS29435/ealc8nze24643U8mrv6+eaze9h5rPGq7wQhIOBx4XHp2HbquYzEE2M+l2dbuvnHn27j99+zeTiUbbqpKs7h9gVz6BmMEI4mCMWSRGKJ67pQeC2cbOqkNxTlG8/s5sCZ8Q0pRRHkeN04dRXTsgnFEsSTV7/Gtp5BvvLkDmrK8qkry7/me/pcaw9feWoH2w83XNWQUoTA5dDxuR0IAeFYMiVGMcE9Ztk2+8+28M8/386ffvAuFlYVTznCQEqJtLuIhb+KbTUjlCLc/j9CKEXj7mMk95GI/ggpR3vbFLUMj/8P065NZFvtJBNvYhnHkHYfCA+qVoPDuQVFqwEx+SmvlAaWeRojsRvbuoBtDyCEG0UtRXesRtNXIZTR7ZNSYib3Eo/+FwAO1wM4XA8gxMQOAClNYqF/wLIuIkQAp+dxdMea1Hd2hMjAf0dioOmLcXo+iKLkjnMcCyOxnUTsp8BQ7pJj07j34+U+O55S3xvqM925GVWrnVSfSSmJhf4Oy7ow6juBA911P073O656HDN5mFjkmwih4Ql8HkXJxbYHMRI7sYzD2HYnSBuh5KHpi9GdG1GUwkl5PqU0MJN7MZP7sa0WpIyDcKFqc9D01WiOFQgxvujc1chIYwpShVwfXj6f5ZWlvHDkND/ec4TOwTCn2lOhf9tONvLdHQd4Yv1KHl2xAE1VRt0sCcsals6ejCcLwOe87G2KJVOFeMdygU/2eNeLpGnxD89v59lDpxiIxbFsiUNTqS3Kozw3SI7bhcfpwO3Q+N6Og4QTkw8DkVLSFYrwj8+/wdmOHgr8Xj6+aTVLKoqnpA40VaJXtNmlaxMqV6lCwall7O09YwghWFZTyuLqYlq6B8Z8meYHvKyqL2d+ZSHzKwspyvGjawqqoiBJibt094c5fL6dF986xZmW7nHPZ1o2v3zzKPetmXfNAgAD4Ti/eOMIZ1t6sKUk1+/miXtWsmFRNV63g4Rh8uzuk/zo1YNjTuAOnm3h1f1neP3gueHPKgtzeO+WZaxdOAeXUyMaN3hx3yl+vu3ImPlJrx06y+feu3lKxtSDty/kjuW1WLaNacmhxQubaNygPxxjIBKnPxzj9UPnOHC25ZrCi6ZCbVk+9RWFNHb0jcgnARiIJNh68Bzvu2PZtBo2g5E4B860DHuUr8Spq9y5onZGhS8yBSklsaTBM7tPsu1ww4SlL0rzAjy0dgFrF86hIOgdHmNN26ZnMMKRhnZe2X+G4xc6RuzX2NHH//vRaySNmTHe1y+qZllNGaaVuq8ty8a0h/K4wjH6w3H6IzH2nmpix7ELJDLMyDp5sZN/e2onbx5rHPXs+dwONiyuZuOSauorCnE7dJSh/EvTtmnpGuCt0828sOckXQORcc/R1NXPv/1qJ3/3m49MuZ1SSroHI3znpX28cbhh3AgDh6awflE1axdVsaiqGL/biaqmlnFN2yYUjXOssZOdxxvZeezCmAaZbUuONnbwdz9+nX/4rUfJ8bmn+PxLYuGvDCn+qbi8H0V33DbhsWyrhWTsWaTsH/Wdqi1A+n5nUsZUalHCxkzuIRr6OyzzNNIOAyagIoSbROS/cPl+Y0gQQQXGf0aklEgZIhb6O5Lxl5B2f2rijQkoIJzEhR/dcRuewJ+hqNWjrlMoAYz460jZh7S60Z0bEWJi1VjLOEEi9jNsqwVVW4DL+/HLbcIgEXsKSCDtwSF1xPGwscwGkrFfAqA7bgfHprH7zHiL6ODfYZmnkHYEMIb7LB75L9y+30B33XfVPgMwEtswjQOjvxBuFK0KuLoxZdvtJGNPAjYu7yeRVg+Rwb/GNA4h7dBQ+ySgI4QXVavBE/w8mr5mXOl9KSWWeZpY+F8wE7ux5cBQ/p8NKAjhQig56M47cPt+G0WdM6VnIGPfYkKk6jbNLczlU3fezkc2ruKV42f55b7jHG/tIJxIcKI1zhefepV955v5owe3kOt1jzBQdUUdVoxLTHJ1OGZcfuk7NRV1nE7NpIVUKSX/9cY+frDzEJaUFAd9/NqGFbxz5SICbicKgqH/Ykv45b7jkzampJREkwZff20PbzU049A1PrRuGfcvrb+uhhSA4wrjyLxCaWksJPK6eAMzEY9T5+5V9ew52URfKIpD1ygIelm7cA73rKwf8rwoKEIglJQH9e2DR3VxLqvqK3j/Hct54a2UElxnX3jM0LtowuD7rxxgaU3pNeVO2VLy1qkmpIRcv5u//dTDrKwrH1bKklLyqYfWEvS4+OqvdmK87ZnuHozy5Sd3DIsRzKso4E+HVN4UcfkYNaV5SAk/fPUAibdNPPvDcY40drB+UVXa7fe6HWPmW0k5VK1Npu7LwWicI+fbsezrO9nUNZV7VtbzxpHzo7xzUkqe3X2CxzYvmdDjmw5SSroGIuw+eXHM7xdXl1BdnJdRY+lMcuJCJz99/dC4RoZT13jPlqX8xoNr8Xmcw4tFV6rPVRfnsrK2nA/dvZJth8/xb0/t5GJn//BYOFZO3HThdqa812/n0jgrh+5vl0Nj/5mWjDOmwrEkT755bMR7w6lr3LG8lk8/vJbKopxh9Vu4st+huiSP9Yur+NBdK/jW83t4dtcJYuN4q3Ydv8C+082smV+ZdhullCSNlPrmc7tPjml0OzSVzctq+NTDa5lbkoeiiKFxV4x4lqSULK4u4fHNSzje2MHXnt7F3tPNo4wqKSWHz7XylSd38P996G7UMSJxrtZmI/EK8ch3ABvdeRdO97tBuJkoREzTV+EJ/k9sqw1p92JZTZiJN5Ey/RBVyzhEuP8Psa0WUv3gQSgFIJxIexDLaiUy8Be4rQ6E8CHleKVnJNLuINT7WUxjSApeOBFKAEXJQdoRpAwj7W6S8WcwjUP4cv8NTV86PJkXAhS1CN21hWTsSYzkLmyzCaHnjjtJl1KSTLyGbfcBKpq+FFWrS7sf0sEyDhPu+4O39Vn+cJ/ZV/aZ4kPaE5frcfs/h2U2IO0ebLsHM7kbyzw34T7jY2MkdpOIfgfLbBj6DYIoij/VNhlGyn5MYx/h3s8SKPgZqjb6nS2ljWkcJDrwF5jGQVKGogeh5iBwYcsQUkaRVhuJ6A+xrRa8gb9E0WrSNqgy1pi6xGXlPgfvWrWIh5bP51hzBz996wjbTjXSE47ywtEzzC3K42ObVo2YCPhcjmHZ8Z5QBMu2r2oAdA6FkqmKwOdyXLWGTSYwEI3zg10pQyrX6+Z37t3Au1aNLbZh2fakDUtIebx+deAEzx46hSVtHlm6kE9uue26G1LAiELKoXhiwtAH07LT8r7dTAgh2Li4mhV1ZUTiCe5dPY87l9WSH5x8AUQhBKoq8HucPLZ5KXkBL//08+00jaGmBimvUFv3IOWFwWtqu5SpMJtPP7xuVO6SEAKPy8FdK+vYdeICe042jdr/ktJYwOPiw/etZlV9xajrcuga79m8jFcPnB3zeg6fa52SMTUeQgyF/A7930yLtUzE+sVVFOX4ON8+OtSvqaufQ+daWTMv/UngWFi25MCZFjr7wqO+UxXBmvmVFOZ4b/oQPyklkXiSn7x+iJ7BsQUEcnwuPvPoeh7fvGxcMYBL/aSqAlVVuG/1PKqKc/nST7ez70zzjOZITsRl4wMu3d+Z+oteaUjlBTx84oE1fPDulRO+z4RIhe0rqkppfoDfe3wzfo+LH716cEyP6yUPekoQJP2eON3cxXdf3j+mOFR+wMMT96zkA3etwHOV6BghBKpIlbhYWV/O//joffzbr3by4t5ToxaRJPDUzmPcuaKOjUuq02qvbTUQHfwbwEBRK3B5nkDVrn4MVatA1d47/G/LbCDU+5tY5om0zi9liMjgX2FbzYBj2MOgOVYhhMC2+0jGniEW+Qax8D/DBNm4tj1IZOB/DRlSKprjNtzeT6A770AobqQ0sYxjxCPfJhl/DttqItL/J/jzvpoKiQNShokfh/MukrHngCSJ2C/w6EsZz7iUshcz+RbIKEL4cLgfuWqR42sh1Wd/+bY++yyaY3XafQZD71XXXcBdw59FBv8SK9w45TZGB78I2Dhcd+P0fBLduRohnEiZIBl/mVjoX7HMY9h2O7Hwv+DL+X9c2b9SSmyrNeWRMg4glFyc7sdwej6MqtUihIqUCczkPmLhL2MkdmAkXicW+RrewBcAb1pek8y3FN6GrqqsqCrjf7z7Xn773vWoiiCWNDh0sY3u0Ej3e2nQT74vpVDVG4lxsad/wmObls2R5nYgNXEvDvpndeIzWc509AxLTFfl57Cqqmzcl0NvOEokMUmJU9tmT0MT33nzAP3ROBvqqvjDd2ycUgjUdFBdkDvsabzY0090AjnkuJGSfr9VcTt1PvfeLfzjZ9/FezYvS8uQejuqorBlWQ3v3bwMl2Ps9Zd40uRQQ+uUz3El1cW5PHj7gnG/Ly8IsKymDMcE9+Gi6mLuXVU/wTGC1JcXjPlqO9fak05zbyi8Lgf33zZ/zO8isSTbD5+flkT31Aq7yQt7T435fVGunyXVJbgmKIx+M3GqqYvXD429Sut26rz/juU8tHbhhKpqb0cIwbyKQn7zneupLcvPWAMmE8nxufmNB2/nvXcsT3th0O928sTdK1k9r3zMuZZtS45daKc3lL7yXtK0+Nbze+geI5Qw4HHyobtTNc6uZkiNRWl+gE8/MnqR6hKmafPdl/cxmEY5EdvuIxb+dyyzEXDicL8L3XVn2m27Foz4y8MFhTXHbXgDf47uWD1kjAgUJQ+X9yN4A/8dISZ6D0qS8ecxEm8AEk1fgjf4FzjcDyKUVM0rIXQ0xwo8wS/gcL8T0LDMs8Qj30bKy4JHQmio+kJUPTXWJuPPIeX4XmMzeXTYi6Ooc9Ad666tU67CyD5bM9Rna6bQZzNJHN25CU/wizhcGxHCReo3cOFwPYjb95sIJSUql0y8NhQGeCUWRuJVjPhWwInb+2k8gf+OptcjxKU6mU40x3q8wS+iOVYCkIj9Ess4OWkBrEvccMbUJRyayrtWLSTgSiXbhmKJUW738twAdUX5aIpCwjB54ciZCUO/DjW10dCZWrGdk5dDTeFEMa6Z8+qKG+bwdemqOlxQdSxeOHJmUrkaUkou9vTz5Vd20djdx9KKEn773vXk+2bnwRJCkOdzU1ucqkdzvLWT1v7BMX9PKSUDsThHW9qvdzMzirKC4LRNVjVV4dENi6gqHjvpNWGYNEyTEbJhcTWuCeqfaKpKfUUBQd/YifaKENy/Zt6E1y5EKsxsrHM0d08cznCj89DtC/CMEa6VNC2OnG+bNiW4s609HGvsGPO72rJ8FswZPzn9ZuOn2w6P8gZcYuncUh5au3BCddjxEEKwdG4Jj21agmuM3zTLaFRF4d5V9bzj9gVTztcrCHr54N0rx1XAC0USU1qU2XuqiZ3HRifxK0Oe3HdtXIx3CvfJJcoLgnz8gdtwj7EoJoEzzV3sPTXa4z8WUhok4y+SjL8IJNEca3B7PzE06b1+xGM/ByQILw7XvSja3DE9CrrzLjTH7eMex7YHMOLbhkIAdZye96Lpi8bcVlFycXk/hVCCQBIjuQfLODtyGzUlbAAKttWGkdg+5rGkTGAah7Ct1GKk0/0uhDKz86zENPXZzKLh9v8Oqlo66hshVDTH8sseUDuKZTWP3EgmiEd/DJio+kIc7ocR6Lx97i6EQFFLcbgeGNovQiL+fNqtzUhjKpJI0tg9tvrTlbT2hYgOqfX5XI5Rq+Yuh879S+vJ9bpJWhbPHjrJ3vMtYx6rYyDM11/bQzRp4NI11tRUUJk/UchS5uTjFPo9w+EEfdEY7QOjw2oADl1s4we7Dk1KzS+WNPibp1/naFM7pTl+PrFlNQvLCmfVU+fSNe5bnIojHojG+a/t+8cUIjBtm+cOneJ859XvoSyTJ8fn5o7ltWN+Z1r2tE3Cl8wtQbtKeExlYQ7+cSYVigLrFl49TG9OUc6YK8vd/ZFRAg03EyX5ftaNE8bY3NnP0fPTswjx7O4To/LaIJXTt7K2bLgm2M1ObyjKjqONY37ndzvZsqzmmsJjVUXhodsXUlmYM+Vj3EpUFgW5f808gteoerh6XsW4i0vRhEFzV3qLMlLCD149MKb6p9/t5PHNS8kPXPske0VdOavqy8f8biASH1es4u2kPDLfQdrdCBFIqa9Nsh7VdGHbfdhGyvutKEVo+kLEuOpzKg7nHeMfy2zGthoBGyEcOFzvYKJFc1WrQdOXDe9rmWdGfC+EL+UhU/IBm0T0p4w1b7StziEvkQHCcxVxiWvHtvuwzNMAKEohqna1PrtzRtszHqpahaYvH/d7oeQhRGDoX3ZKvXEIKSW23Y5lHAVA05cglLwJwvYcKGoZkJpTmMZh0p3jT1vOlJQp9SpbDl2IlCSviPk1bUncsJDycgyyqipjJr93DYZ54qs/YlllCXctrGFFVRmlOf5hd3wolmB3QxNf27qHhGnh1FSWVJRQ5B8t67u+bg6PrV7Mf27fR0NnL//zFy/z4Q0ruGdxHV6ng6Rpcaipjf/YtpcDF9qQSBaVFfGh9cunLRF7vP5K9VkqOf1SknrStIaNnUv1qRTlcj8JGE44vdRvdcUFVOblcKylg4bOXr775gFyPC6KAz4QglgiyWsnGvjmtr209g/iczomzCcyLIu/f/4Ndp29iEvXeHTFQtbVzcGw7AlVqDRVGdVnl+6FlDdMDiUpp85x6Va1bUncMFJi8kP3hhCpScKVxpuuqtyzuI6Xjp7lVHsXrx4/x+e+/zS/dc96agpTieytfYP8cPchfrH3GLqqTqmWVpbxuX3BHL7+9K5Rw4wtU8IKlmVfU56hpiqUF+RcNY8m1+8e1/NUnBugMOfqk46C4KV8nZFXY1gW8aSBx5VZip3ThaqkvIxbD54dJbPdMxjlcEMbm5fNnVIo0SXCsSQv7z8z5nd5fg8blsy9IUKop4M3jzaOUCK9kuJcHxuXVF9zDqrX7eD+NfM409yVQct8mYciBIuqSlhWU3bNuXoOTWVFbRlnx1A7TRgm3YNjL2qOx6mmDk5c6Bzzu3mVqbIL04GmKjy8bhFvjGHgW7bkfHsvrd2DVBbljLn/JbW7ePS7WMYhQMUT+FM0ffG0tC8dbKsFSSptQVGCKErxhNsr+rzxj2V3Ydspb6JQiyaUdQcQQkHTl2IktiJlP7bVjpT2FUIUAs2xBlWdg2l3YRpHMZMn0ByXvV2pvJ6LmMl9ADhc96GoM+uxH5YFJ6U6qKhT77OZJBUiOb6JItBG1DCTb1MbNI1jpBQYIRH9EYnYL5gom1NKE4buJWl3pd3eaTOmeiJRnjt0iqaeAQbjCQZjCVr6Lq/MbD1xjua+AYIeJwGXi4DbyXvWLBmu6zQCIQgnEmw/3cj2040A6KqCz+XEsmwiiSTW0CzA7dDZMn8u71w5dry5qij81j3rCMcTPHP4FI3dffz1U1v5m6dfw+9yEksaw4IMTk1jUXkJf/HYvRTOcDibLSXHmjt45fg5Iokk4USScDxBTzhKS18qtrapd5A//P7TBNwuvE4HXqcDn8vBlnnVrKq+vLKkKoLfuW89//2nL9ITjvL8kdO8fuo8ZTl+NEWhfSBVvDfodvHJLbdhScnXX9szbtt2nrnIy0fPpIxjRfDayQZ2N4ytyHUJTVG5f2k9H96wcsTnccNk+6lGDje1D11ngnA8QXPfIKFY6sbdf6GV3/n2U/icDryu1HXmed3ct7h+OKwPUoPT3MJcfv2ONfzLSzto6Rtg26lGtp9qxO1IhYVFk0kUIVgxp4xN86r57o4D9ISvrWp8lsvUluanFuvGmLFZtsS8RmMqP+DF5dCuOtEJeFzjhrPWlOZNOGgOH2OclWkpJdHEzWtMKUKwoLKIeRWFnGoa+dKQwJGGNlq7B6krL5jyObYePEtoDOl5IWDBnCLqr+HYNxJSwp6TF8dc0FGEoKYsnznjTFrTQQjBnStq+bdf7Zw1IYobAZ/bwbqFc9C16QnKWVg19kTUtCwGI5PLTb7Em8cuDOc+X4kQcNfyumkVfVpWU4KqiDFD/rv6I7R0D4xrTIHESGwlEfkBIHC4HsThftdwHsr1RNohkEP3u3CAMrG3W1HG9wBLGRs2MhQlb1LGtlAupYJIpAyTku6+HDGhqBVojlWYxhGkHCSZeBlVX3jFseMYiTeHQgs1nK7HSMmQzxypPkv97kI4EGLqfTaTCCWX9NJpRt7L0r4yzNYCmZzEQlNqgVbK9MfQ6TOmQlF+uPswjV1jh1Z1hSJ0vU0g4raaijGNqRyPi3evWszZzh66BsMMxhLETZP+SCxVnE7XCHrclOcFWFtTyWNrFlMS9I/bNl1V+KOHtjCvtJBXj5/lXGcvvZEYg7EEuqpQ6PdSkRdgdXUFH1i7jNKcmS9Ea9uSgxfb+Mbrb427TdwwxgxLdGnaCGNKCMGm+mr+v0fu4Od7j3Gus5f+aIzzXX04NJUcj4uFZZXcv3Qe71y5kLcamkcd80rCieTwIJswLU63j19n6BKaorC4fPSLJZo0ePHoGZ47PHYiOkB/NMbOsyONNa/TwZz83BHGFKS8U/ctrsOhqTy1/zin2rvpDUdJmBYuXWNuYR7LK0v58MaVqbouh05mjalpxO3UcWjqmPkf9pB3+loIel2Tmug4dHXcyUVJnn9SY/B4AhYSbvoJacDjYsuyGk43jfZknG3t5lxrD3NL86Y0gUsYJlsPnMUcQ41MU1UeWrtwSipnNyLxpMGZlu4xC+3qmsKqurHFAKZCZWEORTm+GZVHv9Hxuhwsqy2dtj7P9489EbVsScIwhyNxrkbSMDne2E7SHB22LoRgw+LpUxcFyPF5KM71j3mv9IWjdPWP71WzzTNEB/8vkETV5uHyfhIhZmfCPbL2keDqmSsTLZDZXJ6QT9KgGeUZGfmgp1Tu3kEi9jOk3YeZ2IX0/BpCzR8qdBwiGX8pdUZ9Eapj0TSo+Ekmrgl1ZTsVuOr5ZmdRUYip5wYCSHk5GkBzrELTVzLZ3zV9Q24ajamigI/funsdodjklWBqCvPH/DzodvH7D27kX/fspPV8iGTMJpm0caga75u3mOVFpeR63VTmBanMyxn3xXy8p5PnG8+woqiUOyqqeXzNYjbNq6ahs4fucJS4YeLQVIJuF3Pyc5iTnzOhQtjCsiL+26N3IqVkQenErlinpvLE+hXctbAGh6ZRXTgytlpVBGtrK/nv77xrnCOMz8lYN1/av4N31S2kJphaGVEUwQNL57GsspQzHT30RqKYlo1T08j1uphbmEfZUKjkoooiNq2q5mBvO42RPmrtkZOmxeVFfO7BTWnVCVGEoL5k9Gqz1+ng8TWLWV2dXkFXXVVZXD52Hzt1jfsW17OssoSzHT10hSKYlo1L1yjLCTC/tACv00F/NM5v37OennCEVdUVYx4rS3oIkfIGj5dMf614XY5hxcaJUBVlXA9YfsA7qWFQV9Wxt5NMi6JdJuNyaKyoK6cgx0tX/8hFrnjSZOfxRjYsrsbvSf+Fdrq5i7OtYxsQFQVB/n/23js+juu623/uzPaO3jsIEGDvvah3yZIsucqO7diJkzhxEjt+X795S5qd4hT/EkdOXOReZcnqElXZeydBgiB67wtsLzPz+2NBkCAWIBaFBKl9PqJAYqfcuXtn5p57zvmeNQtnR3r9ZqBzYBhvHA8dxAzLqqLZC+mRhGBhYWbSmJqEdJeV3DTHtTecIrZJ7o/YFvjPLgABAABJREFUM0RjKpOy7kEvXYOeuPeMw2IiZxbbDLHneKrdEnes+IMRBr0BVFUbN7dSVTd+zzdQlWaEcGG0fASdYfGcynhPhhCW2MVogBYdKcY6MVcq7o0/likmvQ2TKu+NOd4VtZdiHp7xU+qYUMJCouF9KEoj0chJDPLtQCw351L+ksF0B5JwTem8k6OOetjiEeszaaTPIjPqs/nMlQa+zrAGi+1PENL4VKDZYtaMqRSrmQeXTyxnnAhCCPSyhN1uxJZiJGrRcHtDmIx6NlYXcXtB/CT4K1E1jQOdrTx96iCb84rYnFuEQZbJcdnJcU3sxZqMSwbXVNDrZLZXlU74uSRJVOZkUJmTkVAboqrK7b/+HkPtQdItllFjCmITzPxUZ/zQySuwmYwsKs/m9aMX6Q55UTVtjL1elJ5CUXr8xNpEMel1bFxQxMYFs7uyJgRkO+2TeiRTrGbuXjKxPHaS6TGXXluLUT/lMMGJcm4cUzQAJruOWz3vRAhBSXYKi4qyec89XrJ7z+kmPnNfAJvZkND3rWlw8FzLhPWU7p1ASfBWpbN/OK6gAMQW1IqzJ1OMTQwhYmUFksQn1j+pEyrwTQf9NZ5VUzOloGvAg9cfP6+uMHPiBePpIoTAbonvcVA1DY8/RERRMEpXThFVQr6fEg7tBGT0xg0YzY8ihDnuca4HQs7kkrdB03yo6iAyxRNuryqdEx9LSkUIF9ARy39SfddU1VOiDSM7m5GkNOJ5PoQwYTR/gGh4P6rSRTR8HL1xCyATCrwIKEhSNjr96pFCxxNxaaxd6UEbj6aFJ835GdtnflTVPam/5pLK4M2GrCsZ/bsabUPT/AhuAmNqtrEbjPzBsvV8dskaVE3jnueeIRQnbGQiBJBnc1Bod7EmK++WSXaWhWB5Zg61A31UpLw/8g6SzD7aqMjJJfETbXRVNPZTG/O4vvS7SFS96pPZRa+XZ3yvmt9Hk/WZkOmys6Q0h/01zeO80AMeP3vPNvHktmWJ1C2kb8jL6cYuguHxXm2zQcf962Znwe1moW/IF1fREMBpM2Mzz2IIjRDkpt+ocKv5j0CQP8Oi4nNFz5AXXzC+MXW2qZs7v/Rfs3o+DfBPcD6IheoqinophQRN04iGDxAK/Bo0P5KUi9n+JyNKdTcOScpFktJQ1D5UtQ812oSmXz7hAlA0cmLCY8lyPpKcixKtQdOCRMIHRwrRTlBoV/USDR8aaUcmkjxxyK7B/CB+z9fQVPeIDHonQkohEnwrdm7DEmR9+SQLVwIhWdDUAJrqjXnh4rVJ00DzoUQmTquI9Vkqito70meN1+izkxMeaz4j6ysRUjqa2kc0cgxV7UNIGXO2GDxvjSkhBCadDtNIE6UE4xeFENxdVM7dReVz0bwbhhCCb25/4EY3I8lNiKpqBMMRfMEwgXCEIV+Q9t4hugY89A35GPQF8AfC+EMRgpEI4YhCKBwlGIkSjkQJRRRCkeic5hPpdfKMV2FvVFHpmw0hBCsW5JGT5qCpa2Dc5y8fqOHRzYuvWp2eGE3TuNDWS30cdTOALUtLSbVb5jwfdT4x5AtOeL9kumyz2hcCSLHdOC/BfOdSaNt8ZNgXnDCsXlFVhnxTT5+YDSJXqQqrajdB/49HCssaMdv/GFm36Ibfy0JIGEx3E/DWoqn9RML70Zu2j3iYxrZN0wYJB16Z+FhSBnrjOiLh/aAFCPl/js6wGkkaH2KpaRGC/l+jKn2AQNZXotMvnqSdNozmRwj6fogSOYuqtKCGj6FpPsCETr8SSRpfT+kyEpKch6L2oygXUdUuJK0gTv9rRMNniESOTtIWCYPpHgLeC2jqwEif3TZJn708SbvmJ7F+MWM0P0rQ911UpZ2Q/5eY7X86cp3xiQlPhAFjwmN73hpTs8GNvtHnilv1upLMPpqmEQxHaekZpLFrkNqWHs639tDYOUDfkG/eycbLQkxJiW8y3i/iBjNFCKjMz6AsN5WW7sFxY+F8Sw+1rb0sLZ3sJX+ZcEShprmHrsHx9cYMOpk7VizAMElB8VsRXzA8YZH0qYajJsJkOTxJmFZh5OuBNxBKKEd5rrlUriVGiHDgFcLBdwANvek2DOYHQfPHzfEah5AAw5yp/RnMjxH0/xJN7SEc3IGsK8dofhghZSGEQNNCqNEWAr5nUJU2JpKjjYlF3E84+C7R8H4iob0Evd/GaPkgklyAELoR0Yi+2Ge+7wNBhJSB0fwwkjxZpJDAYHqYoO9XqGo30ch5IuGDgIok56I3rJs070wIA3rjRpTIKTTVTdD7fcx2O7KuHCH0aJqKprmJhk/i9/wTaBN7Hcf2WTfh4JvIugWT9Fn7hH02vzFgNH+QSGgXSrSWoO/HgBGD+X5kOR8h2QEppvKneVDVftRoK6rai9H8OFxD5fBqbmljKkmS9zORqMLh863sOdPI6cZOGjoHCMSR3p1PiFgRupkeZTaa8r7AbNSzeUkpB2paxoUZqarGS/vOTtmY6hv2ceRCa9yCx+V56VQUZMyqvPPNQDiqXDEpHctchKNeXbg+yVjmq9c6FFHmpehNrA5SJ0HfM6CNCNVofvzDX5vyMSQpA6PlCWRd8egxNbUfRWmGETlyTQugKm1oqhuICV2EAy8gpBSEMIEwIYR5ZBKcOWZBWdaVYbZ9noDnG2hqHwHPvxMNH0bWlYEwjITW1RANH0NvupdoeD+aOt4THztWERb7F/ENDaBEzxP0fZ9o+BiyfiFCcqJpQdRoM9HwEVS1C4QZk/V3MJjumbQPhBDIunJ0hhVEw/sIh95ECddw2at1rRpdegymewkHXkNVmgkHX0FVe9DplyKEA40QqtJBNHwITfWhN24lEjoAxPdoyrpSzLbfn2Kf3TNpn2laCCXagKYOjX6XaEGUyAVABU0hGjlDyP88CPOI0IcJIbmQ5ULENeTsp4sQAllfjtn2xyOiKY0Efd8mEnpvJKQyBSEkNC2Epg6gKl0o0SYkXQEG84MI5tCY+l97djAYCvL3W+6medjNi/XnqHcPYpBlVmXmcn9pJXm28S7RUDTK0Z4O9nU0U+8ewBeJYNbpKHK4uLOonDVZebPmbdnb0czTJw+O1qECuC2/lE8vXhVXJaxxaIC/PvAujy9YxO0FpbzaeIHd7U0Mh0NkW+3cXVjOlvwidNL4h7CmaXT4hnml4QKn+roYDodIM5nZkFvIXYXlpJjGh1zs72jhBzXHeLhsIfcULeB0XzevNNbSODSILCSKHC7uL6lgReZl9bvhUJCfnDvB7o7m0d85DEZ+p3olG3InLuSnaRq1g308f7GGi+5+9JLEkvRsHi2vRj/JpMYXCfNOSwN7Oprp8XsxyDKVKek8VLqQMlfauJyWL+16DYC/XLudxuFBXm28QMNQ7MYrcaZwf0klS9Oz4/Z/WInyWmMd+ztb6PZ7McoylakZPFpWTbEzmUw9XVp63PzkzaPsO9tE16An7gR3PpJ0ul5/ti4p4fuvHYqbs3HgXDM9gx4yUyYX7VE1jdZeN2cau+J+vq6qkAzn3Nbum49EFXXC9dzZFEK4fMz3l7GaKPPRaa2NlJSYZ0ECo2iqB1VpGv13JLQrof0luRS9cfuoMQUKkdBuAp5/QyMKRGMFU7UQmuYZOWcv/uF/AqFHCB2gA6HDbP0URssnrzqDwGh5ErQgAd930NQBwsHXiAk2yMQKt+owWp7EZP0MPveXiU5gGADoDOuxuf4Jv+efiYR2EwnvIRLeG2sDCjEBCJDkAsy2P8JgfnhKIhxCsmMYMeaioSNAGIQFg+m2awpdxAoEL8Js/2MCnn9BVdqJhg8RDR8e0y4h7Jjtf4YsF6BE60a8SnGPONJnoZE+65+kz34Xn/tLE/aZqnTjH/4aSrSJ0e+SaKyeFbGwuUjoPaLhIyOFdmPfp6yvwGL/c3RSddzjzgZCGDGY7kJIDgLep4mGD6BEa1CiNRPsISHJOUyn1ldCxtTJ3i7avEP8qvY0Pz1/ii6fh6gae1m819bIzvZG/nLdbVSmpI8aR1FV5V+P7eWXF04TiEZjD40RjRtJwLN1Z/nTlZv4eNWyWTGoTLIOo6SjN+ij3TNMf9BPvs054eqgNxLmQGcrOVY7rzTWsq+jhUA0gqppCCF4ueE8n1m8ij9esXGMEaFqGsd6Ovjqnh20eoZG+kFDEoIdzRd5t6WB/7F2G4V255jr6gv4ONTZRr7NiarC3x/eSX/QT3RkVcplNFPiTBljTElCYNLpQYO+oJ/GoQHsBiMPlk6czK1pGrvaG/nzna8zHA6haioCwe72Zl5pqGV97nh5Yk3TaPUM8Q9HdrGrrYmQEoubFsDOtiZ+dv4Uf7luOw+XVY3pi+M9HQSiUX5Uc4LnLp6ly+8d/Z53tzfxauMF/mbjnWzPLxldmdY0jd6Aj6/u3cGBjlbCqjraxvfaGnmu7iz/Z/1t3Fk4WVJmkqvRNI1TDZ382292c7apa0r5TdKIN0gQW80RAkwGPVaTHrPBgNmox2zUYzHqMeh1vH2sbu4vJMl1w2Uzs21pKT9569i4zwY9AfaeaeIDmxdPeh9GIgq7TzfG9XxmuKwsKc25qYRBZmtiO5mYykTvpJkw0xDZJDeISYZCmsNKVqrtun6zOamOq7zI0793Y8bQla3XUNVhFKUlztYSl1TrNM0D2tiuUUc8V2OPLwAHJttn0RnWEgo8RyS0H03tQUh2dPplGM1PoDNuQCAh68qIRk4hJpgwxzway7C5vkkkfIBw4AWikdOoaj9CpCDrSjGYbsdgug9Jzmfq02j9iEx6KUq0BdAhSakYjHdPae+YKuCj6PSLCQWeJxLaiRrtADQkOQudcSMm84eQ9ZUokTokKQtV6SFe7a3Lffa7I332m0n6TB7ts3hGhqZFUJX2kRDK8dcc2yiKprnHfJdCsqGNk2WXQOhBm0rNMEa+Q/3In/jbC8mC3rgVnWElkfB+woE3UMInUNUeIIIQViRdMTr9MvTG7ej0SxAicdW/hGMC3KEg3z51mMcXLOKpquVkWmycH+zlX47sYVd7Ez+sOc5X1mzFZTQBsRyIZRk5DIWDbMotYlVmHikmEy2eIf7z5AFeqq/l+2ePsL2ghAL7zJV2Vmbm8t27H0UDfn7+JH9z8N0p7ferC2eoSEnjX7c9wPqcfEKqygsXa3j65EG+deIg1WlZY8QsOrzDfOGdl/BFwnysahkfqlhKrs1O7WAf/3HiADuaL5JmtvCVNVux6cfKC2vEPGg72xq5s7CcR8qryLbY6PJ5qRnoYXVW3pi2WfUGPrVoJb+zaCUA9z//Q7r9ExfVA2j2uPnqnjfxRkJ8uHIJn1uyhnSzldrBXv7pyG5+WHN83D7uUJCnTx3ijaY6NuQU8qcrN7EoPRNvOMxLjef571OH+Z97dmA3GLm9oHTMNXV4h/numcPcW1zBpxevosSZStPQAE+fOsRLDbF9V2XljY4LTyTM3x58j/daG1mdlc+frNxAVUomnkiIn54/yTNnjvIPh3eTYbayLGP2iizeyqiaRk1TF//4i3c519Iz4XayJLCZjTitJkpz0qgqyqIkJ5X8dCdpDgtOm3ncCvel3g9HFd45XjdvV1GTJI4Qgoc3LuJX750cJ+MdCEfYfbqR+9dXYdTHf11omoY3GOLdCYzsBXkZVBbMnYrSrKNBZJZEVnSyNKG3dSKVv5kw33Igk0wNnS42TuJ9fXevXsCffXAb4jq61a48k6xfQmrO+PIJ0z+iDpP1E5isT83wOFf8VgjAiM6wFp1hLWNNsLH7WF3/jNX1jQmPBSJ2PCkVg+l+DKb7GW/tiivOO8WWC4FOvxJnxtVz0qkeQyCEAVlXjcVeDfavTtgmWb8IR/pvJz3+5T5bg86whun2mawrxZnx1hSvYVwrxvxLb7yD1OzauJ+N39WKLeXbEx5rzKZCRggnBuM9GIz3EH/1QlyxfeL3WkLGlDZykhWZOfzR8vXYDbFkziVpWXx5zRbavMPsaKrjqarlOA3GkVVuwb0lFdxbUjHmUitS0vnq2u3samvGGwlTN9g3K8bUpU4QJNYhRlnmK2u2sSWvCEnEoiU/Ub2cTp+H7585yk9qjnNbfgn6kdCM75w5Qm/AxyNl1fzJio2jfbEyM5c/X7WJDu8wL9af46MLl1GVOr6WVMPQAH+0fAOfX7YW/UgIYa7Nwcqs8cVtr7ymqfLCxXP0Bfwsz8jhL1ZvwTbSvqXp2fzdprv52Ku/otV7ueCcpmmcH+zljaY6qlIz+NtNd1JodyGEwGjW8TvVKxEI/vbgu3zn9GFWZ+XhHDGMLrEmO58/XbWJHGssJKgyNYNPLVrJuYFeTvR24o+ER8fFvo5mDnW1kWWx86/b7x/dx2Uy8Rert9DqcfNG00XebKmnOi0LwxyExNxKaJrGwLCf77xycFJDKi/dyYryXLYvL2N5eR4pNnPCL4Qktx4lOaksL8vlUG3rmN9rGjR1D3C+pYdlZRMX3j50vpWuwfELPEa9jsUl2WRNs7bfjSI8S2IAJoNuQu+UNzB5kvh0iCdJn2R+I4TAqNehk6S4Rrw3EEaIyb2cc88sqk6OXsdsX4+4YuHiWse+9rnHvutmp62xY87sWFPpv6mfZ+Z9NhvXNJ1jTee8czf2puJHuwqjLLMiI3fUeIBYA3OsdlZk5tAX9FPvHhhn48ZreqbFRrbVjqJq+KM3NjG+zJVKkcM55oElCYk7C8swyDKNw266RrxB/kiE91obseoNbM0vHtMXANkWO1WpmQyFQ5zq64prAzsMRj5cuWTUkJpNIorCqb4uIqrCHYVlo4YUxL6rVJOZtTn5Y/dRVc70ddMf9LO9oJQM83jZ3odLF2LV6Wn1DHFuYGxROLNOz8rM3FGj6BKpJgs5VjtBJYo3Eh45l8LZ/h56/D7uKionyzLWpSqAe4oWEFEV6t0DDAZvzgrc15s3Dp9n75mmuJ/JkmDdwkK+9OR2/vKpO7l9xYL3nUx1komRhOCRTYvielG6B7ycuNg+YYK8Bry472zcz9IcFjZUF91UCosasaKls4HdYpowj2nQG7+w8Uzw+K+vhHaS2cFuNk7o+e1xe286HbUkSd5vJBzmJwuJTMv4ZDmzTk+GOfb7dt8wqqaNMUwa3AMc7GqlYWiQwWAAfzRCWFVo8wyhk6Qb/rBIM1kwyuO7I9/uRBYSEVWh1++jwO6kN+BjOBzEF4nwvTNHeP7i2GS2qKpS7+4HoNPnGc0Ru5IUo3m0v2YbXyTMcDiEBpQ4XeM+10kS2ZaxRo+iqbR5Yp6qPJsDUxzVI5fRRLrZykAwQKdvrPyxSacjN474iE6SMIzEXl/KCwtEo/QFfCiays62Rj69Y3DcfgOB2ERjOBzCF539FdxbDW8gzM/fOTFhmM+yslz+6NFNLCzIRJ5BknpkHsn3JpldlpXnUZSVQlPX2PsxEI5wprGL/iE/mSnjY8lbugfjCk8IEVPxW1iYOWdtngs0LVZsdzZIiRMye4letw9FVWdN4VAjVmw5yc1Hit2MyajHG0cEpqVn8OZTpU6S5H3GtHRU461mSwjkEZ38K1cwfZEwP6w5zs/Pn8QdCqKXZLKtNpwGEyadbsTQmL/ohARiRHFHi11XRFXQtBEPS1/PhDHxekmasMaIXpbnzCugaNropDqe50sgMF4VNqdpEB1pq06SJkxkjhm+2rhVainOMSdC1bTRczUPD9LqccfdTi/FSjUn0wCuzdG6NrrjhFlBzDvw6OYlLCzMnPHEze0LJl/styBCCFw2E1uXlNLUNb7g49nmblp6B8lwWcfmf2oaO082xA0v08syd65cMOGK+2wym88ITdPo6B+elWNluWwTynEHQhF63V6yU8cvQk0LTaO9b+ja2yWZd2Sl2LGZDXGN+F63jwGvnwxn4knxSZIkuT4k/JZTNQ13aHzYVUiNMhSOhRikmswjk2CNd1rq+c7pwxgkmb/ffA93FJaOmeA/9MKP6fJNLqZwPfCEQ0TU8QnBfcFYYVOdJOEwxHKEUoxm9JJEhtnK03c8PEZ572okcf31lSw6/aiXrS8wfqVS1VSGwmPDWGQhSLfEdPUHAn4iqoLhKk9dVFPpC/jQSzIu09h8qUQwyTJ2gwGA/7fhDj6ycOmExpvgRseK3xwcvdA2oVcqN83JxkXFs7IC3jeUXPm+VTEb9KyrKuL5vWfGhbl1DXg419zN0pIcDFcYR5Goyq5TDXFDAFPsZrYvL5u19k3kUVU1jWB49sLEVU2jrq1vVo6Vm+7ANIExGVVVLrT1zZoxpWnQ0Dmx5HOS+UteuhOn1QyMj9JQVJUj51u5b13V9W9YkiRJpkTCs6uwEst3CSmXVyI1TaM/EKB2sA+TTseClHQkIQgpUercAwwEAzxZuYS7i8ox6fTIkoQsSQyGAvQGZiecYqY0Dbvp9fvGyNVqmsahrnYiikKa2UK+PfbSSzNbWJSeSSAa4XhPJxoxY+vqP/KIIXW981LMej3FDheykNjf2TrGSNS0WH7a2f7uMfvoZZml6dlYdHqOdHfgDgXH9gVwoLMVTzhMmslMhWuyat+TY9LpKXel4TAY2dveTFhRJuw/aUTEJMnktHQPxpValiXBgvx0UuzXroMxFWqa4+cAJrn5EUJQmOliSUn8Ir37z7bgCYw1ss41d0/oxbl7TSVWk2HW2jeZmqBnFsUc3N4AzT3jJ7XTId1lm7BGVzSqcLqhc1bOA7Fc2fPN3dfeMMm8I81hoTgrBTlObqGmwXsn4y9YJEmSZH6QsDEV1VQOd7XxauMFBoMBFE2jy+/lhfoaTvV2sT67gAJbrLaSJGKhXwJoGXYzFI5N0COKQu1ATELcG54f+TB9AR8/PX+S8wO9hBWFQDTC4e42nqs7i6Kp3F9SiVV/eWLw6UWrMEgyz9ad4cX6czQPuxkOh+gP+GkYGmBXWxOvN9URuEHCGncXLcBuMLCzrZFXGy8wFAqiqCo9fi/P1dVwum9sjoMkBAtTM9icV8S+zhZ+WXuadu8wUVXFH4lwpKuNp08eQkPj3uIK8meovLghp4Cl6dnsam/iu2eOcLa/m4FgAHcoQLt3iOM9HbzcWEvdSO5ZkskZ9sVPPJckiUzX7ISHqJrGvgkELpLcGmSk2FhWloMhTmja6cZOOvs9o0a7pmkcudAad+yZDDoeWDu7K+kOqymu/zqqqnQNzE5YHsC+s02zJlsuCcHysty43vWoonKqoRNvYHbELuo7Buhxz4/FySSJIYRgXVUhJkP8ek4nLrZT3558FyaChoY/2s8598vUDr1OWPVNK61EQ2Mo3E6DZydnBn/DiYGfcXLgF9S4X6DJu5dAdHYWXuY7Gho9gRpOD/6aJs+eG5Kio6ERVYNcGHqDGveLeCLd8yZVKOEwP7Oso9SZyn+cOMBv6s5i0ekZCgc5199DpsXKx6uWkWaOrYLrJZnlGTkUO1N4q6We/mCAdLOFQDRCh9dDpsXKlrxijnSPrdKsahr7O1o4PiKn7Y9GcIeCRDWVn9Sc4EBHKxa9AZtBz1MLV2DUxS6j3TvM2y319Af8+KJhTvd1E1YUjnS387cH38NmMGDV69mQU8SS9Cx0V4Q9LU3P5lRvF1/Z8waZZhsqGi3DbhqHB7mzsIwnFiwe08b1OYX82epN/MfxA/z94V0U2l1Y9QYUVcUfjdAf8FNgd7I6Kw+Lfvqrs4qmcqy7k0NdrfgiEfzRMJ0+D4FohF/VnuZUbxdWvQGbwcATCxaPypWvzyngqarlfOvEQb5+aCe/qTuDSdYxHA7RF/RzX3Elz9adGXOubIuN3128mh6/j++cPsyu9iZcRhNRVaXVM0Szx80TCxbz8arlMw69K3Kk8McrNvB3h97j6ZMH2dFUR4rJjEAQVKIMh4JEVJU/WbGRipTpe8HeL6gTPFAEYNDPjmLk+ZYezrdOLLue5ObHoJNZVpZLdqqdlh73mM98wTD7a5qpKspEFoIhX5Ca5u64IXarKvIpzHLNqlc5O9UeG9BXDfVIVKWurW9WxByiisIrB87N6BhXs2lxMT/ccQRVGdtwDWjtdXOqoZONi4pnfJ7XD59P1pm6iVlfVUSmy0Zj1/hQTbcvwG/3nuGLj28ZE2abZGI0TaHdf4wDvf+JQMKmzyTXvCIhVWxVU2jy7qHG/QKD4SZCigdViwICnTBg1qVwV+5fY9alzNl1zBfCipez7t9y0fMODn0O6aZKbPrxZX/mFA36Qw3s7/0WihYBNCqd9yOLG18QPuG7UifL3F9SgSQEPz1/kiPdbZhkPZtyi/hE9QpWZuWiG8mJEkKwOjuPr2+6mx+cPcbx3k4OdwfJsdi5t3gBH6pcyoneTo72tI8Z36qm8XZLPb+oPTUqpnApVG1nexN7OlqQhUAvSXxwwZJRY6ppeJDvnI7Vf1I1laga27dpeJA2zxCyFPOWSUKiKjVjjDGVY7Pz6UWreLHhPG+1XMQdCpJvc/DFFRt5smIJqaaxYVJ6SeKJBUuoTs3k+Ys17G5v4kxfNwY5JrCxPqeAh8uqxtViivXL1CvVq6rGno4mvnPq8Li+2NfRwsGuNmQhMMo67iwsGz2fSafjc0vWUOxI4cfnTnCkuwODJLE6O5+/WLOV4VCQ1xpHiqONNEWWJFZl5fGv2+/n2QtneL2pjtO9XRh1OhalZfGFFevZll+Cyzi2L8RIrYIJryhO3pgkBKuz8nj6jkd4qf4crzfVcaK3E0XVSDWZKXOlcm9xBRvzCqfUT+93rMb4BrumxWSeNU2b0cQ2qig8u/Mkbm9SevlWZ1FxNkVZKeOMKYB3jtfxO/esRpagqWuAlh53XDP+vrULJxRemC6lOWkIxLiVSE3TaOlx09Q1GNtmmsNc0zT2nmmitrX32hsnQHVxNnnpTpq7x69g97p97DrZwIryPMzG6U8IugaGee/ExZk0M8kNxmkzcd+6hfznC/vGfRaJquw+3ciGRUVsXlxyy4W+R9QAL7V+kbAy1rMqS3qMkgOnIZ9cywoKbRswiKmV9NDQCCnDhNXYMWM/xysrT8ZAqJHTg8/SFTiNQJBtXoLTkD/q9fJH+3EZChK51JsWVYsQUNyoWgR/dABFmx2PeqKEVS9BJSa0E1I8aJo6F2WjEibxJQ5NwyjreLisig+UV4+qKElCxHKErhrkRlnH+pwC1mTnj66aXRIVkISgyOHigZJKdFfECstC8NV12/kfa7deozExg+oSG3IKefuDn+ZacmOykMZ5VhRVpcjh4q823MH/XX/7uHZefV1iJIRxZWYuyzNyULXLr/hLeVLxxCceKK3knuKKKX/3OkniC8s38IfL1l1jy7F9AWDVG/hAeTUPlS0c9z1pwImnvjCal3Tl+UocKfz5qs386cpNl69JxPotXrtfe/STaCP7Xk22xcZ/3v7QiIjH2MmVLEnkWu18dukaPrNk9RhFLknE6nzNg3vkpiAn3YEQ41XNoopKbWsvUVUdLTidKFFF5fVDtew505SM238fYDHq2biomGN17fiukmq+0NZLS4+b0pxULnb0x1WPK81NY1Fx9qwLxywuzkKWJdQ4IXjtfUPsPdNEUVbKhFLkk6FpGj1uLz/acRR/HHnqmaCXJR7bsoR/fXbXuM8UVWX3mUY2Li5m8+KSadXjikQVfv7OiWSI302OEIIPbV/OC3vPxr2v2vuG+NGOo2S6bCzIz5j1+yuqqGho035PzARNUxmOtBNSPAhkJHGpDRqaptIVOEXt0KvYdJlszPwCBbb1yGLy6auEjhzzMnItKzDKDrJMi0hk1q1pGgOhevqCFwCN9Rl/wOKUx644RmzOJ3H9++tGYJJTKLZtwhvtodC6Doc+74a0I8NUSZFtE1E1SL51NbKYvbzcmTBtf3HMyJjaIBJCoJvgxheA4aqb9/L2ib0UJSHGHStR4hkEE3HJwJKFmPLtJAkJQwJNnG5fXNo3ZhDGk0cf3+9X7pfINU328I21f/LPZQRy0mqaEVUFWbwgzo4TodCI1Sk5Vd/JygV5Ca1oappGOKqw72wTP9xxZNZq7ySZ3wgh2LSkhJ++fWycMaVpsPt0A+lOK7UtPeMk0QWwvqqQVMfsF4ROdVhYVJzFiYsd4z7zBcO8fvg8i4qzWF6em1C4n6pp9Lq9fPeVg3MmsHL36gp+9d7JuJPkzv5hfvb2cTJdNioKEpskB0IRdhyp5Y3DtbOW55XkxmE1G/jcA+v4h1+8iz80Pnz26IU2vvmb3Xz2wfUsKs6Om9uYCKqq4QmE6Bn0cKGtjzSHhfXVRTM65kzJNi8m17ICSehQtBD+6ADucAuDoSY80S52dX+DLfwZxbbNCDHxfS6EIM1UzkMF/zatdmgoBJRBoloQCT0VjrsRzF1Jm/mOEIJq1yNUux65oW0wyU7uzfvaDWvDRCSDb5MkmQaKotDQ0Y9eNzsFN6/GajKS7rROeZV9TWUBJr0u7gu4e8DDs7tOkZViJy/dMeWXQe+Qjx1HLvCbXafihigluXXJS3OyuqKA9t6hccbF/rPNbF1SSk3LeOU4l83MivK8WVXxu4QkBA+sq4prTAHUtvby3VcP8sm7V7O6Mh/dFBbWIlGFUw2d/HbPGd45cZFQZPYNEiEEKXYLT25fxrd+u5dwHKPn0PkW/v35PTx11ypWVeRfM0TykiftzSMX+NV7J+lx3/jyIklmjiQE25eXc7Khkxf3nSWqjI8EOHCuhc4BD49sWsS6hYWU5KRhMkx9KqeoKr1uL609Q7T0DHK+tYdjde209br5w0c2zQtjalnqh9FLsXQCDY1AdJC64R0c6fsBAcVN7dDrZJuXYta55qwdqqYQUWNh7UbZiiR071tDKsm1SRpTSZJMg2F/iK/97O05q4G1uiKfj965klS7ZUrb52c6WVtVyHsn6sd9FlFitYDCkSiPblnC2srCCUUpIlGFjv5h9p1tYt/ZJk5c7BjjnTDoZAoynNQn69lcE0VVCUWiBENR/KEwgVCUQDhCR/8wqhY/XLK1182p+g5MRj1mox6zIfbTZNDNSp2wqSIEfGDTIl7eX0P0qtDOhs5+alq6aYwzBhbkp7MgP33O7osNi4pYkJ8etw6UpmkcPNdCj9vLhqoitiwtpSI/A5fNNGYSFIkqdLu9nG/u5tD5Vo5fbKexawBVvRyGnp3mYMgbiLs4MR30ssTtK8o5XNvCntNNcbfZX9NMZ/9wLORvSQnVhVnYLcYxbfcHw9R39nOmsYs9pxs529TF8BU1wVJsZlRNY2gCdc/ZRNW0kfEdIRCK4B/52dw9SCSOEQCxemWn6jtiY3vM+NZPKzzzVsRmNvDRO1bQPehh/9nmuKIizd2DfPvF/bx55AIL8jNYWJBBUXYK6U4bdrMRSRJEowrBSJRgOMqwL0jXgGfkzzDdg166Bj30ur2jYzyeLPt8QCCw6FKpdn2AZu9+OgMn8EQ7GY50jDOmBkPN1A69il8Zr3y4LuP3seomFrMKKV46/Sdwh1sIKkMElEH6gnUAhFU/u7q/gXRVaGGV8yGyzUvHGVmqFqU/1EBP8BzD4TZCigcQGGU7LkMBuZbl2PV5SFd51jr8x6kbfpN86xoKretGrvckRslOiX0rGaZKomqIJu9eOv0nkCU9BZa15FpWIEuxBayIGqB++B06Asepcj5ClrmaQHSAZt9+BkONRLUwJtlOlmkJedZV6KWJa4a2+Y5QN7wDjbH3s16ysCXrzybcLx5RNURv8Dw9wXN4I91EtCCyMGCUbDj0uWSYF+IyFI4Tk/BHB6gdeo3BcOO4Y1a7PkC2efG4318irPqpH36HzsAJql0fIMtUjV8ZoNV7kIFwI2HVh04YcBoKybeswmUonNTbORkJGVPz81ZL8n7BM+Tnf33qe0SuCi26Fh/9wzvYeNdi5Fn0IkUVlTONXdfecJqkO60Jhe1IQvDJu1dz8FwLgTgTwEAowq5TDZxu7CIv3Ul1YRb5GU5sZgMRRWXYH6JvyMeFth66+j0MegPjQryEEPzBIxtxWE389Y/enPE13uxomkZr7xA7DtfiDYbwBsJ4g2F8gRC+QBh/KEJUUVBUDVVVR37Gwmoi0fiTzdcPnWf3qcaYWI4kkCUJSRLoJAmTQY/NbMBqNmAzGbGaYn9fUZ7LivK8WVf5WliURVVRJqevGucef4jndp8eF+Jn0MksKs4mN21mZRMmQghBhtPGk9uX8U+/fI/wBF6kxs4B2nrcvHnsAnazCZfNjNNqQqeTCITC9A/78frDeIMhhn2hcXmALpuZr3xoO9977dC4a59J27NT7TyxbTnNXW5ae91xt2vqHqS9f5g3j1zAbjGR7rTisBqJRFWGfAE8/hC+YBhvIDbersSol/mzJ7byxuFYfuNM0TSNAU+A3+45gy8YwhsMx8b46PgOE4kqqKqGomooqoqqafiDsc/ised0IyfrO0bHdUwUSkKWBCaDPja2zSNj22TAZjZQkZ/BhuoiLHPg7ZyPCCEoykrh9x/awJAvyNnG+KGn4ajCuZYeatt6eed4zCA16OSYUSpAU2MGr6qqRBWVUEQhFIkSjkbH5dbOhEuh5T3tg+x78yy1p9vo63ITCkSw2Exk5blYvKaUNdsqcaXZRq8xUfSSiTRjKZ2BE0TUACHVM26bgDJIs28f7nDLuM9Wpn5i0hmvP9rPWfdv6Q6cQSE6otoXuzZFC1PveXfcPnmWVWSbl4753WCoiQO932Yg1EBY9RHVgqha7FklCRm9MGPRpbIy7ZOU2W8bM3kfCrdRN/wmUTVIRPVzpO8Z/NF+JKGjM3CSjZlfoDtwhhMDv8Af7UMg0eo7yLqMz1Nk3YgQAlWL0h2soW74TVINpYDK/t5vMRRuJ6oGUFGRhY4L0g4KrGtZnf4prLrMuN9JrD1voTH2WWuUHVMypi6NDXe4mWP9P6YrcIqQ6iWqhtBQEUhIQkYnjNj1OWzM/GNyLEvGHCOi+mn3H6Xdf3Tc8Qus6yc1plQtQnfwbKwvjOWAxv6e/2Ao3E5EDaCiIJDQSyYu6F9jRdpTFNs2jTOap0JCezz70EdRNW3GeUnziUVpWRz92B8iSwK9dOtc162Iqmg0X+ginKAx5XH7500tgrmksiCDT9y1iu++eiiuUISiavQN+egb8nG6oXNMsrumxcIpLq3OX41BL/PUXav54Nal9A35sZkMeGc5Uf9mQ9OgoaOf/3p5f2x0jfThyH/TIjZZnbhfxcj/ROx/CODJ7cuoLsqadWNKL0s8tGHROIMiHFU4WT8+1C7NaWXNwoI59TDoZIntS8s4Xd/JKwfPoUwwXiOKSq/bR++IKMPoPOEa343FZOCrH7+DpWW5FGenzpoxBTHBnY2LivjYHSv4r5cPMOgNxG97VKF3yEfvkI+Gzv7Rtk82ATboZf7k8a1sW1bGxfb+WTGmAHoGPXz7pf3EhABG+k6b/tPUP+LBmgxx1fjeurSUxSXZ7xtjCmJjpaooi7/+nXv4vz/YQU1z14RjXVW1az435gpN0/B7Qzz7nfd46Sf7CQbDqIo2JndXSIJ3XzpBRraTp754D5vuXozBOA3tM7QROeyY6IMcZ/qabV7EA/n/TEAZJKAM0uE7wcnBn0/p+BZdKotTHqfMcfvItSm0+A7R5N2FQbKwNv1zyJLxqvMtHXccg2yLGWRaBLMulXzTahz6XDRNozd0np7AOQbDzezs+idchkLSTQvG7K9qCh3+k4RUDzmWZaBBo3cnPcHzHOr7LhHFR6qxhGLbJho8O3GHW2ny7iHLtGicp67Vf4jT7mdR1Ag55iWkGEsIq37afEfwRDqpG34TWRhYk/EZjLJjnMp0pfNe8q2rCShuAtFBTg78gu7g2JI612Iw1MS7XV+jP1SHQEYvWcg2V2DRpRJW/QyH2/ArgyAg3VQ+bn+7Poc7cv4Sf3SAgOLGHW5lb8+/JdQGgHbfYc4MPktI8ZJqLCXLXI0kdPQEaugJnqMvVMeRvmdw6HNJM5YnbPAnNKJNulsvKlASAov+xmvUJ5lD3gcuVSFiK7uPbVlCj9vLG4drJ520qJo2ru5N3OMCKXYzT2xbzkfuWI7FZMAailBZmMnRC22zeAU3JxrahJOcuTkfY4w2iE2m5qoFm5eUkOG00Ts0Nifn6om9AAozXSwtzZ2jloycRwjSnFY+ec8aPMEQe083xc1BupprrcQLAZkuG7/30Aa2LilFVTUKM12z0+grkCWJD25bhgr88I0jdA+OX12/mmu1Pc1h4am7VvGBTYvRyRJF2SnxynFNi9j4vr4KntpV4/t63l/zCUkIirNT+eYfPcK/P7+HXacaGPD4Z9WrdCVCiIQFLYYGfHz3H19l58sniE7gKdZUjaiq0Nk6wD9/5ZcMDXh58KMb0CVY/zAYddMViE3kLbo0bPqscdtIQo9Nn4lNn4mmaaiaOmVjyijbKbJtGP13VA3jjw7S5N2FThhZ4LgLg2y75nHMcirrMn4fiy6VHMtyDNLlUP2oGuSs+0WO9/+IkOrhrPu3bMv+8rhjhNRh0owLWJ32O0hCz9udGvWet2nzHabCcTfrM/4Ao2wn01zFu51fZyBYT0gdxoxrzHE6/Mex67O5M+//kWO5bPiFFA+7u/+Fes+71HveocC2liLrxitWnWLoJBNOQz5O8tE0lXrPuwkZUxHVz8G+b9MXuoBBslPhvIflKR/BoksbNVZUTaE/dJGIGhjNk7sSSciYdamYdalomobTUDAtY6rNfwSjZGd95udZeEVtKlVTODP4Gw71fZfBcCPt/qOkGIoSVglMBiknufV5H72LM1w2PvvAej5250qyU+wzOpYkBItKsvnDD2ziY3euwGGJxVabjXoWFY1/kSW5tRBC4LAY2b689JrbGvQ6ti8vwzKDWkmJUJKTyhcf28oHty0l03XtCc5kGHQyqysK+NKT27lvTaw+ll4vk5vuRD8HXjZJEjy5fRlf/tB21i4sSEg84Ep0ssTikmy+8OhmPrh16WheXVaKHavZeO0DJLkpcFpNfPlDt/HnT25n69IyXLaJc1ymg9mgp6owk0c2LmZ5+dTlriORKLtePcXBt2smNKSuRomq/Pzpd6g53nzNbWPGUJSgMkR3oIaj/T9gKNKGTpjJt67Frs+ecluvJ5KQqHI9SJFt4xhDCmLGSZl9O6nG2DO1J1gT9xgm2UmWuXo0D6rEviW2vzCSa1mJSXYgCYk0QxkGyYJfGSCqxq/7tDz1Y2Sbx4bOGSQbq9M/jUOfS0j10OI9QET1z+i649EZOEmr7yCy0FPpvJfVaZ/Eqk8f4/WRhEyGqZJcy/JZP//VVDjuodr58Ji8LEnIlNlvI9NUBUB34OyoBzQRbj1XU5Ik73OyU+188u7VLC3N4b0T9ew+3ZiQ2pdelliQn8G2ZWVsXlzMgvyMMaFbRoOOioJMdLIUV20qya2DyRCrOfXaofOThhE5rSZuWzY+RGMuKch08fmHN7K2soCdpxrYX9NC9+DwlFfudbLEktIcbltWxsbFxRRlpiCPjHNJCFLtFlIdFroHZ18pTxKC7cvKKMtNY8+ZRt45fpGzjV1T8rIBLMhL5/aVC9i6tJTy3LRR9T8hwGkxkZViwxu4MUU1k8wusagDHXevqmB5WQ6nG7s4dL6FoxfaaO4enJanymTQsSAvnYWFmVQVZlFZkEFJThrGBLxF/V3DHN55Du9w/HDVifC6/bz+y0NUryiK651q8R3AF+1DCBlNUwmrPjyRTtzhZgSCRa5HWOi8f1p5LfMBqy4dsy4VEIQUD6qmjCtfo5fMWOTLYhk2XWzx0iQ7scgpo3lWktChl6yxXChtfPqDQbJRYF077vdCCCxyKvnW1dS42+kKnCKiBqfkeUuEWL6Vhl2fS4ltM0Z5Zgu8M0FCR5Xr4bif6SQzKcZiOgMn8EX7UElc1fXmHI1JkiTCNMP8FhVn8Y3ff4hwNLEcrdnAYTFNWckvHhaTgY2Lillcks1jW5dyvqWbUw2dXGjrZWDYj8cfIhSJotPJmA16MpxW8tIdVBRksqQkm4LMFDJdVoz68XKwkpDYsqSEH37lw2OUpqwmA8YprrJvXVpKRV76OKUqp9U86gG7Fn/x4dviThjzM6YmgOCymXjmKx8eV5tLliQyndZr7i8ErKrI58f/8yNTOt9ckWq3YDXOTT6JJAnWVBbwnT9/YlLD2aDTkeG6dp/NNlaTgc1LS1lWlsuHb/NS29bLmcZO6tr66Rocxu0NEgpHkSSB2aAnxWGhKNNFVVEWK8pzyc9wke6MjfOrWVySzf/3hUcJR8be/zP1hF1CkgSFmS4+uHUpty0rp7l7gKN17Zxt6qKtd4hBj59gOIpeJ+GwmMjLcFJZkMmaygJKc1LJSrFjjuMJLM1N5R8++wCB8NjV1VS7JeEwrpLstBs+vu1mY0LPws89uJ4PbV82LiBBIMjPnF1xlLK8ifvHZTPPaoS5JAmyUx1kpthZu7CQAY+f9t4hzjZ1UdfeR3vfEL1uL75ghIiioJNlzAYdFpMBh8VIfoaLwszYn7LcdFw2Mw5LTOxDnoYHtrfLTcO5zoT3U1WNpgtd9Ha6ySlMG/d5f6ie/tDVqrSCPMtKFqc8Ro552Q2dlM8UISRkoR8JxVVHlPLG3peS0I/xal0KOdNJJnRj1PcEEjIqSty8cLs+C70Uv+afLBlIMRQDMBTuIKqF0NDG5U1NFw2V7pGwTLs+G6ehgBuZc2HVZ2LVpcftCyEk9CLWr1EtzHTCmZLG1E2CqmpEQhGUaXgCJEnCYNIhXUdp5XnFNMP8bGYjC/Jv3nAZIcSocVKRl87966pQVQ1VuypBWAiEYFRVS5YlBBMrLgkBdouRqhmE+qXYzKTYxsdHJ0JRVsqM9tfrZKpncA2xMDgTi4rnZ7jJbGExGagsyLzRzZgQSQicNjMOq4nS3DTuXlURU068epwzMs5HVBIveVsnGudWk4EFeRNLKc8GQgiMeh256Q6y0+ysriyIqeKNtP/K7SQRU7/TyXJMpGGCdpsMekpzx09Sp9M2s1F/043vvHQneelzoyh5JUIILEbDde8fSQicVhMOi5GirBTWVRWOGe9XP9sv7SOJmEKoJMX+PpOaSaqq0t89zEDvtXP+4uHzBGhv6otrTKUaSkg1liEJmbDqo9V3GEULkWdZRb5lTcK5LNebWHhiBG+0hzb/EXoCNXgiXQQVNxE1iKKFCKneSUWxBGKM5+3SNyUhIUS8BZEJhKMk+4TGkYSMSY7dJyoRIqovdphZsnciSoCwGhMAMkq20XPdKK706MXlSpWiaZA0pm4SOlv6+Y//+zwn9l9MeN+Symy++LUPUrGkYA5almS+I4RAlsW0Vh+TJLlZEEIgC3Fd63HNJpIQSDoZPdNTldU0jda6blRFJT3Xhc05fc/2XBPwBulq6Udv1JNdmJawGMHNQsAXoqdtYEw5D51eJqcoHaN5ZkaBELFpcmzMXF9URcXjnn6OTSQcnTA8sMi2kRVpT6ETJoLKEPt7/5O64R2cdT9PiX0zTn3htM97PfBFezkx8FNqh99AUcMYJCt6yYws9OgkE3rMKFqEcJywvMsI4ksaJOY3mtxgFmPCC6eTJzQZV3p4hNAhpvlcmy0u5Z/NFUlj6iZA0zTaGntpqe+Z1v49nW4unu2gfFH+GDnsJDeOuu5+LnT1siArnQVZ6VeL6Lyvael3c7qti/wUJ0sLcqbdNz3DXg41tuEwGVlXWhA3lCtJkrlCVTVO76+ju23yAtfOVBtVq0twpMwsTFJRVP7u976Hd8jP7//V42x5aOWMjjeX1J1q4e8+933yy7P4X//9GVIzHTe6SXNC68Vunv7LX9NW30M4GCYcipKRl8L/+d5nKb+JFzdVFcLB6U++VVW7Zr1IIQQm2cECx510+k/ijXZxvP+nbM360rz1TgWVIfb2fJMm7x6MkoMSxxZyzStwGQow6VzohAlZGNjd/Q0avbvnvD1RNTihB0xDJapeLu4dT0lvJuglE2LEIFS0MIoWRidu3kifa5GcXdwEhEMR6ms6GOybpkt9OMjFs+34PAHs83i1cs6YJUPF7Q/w+ukL1PdcnhxJksBqNJDjtLG0IIcFWelIU5j9/2jvMV4+eY4Prl7MV+7fhm6Wa7edaOnk7XMXxxRWlSSBWa8n22ljUV4WC7MzRhPX5xMvHK/hmT1HWVOSz79/7OGE8zwuUd87wNdeepfyrDQW5WUljakk1xVNVXnpB7vY++rJSberWF7EH//Dhyc0pg69fYbGmg4e//07blkPzvWmpa6LXS8e44FPbMaVbp9RyNtk5BSl89SX7md4wEdPxyAvfn/nnJzneiME6KapQgmx1AO94dr+NCEkMk1VFNk2cG7oJRo8Oym2babEvnXa555L2nxHaPcfQxZ6Su23sSb90+NqP2napVSNuZcZ9kcHrjjfWFQtii/aB4BRsseMqVm8DXTChEWXSijsIaQME1Dc2KVbVwU4Obu4CRge9HPmSCPaDOptXDzbRm+n+/1pTM3SM8sXCvPu+QZ2X2ga/Z0gpgpmMRhIs1m4f2kln922Bv01jKMMRyzpPc1mmZNctos9/fz68BmGA5dXngQxcQWLUU+Gzcrdixfw8Q0rSLHO7orUTEm1WTDIMlkOG3LSk5rkFmDNHYtYtb0q7mcp6XbSc1wT7vvaT/bS2dzPo5+7jasT1ZNMj5ojDbz4/Z1sfXglrvS5EzOwuyys3Bb73jub+3j3uSP4PImp381HZFnC4Zr+XEJvkHG4pvbeMcg2yh130uY7wlCklRMDvyDTVI1VP7f5jNNhINSAqkXQSxYKrGvGGVIAfmWQkDK9hfFE8UX78Ea7McnOcQsGUS1Eb/ACAC5jEbIwzpr4BMQ8i9nmpQyGmxkKtzMQasQepzbYrULSmJrnaJrGQJ+H8ydaZnScpgvddLT0U1yR8/4L9Zuly73SJvvfD91ORXY6EUWhfXCYN85c4FBjG8/sOYrZoOd3Nq2cdLXzc9vW8ImNKzDp9VPyZE2XNJuFf/vIQwBElChtg0O8duoChxpa+cGeo7gsZj60dum0vT9zwQdXL+aBpZUYdLqbNv8lSZIrqVhWxANPbY77mRAgTZDP6B0OcO5YE660m1e9bL4RCUdpudCFd2j26+q8XxCSICXDjt1lmVbulM1hJr8kY2rnQox4pzZyZvA3DITqOT/0MivTPjG5oMANIfYu1zQNRYugadroPEDTNDQ02n1HGQxfu87WbKChcM79MpuzvjgScne5LcPhNtr8hwDIs6xCL83+QvtC5wOcH3oFb7Sbi543STeWYdHFjOAr50exvlERSHPmJZ5rksbUPEeJqhzfW0fAN7OaIZFwlFP761m5cQGWWS76N++ZJc/Ulbd4RXYaK4tyR//90PIq/vald3ju6FlePnmOB5ZWkumYWELZpNdj0s992rBBJ7OyKGf03+so4KHlVXxzx15+uO8Yb5yp47aFpeSn3lilnSsx6nQYdclHU5JbB0kWUwrR0zSNaETBM+gjFIxwcu8Fgr4QEbuZlrou9FeEquoNOnKK40v9giDoDzE86CMUiE3q9AYddpcFi908bkHtkgqcbziA3xsiHIygqRqSLDCY9NidFkxW45hzBXwh+ruHSM10IIRgoGcINHCm2bA6zAR8IQZ7htE0DUeKFZtrvBf+UjuGB314h/woEQVJlrDYTTjTbOO2VxWVzpY+0CA1y4nZOj4Ho7djkIA3hCPVOup10jSN4QEfwUCYrpZ+6k+3oWnQ2dQ3LuIjtzgdnUE3frKnagwP+vB7g0QjCpIkMJkN2FOsMxaTuNkQQpCW5aB4QRanDzcmtK8kS5QvyiNjEm/suH2EzNLUJ2jy7mE40k6Ddxf51jVkmqqvMlZUNE1FQ0G9KicoovmJqP7YhB0ZIaRZn7ynmxYgCwNh1UejZycZpooRGXdBVA3SHTjDyYGfxZTzroNMuCwM1A69ikOfQ6ljOzphQkPFG+lmV9c/EVEDOPUFFFrXjctnivWjijr6M3q5lpUGYcV3RR9KSCN9eiVppnKqnA9yfuhVLg6/TUTxsyz1w1j1mUjIaFxWPuwN1FJi34rTkHdFG7RR+fhL7bmyuLCihgir/pjK4YjS4Y0yyJIzlnlOJBLl4NvnZuVYJ/ZfxDscwHzVS/GWZw48U6OHHulHg07m8VWLefHEOTyBEE19g2OMqYiicLG7n8a+wdHfSUJQmOaiOndy2WlN0/CGwjT1DdLn9RGKKEhCYDHoSbWayU1x4DCbJvRwXf1dG2SZB5dX8eKJczT1DeANxS/G2jPspbnfjdsfQNPAajSQl+KgMNUV17sZCEeo6eghFI2ysigPnSTR1DdIh3uYYCSKTpZIs1koz0wbUxdJ1TSa+wY519l7uc1Aut3KmpL8a/aNLxzhYncffV4/mqbhNJsoy0wbkXefeF9V1WjuH6TD7cEXCiOEwGUxUZyeQoZ9fP6KJxjicGMb2U47C7LS6PX4aO4bxBMMx4qlmk2UZqaSZo1f1wPAGwzT0j9It8dHKBLFqNOR6bBSnJ6CxaB/f92XSeLSdrGb73/tBdobe+ntGCQaVuho7OVP7v/GmO3yyzL51o6voLsqF1CSJAZ7h3nxmV3sfuk4bQ09KBGF9BwXK7ct5L6Pb6K0Om/cWNv/+ikOvXOWC8eb6W4bIByIYDQbyC3JYM3t1dzxwbXkFGeM3vs1hxv4ty//jE986QG62wZ45Ud7ALjzibXc+9GNvPXsIV77yV6iEYVN9y3jo396L5n5qWPOq9PL1J1qYc/LJzixp5ahAS9Wu4mFK0u472ObWLmtcsz1Bfwh/s/Hn0ZVNf74Hz7Miq0Lx/Xff/2/5zi44zRP/tFdPPWlBwAIBSI88/UXuHi6ja6WfnwjSnJ//Zn/5uoXxNNv/08KyseGIwUDYY68U8N7LxzlwvFm3P1eDAaZospcNt63jE0PLCO7IO19df9m5aawYtMCLpxpIxSYuhhFZq6L+z+yHpFghIxVl8Gy1I+wp/tfcYeaqPe8i8tQOFpzKqAM0u4/RiA6QEQNENUCDIQue4BOD/4Gqy4dnWRGL0yYZBfFtk0Y5Nmrj5dvWUWOeQUtvn00efcwFGkn1ViCQGI43E5/uIEsUzWZ5mrqh9+ZtfNORKapCoHEkf5nqB1+DYc+l6gWpi94gbDqxSKnscj1AVKNZePGbn+onp7gecKKl6gWIKIGGBip/xXVghzu/z56YUYvmdBJZmy6TErsW8YcQ0LHirSnCKsBWnz7afbto8V3EKchF4NkQ9GiBKL9+JVBLHIqedYVY/ZXtDAtvgN4oz1E1QBRNYg/ejlnvd77Lu5IC3phRieZMcp28iwrseuvfzmHpDE1z2lv6uNiTfusHavhXGdCK0K3BHPgmYpHhsOKQKBoGmFlbAXtcFRh94UmfnnoFL5wODZ5R/DhdUsnNaY0TaPdPcwP9xzjcGMbHe5h/OEIkhDYTUZyXHbuqC7nqQ3LsZmmppQjhMCk1+GymOke9qJelaCqqCp765r57fEaTrd10evxoaoaTouJBVlpPLh0IQ8sWzhO0MHtD/DMnqO0Drj59ic+wK4LTbx04hz1PQP4QmEMOpnSjFT+/ol7Kc1IHd1PVTVOtHTyrXcO4A+H8QbDKKrK5oriaxpTfV4/39l5iH11LXQMDaOqGul2C+tKC6nMSccwgYfLGwrz0olzvHGmjoaefoYCQSQhSLdbWVaQw2OrFrG+rHCMgdo15OFvXnqHTeVFbCov4pVTtZxp62LQH0AIQbrNysqiXD67dQ0LssfG82uaRtvgML8+fJp9F5tp6XfjD0ewGPQUpDrZtKCYj21YTqbd+r6akCUZj8VuYuW2KlZuq+Li6VZ2vXgMe4qVxz53G/IV4bg2pyVueGDQH+bNXx4gGIxQubyQ1bdV4xn0ceZQPa/+ZC9tDT387+/+Llb7FTkrGrz97GEunGxmwdJCVmxdiNFkwN3n4fju8zz79Nt43H6e+tL9OFLHetx3/PIAVoeZ2x5bzbH3zvPaT/fR3TqAu9/DnU+s4/zRRt797RGq15Zyx+Nrx3joetoH+e7f/Jb0bCfbHlmJLMs01XZwbNd5Gs628bm/epxN9y2bcZ9KsqBieRFFlbkM9XnY/fIJOpp6+eDn7xyXM5WSMfbfkXCUl57ZxbNPv43eILNiy0LSc12EAhFqjzfxk39+habz7Xzsz+4np2j+5fHMFQaTnq33LaX2VCtHdtZOqQZmaqadj3/hLhYsnvy5PhHl9tto8LxDu/8YDZ6d5FvXkG9ZgyRixsrh3u/iicYvJFw3vGPMvy1yGpnmqlk1pgyyjfWZn8c+mE2H/yhD4TYGQw3oJBN2fS5VzgdY4LiHsOql2btv1s47EUbZxqq0T1HveZc232E6A6dQtDAGyUaBdR3l9tspsm1CL42PVmr27uPEwE+JauOjohQtzJnBZ8f8Lt1YMc6YEkJg1WWwLuP3yDYvos1/lP5QPd5IL4rWjhAyRslOpmkh2ealWHVjQz/Dqo9j/T+iPxS/JFCb7zBtvsOj/zZIdrZnfyVpTCUZz943zhCNKNfecAqoqsbeHWdYu30hQn4fTdjm0DN1JT3DPjQ0jLqYoXIlJr2Oh1dUsb6skIii8Myeo+yqvXZ4hKpp/Pd7h3j55HmW5Gfz+OrFpNstDPlDNPcPcqihDUVVExKx0DSNUDSK2x/AaTaNE8vYe7GZf92xh8a+Qe5dXMGKolx0kkRNRzcvHj9PQ+8gEVXliTVL4nrDBnwBnjt6luePnWVpfg63V5UhCUHb4BAt/UNkXRX+KEuCrZUllGelEVEUnjt6lhdPXNsbG1VU/m3HHl4+eZ4cl4PPbVtLYZqTnmEfr56q5UBDC57g+BdBJKrws/0n+OG+Y2iaxmOrFlGRnUEkqnC4sY3XTtfS1DfIn92zmY3lReP2P1jfysH6VlJtZj61ZTWpVjPN/W5eOF7Dq6dqCUYi/OOT92O6wtgcCgT51jv7eevsRRbmZPB729eS5bTTOjDEW2fr+On+43QPe/jbR++elwqLSWbGW786yJkD4ycEQhJsuGcpD34yNgkRQpBVkMajn70NgPd+e4S9r57AkWLl4U9vw2C8dmiwb9iPZ8jEx/7sftbcVo3FYSIcjHBqfx3PfO1FTu+r4+yhBtbeseiKhsBTX36AoD9EWrYTu8uKrJMI+sOs2F3J0//71xx66wwPPLV5nDHV0dTLX//o8+QWp5OVn8Z3/vp5ju+u5X9/73epWFbIwTfP8h//85fUn25j64MrxhhTnc19bHlwOZ/48oOkZTsRksDd5+UX/98bvPmLA7z8g91UrSqZsXS6wajn/o/Hctba6rs5f6yJjqZe7vjgWgrKsyZdwDixu5aXf7ALTdX4/b/+IEvWl2Oxm4hGFLpa+vn5N99gzysnKSjP5pHPbMNkuXXln68mtyidz3z5fuxOC+++eHxCg0pIgqrlhTz5e7exctOCcZENOsnE3bl/g6pFsetzJpQ+10tWNmf9Gd5IFyBIMRSNiiakGIu5LeerKHEm//GQhGHc5P1KZKFjgeNOssxVSCM1oqaCU5/H6vRP4Y3cFyvOqylIQodBtmPTZWCU7UTUAHfl/lWsHVeIyhRa13N//j+il8xYdJeL0tsNuTyQ/w30kgWX4fI7yabP5Lacr6ISJcUwvv5WVA1h1+ewMu0pFjjuJKR4UDUFWTJgkdOw6TPGFAe+kgWOu8g2L0bj2kYyxL6beAghsOkzWOh6iCLbJgLKABE1iKopI7UBDRglGxZdGgZ57LPFKNvZkvVnY0L7JkMSOlIMxWPatDTlQ5Tbb8coOyYcVzphpMr5IPkjuWMTXctkJI2peYwSVdnz+ulZPeaBd2oIBsLvr7ypOfRMXao2H1VVnj96FlXVKExzUZ45trK7LElkO+1kO2Ornq+cOj+lc6qaxhtn6sh22vnctrWsLYnVClM1jaiiEhwJFTNfQ/b7UjsBQlGFHWfqGPQFuKM6D6f58ljoHvby3JGz1HX38+f3buaJ1Usx6mUEgvuWVrAgK52/eeldXjx+jtXFeZRljq9gP+D186N9x/irR+5kc0XxiLiFIKqqRBQFy1WSuEII0mwW0myxBNhDDW1IU7CADzS08M65BhxmE1+5bysby4vQyRKKqrFpQRFf/tVrdLrHqiZpmsbxlg5ePHEObzDE0099gBVFuRh0MpoG9yyuoDg9hf94ez+/Pnya8sy0cblvHe5hlhfm8k8fuo90mxVZEkQVlfLMNP7yuR2cbuumpqOblUV5o9/hu+caeO1ULZsWFPHn92yhINWJLElEFZW1Jfn8zYvv8PrpC9xVvYA7F5Vf89qT3Fx0tfTHrTclSYKiipw4e0wfTYNV26vYeO9SLHYTQggMRj2rb1vEW78+RFt9D3UnW8YaU0Dxwlg7rjQs9AYdVatKKFtcwLFd5wn4Q2OS6gEKF+SQU5SOyWqkoDwLZ6qVjLxUiitzMZoNZOan4EyzMtA7fMVkW4xe/6OfvZ3ckozRY2blp/LhP76Hd35zmLaGbmqPN7PhniWz2kdTRVFU9rxygv7uYe7+0Do23rt01DtoMOopqcrlA5/Zxul9F9j98nG2PrSC7KKJ8thuPYQkyC/N4PP/+2HufWINO189ybkTLfR2uAkFwthdFsqq89h8zxKWbyzHlWaLGyIuCZlcy4o4Z7jqfELgMhTgMoyv0WWU7eRYls7KdcXOJeEw5OIw5F574zH7CYyyDaM88XNcL5nJsYz3uFr1GVj1Yw08IQQGYSHfumaC40x8zZdqTOklM6nG0qleAsC0rn0yZKHDps/Epp88rWHsPnqyzIuuveEk50w1FpNqLJ50O0nIOA35OA3T85hC0pia15w92kRvl3tWj+kbDnB4Zy3bHph56MT7jSttsu4hLy39biKqSvvgMC+dOMd75xvIddn53LY1GGfJuyCAFIsZbzAUyz2KRrEaDeiEhF6WR0UsJnp3RxWVln43GhrBSJS2gSFePX2BHacvkOGw8cCyhaTbYqswmqZR19XHydZOSjJSeHzVYmymyys5OtnAoysX8Z/vHKC5f5Cajp64xpQG3L1oAXctXjBGjc+ADMyO6IamwXvnG/CHw6wrK2T7wtLRCYwkYgbtw8ur+MbrYwsjKprGseYOmvsGuW9pJWtLC9BdESpllQx8ZN0yXjhew/HmDs539pJxVeidEIJPb1lFtsM+OjGQJYk7q8v4+iuG0X6+ZEwpqsqvDp/CbNBzZ3U5pRmX80ZkSWJFUS6L87Oo7+3n5VPnk8bULci9H93AXR9aP/4DAakZs1uw1mw1UrIwd9SQuoTeIONMtSHrJLzDY1d6hRBoWqyQatAXIhyKoigqmqoyNOBDb9ChqRrRyPhCqymZdoQkEEKgN+owmg2kZTuQdbFEcFmW0Ol1REORKxZ1Yj+zCtJIyx4vfpOZl0LhgizaG3rpbOod9/n1or9riM6WflRFZd1dS8aEWV4iLcdFSXU+pw/U4e73kv0+CvWD2NgxW41UryqmelUx2lWLl2L0f+Pzd5MkuVVIGlPzFE3TOPBODdHw7IT4XT4u7H7tFFvuWzIn9Y3mJbP0/L7yMF/61WtjPjPqdGwoK+AzW9eMTqJnA0lIfHjdUv575yH+/a19nG3vZktFCaUZKeS6HNcsRNvr8XHvvzwz5ncOs5El+dk8umoRWyuKRw0CTdPoGvbQ6/GR7bSz+0LTuOMrqorZoKdryEO/d2LX+5aKkjmVfFc1laa+QVRNY1lB9jhjxyDLFKenoLtqjHuCIVoHh1A0Leblu6qNQsTERJYX5vLSiXN0DnlQNQ35iu0y7FYKUp3jQ1VkmRSrmS63h1D08n0bCEc419mLw2SkfdDD2+fqx12PJxhCCEFDz3jvRZKbn/TcFKpWlVyXcxktBmyu8SIoQoiRHCsxbsKrqRoN59o5sbuWM4fq6WjsJegPoyoq0agyKtgQ93ymy8IpQohRT9jo+Ud+aKP/u/xLu8uCLMdX30rLctFU23lD6zL5hwOE/CEQMQPvaoQQGI16nGlWlKjKYK9nnOfu/cDY5+8NbEiSJDeIpDE1Txka8FFztGlKSZ2JUnuqlZ52N9kFqdfe+FZglsL8rjzMndXlZNit+EJhDjW24g2G+fC6Zawomj23OMReTI+vXoxJr+PtmnpeOVXLKyfPsygvi9XFeWyrLGVhbsaERYItBj2PrKhGiJgXxGo0kOtysDQ/m7LM1DGeo6iqMuQPomoaJ1s7OdkaP5EXYlOhiDKxoZ9um9vi0MFIlODIKnmadXx88yWRDfNVIYXhSBTvSB5Vut0a19CWhCDdZkHVNIb8QaKKOqafnJbxeWZX7qsxNqxywBcgElXo8/p5+t0Dk16XPxxfWTFJkqkiSTFvUCLUHG3ku3/9PE3nO1i4sph1dy0mJcOB2WokFIzw3nOHOX88fm2ciaTZJ2cKD2UR2+xqw+9aKNHZe2dqXGn/TXBN4nIfqHPwvk6SJMn8J2lMzVNqT7bS1z00J8f2eQIc31fHfR9aNyfHn3fMgWfqQ2uWsKwwh0Akyo/2HeNHe4/x433HWF2ch8U4ezVHxIhq3+OrF7OxvIi67j72Xmzm7Zp6TrR08l5tI5+/bR3bKkvQxZngO8xG/vSezQhiE329TkYeWT2e4IQAbCov4sHlCyc0GgAqsycOZ5HnuDD0lUfXJpmYjWuFEKPeKGWSWZo68pkQ4w8yaf/FOfGlTbOddp5cs4TCNNeEu5mu4WlMkmS2URSV33z7bepOtbLursV8+qsPk5mXMlprqb97iFP7LszJub1u/4QLhoM9HvQGHVb7Vfm9IyGJ8W5fJargG/aPWcyYCVaHCZPFABr0d7oprR4fdRAJRRke9CHJEq50+/vOK5UkSZKkMTUv0TSNs0cbGR70TXkfnV6esupfMBDh+N467np8Nbqkcti0MBl0WI0GrEYD9y+t5FBDGwcaWvnVkdN8cuPKWX+h6mWZwjQX+SlO1pUV8tSGlfx4/3GePXKa7+48zJL8bDLstnGLp0IIbFM07nSyjGukXpXVqOeOqjIshon3vZFzhlGvkzaioqiNbc8lxcJAZGz9E7P+stJip3uYcTsSM7K6hjxIQpBiNU9qUE7IFXO5NKsFg05GL0ssystiUxyFwFGS87AkVxCrxRMzHpSoCnMgFOcb8tN2sRudTmLt7YvIK72cIK5pGkF/iJ62wUmOMH162gfxDPpIz3GNeWYOD/povdiFxWYiM/9yBIUQAqPZwED3EMGrxDA0TaOrpR/PoG9Sb5YQYrTG0bXemamZTjJzU5AkwfHdtay+vXpMOzUtVsi3ubaT7II0nGkTF2pPkuR6IS4VsU2+UK4b75OkmZuL3s4hGs53EkkgX+q2h66thHMJTdVoa+qj5WL3dJqX5AqEECzMzuDBZZWY9Xr++71D1Hb1zdrKaGwF9vKxJElgNRgoTnfxsfXLWVaQQ01nL/7Q1IsmToQA8lOd5KU4ONzYzoAvgBCxc175R4gbHxcvhKAyOx1ZkjjW3EY4OjYxPhxVqOvqJ3LVqrfdZKQsMxWTXseuC41jcptgZHLkD3K0uZ0cp508l3PGryOTXs/qknx6hr2c6+xB0dRxfTrarzM8V5L5iaqohEORuH8ikSiaGv954UqLiZwEfSEaz3UQjSixPKaIQiQ8XgxiOuiNOmSdjKpqDPQOEwlH0TQNVVHxDgXY//opGmraZuVcVxMJR3nh+zvxDvmJRhSUqELAG+Q3336bUDBCZn4qVauKR7eXZYnC8iyGBrzUHG1keMCHEo3t5/cEee+3R+lpn9zwM5r0o2q25442EglFURUVJaqMXvvo+XQSmx5YjivdzjvPHebc0UZCwTDKyHfg7vXw2k/3MtjrYf3dS0jNdCQ9U0luKAbJxuasL/K7FW9yX/4/YpiGzHeSxEl6puYZmqbRWt9NW8PUFYysDhP3PLGGd188TjQ6NQOsr2uIC6fbKKnMST78Z4gQgoeXV7P7QjP761t4+t0D/NUH7hxXa2o6DPoD1HX1k+2y4TKbMRl0oEEgEqGpb4ABn58UiwmdTpqxgSOEoCIrnQ1lhTx/7Cz/+Nou/uD29WQ5bBh1MoqmEQhHGPAFiCoqFdnpNywsTQjB7VVlvHj8HBe6+nnheA13LirHZjQQiirUdPTw2unauJ66NSX5VOdmcuBiKy+eOMf2haU4zSZUTaPP4+OZPUcZ8AZ4cNlCKrJnLnMsSYKPrlvGmbZuXjp+jjyXg5VFuaNFlkORKMPBEN1DXqpzM3Fa3kdlC94nnDvayAvf2xn3s9QsB6u2VuG6qlgsQPmSAvLKMmmsaecHX3+RbY+sxOowE/CGkHQS93x4w4zbZraaWL29irb6bt74+X7MViN5pZn4PQGOvneOUwcuUrggh6bzHTM+19XklmRw9L1zBLxBVmxZiN6oo+ZwA+/99iiOFCt3f2QD6TmXhR90Bh2b7l/OsV3nefXHe/ANB6heVYIGnDlYT+3xJlIyHHS39U94Tme6nfKlBRzdeZ6f/vOreN1+sgpSiYSjeIcC3PXkOmzOWM6nEIK1dyzijifW8eqP9/BPX/gRtz++hrzSTIK+EIfePsvR986xZF0Ztz22Gqvj8jM/HIzQ3TaAd8iPElXobR8k4A8RCUW5cLKFgC+ETi9jshjIyk/DcnU4Y5Ik00AIgSAZcXS9SRpT84xoRKGxtiuhfKmSyhzyitPJKUqjtb5nSvt4hwJcPNPO1vuW3vo1p+ZAgOJqnBYTn9u+lpqO7pHCrxf44OrF6GUZVdNo7nNztr2LUFQhFI1S29WHqmmc7+zlZwdOYNTpMOp1lKanUJ2XNXrctoEh/vTnL1OZk0FhmguXxQRazMg60dJJz7CPj65fNiuGG0CK1cyH1i6l3+dnZ20jzf2DVOdm4TAZiSgKA74ATX2D5LocfO2Dd8/YmNI0ja4hL8ea2wlFo4QiCsdbOlC0mOT8T/efwKiTMep15KU4WFGYO2rcLC3I4Yk1S3hm91H+892DnGjtJNNuwxMMcbK1E5vJQIZ9fNhNeWYaT21Ywb/79/PPr+/mQH0L+alOFEWltquPI01trCzK5cm1S0drXyXMFfaXJARrSwv4nc0r+dmBk/zDqztZWpBNlsOOAIaDIdoHh7nY089PPvdk0pi6BTm28zzHdsavLVexvIjiyty4xpTVYebTX32EZ59+i4az7Tz9l8/GpKjtJpZuKJ8VYwrgkd/dHsul3V3L9//uBUDD6rBQUp3HJ//iQTxuP9/5q+dm5VwxYjfI3R9aT0ZuCm/9+iA/+IeX8A0HMVkMFFXmcPvja7j9sbG1dWRZYvmWSp74w7vY9eIxdv72KDt+vh+zzURhRTaPfHobQ/1efv2fb014Zr1Bx7aHV+Hu83L4nbP89F9eQ4kqGM0G0nNdbHlwxagxBSDrZD7yJ/fgSrex//VTvPzD3fiGAuj0Mhn5qdz55Dru/tB6SheNzafq63Lz0395lbOHGwgHIoSCYcLBCJoG//V/f4PRpMdgMpBfmsFTX36ARWvLZrF/kyRJcj1JGlPzjKFBHzXHmxNSJFqwKA+DUceSNSVTNqY0TaP+XAc9HW6KK7Kn29ybg+vkeFtRmMOH1y7jP989wAvHalhWkEN1biaqqnGwoYV/f2s/EUUhoqiElSiaBseaOzjd1o1eljDqdHxgZfUYYyo3xcHdixdwqrWLHZ0X8IZiam9Os4nK7Aw+tG4pd1WXYzXMTv0mgIU5GXzpni2sLsrj7XP17LnQiCcYQpZkMuxWqnIyuHvxginnYl2Lmo5uvv7Ke0SUWFHfcFRB1TQaewf4xuu70MmxfKNtlSWsKLyslqiTJD65aSXpNgsvnTjPm2cvoqgqhakuHly+kEV5WTz97sFxcmCyJHF7dRnpdisvHK/hYEMr755vQJYkClNdfGrz6tECxdPmKsvbYtDzkXXLKElP5c2zdRxv6WTPhWZUTcNpMVGSnsJH1y8bLeqc5OZHkiQe+73b2fbwqkm3s7ksZE2irLp8UwXZBWl0tvQR8AZBCIxmPWlZrnHn+9z/fYxoJErpovjFJ+/96EZWbKkkp3js2E7LdvKprz7M7bVdDA960TQwW4xkFaSSU5xBX+cgadlOChdcfleUVufxR1//EKmZDvSG2FSioDyL3/+bD2J3WTCYYs+knKJ0Pvt/HsVkMWCyxryxhRXZfPGfP0pJVR6Z+SlUriiiq6WfYCCMwaAjPTdWZypeXSe7y8KDn9zCiq2V9HcNEQlFMZr1ZOSmkFOcjrvPS1Flzpjcr6vJLcngo1+8l60PrWBowIeqqOiNOuxOC47U8WFRJouBRz69jdW3VdPbPkjQH0KWZZzpNnJLMnCmjl+0cabZuO9jm9h03/IJ2wFgshrILc6YdJskSZLMb8Q1cjtmaU0/yVTQNI36mnb+9+8+g7vfO+X9vvLPH2HzfUvYu+MMf//Fn015P5PFwJe/8WE23FF9U4T6DQ34+MTWrxFOMFfgC3/1KHc/sWbGYhsRRaHP4ycQjpDjsmPS68YlI/tCEXqGvehkiXS7FYtBj6ZpDAWCDHivUS9FxHJ6MuyXX+aapuEJhvCFIoSVKMpIboVOkjAb9DjMRgyyPO77Gw6EGPD5kYSYVD1uMkLRKEP+IMFIlKiqxopyyhIWgx6b0Yjhqv6MKjH5b38oQm6KA6NufLuuJtZnYXqGry22YjHqyXLYxvV5RFEZ9AVGxSaMuli9J1mS6PP40dDIctjGyJtf2tcTDOEJhghHlVhyu06Hw2zEGsdQDEejdA55kYUgy2FDH2c8tQ0MEVVVUq1mHObxHqaooo58n+FRaXlZkjDpddhMRsxXjakkSZIkSZIkybxgwpdz0jM1j1AUlZrjzQkZUinpNrILU5FlifLqPOwuCx73xMVUryToD3P2SBPL15djsc2BTNR8YZbmpnpZJsc1sedACIHNZMBmSh33e5fFPK1QPCEEDrMp7sR8MhxmIw7zzL5To05HpmPq6lQ6WU7YsxLrM+No/lCiCCEw6GSynPHbea3vK5G+Neh0FF3DMM1PdU76uU6WSLGaSbHOTlhmkiRJkiRJkuTGklTzmydomkYkFOXgO/Hj6ieioDQTx0i1e4vNSMWS+OEdE3HywEW8w4FZU5+bjyTlQZMkSZIkSZIkSZLMBUljah7R1z3EuWNNCe1TVJGNIyUWFma2GqlcVpDQ/k0XumlrmFqe1U1LcpQnSZIkSZIkSZIkmQOS08x5xKF3zhHwh6e8vdGsp7A8azREz2DUU7owF4t16iFTSlRh/1tnUSeoQn8rIMtS0jeVJEmSJEmSJEmSZNZJGlPziJ2vnkpo+7RMB3lFaUgjifWSJMjKTyG3OC2h4+x762xCBYJvNmL9kzSnkiRJkiRJkiRJkswuSQGKeUJjbSctF7sT2iczN4W8krEStxnZLgrLsrh4duoFFgd7PZw8WM+626oSOv/Ngk4vz8iW0jQNVdVQFRVVUVFULZZjpmkx1W0NECPF8kZ+SrKEJIuYV0yIpELbFVzKzxvtS1VDVVU0Ndafo/l7l9L4Rrruyv4VUqxPJWmkr6VkH8+E0TE+8j2oI38ujfGpfifSpZ9SbPy/374TTYuNZ0VV0RQNVdNG+xOueF7AFX0Y+0es/y71Zaz/JEka7d8kSZIkSQRN1VAUFVVVUZXYc0jTtLHPczHyDBICwaV36sgzXLr8rk0yOUljap6wb8dZopGpe4dknURBWSbp2WPVwxwpFgorsjEYdYRDU5MQ1zTY+cpJ1m5feEveNDq9jkQvS1VVAr4Qw4N+hgZ8tDb00N7UR3tTH12tA3iHAwT9YQL+ENGwgsGow2QxYrIYSEm3kVOYRm5ROgVlmeQWpeFwWbA5zZjMhluyjydD0zSiEYWAL4TPE8TvDTHs9tHZ0k9Hcz/93cMM9nlw93vxDgUIBSOEQxGiEQUhCXR6GZ1ORm/QYbWbsLssOFIsOFNtZOWlkFOQRkauE7vTgsVmxGIzYbEZRz22ScZy6WUa8IXx+4IEvCG8wwHaG/vo7Rqiv3uIvu5h+ruH8HtChEJhwqEo4WCESFiJLRLoZHR6GZPZgNVuwuaIfS+pmQ7SMh1kZDvJKUjDOjLmzVYjFqsRozlWe+hWuAe0EUMz6A/h94bweYMEfSF6Oty0N/XR3T7IYK+HwX4PQ/0+gv4w4VCESDhW4mB0XOtljGYDdqcZR4oFR4qVtEwH2QVpZBekkpJui41puwmrzYjeMP/k8zVNo6t1APfA1JVoL1FQkonVYZp315Qo4VCEtoZeQqFIQvsZjHqy81Ox2ue+WHdvl5uBbg+qduPC+mVJorA8C5NlduoUzkeiUYWu1gE8Q9dWVtbpZDLzUnCmjK9vliiX3rXDbj+eIT+DPR6a6rppb+ylq22AgZ5hht1+/N5Q7DmkqBiMOswW4+hzOiXdRnZBKjmFaWTlp5KZ48TmMGN1mLHYTej11y558n4kaUzNA/zeIMf3XURJIG/JajexcFnBuAmjEILShTmkZNjpbhuc8vFOH25gsNdDaqZjyvvcLBgMMlN1TSmKSltDD3Vn2rlY007d6TYaznUSDEyeyxbwh0fz3Tpb+qk51jz6WWqGndKqXMoX5VGxNJ/y6jzSs5wI6dZ9IGmaht8TpLN1gK62ATpb+mlv7KWlvpfOln6GB30jq/XXQNVQoiohYhOUicoGyDqJtEwH+aUZ5JdmUlSeFft7cTrONBuynDSsVFVjaMBLR3M/bQ09NF/sob2pl46mPrraBqe8mKNEY99JOBjB7wky0DMcdzshBM5UKxk5ztHFheyCVDJzXWTmppCe5cBg0t90L+ZIOEp/9zCdrf10tQ7Q0dxHa30vbY299HS4iUyxDl4kFCUSihIAcPvp7XTH3c5iM5JXnE5+aSaFZZkUlGWSX5JBTmEqBuPsFeueCaqq8d4rJ/nRv76R8L6f/z+P8OBH19904+Bq6s608Y9//gt6OtwJ7Ve+OI8v/u3jlFXnzU3DruCNXx3m1995b8oLrXOBxWbkH378e5QvmvvrvVH4hoN8/xuvsf/Ns9fc1pFi5TN/cT93P7562ufTNI3BPi9NtZ3Un+ug9lQr9TUd9Ha4rzmvDAUihAKXFwAaa8d+bjTpyS/NoKg8i8IFWWQXpJJXnE5uYRoW29wvANwsJI2peUDdmXZ6OqZu+ADYHGaqVhbF/aysKpf0LGdCxpR3KMDxfRe54wMrE2rHzYDBdG3PVDSicP5kCwffOUfNsSaaLnTh94Zm5fwDvR4Gems5uvsCqRl2ShbmsHh1CVvvX0pOYWL5bfMdnydI3Zk2zh1vpulCF50tA3S3DeAZmlv5fSWq0tPhpqfDzbE9dej0Mtn5qeSVpFO5tIA12xZSWpWLdAsbsBMRCUepPdXK8X0XaTzfOeJd7Z/zCZWmabj7vbj7vdSdaQdAZ5DJyHKSkesiOz+V0oU5VCwroHRhLkbT/DAM4qFpGh3N/Zw90kjd2XbaG3vpbB2gr9NNNDq3q/x+b4i6M+3UnWlHCHCm2sgtSqNwQRYrNy5g6fqy0fIYNwpJEqzZWskLP9zD0MC1C3BfydvPH+W+J9ciGW7eBQ9VVTm+72LC1y7rJMqqcskvzZyjliWZ74RDEbxT8GDFQ9M0Bno9HHynhmN76qiv6aC7YxBtKguVUyQUjFBf00F9TSx1xOYwk1OURmFZJhVL8qleVUxReRZ6w/vbnHh/X/084fThhikX2oXYim9JZQ6ZuSlxP3elWSmryqX2VOuUV5vDwQhHdtVy28PLb6nwKCFiYX4ToWkaAz3DvPjjfezdcYae9kEiCYRbJoKmafT3DNPfM8yZI43sffMMdz+2mu0PLcfmuHmLuGqaRltDL3t3nOH4vjq6WgcYGvSNWe263kQjCm2NMW/ByQP1vPXbYyxaWcTDT226pVdEryQSjnJ4Vy1vP3+U+nMdDPZ5CQdv3HcCEA0rdLYO0Nk6wOlDjVhsRhwuC+nZLlZvrWDDXYvIK0pHmieeRI/bz8kDF9m74ywN5zpwD3jxDgdvmPqppjFqoJ4/EVv8KSjN4I4PrGT7g8tvmKdKCEFGjotl68vYlaCQUsP5Tupr2lm4PP7i4M1Af88wF061Ekrw/rLazazctGBeLyQkmVvCwQje4WDC+ymKyr4dZ3npp/toqu0cqRc6Bw28Cu9wgLrTbVw8086Bt2vIyHHyP/71oxSWZ9303uWZkDSmbjDufi8Xz7Qn9BCWZMHa26omDF2SJInlG8t4+8VjUzamVFWj5WI37Y19FJTdOqtkOr1uVATiaqIRhRP7L/LMN16j+WI3yhyvMF9J0B+m7nQbTRe6OPBODZ/58v0ULsi6KYQULokVhAIRao428covDnDyQD2RcJRoVLmcYD9PCPrDsVC2ln6O7qnj3ifX8MBH1pOSbgdujfwduCwSEQ5FOXngIj/71ts0XegiHIzOy6Lcmqbh8wTxjYSDnjvRzLPf3cmf/N3jbLhj0Q0xqDRVIxpVGOj18NZzR3n35eP0dg4RDUenFpZ6HVFVLZaT1efh3IkW3nzuKJ/58v2UL86b8Jk3l9icZlZtqWTvjrMo0akvSEUjCu+8cJzKZYU35b2oaRpNtV001yUmIAWQmmln5eaKOWhVkpsFVdXweQJEwtEpeXdUVWWw18sz//wau187TSQcuS5G1NVcen7nFqXPm3DjG0nSmLrBNNd109bUm9A+JrOBVVsmfwAvXl2K3WnBl8CKR3/PMOdPtpBfmnFTvtTiYTDqxk3KNE3D4/bz5vNH+eG/vH5DZeEjoShHd1+g5WI3n/mL+1mzbeG8jkMOBSP0dbk5eaCe1391mIZzHQnl+t1IVDXmhfzZf7xNzbFmPvEnd7NgcX5M7fEWIByK0ljbyUs/2c/eHadvqGdwOkQjCo4UK5l5Kdc9n1BRVDxuPy0Xu3nz+aPsef00wQRq/t1QtNhz5MzhRv7XZ77Hh3/vNu56fDXOFOt17UdJEpRUZlNckTUaEjRVDr53jo994U6cqbY5at3cEQlHuXC6bcKct4mQJMHGuxZfF+GJJPMbnydI0B++pjEVCkY4c6SR7//jqzSc77xOrZuchcsLsN/gMOP5QNKYuoFEowqNtZ30JpiwWrWiiNQM+6Tb2F0Wlqwtpat1YMrH9bj9XDjdxpb7lmIy3xpKO3qjbkyejKZpdDT18Zvv7+Kt54/Om/pavZ1D/Mv/eJbHP7OFBz66gbR5JgSiaRr1NR0c2V3L7tdOxR7k82uhPiFO7LtIZ0s/n/zTe9l092IMxpv7UdjTMciuV0/x2x/uob87viDEfEcIWLK2lKy8lOv2Yo6pGoY4+O55Drx9liO7LuD3Jh5yM1/we4L87D/fpr25jyc/dxs5BanXzaASQpBTmEbFkgIaz3cm5MnzuAMceu88dz02/ST8G8VAr4fThxoS9g6YLAa23b/sfT8JTTJiTAXC2F2WuJ9fUl/d+coJfv2dnXS29F/nFsbHYNRRXp2HxWq80U254cyPwPT3KcODfi6caks4EXzzPUumvF0iz2lV1Wis7UxIuGK+YzDqR8MhNU2js2WAn/zHW7z922PzxpC6RDgU4bln9vCL/3yHrrapG8HXi4PvnuPn33qbhnM3tyF1ie62Qb73D6/w5nNHbngu0XSJRhVOHqjnO3//Cj/65o6b1pACsLusLFpVjM0Rf0IxVwwN+Hj+md3sevXUTW1IXSLoD/Pui8f50b+9QW+n+7qGeFrtJqpXFk04KZyIUCDM4Z21Cecc3WhUVaO9qY8Lp9sS3nfx6hLyS9OvvWGSWx6/NzihYrCmaURCUV7+6T5++u9vzRtDCiArP6bsN19yXG8kyR64gQz0DnPuRPO1N7wCq83E8o3lU9p28epiUq7hwbqa5gvddDT3zcsci+lwKcxP0zSGBnz8/Ftvse/NszdUGnYyQoEwbz5/hF9++136J5CcvhEIIVi9tfKWS5Tu7xnmV//9LvvePDPvcmKuRSQcZc/rp3n6b15g35tniczTMT1V8kvSqVpeeF0VF4UQOFKsLF5dfN3OeT0Ih6Ls3XGG7/3TqwnVL5wpQgiWrCkhM9eV0H6qqtFc10XTha65adgcEQlHObKzloAvceXXe55Yk/RKJQFiUuoThhVr8Itvv8Ovv7NzXs0JAPKL08m+xRSJp0vSmLpBKFGFxvOJe4EWrynBMcVVP5PZwOqtCxM6vnc4QO2p1mvWVbpZMJpinqloROGX336Xd18+Me+9EKFAhLeeP8prvzhI0B+eN4Zt+aI8lm9ccKObMev0dLh5/gd7qD/bPm/6+lpEIlF2v36K//q7l2iu675h6nKzhd4gU7mskJyi6/9ittiMrNhcQUaO89ob30REIwp7d5zhV//17nVdKMjITaFqRXHCuYi9HW5qjjbdNPegpmmEAmH27jid8L75JRksWlU8+426BnaXBWeqFb1BFysarZeRdRKyLCHJUkwASRIJF7lPMjN8E3imVEXl2e/t4vln9uAdDtyAlk2MTi9TWJ41KuT0fufmThS4iQmFohx673xiLw4Bq7ZWoDfoprSiJSTBxjsX8eZzRxKqO3DyQD33f3g9JrPhpl85M44UBd3z+mle+NHeab2oL8mr6/QyOp2EkGIvHU3T0FQNRVGJhBUi4dlTTYtGFH7x9DukZtm55/E1yLobL5IgyxKPfXoLB9+pmXXPniSJkRd77OV+SdVQCDGqHqhEVaLRkX6ezcmhBhdOt/HqLw/y6YL7sDnN83rch4IRdvzmMN/5+itTLhA733G4rKy/o/qGlGUQQrBgcR6LVpWw85WTszuZF6DTyegujWv58tjWNC02thVtdFzPtqKoElV54Ud7Wbi8iJWbF1yXcS1Jgs33LObdl44nVPIj4A9z7kQL2/q818wJni8c21tHb+dQwvttvncJZqvxuj9nHn5qIw8/tZFoRGF40MfQoJ/hQd/onyv/fenvQX8YRVFRFRVl5I8ajf0MhyLzLlz+ZuSSAMWVRCJR3n3hOM9+d+e8XNx2plhZsCT/fVm7MR5JY+oGoGkawwM+Th2sT2g/Z4qViiUFyLqpTzhKq3LIzk+hs2XqOTj15zroahu4JVZqNU2j5ngzP/7mjoQmSUaznowcF6kZdtIyHaRlOUnNdOBwWTCa9BiMupg8eDCCzxOgr2uYno5Bejvc9HS66e8emvFLRlFUvv+Pr5FTkMaKeeIRKl+Ux8rNCzjw9rlpH0NIApvdhCvdht1pxeY0k5Jmw5Vuw5lixT7Sx3pDLEQzGlUIByN4hvy4+7z0tA+O1uvq6XDPmura7tdOsf72KtZsr5q3K7OhQJi3nj/Kd//+1TkzpHR6GZvDjMVmxGwxYrQY0Ovl0dVriMnzRiOxyVQoGMHvjUmcB7yhxNUdBRSWZ7JwWcEcXM3UcKXaWLVlAcf31SVcePVKDEYdrjQbjlQrdocZR4qVlHQ7zlQrjhQrFpsRg0GHzqBDVVUi4SgBX4ihAR99nUP0drkZ6PXQ2+lmqN83K0qZPk+Ql366j9KqnOu2irxwRREFpZnUHGtKaL/6kYLIKem2eb2gATEZ/bd/ezTh/RwuCys3LbghRU4v9aneoCMty0la1uTv+Ev5Ot6REga+4QA+TwDvcBCfJ8Chd89zeOf5my5Eer4R8IZGo1CEEChRhdOHGnnumd0MDyb+PBICTBYjdpcFi9WIyWLAaNIjydJoDrmqqEQiCqFAmIAvhM8TxDPkn/K8xZlmo7z6/VGzcSokjakbxIn9FxkeTKzqdcXSAlIz7FN+yQghsNhMLFtfTmfLoSmfJxKKcui9c1SvLEI3DzwiM6GtsY+f/H9vTjnWODXDzvKNC6hcVkDxgiyyC9NIy3Agydeu/6SqKn2dQ7TU93DhdBvH99ZRe6p1RpNenyfIj7/5Jpm5KeQV3/hkZVmWePCjGzixvz4hI8Zg1JFblE7JwhzyitPJzk8hMy+F1AwHrnQb1gTk4BVFZWjAR0dzHy113Zw+3MipQ/UM9Himc0mj+DxBnv3uLpatL8dkmX9qlpFwlN2vn+bnT79DODS7oaquNBtl1bnkFaeTlZdCerYTu8sSM6rsJoxGPbJOioVuaYx4Y6ME/WH83hDDbh9DAz4G+zz0dLjpahugraGXng73NUMQZVni9kdW3vBaJSs3V1D03NGElNmEgJR0O8UV2RQuyCKnIJWs/BTSs12kpNtxuCwJhbsFA2G62wZpre+h7kwbx/ddpL6mfUaTVVXVOH+ihcM7a7nr0VXXRd1Pr5e589GVCRtT3e2DXDjTRuWywnmvsNnW2EvNscRyngGqVxaTXZA6741FiM0hDCY9qSZ9XG+h3xPi6O4LqGrSOzUTolEF73AAVdGQZOhsHeDZ7+yk5WLPlI8hhCC7IJXyRXnkF6fH3q+ZDuxOMzaHGZPFMBJdI4OIpZqEglH83iDeoQDuAR8D3UN0tQ/S3thLy8UeejvdcZ89kiQoKs+6JRbcZ4v5/bS6hdn5ysmEthcCKpcW4EyxJrSfyWJgyZoS3nzuSEIhJPt2nOXjf3TXTW9Medz+KYWa2Bxmtty7hO0PLaegLBNnqjXhkCNJksjMSyEj18XStaVsvX8px/fW8ex3d9KToPz9lVw828aLP9rLp750LybLjZcgLavOY/mGcg68XTPpdpIsKKnIYdXWCqpXFJGRG5tg2p2JTTCvRpYlUjPspGbYWbSqmPV3VtNwvpM3fnWYQ++dn5Ghce5EM6cONbB2e2K5hnONqmqcPFDPr/77PQZmKQlZb9BRtaKQjXcuoqw6b9SAMlsN0w63UxSVgC+EdzjA8KCPvq4hzp9s5fTBeurPdcZdWEjLdLDu9qqZXs6MSUm3s/nepZw/0XrNMeRKs7F0XSkrN1dQWJaJK82GM82G2TKz0GiT2UDRgiwKyzNZtbWC2x9ZwbE9dfzm+7tmpNQ4POjj+N46Vm+tvG4hdBvuXMQP/+0NhvqnvrKuKCrH9lzgtoeWk5oxv8pDXM2u104RTLCWm94gs3hNSTLPJMk4hgZ8RKMKWkTj+R/s5vThhilF05jMepasLWPLfUsoKs8iLcuB3WWZcjrIlWiaRtAfZnjQh3vAR0dTHycO1HNy/0W62y/n9+sNOpZvKEuq+F1B0pi6AfR0uBNW8XONrH7qE1ytkyRBXkkGuYXptDZMfZWjq3WA2lOtLFtfltD5bjpELBn4E1+8m1WbK2Yljv3Sal5+SQZZeSms3FzBt//2RY7urp1WpfJIWOHge+dYuaWCtdsX3tAVTSEEdpeFrfct5dieC+Nyp4QkSEm3senuxWx7cDn5xRmYzHr0Rv2cxFYLIWLerTQblUsK2PHcEX72H2/h9yaurgWxHJMXf7yXNdsq583KsaZp9LQP8sKP9tLW0DvjaveyLLF8YzmPfGIzlcsKMI+sWM7G9cqyhM0RWwnNykuhfFE+qzZXEPrMVvp7hjnwdg27XztNy8VuVFVF02DbA8uxOcwzPvdMEUJw20PLef6Z3ePkh4WITSAqlxZwx6OrWLquFIfLitGsn5MFJyEEZouRogXZ5Bals2RtKd//xmsc31c3rbIEmganDzfSWt9z3ULo7C4Lm+5czKu/PJjQfmcON9LbMURK+tSjMK43fm+Qg++cS1j4JTs/jYol+QmF6id5fzA06CMaUTj4zjne/M3Ra6pwyjqJZevKePL3tlNalYvFakSSpRndM0IIzFYjZquRrPyYl2vdHdV4hwKcPdrIm785Qs2xZgwmPcs3zY/Ug/lC0pi6AezdcTrhfJrcojQKyjITvlGEEGTmuCitzknImNI0jZ0vn2DputJ5+0KbKZIkqFpRxBf+5jEKyzIBZv1a9QYduUVpfOkfP8RPv/UWb/z68LTUBLvbBtnz+mkWLivAmWqb1TYmiiQJKpbmU72qmBP7LsYm0E4zhWWZ3PGBlWy4cxF2pwXE7PfnxG2KteGxT20htzCNb/7lb6ad+3L+ZAsdLf3kFd34sEpN0wiHorzz4nGO7K6dUX0vvUFHfkkGH/78bWy+d8nodzNX31FMQASMZgNGswG7y0JxRTYf/N1tNJzr4K3nj3LqYAN3Pz5/CrVa7SYe+vhG/vvrLyGIeYpc6XbWbFvIXY+torQqdzSf7nqNbZ1epqw6lz/+m8d45p9fZ9+OM9OSO+/vHuLi2XaqVhRdlxA6SRLc9sgKdjx3JKH2hkMxpcryRbnzQngnHicP1NPXnZjwhBBQXJk1MoZuzXdqkukz0DNMc1033/mHlydNDZB1EtkFaXz0D+5g+4PLRsN252JMybKExWrEbDGw/cHlbHtgOY3nOzl7rImM7GSI35UkjanrTDgU4dC75xNa0ZIkQUFpJtn5KdM6pzPVSllVLvsTrK90dM8FvMOB2MT4VkPA8g3l/PHfPkZWXurcnkoInKlWPvS57SgRhbd/e2xaxSmP7Kpl092LWbt94Q11rwshyMpPZe32hfi9QYorstl6/zKWri29IUnVV7YLYP3t1QS/Gua/v/4y7n5vwseJhKIc23NhXhhTAOeON/P8M7tnZEg5U6xsfWAZH/zMVjJyXTdkMndl8nvlskIqlxXicfuxOkzzZnIphOD2R1bw7kvHcbgsrN5SyeZ7l5CW5bhhbbx03uz8VD7+hTvxDQc4vrduWnlUpw83cMcHVmIwzv2CjBCCvKJ0qlcWcepgQ0L77n3jDB/6/duxO2+8x/JqIpEoJ/ZfxDuUmFS1xW5iydpSrPap54cmef9w7kQLrfXPMTTJO8tiM7FmWyUf+cM7KJzG4vp0ubzwBmXVuZRV516X895MJI2p60zThS7am/oS2sdqN1GxNH/aCdqSLFFalUtaljOh6tnDg35OHqhn8z1LpnXe+Uz1iiI++9UHycydnoE6HdKynDzx2e309wxz+L3EFZDc/V52vnqSxWtKbnhYlE4ns+XepazcVEFecTqybmbhBbOJkAQb7lxER3M/v/7OewkbrpGIwqmDDTzwkfU3RKr7SgK+ED/+5o4Z1RhJz3byxOe2s/2BZTgSzLmca+xTrJl3PbE7zXzhrx4lNdORkODP9aCgNJOP/uEdtDf20dU2dYXWS9SebMXnCeBMtV6X67I6TKzdXsWZw40JPe+62gY4dbCeTXcvnsPWTY+u1gHqazoS9g6mZthZublijlqV5Gant8NN7ySfW+0m7v/wOh5+atMNXdxJEp9k4O515sT+iwlPjOwpVqpXFM/ovGVVOQlXpQ+HIxx699xNU0RxqqRlOXjy926joPT6rexcIrsglaf+5K6Ev4tLHH7vPJ0t/fPiO0nPdlK0IGvW8m1mE6NZz7YHllG1oijhfTVVo7ttMGG1zbngvZdPcuF027T3d6Va+b2vPsg9H1wz7wyp+YokSSxYnE9a5vycsCxcXsjDT22c1r7ufi9drYkbYdMl5oUsIGsaURU7nj08L55zV6JpGhfPttPaMNm0dzySJFi0qpic/LmNgkhya6I36Hjs01t5/DPbSM92zsvn0vudpDF1HfF7g9SebE1IUloIyCtKI78kY0bndqbEpI/1hqnHoKuKRsO5TrrbBq+98U2CJAm23r+UxatLRustXG9KKnP58Odvn9a+Pk+Qt184Nu8mGfMNIQQ5RWmsv6MaSwKy65fweYLXddIZj/6eYV75+f5p5cdATOXpi19/gvV3LsJourGy40lmD0mSuPvx1RSM5HkmysWajtktej0JQgjyitOpXJp4DbHaU60JGy1zjd8bovZkKx53YvmYOr3MbQ+tSKqfJZkW93xwDY99agvO1OSC2HwleWdfR5pqEw/xk3Uyq7ctnLH6j5AEyzeUY7YmJq3d3zNMzfHmW2byXlCWyca7FmOx3TiJcUkSbH9oxbSVEt96/hjeoeAst+rWQ5Yllq0vI684LeF9A77gtMKoZgtN1XjnheN0Nk89LPdKDEYdn/yz+1i5acENWzRIMneYrUbufWLNtPatr2lHvY7Pc1eajaqVxQm/e/zeEPt2nJk37x5N0+jtdHP6cGPCipr5pRksXlMyNw1LcusiYNWWCj7zF/fNy9qHSS6TfMteJ1RFpaG2k572xLw8RpOeVbMUZ121oghXWmKJx/8/e/8dH0dy3evDT3VPRs45kwRAgjlv4HJz0mq1WmVbsiTLki1dy9nXlv279ut0bV/JUbaSbSVLlrQKK23OiTlngETOOU+e6a73jwGw5BIEpgcYYAD289GK5ExXd02H6jp1zvmeiTEvl892EDaoPpiIqKpCzZZS1mwoWnY3udVm4bFP3I7dadxj4J30c+z1+jj0avVRUpVL+bp8wyvCgUA4ZjXAxWB02M3ZI034DHixp1EtCvsf2cL+d22OqdaISeIjFMGOfdWkxpBzNtgzviAxE6MIIVi/tcywgFIoGOb0wUY8E4mxcKTrkvbGftob+wy3ve99O83n0MQwBSVZfOy378fuNA2pRMc0ppaIyQkfjRe6DU+OKmoKKSw1vrI+G8mpTjbvWYORMV3XdNou911TsG2lkpLuYvedtTgSYGBSFMGa9UVs3FlpuK2UkoMvXohJzetmQ1UVareW4TBotIYCISZGl8eYklJy+WwHHU39MbUvqczlvsd3miEhq5jpem9rNxUbbjvYN7bk3p7SNblU1hYaXtTo6xoxXJMxXgT9IY68egktbKy2VHpWMnvuWh+nXpmsVhxOGw99aDdla/NMQ3wFYBpTS8Rw3zhXznYYbnfb/RtgEZ+jW++vM/xgdjT309U6mDDhFrGSlZeaUKEWaZlJ7L6zFovVeC2V5kvdy57Ts1KoWl9kOGcoFNJwT/iWxWD1eYNcPNnG8MCk4bYOl43b7t+YEN5Xk/jicNqorDEuUTw+7EELL22kgc1uZef+GpwGQ5VGBye5cLw15rzBxUJKyeiQm5NvXTHcdtedtaRnLU2hZJPVw5oNhezaX2Pmu64QTGNqCdA1na7WQTpbjSXTWqwqu/Yv7opWzeZSsvKMFVsbH/HQdLE7ptpIiYKiCDbvqVp2SfGrUS0KFTUFFJQYV3jyTPq5eLI1Dr1afZRU5mAz+kKSkXpTSz3plFIy3D9O/el2Q7XopsnOT+POd281X8A3AXaHleJy48JEYU0j4I++3uBiseP2ajJyUgy1CYU0Gi90MdCz/JERR1+7xOSYMYVPi1XltvvrlrX+nsnKw+GysX1fDUXliVHr0GR+TGNqCfD7Q5w82Gg4PGD9tnIyshd3Rctqs7D3HmMGmpSRYo8To94V651SVIXtt61LqNVBIQTFFdlU1BYYbhv0h7lyvmvFXo+lxOGyGc4VBAhrOloMBs1CGe6foPWy8bwM1aJw2/0bKSg15ZdvBoQiSM1wxZSYHvAbz8VbKK5kO/se3GQozBygpaGX9qb+ZR3rNE3n5Z+eNNyuelMJxRU5hn+zyc1NbmE6O25fh2oxHrVisjyYxlSckVLimfBx5mCj4bY799fEFAI2F0LAnrs3GI5dv3K+i8HesUXty1LicNpikueNN6kZSZRW5RleuQyHNbpaB/F5AnHq2epBCEFWbqrhdlpYW3JjKhTUaDzfFdN1dSU7uP99OxJqwcAkfgghcDitMSmTLkeUgRCC/Y9swe4wZvyNj3ioP9URkxjLYnHlXCftBnMYp6MhMhKs8LNJYqMogorqAiqq85e7KyYGMI2pJeDy2U4GesYMtUlKdbJ+W9mCJdFno3xtnmH3sd8b5HQM3rVEobK2EFeK8XpD8UYIQdnaPFIzjKtyjQ976IlROvtmIznVaXh1WNckUlva1fBgIMS5Yy0xta3bWUGeWRT0psJis2C3Gw9hXa4cpKKybDbuMi66c+rgFcaH3cvinZJS8sqTp9ANjgVZeWlUby41Q25NDGGzW9m1v8b0Sq0wTGMqzkgJbzxzxnC7tRuKyM5LXfQVLSEEjiQbW29ZY7jtoZcuEg4tfaz9YrC2rmi5u3BDytbkxSRxPDHmWdZaSCsJwzlTAEjkEmpISynxe4NcPtsZU/t7Htu+yD0ySXRUVUGNIXphuSLmhCK49/EdhkWV2hv7aa7vWRZjarB3jPPHWgwfu3xdPpW1BaZXysQQdoc1pgWHhfD9M2f538+9wJutbTHvIxAO85Ujx/ja0WP0TboXr3MrBNOYijOTY15OH2oy3K52aymp6fGRNrY7rGzaVWU4hLC9qZ+2K7HJNS83lTXG85KWityijJiEMbxuP8P9E2beVBTEw8MbD3o7hpkcN5bkDpCa4WL9tjJz4naTIYRAUVbWNa/ZXEJpVZ6hNuGQxsEXLyx5ZISUkjOHmxgdMjY5dDht1G4tJTPbmOCGiUnZ2jyy8oyHpS+EE13dPHnxEs3DsS3OSinxBEN85chRfnjuAk3DN1/EzMqYYaxgjr56yXD+Q0q6i8rawpgKukaDEIKCskxKq3INtdM1nTefO7ciJ+8VCWxM2ewWCkqzDOex+b1BRocmV+T1WHpWxoSz6WJ3TO1qt5QlRP00E5O5EEKQkuZi793GVWqPvHyJCYNqegslFAxz6kAjnkljhYPTs5PZestaw2O6iUn1llIUZWXdN0IIHBYLO4qLqM7Joih1aY3BRGBlXbEVhhbWOfjSRcO1aorLsykqz47bKrMQgqy8NNZsMB76dvjliytOIt1mt5BpUJJ3KRFCUFyZi8Wg90RKGBty43WbIhSrAglNF2IzpjZsL8dixtibrADsTiub91YZDm32+4K8+czZOPVqdlov99LRPGBowUoIQdmavIQOLTdJXGKZlyUCLpuV/3rfe/nKex6lIjNjubuz5JjGVBzp6Rimpb7HUBuhCEqqcuOeSJ6S5qSyttDwavZ0EcWVRGZuKoqqJHQIVG5hWkyrmGMjbrwGV01NEhMJNDcYGy8gMmZUri9ENVfBTVYAQggKS7Oo2VJquO1rT58huESLeZqmc+Vcl+Hi6Fabyr6HNpkCAiYxUb7OWAisSWJgvn3jyOmDxsMDXMl2qjYUGa4UbxRFiRSMzS4wVsA3FNI4/PLFFRValpWXmvBu8+z8tJgmw54JP37f8kkGmywe4VCY/m7jxUlT01yROlqJu1ZgYnINmbmprN9Whs1urCREZ/MADWc74tSra5kY9dBwtsNwmH5mbio77qiOU69MVjOqRSE719icbDFREnjBOdExy3LHiYA/xPnjLfgN1sZIz0ymZnPJknhRytflk1ecSVfLYNRtdE3n8rlORgYmyMpbvofeCOlZyQmfpJ2VF5tnyucJEAysTIXFufC6A3gmffg8AXzeID5PAL8vSNAfIhgIEwyECQVDBPxhQoEwwWCYUGD6u8if058HAyG6WgaXTcEsWsZHPISCxq9lTmE6DqctoT2vJhFCwTCeST9et//t+9obJOAPEvRH7utg8Kp7/Kr7efqej3weIhAIMzHqpa/LuAG+3FhtFmo2l5JTkE5321DU7UKBMG8+d55Nu6vi2LsIgz1jXDrVbrjdrffWkZJmXJ3VxCQtMwmLbfk8mhZF0DIywo/PX+TSwABI2JCXy3s21LI2+/pyOh1jY3zt6HGuDL39DJelp/Pp3TtZN8v2VxMIhznZ3cNrLS20DI/gDYVItdspSU9jR1ER+6sqcVgiJsozDZf53pmzfGH/HZSkp/Hj8xc40d3DhN9PhtPJLWWlPLq+liTb204ITzDI53/xNFkuF5/evZM1WVnXHL99dJR/PHCIAY+Hr77n3aQ6FlY6xzSm4kRH0wA9bUOGPTg5helUVC+NWEJKmpO1dUWcP9ZiKHRiZHCS+tMd3PbAxjj2bvFISnYgEtyYSk1Pisng83oCKyKHTUqJlCB1HV2XaJqOe9xLd9sQnc2DdLUOMtg3znDfOMMDE/i9wUiuoZSRtlP7QDLzTEX+iOwXGREyv+bPq/6+EhjqG4+pr9l5qWYtm2Vi+l7UdYmu60hNEgpp9HeP0Nk8QGfzIP3dowz1jTPcP874qBctrL39PFx1T0duZzlj9L99n0/f11Pfv2O7lcrajSWUVOYaMqY0Taf+VBsD3aPkFsUvLyMUCnPlfBf9BktPqBaFex83SxSYxEZG1vIWeG4fG+fbp37OgNuDLiW6lBzv6uKV5mb+eP8d7Ksov6Z/NlUly+XCabUy5PHQPDyCLxTCE7yxE0FKyYjPxz8dOMRT9Q2E9XcodLZDff8gO0uKZ4ypQbeHsz29HOns5M9ffpWm4WH0qbmBJiVvtLRypKOTv7zvHtKmjCJdSs719VOYkoI3eP0cyRcKUz8wSNfE+PV9iAHTmIoDUkqaL3UbLtSrWhQKS7Poao3eU7RQMrNTsNsthoypiVEPF0+1sfee9SsiLjwpxZHwq/ZOl82wVD1Me6YS05iSUs6sxHsm/PR1jXDlfCdXznXSXN/DyMCkYXGW1cxg73hMdl9yugvrMq5m3oxomo7PE8Az4WdsxE3r5V6unO3kyoUuOpoHCK1Cb/Fi40yysfXWNZw92mwolG54YIJzx1q4+z3b4jKuSynxeQIcevmiYYN1y9415JdkJfz7xiQxccQ5vWMuJPCDs+d4V001v7pzByXpafRPTvLlw0f5+aV6vnnyFOUZGZRlpM+0yUtO5nduuwUAdzDIff/5rXmPE9J0vnzoCD88d56KzAzeV7eB2yvKyXA6GXC7OdPTR06yi2Tb9efiH946SGVmBl98+EH2lBQT1iUvNF7h715/i8MdHbzU2MT7NtYt0hkxhmlMxQGvO0DTpW7cEz5D7bSwzrM/OMqzPzgap54tDlpYp+1yHwM9YxSUZs3fYJlxJSe+MSUUQVKqk+H+CUPtAv4QoaAWp17FRiikMdA9SmfLAB2N/TSc7eTyuU5GB00Z97kYHZqMqZpqSqoTi9UcyuON1CWT4166Wgfpahmk8UIXDWc6aW/qjyk882ZHCMGOfTU8+e2DhoypyTEvF0+2cet9dTiT7HHpW3/nCJdOtRlqo6gKdzy8OaZFMRMTiCgPL2fua2l6Gn9wx+1kOCN1L4vT0vijO/bRNjrKmZ5eLg30U5KeNpNbFcu8qnlkmB+dv0BRair/+47buaOiAnUqpz0vOZmN+fk3bKsqCn9x7z1sKyqc+ewDGzdytrefH5+/QOOUx2o5cr/MN3AcGOwdo/F813J3I650tgzQ0TywIowpu9NKgttSALhimBhoYQ1dW9pClrMxvZp76VQ754610Hi+i5aGXiZGPcvdtRWD1x2IzTOV6jQncHFESkln8wBnDjdTf6ad5ks99HYMEw4l1iLGSqSgNJONuyro6xyOeh1B1yORH12tg6ytK178Tkl487lzBHzGPP5F5dnUbClN+Pxck8TFYlveKfm2oqIZQwoixpLLZuWOigpOdvfQPDJKMBzGYY09rPz1llZCmsbG/Dx2l5TMGFLRUJuTw6b869UON+Xl8aNz5/EEgoQ0Dbtl6c+jaUwtMrou6Wkfpr2xf7m7EldGBydpqe9hy941CZ+voVrUFaF0Zo1hINU0HX0R4n0XQjisceSVS7zy5Cla6nsYGZw0J5oxEKvks81hNWXR44CuS7paBnjxpyc4fbCR/q5Rw+qsJnMjhODe9+7g5Z+dQhpYFOpsHqC1oZeq2sJFL4wb8Id4PYZ6VltvXUtmzvLmvJhcS+PpVr71Zz8iOIdh7Ep18kff+RzOpIUJECwGQgjEMk1WBFCYcn09TouiUDhVhHfY4yWo6yzkTLWMjGJRFIpSU68RjIiGisyMWZ8vx1RkxnQe1XJgGlOLTMAX5PzxlhUhCrAQdF1y6VQ7d7/HQ25h+nJ3Z05UVVm2AcoIRov2QiTkUtcjA8hSvsSllOi6pOFMB9/+pxdoutCN3xdEmjlQMRMMhmISoLBYVHMCt4hIKXGP+3jq+4d5/kfHGDUXB+JKzeZSytfm0dLQG3Ubvy/EhROt7L5rPWmZSYvan5NvXWZkYNJQm+Q0J3Xby3ElL/+E3OQqpEQP6xHRFyTDPWMM946SX55DWlbEcNDC2ooRKYo36g28qtOf61LGFIp+NSFNRxECq2o8mmIxPU6alMhFvPCmMbWISCnxTPo5daBxubuyJDSc6WC4f5ycgrSEnsypMRgpy0GseS9aeGknerquM9A9xnM/PMqzPzyKe9xYbqDJ7MQqcW+xqgmvVrlS8HkCXDrdzje/+DzNl7qXuzs3BREFvB187a+fMtTu7JFmhvvHSc1wLdr7R9N0XvnFacOh05U1BVTUFCT0e/BmZM3WCv7mmT+K/EPCT/75WX76r8/x8T//ALc9tnN5O5eADHquD8vXpGTI4wUgzWHHssCanXkpSYQ0jUGPh7CuG9qf0adLADqzG00Tfj9BbfHmTitjlrmC6Gjqp7N5YLm7sSS4J3ycP96KFl7+nJ2bmaX0amthjbNHWvjyn/+MJ/7jDdOQWkQiIgbGL6aiihWRE5jISF3S3zXKT/7rTf76N79rGlJLzK47ayOFpw0w0DNG/emORc0Z7Wod5Mq5TkNtLFaVtXXF5MVRqt0kNoQQM/9dMxMX135nGsGRN8/Z3j68V8maSynxh8Ic7+7CpqqUZWQs2Du0p6QECVweHKRxaDhuYXkCSHHYmfD7Gff7rzlOWNdpGBxi3G+sIPdcmJ6pRURKyZvPnb+pFMuOvHKRR35pb0InwCeCQEM0hGP0MC2V5y0UDPPST0/y0/96i+62pZPvBxACrDYrdocVm9OK3W7Barv6P/XG/7ZaOPzKRfo6jdWMWWoieU8CowaVpkVqDpnzgdjQdUnblT5++NXXOPraJcPCAwtFtSiR+9oxdX9fdR9bpu5j2zvubcvUZ8P9Exx/o2FFh5ULIUjPSmbn/hpe+skJQ21ff+YMd79n26KV6Dj66iU8E8by4jKyk9m0uyqmnFcTk0Ti8uAQ3ztzjkdqq8lOSmLC7+cX9Q0cauugJieH2pwcQ4IRs7GjuIjdJcWc7unlK0eO8v6NdazLycZhseAJBumdnGTE6+O28jKcCxC6UBWFDbm5vNTUxIuNTZSkpVOSnoYvFOJ4VzfPX7mCJxjEukg5l+bTv4j4vUGOvVa/3N1YUpoudtPTPkRlbWHCru6Ew/qKCImOJS9DUQWKqsT93IeCYZ7678P8+D/eiEh4xwFFVcjITiGvKJ3cwnSyC9JJz0wmLTOJlHQXNrsFi0VFtapYLAqqqqCoV/059ZmqKqgW9ZrvOpr6E96YssUo5BIOaZFcNTPUzzBSSnrahvivv3+Ws0eb45Yb5XDayC/NJLcgnZzCdDJyUkjPTCY1IwlXkh2LVcViVd++h99xf6tq5Lt33u/njjSvihxdh8PK7v01vPHMWUNCLJfPdtLRPMDauqIFj4ETox4uHG8l4L9xwdHZyC/JYv22sgUd28RkuRHABzdv5H/OnuXFxkaSbDb84TBNw8PYLRY+sKmOqqzMme29oRAH29q50N+PJxhk3B9gwu8nEA7z1SPHKU5LxWWzUZiSwrvX18yITSTbbPz+vtv529ff5OWmZi7095PtcmFRVYJhjclAgKwkF1sLCxdkTNlVlcfr1nOiq5un6i9zsX+ANIeDkKYx4PFQl5dHv9s9a2hjLJjG1CJy9kgzYyPu5e7GkhIKahx86SKVtYXzb7xMRBJME9+cCsdQq0ZV1bhL8Wqazgs/PsET33idseHFub+FECiqoLA0i017qqjZXEpFTQHpWcmRiaXl7Ymloigoaux1LYAVIVdss1ljcUxFkqtXwP2diLjHffzjF35Mw9l2dG0RzqEARQhcKQ5qt5ZSt6OCtXUlFFVkY7NZUC0KlncY+kLEfl9b7avjFS4UQcmaPKpqC6k/3R51u1AwzOtPnWZtXdGCji+lpOlSD12tQ4ZeFVabhZ37qklKMYUnTFYuiiJIsdv59d27uL28jG+eOM3Z3l4ksLkgn1/ZtpXdpSXXhPh5g0FebmrmuctXZlT0wrqOFgrxVlsbihAoQlCZmcFdaypnjCkhBHV5uXzxoQd4obGRF6400jw8QiAcJsPlZE1WFg9XV19TtFcIgaooN6wfpQiBKsQ173khBHtLS/m7B+/nv0+f4XRvL03DI5SkpfGBjXU8ur6WP37+RcZ8i6PQujpG4gRA6pI3nz13U6qZvfXcOT7y2bsTNtQv6A+tBFsKj9v4Q61aIsZGvNB1nXNHmnny228t2JBSVIXkFAcFZVnccu8Gbrm3jvzizJkJ5TSJ6uGMN7GWGAj4Q2ianrDPX6Li9wX5yl/+3HBx1nciBNgdNtKykti4s5I7Ht7Ehu0Vkfp2vJ2rcbPe19EghCC3MJ2NOytoONNhaHHgzefO8cufv3dBSnq6ptNwpoPB3jFD7VzJdm5/cJN5bU1WNH//4APIqWK3t5aVcUtZ2cwzGJFrv378ynK5+L8P3Mff3H/vvPt/pxGkKgqFqSl8Yvs2Pr5t6zXrh9PHu5qPbtvCL2/dPOt3AI/U1vBwTfU134spxcDbysu4tbzsmjFlertvPP7YzO9eKKYxtUgMD0xw8WTrcndjWRjoHuXy2Q427KhY7q7MiscdSPiVe13XY6phY7NbsMZpEi2lZLB3nJ/855t0tw7FvB9FVcgrTGf9tnLueGQLW/aY+QWz4XBZY3FM4R73EQ5pCV/vLZEIhzWe/t5hDrxwfkH7cSbZWVtXxK79Ndz+4OaEVzZNZBxOG9WbS8nKS2WobzzqdhOjXo6+Vs+dj2yN+dhDfeM0nO0wHOa5eU8V+SWZ829oYpLAKBH3+My/BcybhDtjuMQ43k2Pk9GMl+/s32z7UWf5fuYYN+jnQvr/TswZzSJx+lCT4cmwogqy89IWvU7GQvB5gwx0jxqSaQ6HdQ6+eCFxjalJf8IbU35vMKZ8DWeSI+Zcm/nQNcnrT53m9OHYpf5dyXZ23VnL3Y9uY9PuSqw2iznZvAHp2SkxFZd2T/gIh2KTVb9ZaTzfxQtPHCMUjD1HqqKmgPveu4M9d68nr3j2YpImxlhbV0RpVa4hYyoc0jj4wgVuu39jTIs0Ukq624ZoPN9lqJ0Qgvvfb8prm5iYmMbUohAOa5w53IjfZyxxNS0jmcc+cTubdlXGqWfGGegd47//5SWaL/VE3UbXdM4fb2V8xJNQhuE03klfwodfTox50WPooyvJjs0eH2Oqu22QJ79zMOZckuRUJx/+7F3se3gzWbmp5mRzHrLz06aKSxs73xNjngUZBTcbngkfL//sJH1dozG1F4rg1nvreO8nb2fdppIpFUaTxSArN5XarWVcPNkWtaiGlJKWhl7aG/tZs8F47lTQH+LS6XbDYczl1fnUbC41fDwTE5PVh2lMLQI9bUN0Ng8YnnRm5aWy9+715BUnTphASVUubz13npb6XkPenOGBCRrOdLD7rto49i42xobdkcrdCczIwERMEu7OJBs2x+I/xlJKnv3BUcaGYsuTstktfO7PHmXvvXVm+FmUZOelxuSZGu6fWPFqbkvF9MT7/PHWmDzBQhHc/sBGfuV37ie/JGtFCJusJBRVYccd1bzw4+MEDHinxobdnDncRNV6Y6qyUkq8ngCnDlwx3Nf9D2/B7rDNv6GJicmqx1xSWyBSSq6c72KgZ8xQO0VVqKjOJzfBCv1ZrCrrt5XhSrEbajc55uXcsWZ0PfFqOg31x2aoLCVDfbH10ZXswBGHF/rwwARvPnM2prZWm8qn/vfD3P7Q5oQxpEIrIAwuKy8tJjGRgZ4x/N7EzwtMBELBMBdPtdHVarxOmhCwYVs5v/S/7qGgNDEMKV3TE35sM8q6umLK1uYZWljweQJcOt3O5JjX8PH6u0e5fNZYod7UDBe77qyZURk1MTG5uTGNqQUS8IdoutjNxKixQdxut7BjX3XChT4JIajbUUFKmstQu3BIo7Wh11Cs+1IxMjhJOKQn9GRzsHcMLYZJUVpmEq5kY4ZvNBx+6WJM6oJCEex/1xbufPfWhAp/WupCrLFgtVnIKUgz3G5yzMvokNu4csVNyOiQm7NHmmMK+03PTuG9n7yd0jV5CTNu65oec7HvREVRFe5+dJvh8aOjqZ/Wy32G2kgpOfTCBcMh1ttuXUdGdkrC3Acm0ZFbmk3drdWk56Qud1dMVhmJM9tZoQz0jNF8qcfwRD0l3cXGBMqVupqiimxKKnMNi5x0tw/R3tgfn04tgKA/xMjgxHJ3Y066WgfRwgaNKQHp2ck4FyAJPBtaWOP8sRZCMYRBFZRkcs9jO0ha5D4thOlQnkRHQEw5HwCNF7piMsZvJqSUjA1N0lIffT7oNEIIdt5Rw4591XHoWWxIKQmFNEKB1WVMAezYV01WrrGFhf6uUZoudhMyUK8v6A9z6OWLho5jd1rZsncNSamJM8aZzI8Qgn2P7+YL3/1NNt5Ws9zdMVllmMbUApBS0tcxTNsVY6thABt3VZKelRyHXi0ci0Vl1/4aFIMrg8P9E7TU9xhSAlwqWht6l7sLNyQYDNPXOWJ4Mmy3W8nITsFiWdzHeLBvnO72YcOr90JEpIIrawsQCRACNY3XHcDvNSYOsyyI2I2piyfaVp2HYrHRNZ3Wy32GowgAbA4Lj37s1oSS9Nd1GVFyXIXXPTnNye0PbDTUJhzSuHSqjfERT9RtrpzvordzxNBxSitzqawtxGIx67qZmJhEMI2pBRDwhag/04F7wme47e0PJHahv9131WKxGps4aGGdhrOdjI8urLhrPIhlNXqpGO4fZ3Lc+ATPmWwnMw6hJv1do3hjqHmVkp5EzZYyklISa8V2ZHAiJi/bchCrMVV/toOAL5TQoazLjabpMS18AdRsKaNsTe4i92hhhEMao4OTy92NuHH3Y9sMF6K+eLKN4YGJqJ4DKSVvPX/OUM6ZELB2YzHFldmG+mViYrK6MY2pGJFS4pn0c/pQk+G26VnJbNqdmCF+02Tnp1G71bjsa8OZDob7o3uZLSWNF7uXuws3pLNpgIkYEqdT01xxUYIc6hvD5zUeFpeZm0JFdX7CLRL0dowYCv1ZTkoqc3EmGc+B8076OXngchx6tHrQNRmT8ATA7hg89fEmGAjRZ9CrspLILcpgyy1rDLUZH/Fw/lhLVN46rzvAiTeNPTNpWcls2FGBw2mq+JmYmLxNYr0dVhj9XSM0xzBJ33PXeqz2xAkXuRH7HthkuM3YsJvLZzuN5//EmZb6npg8iPFGSkl7U39MKlRpWUkUli6+MTUyOBmT1HZqelJCyfxP03q5l2Ag8QUohBA4XDbWbyuLqf2rvziT8PXUlhNd12M2Pmq2JF49oYAvlJA5qouBEAK7w8qt99UZFqI4/Molgv7wvAt6Zw834R439k7IK8pgw/byhFswMjExWV5MYypGdF1y6JWLhuPVVVVh9121MUkgLzVbblkTU8jW0dfqE27yGgyEuXSqfbm7cR1ed4CO5gHDOT2KqpBXnElq5uLn3fm9QcM1eISI5DkkJ1iIXzAYpu1yL6EEzOObDZvdGnMR7/rT7XQ0Dyxyj1YPUkrck8YXVGx2C9n5xlUW44mUkvERd8yetpWAqiqs21hCYVmWoXZXznfS2zk85za6pnPqUCN+X/Tj7nTZkNzCdEP9MTExWf0k/ow+QQkFwxx+0ZgKEEBhWRbl6/INK+UtNUII0rOS2bC93HDb+tPtDPaOJ1Son67pnHzLeGHGeNPbMUz7FeOryza7hTXri+JS6ybgDxmuXaMoCsmpjoQLheptH6a7bciw9PFyYbWprKkrjmkRw+8N8uwPjiZkrbdEQErwe4wLkSSlOLBaLQnljZC65PzxVjwx5DauFIQQ5BSksWlPlaF24aDGwRcuzLnNUP84LfU9hhaNHE4rtz+Y2LnOJiYmy0NizXxWEFfOddLXZTxkpG5nBclpzhUxIFttFnbcYVwK2O8Ncvz1+jj0KHZ0XXLheKshpad4o+uRHI6OZuPGlMNpi8nQjYZwWDNsfAhFYI9D8eCF0nihi4HuseXuRtREJpDpkaKlBtE1ndOHGg3X2rlpkBFPpVHsThsiwd6Uui5567lzy92NuJOU4qR2axkp6cbqHr713NzCEk0XexjsNVYTsaKmMGaBGBMTk9VNgr0iVgZSSt589qzhCafFqlK3ozIuRVbjgWpRqN5UQnpWkuG2rz9zNuHyN0YGJzh3rCVhPGbucS+nDjbGVFC2oCSTipqCOPQKLKpqXNpcknDXe3zUw7mjzYyPJo4BHQ25BWnU7ayMacGlr3OEl35yIuHCbBMCAVaD6nAQua8TZMiY4dLpdhrOdCx3N+KOogjWbiiipDLHULuBnjHqT89+frSwTuOFLmNKiALueWwbVoMKtyYmJjcHpjEVA55JPyfeajTcrrgih6KK7BWRLwWRVfKM7BSqNxtPvo6lGn28mRz3cey1+piMl8VGSklf5wjHXjPuwRMCbokhMTtarHYV1aAxpes6Pm8gYQxVXZe01Pdw9kjLcnfFMHZnRIQip8B4nk44pHHs9QbOHG42HKq52hGA3WE13M7nidzXiXJvB/whfvbNt1ZM6OpCKSrPZs2GIkP19LSwxpFXLs16zYb6x2lp6DVU1y89M5m992yIensTE5Obi5Uxq08wzh5pZnLM+Gp3+bp88ooy4tCj+JGWkUT1phLDuTBaWOet58/HqVexoWs6DWc6uHyuc9knRuGQxks/OxlT2KHDaWP3XbVx6NX0/u2oBgtS6rpkYtRjWLgiHkgp8br9vP7UGQZ6Rpe7OzGxtq6I8urYcit7O4Z5/kfH6O8ZW/b7PJEQiiAp1Wm43eSED6/beKmAeCCl5Oirlzh7pHm5u7JkqBaVbbetIzUj+ggJXZecP95yXb08KSX93aOG643te3ATrhhKFpiYmNwcmMaUQXRdcvKty4alox0uG1XrC0nNMBb7vdxY7RYqagrIyDamGqfrktOHGvHEoJ4VT/q6Rjj88sVll0lvONPBa0+djqntllvWUlhqTOHKCKmZLmwxrOC7x32MJEIRUQnHXqvnwAuJZcwbISM7hR23V+NKjk0d8cSbl3nyWwfMQr5XIRRBdp5xb5/UJR1NiSFB3t06yNPfO2xY/XOls2F7OQUGx7zhgYnr6guGwxrtV/oY6os+X8rhsnH7gxsTTlzHxMQkcTBHB4MM9IzSXN9ruI5SZk4K6zYWr5gQv2mEEJRU5lJYZrzi+1DvGFfOdcWhV7ETDmm88cxZLp/tXDbVM4/bz3f/5SU8E8aVuBRV4eGP7Inriz09KyWmcKjR4cSQam5r7OPb//hCwngTYkEIwb6HNlFSmRtT+1AwzIs/Oc4Pv/pqwuWyLReKopBblB5T2zOHjRdnX2wmx708/f0jCeFZX2qSU53svrMW1UCon3vCx6VTbdd85nMHuHCyzVAIbO2WMgrLjeVsmZiY3FysrJn9MiOl5Mq5Lob6xgy3zS5Ip2r9ylQCyivOoGRNLopqLObIPeHjzOGmhHvxjw27+c4/vcDIwOSS900La/zg31+l4UxsNa/qtpdTVVu4yL26lryiDJwxhLQM90/QdLF72XJ1pJQM9Izxz3/6EwZ6xpalD4tJakYS7/mV27DEIJoAEVXNn37rAN/5pxcJBeYvYrraUVWFsrX5MbU9/PIlgstUq0xKScAf4vWnz/Lyz04uWz+Wm/2PbDG0yBPwhWip752Rj4/UGfNz4ZixPMpdd9aQskIUeE1MTJYH05gyQDiscfl8J2PDbkPtrHYLG7aXrxgVv3eiqgobtpaRkmYsRDEYCNN4sZvRoQQI/XoHjRe6+dc/+xljw+4lm2QGAyFe+cVpXnnyJKGg8dwim93CXY9uJTk1vi/2wtKsmMJRQ8EwZw430dsxvOQTd13T6W4d5F/+9Mc0nk8sb2isCCG4/cGNC5LAD/pD/OzbB/jq3/yC/u5RQ0n3S4WUMiJg4gkQikG6PFpUVYnUZjO4KAQwPDDOq784vSwGacAf4s1nz/Ltf3h+VdeVmo/s/DR27Ksx1Kava4Tutoi3XMpISRMjociFZVmsrSuOeUHDxMTk5sA0pgww2DNGa0MvumbshepwWNl+27oVu7IlhKB2a5mhBOBpejuHaW1ILFW/aY6/3sDX/+/TdLYMxj0UKugPcfjlSzzxtdcYHTJmjE9Tt7OCjbsq4/5id7hsVNYUGAqpmab+dDvH3rgc10nxOwmHNRrOdvCNv32GM0eaV5XKmVAEH//dB8gpSI95H0F/iBd/fIKv/uUvOPnmZbyexFFd9Lr9tDb08sYzZ3ny2wdob4xfbpJQBFl5qeQXZxpuq2uSp//7EN1tQ3Ho2Y0ZG57kmf85wtf++qmb2pCa5t7HtxtSMR3qHaenPbK4I3WdowbVU6s3lVBYnr1i390mJiZLg1k0IUqklPR0DNMWg9x3XnEma9bHNzQr3uQVZVBZU0BXqzHDY7hvnOb6HjbvqUq41T0pJQeeP8/kmJfHPn47G3dVYrMv7iMhpSQYCPP8j47x9PcO09Ua22QsNcPFbfdvJHeJ1CB33lHDyz89iS9sLNE94Avxi+8epKg8m513VMd9EuL3BXntF6d5/kfHaLzYveryg4QQVK0v5PFP7uNb//h8zMID4ZDG0dfqabvSx847atj30CaqN5dgsxvPjVsIUkoCvhBtjX00nu+iub6Htst9tDX2zeSVxpO0rCRqt5bR0z5suG1nywBPfOMNPvZb95GVlxqH3r2Npuk0Xejm2R8e4Y2nzxoWPFqt1Gwqobw6n+ZLPVFtPzHupatlkFAwTDAQNpT7lpTioHZrGWkxLCKamJjcXJjGVJQEA2GaLnQbDvED2LW/FrvTFodeLR2KqrDzjhoOvXTBUIhaKKjReL6LsRF3TEpa8SYc0jh9KBKaducjW3jow3vJyE5eNCOgs3mAH339dY6/3sDEmDemfQhFULuljN131WIxKFkeK3U7KsguSKezecBw277OEb72N08hpWT3nfGRcJe65PL5Tp789kHOHGqMSWJ+pWCxqtz24EYun+/k9adOL6iAbH/3KM/+8CinDzWytq6YfQ9vYvPuKpxJ9rgZvrquMzIwSeOFLi6ebKPxQjcjgxOMDk7idfuXtCBuSpqL9dvKOPD8ecMGSiio8dZz53C4bHzoM3eSkZOy6P2TUuKZ8PHSz07x8s9O0tHYTzi8/OUGEgEhBHaXjdsf2BS1MSV1SWfLAO5xH61X+gy9v3ML09mwoxzFaAFzExOTmw7TmIoCKSXuCR/njrYYDo9RlEjew2pgxx3V2O1Ww/k+l893Mtw3TlZuakKGS+iaTk/7MD/6+hu8/LNTPPyRPex7aDNZeakoipjp83x9jxT2BKnrDA9M8tJPT/DST04w2De+IFGGjKxk3vdrd5CRvfiTtxvhcNl44P27+MbfPh1T+562If7pCz/m0Y/dysMf2UNSihMh5j+HN2L63OqaRk/7ME/99yEOvXyRsWF3VGG3qqqg64lTeNUIQggys1N4/JO309c5TP3pjgXtT9d0utuG6O0Y5tjr9aRnJbP11rXs2l/Dmg1FpKYnRepbCTFV50ow9cfbSJBX/UUSuUbISG5gX+cILQ29NF7opuFsOwPdYwT8IULB8LLWIlMUQfXmUsqr87l8ttNwe58nwHM/OEJP2xC/+ocPUVIZEeZZyH0NkVISkVDgi/z0m2/R1TIYlbEnhEAoGA49X6lYLCpbb13Dk99Ojtow6modYnLcy/HXL0/ftPOiqAoV1QWUrclbQG9XLteMk7M869P/F5MiroyMQVpYA8T0/2b+751jTSLOGUxM3olpTEXJyMAE9aeNK7BV1hZSXLk6ZFVT011s2lPFoZcuGmo32DNG86UeqtYXLXmoX2F5Nqqq0N06OG8uTSgYpr97lP/6f8/xg6+8ysadlWy9dS3rt5aRkuHCarWgWpSIgTW1Wil1ia5LQqEwIX9EcOPoa/WcPtgYkxfznVhtKo99/HY2bC9f0peKEIJ73rudJ7/9FoO90ddkuZqxYTff/ecXOfjiBR75pb3U7awgOc2F3WHFarPMueIrpSQc0ggGwwT9IbzuAA1nOzjw/HlOHWwkaMCrkJ6dzO/8zft59eeneOOZszH9luVGKILK2kJ++fP38ZW/+PmiSNDrusTrDuB1B+hpH+aZ7x/BarNQUJpFaVUuOYXp5Bamk5aRhN1pxe6woVoUwiGNUDCM3xdkctzH5JiXkcEJBrrHGOgeZaBnjIA/uKQep2gRQlC2No9Nu6toqe+NKbcvFNQ48eZlzh9v4b7Hd3LXu7eSW5SOw2XHZregqsoNn9WI2IacCjsLEfCF6Osa4cQbl3n96TMM9o5Ffd5Ui8K+hzZRs7mMH339NYb7Jwz/lpWGEIKc/HQ276mK+lnu6xxmbMRjKMTP6bJx6311K762lJQSXYsYPboe+VPq13927b8lWljD5wnimfTjmfThnfTjmfTjvurvHrefjsYBNM3Y4ojfH+Jrf/M0WXmpJKU4cCU7SEpxTP3dfs1nTpcdZeqdqyhTf6pv/11c8/n0dgKhKAtavDMxMYppTEWBrklOvHUFv894vsIt99WtqjCB2x/cZNiYgkgR0TvetRmL1RmHXs2Ow2Xjg5+5kw3by/jS/37CkDHsdQc4+lo9R1+rRwhBRk4y2XlppGclY3fasNstICDgD+Od9DPUP05/9+iiFtNUVIW999TxyEdvWZaXQlKKgw98+k6+8bdPxyzHrOuSpovd/OMXfkxuYTo1W8qorMkntyiT5FQHNrsV1RKZfOq6jhbWCYU0fJ4Ao4MTdLcN09kyQMulnpjCJDOyk/nlz9/Hlj1VjA27V6wxBZGJwbZb1/JLv3kP3/rS8/R3jy76MULBMB1N/QlTpDYeWCwq+9+1mVNvXaG5PrpwsdkI+EI89d+HePEnx1mzvoh1m4oprsglMydSp81iVVFUZWpCqxMO6wR8QSbHvQx0j9HZMkB7Yz9drUNTq/TRIwRs2bOGX/pf96KFNV78yfGbwpiCSP5o3c4KjrxyKSrvndcd4NCLFxnsjf55ySmMGGwrdTLuHvfSXN/L2LAbvzeAzxvE54n86fcG8HuC+LzT/377O583gN8bJOAPxS3/VNf06+p/3QghBHanFafLjsNlw+my4Uiy4XRG/u1w2XAm2XC47JHvpv902nAlO6ioKSC3MD0uv8PE5GpMYyoKwmGNQy9eMNzO4bKtaBW/2di4s4K0zCTDOSoXTrQyOujGlexYsvORU5BOYWkWReU5fOp/P8Q//PETdMcgACGlZGRgkpGBpZN4FwJ23lHNJ37/gUUXxYgWRRHccl8dpw81xmRAv5OBnjEGesZ489mzKIqYehHaI5NOoaBpGuGQht8fwuv2Rx2ScyNSM1y8+6O3su/BTVjtFmo2l+BwWvH7VnYy/76HNqGqCt/78stxVb9bzVRUF/Dgh3bzjf/79ILFHQK+EBdPtnHxZBsAVpsFV7Idu8M6ZUyBNuVlXSz597odFXzyDx+iqDybgD9Edn4aLfU9CekNXGxUi8qaDUUUVeTQEqUx/MITxwgEorzOAm67fyNJqUu38LfYdLcP8x9/9wxNF7uXuysLQkqJf8rgM0pyqpPP/Mkj3PPY9jj0zMTkWla2D3uJ6Gjqj0nFb21dMTkFaavGmBJCkJzmYvOeKsNtJ8d9nDrYGIde3Zi8ogwKSiMyyDVbSvnk7z+4Ylap1m8r5yOfu5vcwvRlu3+EEKRnJvHox26lojq2Yqc3YjrEbLh/gv6uUXo7hxnoGWNkcBLv5MINKYfTxrs+speHPryH5KmCm2mZyTEXbU0khIgYuZ/5wiNUby5Z7u6sSIQQ3Pnurdz73sWfaIWCYcZHPAz0jNHXOUJ/1whD/eNMjHoWxZDauKuSz/zJIzPPpN1hpaq2EKvt5lkbLVuTR1Vt4Uy49XwE/KGoxxS73cpd7966gN4tP1KXCVlTbinRND22nC4Tkxgwjal5kFJy4IXzMSkqbdm7BleyIw69Wj4sVpVdMSq0vfHM2SVbOVVVhcKyrBnFLSEEO++o4Vf/8KEF1exZCtZsKOLjv/cAVeuLUJTlfUQVVWH9tnIe+eVbSM9KXta+RIuiKjz+qX2879fuIDX97eLDNodlVRgfQghUVWHTnio++3/ew9Zb16743I7lwJVk55c/f29Mi0PLxcadFXzmC++ioqbwmkWWmi2lSy5zv5w4XDY27qogJW3xvUfbblu3YhbdTExMEgPzDTwP4WBsIX7Jac6pOi6ra7VQUQRVtYXkFBiXOb9yrpPeDuP1XWIhKdXBmg3FM8aIECIiMX3/Rj7+ew9EPFYJ5jBUFMHauiI+/5fvZcP2ckPFKeOJxapy3/t28r5fu4OUq4yTRCQl3cVnvvAIH/ns3Thd9mu+s9mtVG8uXTWeYlVVWFtXxB/940d49KO3JPy1SURSM5L4rb96nC17qxLmeZsNi1Vl5x01fO7PH6OytvC6PNx1G0twuFZ2+Q0jCCHYcssasvMXt9yGogjufe92c3HCxMTEEOaIMQ8XT7YxHEOuTGV1AXnLGKIVLyLhUpHCl0bRdJ0Dz5+PQ6+uJynFyZoNRdd8JkRE8Wf/u7bw63/ybtZvLUuYl6Yzyc6u/TX83t9/kLV1xQl336iqwnt+5TY+8rm7yFuiwsFGUC0KFTUFfO7P3sODH9w163VVVYX8kkwyc5dOYj7eCCFITXfxqT96mN/403ezflsZrmT7/A1NgMj5yy/J5FN/9C527q9OyMWvpBQHdz26jc/+n0cpW5s369iQlplE+SKH4iY6OfnpbNxZuahGcOmaPNZtKkm48dfExCSxSYyZZIIipeToa5cIRpu4OoWiCCrXF5Kdnx6fji0zyWlOaraUolqM3T5Slxx7vT4mVUSj5BamU1SePet3iiLYdWctv/XXj3P/+3aQuswV7gtLs3j/r93Bb/31+yityl3WvsyFqiq8+6O38pkvPMLGXZVLLnN/IxxOG7c/uInP/dl7uPW+ujlzR9IzkxP6HMeKoijsf2QLf/DFD/Hhz97Nuk3FCXN9osXusC1LcXMhBJU1BXzqDx/moQ/vISUtMTx8QkBFTQEf/a17+fQfv4v8ksw5t996y5qE87bHmzvetWVRDeC996wnKWV1heabmJjEn8RbhksgRofcNJztRAsbS2JMSXexZn0RdufqjGG3Wi2Ur80nJz+Nvi5j8sy9HSM0XeymbkdFnHoX8VKs31Y+70u2pDKXj//eA2zZu4bnfniMCydal7SgqN1hZe+9G7j3vTtYv7UMu9Oa8CuiiqKw665aCsuzePnJU7z0kxOGlR0Xk/J1+Tz28dvYets6svPmLwqdnpVESVUupw9FX3NmpSCEIL84k3d/9Ba237aOM0eaeOu58zSc6UjoYsWZOSnsvXcDe+9eT/m65fGuCCEoqsjhI5+9mw3bK/jpf71J/Zn2BQuhxEpKmpN9D23m7vdsY+3G4qi8L1v2rkUgkMvV6WVgzfpCqjYUceF464L3lZGdQt2OCuw3Ue6ZiYnJ4mAaUzdASknjhS6G+owXLM3OT6NqfWHCT4wXQlF5NkUVOYaNKa/bz+lDTXEtQquqSlRJ5ZEQqSRuva+ODdvLOfjiBX7x3YN0tw/HfRJVu7WUD/76ndRuLSc5xZEw4YbRoKoKpWvy+PBn72bvPRt48lsHOPjC+XmLIi8meUUZPPih3dzx0Gay89Oi9sI4k+wUlWdjd1oJrHCJ9Bths1upqCmgqCKbfQ9u4sr5Lp794VHOH2tJmN9sd1qp3VLGHQ9vZtPuStIyk3Em2Ze9Jl9Kuou996xnbV0RR165xM+/fZDezqXJ84TIs7Vzfw3v/ugtrNtYjCvJEbViXXFFNtn5aQz2jsW3kwmE1Wbhnse2LYoxtW5jMUUVOVGfbxMTE5NpTGNqDjqaB1AUMaMIFw1CCKrWF1JSmRPHni0/2QVpVG8qob2x37AEa0/7ED5P0HBuh5i6FsF55IWTU53Ubi2Ner+qRSUzN5V3/dJe7n//Lo68connf3iU5oZegoEQwUB4QQUMVVXBao/Untm4s5KHP7KX6k0lWG3qijW4hRC4kuzUbill3Zc+RPtn7uS5Hx3lxBuXmRjzEgyEDHt0b4SqKlhtFmwOK2Vr87j70W3svquW1HQXQhGGzqEQgtI1eZSvzWdgnklnUqpz2Sf3C8Fmt5KZm8qeu9azc38NQ71jnHjzMgdfvEhLQy/hUJhQMFLbKx6eKyEiz5bFomKxqbiS7FRvLmXHHdVs3l1FVl4qiqIgBAn1HKiqQm5hOo/88l72PbSZwy9f4IUnjtPTMUzQHyIUXJzzJYTAYlOx2SykZyWz/fZ1PPCBXZRW5aKoiuFzolpUdu2v4dDLc9eEEwIsBkO0E5lb7q3jx994E4/bH/M+ptUxF1vQYrlQrQppGUmG5i6rDafLjs2xPKIsiiJISXUaPv/xUKc0WRrEPC+FmydewMTkKkKhMF0tg5w71sLF4630d49eVUE+SCgURtd0tLCOlBKhKKiqMmM4TVdjdyXbKa3KpW5nBRu2l5NfnLmivFBGkFIyOjTJxZNtnD/aQtuVPtyTfrxuPwFfiGAgMhHVNR1dl5EJqQBFCBSLgkWNTLptdgt2R6SyfXKqk8KybKo3lbB+ezkllTkJNfFeiUgpGegZo+liN60NvbRe6WOkfwK/L0jAHyLoDxEIhAiHpq6VJtF1fcbzKBSBIgRCEVgsKqpFwWKNGAU2hxWb3YrDaSU1K5nC0ixKq3KprC2kbE0uNkfih7LOhqbpNF3o4tzRFhrOdjDUP4Fn0o/fGyDoDxMMhtBC+rXnSQgUNSJjb7GqWG0W7A5rpFi1y05mbipVtYWs31bG2o3FJKUsXUFzExMTExPD3HCANo0pk5sWKSW61knI/9zMZ4pagtXx4DWTGqlLhgcnGOmfYHhggpHBSXyeAEF/iGAwjBbWsVgUrHYrNoeF5FQnWTmpZOamklOQRkq6a9kmSVLq6OEmwqHTWGy3olqKl+i4kqA/xEDPGIN944wPu5kc8+Jx+wkFwoTDGrouZ2omWR0WHA4rrmQHyalO0rKSZs6hM8lUp4snUpeMj3oYHZpkcszLxKiHiTEvPk+QUDBMOKQRCmloYW3GQFCUiIFgd1hxOG04XBHDNyXNRUq6i4zs5JliyasNLawzNuJmoHuUkYFJJsa9uMe9BHwRA3S6JqGiKlitasS4TLKRnOIkNcNFRnYKWbmppGcnr8rzY2KyUrg42suxoXb0q+bBmzIL2ZZVgipW56JnNLRODnN8qJ11qblsyixCiWGcGvBN8nx3PUkWGw+XbMChropcxBueCDPMz+TmRvrRw03oWj9a8CSqbRtWxwNc/cwIRZCdl0Z23koMAdHRQucIuL+Gkla8ZMaUEAK700ZJVS4lq1A9bzUhFEF6VvKKKcq83KgWhazcVLJyU5e7KyYmJgug0zPK050XGAv6GAl48YSD/Nq6W9iSWYx6k65z6FLyZn8T/3jhNfYXrOWLO9+DIowrw3b7xvmHi69R4EzlzoK1q8WYuiGmMWVyU6NYKnGk/gl6uAXv2B8td3figIrFcS9Jtu0oSt5yd2ZepJQMjnp49q2LnLvczeiEF9WiUJqfwe3bqti3fQ2KwTwpk5WBlJIJt583TjZx5GwbfUMTSCQF2ans2ljOPXurSXLYzGtvsqyMTfr4+hMHOXO5e87tbttayace34vNak6z5kPXJQ2t/bxwqJ6m9kHcvgBJThu1lfncvbuamoq8uORW3p6/ho0ZhYSlzpPt5/i3hrcWdf8rEQFk2Fyk2hxUpGQhbrZ6CzFiPuUmNy2RgdmCEOlIJR0hVt/KiRACIdJASXyvmq5Ljl1o50vffpWegXF0XZ+JM77Y1MfLRy6zb/safv9X7iY91UzUXU1IKWnrHuGfv/c6Jy51oGk605E3Da39vHmymZ+/do7/+/l3k59jeoRMlg9N0+kdmqCla2jO7daV5ZDAFQkShrCm86MXTvG1Jw4Smgr/nubM5W6eP1jPJ9+zh3fdUYd9jhqCsZBksZFkiYhUZDmSTLOByJzh4eIN3FdUgyqUmEL8bkZMY8pkxSCljpRjSG0AKX2ARAg7QslAKDkzxpCUEqQHXetFSjcgEEoKilqEELEXZJRSR+qjSH36+BaEkomi5l1jiEnpQw+3TG1zPaqlGqEkAwIpdZAT6NrQVF81wIaiZiKU3Kt+Uwhd6wSsKEoWutY9tb2KouZO/f63XfFSamjhepDTCldWFEs5yjuMKil9aOFmFCUPIRxT+/UCKkLJmDpnV+9XAkF0rQepj09dAxeKWohQFqYc1dE7wreePEJn3/Vy+1JKgiGNt041U5yXzq++dy9Wy8oqSmtyY9zeAD964RRHzrVd952UkQlXfUs//+9br/DXn38XDrMWkInJquDQmRa+9sRBArOo9Oq6ZHjMw3eeOkZVSTabq4tMz/QSoCoKKjdvzlgsmMaUyYpASokWOkXQ+wPCwTPAVL0cqaHa9+BK/f9ARAwFqfcT8HybcOCNiGEgJUJJxep8FJvzMRQ1K4bja2ihSwS93506fhAkKJZibK4PYrXfhVCSANC1QfyTX0YLX137RCL1YaQ+SHL2j7HYdkz1dYig978J+V+ZMk4UQEOxVGJP+hQW+60IYUHqo/gnvghCRbWsJRR4HamPgAyhWmuxJ/86qnX72y8aGSTo+RbaVD4YMogr/Ysojjuv+V16uAPv6OewOh4EFMKBA0g5jtTdqNa12JN+Hatj/1U/w0vA9yPCvqfRtSFAA2HH6rgfu+uXUCxFhs8tRF6aF5p6udI+MOd2gWCYU/WdPNBfS3mR8etoknhIKRkYcfP68cZ5t73Q1MPF5l62r4++9IGJiUliEgpr/OK18wRDc5c76R+e5Mi5Nmor8xfdO2USH242k3fR78qLTb28eLgBrz+42LtedFRFYffGMu7ctW65u2IyD3q4Gd/4nyH1CWxJv4JqWQtEjBEpQyAihoyUYfyTXyLkfxV70q+gWjcDOuHgcQLuL4P0Y0/+NYSIXiFOSonUR/BP/i1SH8Oe9DEUSzlSdxPyv4B/4kuINBcW+36EiHiKHCm/fY1nSuqD+Cf/GWGpQChXCzIIhEjF5nwcxVICwoEeukLA810C7n9DtW1GiPSZrcOBA1N9+ARCpKFr7QTc/4lv/K9Jzvo2iEgIlBB2HCm/g9THCfqfI+j5/py/Mej7OaqlGnvypxEiFV3rwD/5//C7/xnVWoeiZke28/4PAfdXIsZT8m8A6ozABdKHI/UPEMIV9bmdxh8M0dE7gtc/f1HZwRE3PYPjpjG1SpAS2nuGGZ2c3ZN7NYFgmEvNfaYxZWKyChgaddM1MBZVOOT5xl5CYW1Zjal+3wRfv3yI4qR03lO6iQz7te+6dvcI32k6hlO18rnafTgtEQ+6LiXPdF6kaXKQ95RuIt+ZyuHBVk4PdzEZ8pNksbMmNYf7CqtJsr49NwlqYerH+zk70k23ZwyfFsKuWihwprEnt5zatLxZPXUBLczFsV5ODHXS55sgLDVSLQ7yXalsSM9nfXoBNuXaOpdnhrv4cdsZ9KtEvHdml/Lu0o1zKhuOB30c6G/h/GgPfi1EvjOV2/OqYI5sK03qdLhHOdDfQodnhKCukW1PYltWCduyinFarq0PdmighRe6G/iVNbvIdaTwau8VGsb78YaDJFsdbMoo5Pa8qpnzfTW6lDRPDHF4sJUOzyhhXSPXkcKunDI2ZhRiVxfnflr0u7J7YIwXDtYzFsWLcbmxqAopSXbTmFoBBL3fQwu34Ez9P9hc750yhuTUIBxEiMitrAVPEvK/gNXxIPakTyGUyGCn2rahh1sI+Z/FYt+HxbbJ0PFDgdfRQpdwpPwWNtcHEMKGlBLVUop37AsEfU+iWrcg1CyEcKBaq2faShnEP/kvSBnAkfJ5FLWI6XUboWRhc30EhBWBBYRA2nagaW0EPT+4Kkxvel+TOJJ/C9UW8UJJGUTX+gl4/oNQ4AA250NM7RhFLUIqeSjKuXl/n9RHcab+MYpl3dR+Q4SDJwkHDqCFG1HUbHRtgIDn2yiWEhypv4+iZAACi20XWugMocCbWEPvwmLbbujcAgRDGmNRFt30BkK4vYm/WGMSHZKIZyoaNF1nZNwb5x6ZmJgsBWOTPkIhLapth8fdaPriFIKPlfGgn593nGdjRiH3FtZcZ0wN+z38vOM8qTYHv1Z9C06mJ/eSMyNdvNbbSFVKNj9sPcWzXZcYCXgI6zqqorApo5C9ueUzxlRY1/n65UM82XGO0aAXXziEJnUUoeBQLfyo7RSfq9nHI6V11/TBFw7yRNtpvtN0nKGAB78WQkqJRVFxqBbSbS6+essHWZOSfU07vx6mzT3CSNDDgM/NRMiPIgSPlGy8oZupzzvBlxve5NWeK4wFfWhS4lAt/LzjPO8v33KN5Pw0utR5qbuBL9e/Ra9vHG84hC517KqFTJuLB4vX86l1t5DlSJpp0zgxyE/bzlKTlsfB/hZODHcwGQoQ1jWsikq6zcUDRbX8bt2duK4yxIK6xsvdDXz9yiE6PaN4w0F0CQ7VwhNtp/lQ5XY+vmb3ohhUpr/UJOGRMkgoeBAhHNicj1zlVRJEFlbeXskJB48gZQir/c4ZQwpAiBSsjvvwjf8ZergZDBlTknDgTYSSGTGYhG1qnwJFLcFi20TQ/wpSTgDXekuk1An5XyLo/R725E9jsd81Y/hF9qEgcQChiCdL6oBEEWlE8qfCXF3uTVHLUSwlM2ObEDYsth0Evd8jHDz2tjFlENVSM2NIRfZrRbWsJRx4HalPABAOnUHqo1gc9yCwIvXpCbCOYqklHDyDHm6HGIwpmM7HimpLzBJ4q4vZXro3QprX3sRkVRD9mM+qGPInQn7+q/EIYV3nl6t2sDenAlVRqB/rQ5c6yZa35zKqEBS40qhNy+P2/Cq2Z5WSbnPS7hnh3+oPcLC/mf+4cohdOaXkOSMRKVJKerwTfKXhIClWO3++5UH25JRjUVQ6PCMcHWynxztOzlWGyjQ7s0r5xq0fRiL5Ycsp/vHSa3P+Fr8W4smOczzZfo7ipHT+evu72JxZzHDAw/+0nOQbjYfxaddHmpwe7uKPTz6FU7Xy8TV7eLR0IylWO+dGe/ja5YN8t/k4LouNT627BYdqucZ79sULr5BssfN7G+7mtrxKwlLj6Y4L/FvDWzzXfYmtWcU8XLIBiLxTzo1083/Pv0RI0/jVtXu5v6gWp8XGgalz9y+X3iDHnsxjZZsWnItnGlMmy4qUEe9SKHz96pTFoqAqSkRoQfdHPCHi+kHganQ9orAk1HfWNhIINQ8pvUg5abifutaPEA7EO1XxhB1E+kz+0jt/mxY6h2/iz7E67sae9CvXiDlE8qg8hINHCPqfRw+3gO5GEkTqw8zkhV19OCUFUEFcXQcrDVAjfYgR5brzBcz0NfIWk9ogkhBB7/cIeX88S99SgdhWDq0WhRRXdOIgLruNJKdZyHe1IBBkps79XE+jKgpZUW6byExPIoOzrMpbVAVVNZO/TVY/KUkOLFEKCWWlJaEqK/u5mAj58YSD/NW2h9mZXTazKFqbFilbcvWEXgjBe8s28d6yaxd+M+0u/mrbQzzy8tcZDfponBiaMaamjzES8HJ7XhW35lWSbY+Ml1l2F1szi687zjSqouCcOr82df5r0uud4MWeBhyqlb/Y+hA7pn5Phs3JH268m37fBK/0XLmmTUjX+IeLr6FLyUcqd/AbNbfNqAXuy6si15HMn5x6mu80HeP+olrWpuZc096vhfmn3Y9zW27lzGe/XnMbTZNDPNt1kYtjvTxUvB4hBAEtzHeajjEe9PG7G+7kw5U7sCmR3/X+8i1IJF+68Cr/1vAWDxavnzVE0AimMWWy7HQPjPHi4YZrPrNZVG7dWkllcTaR21RByiCRyfqNH3TB1IRcvjNkTIL0gbAAxh8aIZwRD807DCakRiTM0AbvUL/Rw034Jv4K1bIWR8rvX5dLJGWIkP85fJNfQrWux+Z8FEUtBuEi5PspQe8T13dEBrhuiW7qMyN5YNcTxQtt6jda7bdjcdx1/dfYpnLUjOOwWynJT8dmtcybjJyXlUJxXnpMxzFJPISAyuIskpw2PL65wzcddisb1hQsUc/iS//wJM+8dfGaz1RF4dYtlawty7lBKxOT1UNeZgq5Gcl09IzM63jaVF20KhRcb8utZEN6QVSS4zfylhS40sh3pjAS9OINB65uQLYjiTWpORwdbONHrafZm1vOmpQcUm2xKxm/EyklQ34PjeOD7MopozQ585rf41Ct7Mtfw5t9zde0a50c5vL4ABl2F/cUVV9nHFekZLEzu5SLo7281d/MmtScayIM16bmsCen/JrzIqVkW1YJT3VewB0KEJoK/ZsM+TnQ30J5chZbs0quC+XblllMtj2JDs8oDeP9bM0qXtA5MY0pk2VFAm+caOIbPz50zecuh4387FQqi7MRIgnFUogWPI8ebromH+mdKNZaQBAOXcRiv+Wqb3S00IUpue9ZvDDzoFo3EgxfQdc6Ua1v59hJOYEe7kBRyxHi7dpHkTymb4D04Uz9M8QsBXOlPkko8CZCpOBI/h1Ua91UvlKAsP9FZvPy6FoPUvqQUs4MKFq4DWQARa28bvvFRLWsjUi1Cyd25wdgjqRUw/tWFGor86kqyaK+pf+G27kcVvZsrqAgJ/HrZplEhxCC3KwU9m6p4OXDl+fcdvemcmqr8peoZ/Hl4OmW68Y9m0UlJyPZNKZMbgpsNgv331rL2Svds3pppykrzOSWzRVYrSvbmLIKhXxn6kxtq2jo8oxxcbSXHu84EyE/fj1MSNcYCURyR68WjBBAriOFz6/fx7caj/KNK4d4rusStel5bMsq4dbcSoqT0hdcO0pHMhxwE9DDFDhTcajXL1AXu64/TodnFE3q2BULpUkZ17VxqFZyHSnYFAuNE4NEZohv72Ntas6sshbJU3lmmpQz56PXO4E7HGAk4OE7TccixuRVu/OGggwHPOhS0u0dN40pk5WNlJKj59vn3EYIFZvzMbyB4/jd/44z9U9R1Jyp9jpSH4jUmhJ2rPY7Caj5hHw/x2rfj2qNqP7p4SaC3idQLTWo1rq5DjdbD7A5Hibo/QEh3/Oo1s0oajZShgkHjhEOHsWe9FGEmhnpk+4j6Ps54cBRHKl/gmJdP/sKkwCBghAKQtimDCkdLXiOUOAQswWJS32EoOd7OFJ/H7Cia/2EA68gCWF13GPwdxlDtdaiWrcTDhwi5H8Bi+O+SNiilEjpRdfaUSxrZnLKjFJZnM0HH9jOl//nDYZGPdcfXxU8eucm3nPnJmwr/KVqci2pSXY+cN82egcnuNjUO+s2d+xYw2984Dacq6TG1OGzbdd/eLPpCZvc9Ny1ex2t3cN8/9mTs+ZQFeak8on37GFdeW7CF5DV5Nxh7opQsCpKVPk5vnCIn7af5WftZ+nzTSClJMPuIslix65a8GkhnLMYMXbVwp35a6lNy+PkcBcvdF/ihe56Xutt5KcpZ/lY1S7uL6qNKpTvhsiIuAOAVVVRZhm4nKr1ut8Z1MNIKVGEwKbMbn5YFBVlKkzvnbgstqiHyOl8rQG/m2c6L9xwO4uiEtLnjoaJBtOYMllWvP4g5xu7593O6nwUW+gMQe8TaKFzqNb1QKROEsJBUsa/ItR8FCUdZ9rf4B39X3hGPjllOOmEgycRigtH8q/PSJNLqRHyP4vUx9DDHZG8KH2CgPtrCCUN1VI2JTjhQrFW4Uj5LfyT/4A2fBHVWo2uD6MFz6Dat2N1Pgo4InlS4csE3F9FUfPQgsfQQteq6Vkd9015oVJRbXsI+l/BO/ZHWGxb0fUB9FATipKMFKm8E0WtIuT7OeHgIRS1DF1rQQs14Uj5DIqlYma7cPA8evgyUh8lFDiGlB5CvqfQw22R32bbhmopN3SthLDjSvtL3CO/hnf8j1E8/xlRDNTH0MONqNb1uNL/YSoc0Dg2q8o9u9dRVZzNz149y6lLnQyPe3DYrKyvzOe992xmS00xNqs5bK02FEVhw5p8/uJzD/P8gUu8daqZnsFxFCGoKsnm4X0buG1rFSlJqyNXzhcIcfbKLOPeKkiyNzExgsth41OP38LWmhKeeuM8DW39eLxBMlKd3LK5kkf211FemIm6kMn/IjHfRH485DckpnMjpJS82d/EVxsOENDD/EHd3ezPX4tdtSBEJM/0Q69/i5HA9YuOADbVQmlyJoWudO4rqqbPN8n3m4/z844L/OXZ5ylLzmRjRkHMogtCiBlvkCcUJDyLEekOB64zjtNtThShEJY6EyEfmfZr81+llHjCAYK6NqWUeG3/jPQ2wx6JFNqTU84fbbqXAuf186lpXAY8hTdi2WYl6SlOkl3L+2JUVYW0FOf8G5rEjVOXOgkE55dGFcKGM/XPsdpuJ+h7KqIah4KiFmB13ItQ0qc3xGLbRXLW9wl4v4MWPA8oWJ3vjtSHUsuuGkA0/JNfJqKYx4y4RNAXEVew2LZhV8tQLUkgrdhcH0RRSwn6nkALXwaRij3ls9icjyOU7CnPkgQ0hJIRUSEMXK+IE/HwbAAs2JzvBqES8j1DKHgEVS3Gnvq7KCINv/vLvDO/S1FzcaT+MUHvD9BCFxFKOs70v8DmeJSr857CgdcI+Z5BTv02RS0iHDpLOHQWIWzY+bWIMSXsKGoFilp4/TlXMlAsVQiR/PZnahEpWd+PFO4NvBWRTRdpWB33Rwr/ziMQMh8Wi8qa0mz+4ON3z/r9QhV3TBIXVVEozEnlk4/t4ZOP7Zl1m9Vy/c82dOEPzFJTbXX8PBMTQzhsFm7dWsGtWytm/T5RnvtpWfKxoJeAFr423F7qXBzrnfHYLISAHubSWB/9/kk+V7OPx8o2oYq3PVqToQCjwetLREwbL9PbWRQFVdioTM7iDzfei02x8K2mo7zV30RdRkHMw810OGGmzUXTxCDjQR8ZNufMcXUpuTTWf52RVZuWT6rVgTsU4MxIN3fmr51pI4HhgJfmiSEkkh1ZJbH3TwiKXOmUJKUz6HczGfJTk5Y3q2fTkKLkHCybMfWhB7fz4G21y3X4CEKQ5Fi4RWoSO0fOt0d9Mwthxep8AKvzgXm2U1Ct63Cl/dU829lIzX0hymMLwIbVcQdWxx1zbmexbSc195Wo9otIwu76AHbXB677Ktm++7rPJCEUtRhX+t/OuVtHyudxpHx+3sOrlnKSs74163ez9UsIAWoGjuTPQPJn5t1/LCTKi9Nk6blZrv3xS53LXjPHxCRRWCnPvdNipSQpg/rxfo4OtpFld5Fqc+ANh7gw2svrvY0EFyFkDCLS6AIYCXrwhkOk2hyEdZ0+3wQ/az/LZChA8js8KhLocI8wEvRS6Eojw+bCpqiEdI0hv5vJUESswqVGHy43G0IIchzJ7Mgp5bWeK7zQXc97y7aQ7XAR0DQaJwZ4pecy4XcYlhl2F4+Xb+Hrlw/yROtpCp1pVKRkYVVURgIeXuhu4MhgG3XpBezIXlhhdrtq4f3lW/na5YP8pO0sdsVCWXImdtVCUNfwhAL0+yYRQrAls2hBx4JlNKZSkuzkZd3Y7Way+vEFQpy7PH+In4mJiclqwR8Icf5KD7puxvSZmCwXPd5xzgx3MR7y49dCHBtsRwKnR7r4VuNRXBYbDtXKlqwiKpKzUIQgw+binsJqLo8P8JWGA5wa7iLT7sIdDnBprI/y5ExaJocX3De7YmFDeiH5zlSe67pESNfIdSTj00I0Tw4R1nW2ZhZNiTS8TSQ8sJnvt5ygMjmbXGcyDtVKUA/T5RnnzEgXtWn53J5fdU27Af8kJ4Y6GA++fS7Cuk79WB/fbDwydS4sbM4soiIlC1UoZNmTeKx0E5fH+vnGlUNcGusj35mKXwtxeXyAipRM6sf7rvttH6naTqdnlJd7LvNnp5+lNj0Pm2Kh3zfJyeFO0qxOfqPmNjLsrgUZ2Rah8GjpJjo8o7zY3cCViQGqUrJxWaz4tTDjQR8d7lHqMgpXtjFlYtLcOcjI+OwxvyYmJiarkbaeEYZG3fNvaGJiEjfqx/r41/o3GfS7CUud4JTgwenhTi6O9mJRFCxC5Xc27Kc8ORMQOFQL7yndhCIET3de4KWeBnSpU5KcwcPFG3ikZCPnR3sXXFhcCMHunDL+aNO9/Kj1FK/2XMGrBcm2J3N7fhXvK99C/Vg//3Txtevabc0q5tRwJxdH+zg40EJAC2NXLRQlpfNo6SYeKdlAeXLWNYZKy8Qw/3LpDYb8nplzEZY6F8f6aJoYmjkX/2v97ZQmZaCqChZF4ZbcCv50ywP8qPUURwZa8WohSpIyeKSkjkdLN3JiqPO635Zpc/F7dXeyKaOQp7su8ovOCwS1MHnOFO4qWMsjpRvZmFGAVVlYjpwQgjxnCr+1fj9bMot5sbuegwMtTAb9uCw28pyp7Mgu5ZESo4Jks2MaUybLgpRwobEXf2BxXOKrHzFVI8uCmVhhYrIykRIaWvtx+wLzb2xiYhI3bs2rZFNm0bxpBslW+4xanRCCTLuLj1Tu4LGyTYR0HZBYhIrLYsWmWPjRnZ8ACSnWt+s6CQS/vWE/n6m+dUa4YT6SrXbuLazm1txKgnoYXcpIYV3VikO1sjY1h7sK1l6zPwGsT8/nr7a9i6AeRpNyJq/LMpXvZVet1+UObc0q5rv7PjbvuUiy2q8xcpwWG7flVbItqziSQ4ZEFSpJFhs2ReWJOz8JIiI8MdNHIch1pPDBym08UlpHUNeQUmJRFBxTv+2d/Xt/+VYeLIoU1p0t7+n+ohr25vw2DtWK/SqVQEUIch3JPFa2iQeKamfOoyIEqlCwqRYc6uKYQaYxZbIsaLrOhaZe/EHTmIoGoWTjSv+n6X8tZ1dMTExiRNd1Glr75y1ObGJiEl+mJ+5GEUJgVy3XFYGdJst+vQiTEIIUq+MaAysaLIpKqm12D81s/RdCoDKttBe9wJtdtZCjJs+/4SyoQpn6bdd/l+WYXZBKCIFVqKTZohOAc1lsN1TcE0JEzoVz9ms5fSzrDc7jYmEaUybLQt/QBL2D44umpLLaibjkTSPKxGQlMzjqprt/7Mb5UuZwaGJiYrLiUJa7AyY3J63dwwyPmflSJiYmNw9d/WP0DU/eeANzvcTExMRkxWEaUyZLjq5L2rqHGZm4vk6CiYmJyWpESkln3xiDI3MYUyarBiHEipH8NjExWRimMWWy5Ex6/LT1jBAMLby4nYmJiclKwOML0to9NHeeqBnmt2oQQqCYtpSJyU2BmTO1xEgpCYY0/IEQwbA2EzuvKAKbRcVus2CzWWZVLJlvv1JGajcFg2FCmoYuJQKBqggsFhW71YLdZkGI5SmSJ6VEl5LeoQlauxdei+FmJKzphMIaobBGOKyh6XLmvAqmX+ACRVGwWBQsqoLVomJRFXOVdAUgpUTT5VXXV0fTJLquI6e+l0TUoRQhZp5lVY1c6+k/zeudOMgpRa3BUTeN7YNzb7zKL9n0eyqkaYTD+tv3uC6RukQS+V6IyD0uhEBRIv9N39eWFTKeKVN9nw8pJZqmEwxpM+dF13V0yYwSm6K8/R63Tr3Ll+s9brK4SCkJazrBUDjyTGjvvP5vv9enx3erRcVqVVGVlecPiaTJR95xwZBGWNPRNB1dj8xjJHLq2eea32yzqlgtiXvfm8ZUDEx6/DS09hPWrq9gn5eVQmVx9qztPL4gbd3DHD3fxqn6Tlq7R5j0+FEUQbLLTnlBFnVrC9hWW8KashzSU5xRGVVSSvpHJrnSNsCRc21cbOqjb2gcty+IRVVIS3ZQnJdObUU+W2uLqSrJIS8rJaqBPlbk1EDg9QeZ9ARwe/1MegMMjbo5Xd9Fe8/InO01XaexfZBkV/SKNNGS7LRTVZqNyzG7OsxC8QVCNHUM4vbOLn+ckepibWkOqhrdQKjpOiPjXgZHJmnrGaGla5iO3hG6B8aZcPvx+kP4gyGEEDjtFpx2GxmpTvKzUsjPSaOsMJPS/AwyUl1kprlIT3HGdTAKhTTON/YQCC2+UqMiBAU5qZQWZC76vpcLXZdMev0MjXoYnfDSNzxBa9cwvUMTDI95GB7z4PYGCIbCBEMaUoLNGll4sdssOO1WMlJd5GalkJuZQl5WMvlZqWSmJZGW4iAt2YnLaTO8QBMLmqbT3DUUt3zItGQH66sK4rLvxUBKkEi8viBub4BJbwC3J8DwmJtzjT00dsxtTOm6pKljkMNnWxe9by6HjaqS7LiMqXMReQ+EGBn3MD7pY2jMQ0ffKN394/QOjTMy7mVswovXHyQYihhXFkXFYlGw262kuuykJjvIyUymIDuV4rwMivPSyUxzkZ2eTFqKA6YmX4mEogqEuPEYr+uSgZFJ+ocnaesZ5krbIJ39o/QMjDPp9eMPhAmHNaxWCy67lcw0F4W5kfG8tjKfwpw08rNTSUt2LPvkUkqJ2xvgQlNvXPZvtajUVOQt+b37TqSU9A1P0jbHYnDdmkKSXbZ5r0kgGKZ3aILBkUlauodp7hyiZ2Cc3sEJPL7AzIK7qkQMiWSXncw0F/lZkfdfVUkWRXnp5GQkk5nmwqLGV61uoUgpmXD76R+ZZGjUQ3PnEK3dQ/QPRZ4BtzeALxgiFNawqAp2q4Ukl52cjGTyslIoL8pkTWkOeZmR91x6ijPqOdRSIOZRUzMcdPDioXr+4TuvMTbpm3O7P/jE3Tx+zxaju08Izjf28rv/76dMevzXfXfPnmr+6jffdc1nUkoGRtw89fp5XjhYT9fA3Cp2mWkubt1SySP7N1K3Jh9ljtWHQDDMiUsdPPXaeY6eb8cXCM3Zd6fdyo4NpTx423r2bC5fNINi2nAaHHUzOOJmcNTNwIh75mXRPzzJwPAkE7Ocs6WmtiKP//MbD1JRlBWX/Xf2jvLnX3mOi82zv1h21pXyd7/z6LznXkro6h/l6Pl2Ttd30tDaT9/QJJp+vRE/HykuO0V56VQWZ1Fdnkd1eS5rSnPi8nIaGffyyf/zPfqGJhZ93zaryoce2MZnP7Rv0fe9lEgZWZlrbB/kYksfTe0DNHYM0tk3itu7cNlsq0UlNzOF4rw0SvIzKMlPp7I4h7Wl2aTF0Zj2+IL8zTde5JWjl+Oy/511pfzrH78/LvuOBSklvkBoZtwbmhr3+mfGvQkGht2Mu+d+Hy4FVSXZ/Omv3U9tVf6SHG96Uam5c4iWriFauobp6htlYMSNvkAVV5fDRnFeOmvLcqgpz2NTdRGVRVlYrfGfUA6Pefirr78wp8ErBLz37s38wSfuue47Tddp7Rrm5KVOTlzsoKG1n6ExjyFlW0URlORlsGldIVtri9lZV0Z2etKyGVVSSi429fGpP/9+XPafmebii7/3nmVfSAlrOj975Sxf+varN9zmS3/wGLdsrrjhtXB7A1xq7uVUfRen67to7R5iwmO87pwQUJCdRnVFLpvXFbGzrpSKoqw554vLgabpdA+McaahmwtNPVxq7qOjbzSmNA9FERTlplFbmU/dmojjobwoC8vSGVU3fMBMz9Qi09o1jKbpMxazlJLhMQ//9oM3OXCqBa9//onSyLiXZ966SH1rH5//yH521pXO+mD6AyGeO3CJ7z97kq7+UaIZi32BEAdONXOlfYDeoW08eufGmCfUHl+QC409NHcO0dE3ysDIJBNuP+NuPxNuH5OewIJfmquRoVHPjaWRpxib9PHcgUu8cbyJxo6BBdelmfQGaGjtp6G1n1eOXqG2Io/Pfmgfm9YVLmi/JsYJhTWOX2jnlSNXuNw+QPfAGD7/3IsgsRyje2CM7oExjp5vx26zkJuZQmFOKjUV+ezfuYbayqWZVK82vP4gl5r7aOoYpKN3lP6RScbdPibc/sh/Hv+8z/dqRdclPYPjHD7Tyqn6Tjr6Rukbmlj0ulpef5Ar7QNcaR/glaNXKC/MZGttMe++YyNlhZlxjbqIBkUIrJbrDbuxSS8vHGzg5SMNNHYMxly0Xtcl7b0jdPSO8NapZtZX5fOufXXs37km4SbTNxuN7YPcsrnius91Xae5c4ifvHyWExc76B0cR1vAOCEl9AyO0zM4ztFzbbxwqJ7bt1Xx+L1bSEuOrn5TvBkac/P0Gxc4dKaV1u5hJmMwGq9G1yMiPp19Yxw41UxZQSY7NpTy+L1byM9OXaRex4ZpTC0yEx4/AyOTFOSkAaDpki9951XeOtk8a1jgjYiEewzxt//5En/1+XdRW5E3Y1BNx1i/fqKJ//jpYcMhNRLoH57k2784SmqygwdurY0pBr2jd4SvPnGA9p4RAsHwggaGm4nhMc+sRub0ymRH3yhff+Igh8+2RWV8GyUQDDPu9pOdPntBPZPFZ/raNncO8Z2njnHyYiejk94lm3QHgmE6+0bp7Bvl3JUeivPTTGMqRnoGxvnPnx7mctsAgVAYzcC4vhqZzoNq6xnmpy+f5dj5dobHPXh9wSXR0/AHQjS09tPSNcSRs2188rE93LlzLZZZjJmlQlEUbLa3p1dSSvqHJvnX/3mDI+faFs24lEQW3g6fbeViUy9nL3fx6fffissxf5iZSXxo6hi45t/TKQ+vHLvCV394kIGRSULhxRXf8vpD1Lf009o9wun6Lj73oX1UV+QuW268lHDwTAvf+PEhOvtG542YigWvP0R9az/NXUMcONPCRx/ZyX17a1CV5cmnNI2pRSYYCtPeO0pBThqarvOdp47x5ommmA2N3sFxvvz9N/mbzz9Ceurbqw1X2gf42hMHFpSbMOH2840fH6KmPI81pbPnec1FWNOZcAfwLvKq+mpnwuPHHwiR4rJf89BLCQ1t/fzdf77ElfaBqDyNsSCEoLwok4Kc5V3JuVmYzid46fBlvvnkEYbG3HG7ttGgqgq3ba1avg6scDRNZ8Ljj8tCx0qkvWeEb//iGK8cu0IopC1bIfZgSKO1e5j/31efo61nhI8+shOHzbosfZkWlALQpaS5c4g//7dnaekeisuzLyWMu/38+KUztPaM8Acfv5ui3PRl99DdjFxpG5wRDgEIBEN8/9kTfPPJI4TC8V148QdCHL/YwV9+/Xl++5f3s622ZEnziqSUjE54+d4zJ3jy1XOL7pGejWBIo7VrmC9961Wa2gf5pYd3kpnmWnKDyvQHLzKhsEZn7ygAF5t6+cmLZxbmygUut/Xz9JsXZlZAJz1+vvKjg/QOLjwnZWBkku89c5xwnB9yk2sZeEetGV3XOXO5iz/916e53BY/QwrAalHYvbHcXLlcAqZrC/3zf7/Bl77zKoOjy2tIAdy9ax3pKYkRBmKy8mnuGuaNE40Eg+FlM6SuJhzW+daTR/jWz4/i8S0srChWFEVgt1nQdZ2Gln7+9F+fprkrPobU1Wi65MTFDr70nVdp7hxEjyG/1mRh9A1PzIhPTXr8fOcXx/jOL47F3ZC6mubOIb78P29yvrFnye4BXUZCT7/8P2/ywxdOLYkhdTUeX5AfPn+Kf/3+G3T2jS75WGQaU4tMMKTR0TfCpDfAz145x9giJB57fEEOn22lZ3AcgOcO1HPiYvuC9zvNa8cbaTGlypeU/uG3jSkpJScudfJ3//kSPQPjcT+23Wph54bSuO3foiqU5KWTn51KeooTh92ScEpbS4GuS85d6eHvv/nyNYshy4ndZuHBfevjtn9FCHIzkynMTSMzzYXLYTVXx1c5t2wuZ01pznJ34xo0XfKTl87y/MH6ZalnqCoKdpuFxvZB/um/X6Ojd2712sVE1yXHzrXznz87TO/gxJJNKh02C6UFGeRmJpOaZJ81Z+xmQNMlLV3D+Pwhnn3rEj995ezcteXixOW2Af7jp4fpH5mM+z0gpaS9e4Qvf/9NnjtwadkW5zVd8sKhBv79h2/R2Te6pMc2w/wWmbCm0zM4wen6Ts5e6b5mAuWwW6kszqI4Lx2bVWVg2E1TxyAjE95599vYPsil5j4URfCjF07PusJVmJNGZUkW6SlO/IFIjsSVtoF549YDwTDPvnWR6vJcQ79VVRVSk+24vQ5D7cKaHlU8vcthjcuAnOyyL3t9hoGrjKmLTb18/YmDdBh8+O02CzaripTgD4aiHsDWlObENcTP5bTxuQ/fjtsbJBAMEwiFCQTDeH1BJn0BPN4A7pn/gjN/j4iX+AzlFiYqUkpOXurka08c4FJz36Ls02pVsVlUVFUhGAzH9ILetK6QqhuUblgMbDaVx+7exG3bqgiEwgSDU9feH8TtC+KZlgv3Bmb+Pv3n6IR3RRTyVlWFlCQ7acnGxj1Nl3h8gXm9E067FVscVOlSXPa4hPw4HTY++MA2zl3pMd7WbiUvK4XM9CTSkh047ZExPxTWIvLyviA9A+P0j0waXoyY9Pj5+WvnqS7LpW7t0grtKIpg0hPghy+cor6lf85rrghBZpqLgpw0stKTcDmsWCwqmqbj9gYYHHXT3jNiaKVfl5IDp1pIctj5g0/cjcMe/3DHwrw0vvBr900981pk3A+EcPveHuPdvqvH/sh/YxM+Jm9QRmQlIqXkcvsAobDOj186Pa+yNUCS00ZhThq5mSmkJNmxWVXCWmS8cPsCdPaOXRfNEg0nL3XyvadP8LsfuyuuC5qdfWP843df5diFDkPtrBaV3KwU8rNSyEh14bBbURVBWNPx+IKMjHvoHhhnZNwTtVdXSsnrx5vQNMkf/eq9ZC1RbrhpTMWBpvZBvvOLY/RPSUMrQlC3toCPPbKLqpJsHHYrihAEQ2G6B8b5zi+OcfR825zhgBMeP/UtfdS39F33UOVkJPPRR3axZ1M5LqcVq6qi6xHJ3pP1Hfz7Dw4wOo/BdvB0C7/xgdsMDbqVxVn85f96l+FkyguNPfzL99+YU9nFabfyqffewt4t16viLBS71UJ2RvKi79cI/SNuAPqGJvif505S3zr3CzfFZWfj2kI2rCmgoiiLvOwUHLapVX8JmtTxB0J094/T3DVEY/sAFxp7Z31J3batMq6KTxZVoabiWnGD6WK02lSBvrA+9efUv6frE339iYM0dQ7FrW9LgZzKkfjmk4e51NIXk6JlRpqLDZX51FTkU16UQU5GykztEiEEuh4p9Djp8dMzOE5b9zAtXcM0tg8yPH7jPMq791TjdFjjFuKpKgqlBZnX1AGbLir9zut99T0wPunjv548yoFTzXHp12JSkp/B//eZBwwbfs2dQ3zxWy8zNnnj8hBWi8LHH93Nvh1rFtrN67BZVbLT4zPu7d5UTk1FLg2tA3NuZ7WobFxbwMa1RdRW5VOUk4bTYcVmidSVUhQFRYAuI7lpmq7jD4YZGnFzqr6Tp16/QL+BSWVL5xBvnGyiojibJGd86grOhs8f5Kk3LjDh9t/w/Zie4uTu3eu4ZUslRXlpOGwRI1pRlMjEVzJTzNXtDXDmcjfPvXWJy239UaUOhDWdl440sL4qn/feszmuYd1CCFwOG1uqi2c+m/aGzDzz+tvP/9V/vnGiia89cXDRRRmWC12XvHDgEhaLSlf/2A23UxXBzroy7tq1juqKXFJcDmzWqYLUikBe9Qz4/CG6B8Z582QTrx27wrg7uhIzUkqeO3CJ+/bWsKm6aJF+4bX7n3D7+bcfvMmJS51RtysvyuLePdVsqy0mOyMZu82CVVVRlMj7LTJfiBSy9gVCdPaO8tapZl473njD+p3v5PDZVr76owP83q/ctSSLCaYxFQf6RyYZGJlEEqkFsHdLBf/fZx4gNclxXchLdkYyf/Lp+/iLr77AsQttc06onz1wiUAwPDPoCGBtWS5/8Im7qa3MR526EadJl5IHM9eT5LDzd//10pwP4Nikj4bWfrbUFN9wm3fisFkpzkuPevtphkbd83qGhBDkZCbHrRbUctM/PIE/GOaFg/W8cbJp1lVXu9VCeVEm77tvC7dsriQlyT412RDXVQGffnGtr8znbrkOXZcEgmHOXu7mjRPNHLvQxuiEF02T3L5t6cUHhBBYVDFnPQiPP3iNAtZKRErJyLiXbz55hNMNXVGvpilC4LBb2FpTzKN3bmJTddFUiNzs13v6WABbZTFyqnp8MKTR3DnE4bOtHDnXRmffKIFgmLCmU16UyYbK/CX3ygohUIWYKj45+zbJTvuSTnYXgt1moSg33XA7nz8Y1biXnbHyxj2X3cr779vKX339xWtCiqwWlSSnLTIu7almz6YyUqbeg4pQZr2vZ6MkL51N1UV88IFt/OL183zvmROMTnjnfb7Cms6hM63cd0sta0qylyxPNBTWZ62zJwSkJjl49/6NfOjB7aQmO1BVBcHc50FKSWVxNg/eWsuLRy7z7SePzswx5iIY0vjGTw6xuaaINSVLG4o5/XusFnXOCJOs9KRVFwZe39oPcvZCrTaryq66Mj752B6qSnOwqNNj/NzXv6Qgg511pbzv3i1888kjvHWqOaoFHa8vyHefOs7fri1Y9LE/GNL43jMnOHqubV5lWlVVKMlP5xOP7uGOHWuwWNTr5qyzIaWkrCCTvVsq+NR79/IfPzvMy4cvz6sQGNZ03jzZRG1lHu+5a1PcSwas7JlLAjN9W1UWZ/Mnn77/hgnfQgiy0pP57Idu48rfDczpQZp4hzGUn5PKp993C3VrCma9IYUQWCwq2zeUcOeudfzi9fM3vOFDYY2GNmPGlEns9A5OcKahix++cOq68DybVaWqJJv33rOF+/bWYLPOn3M0ff2FEJFESBVsVgu3bavi1q2VDI97OHCqhcb2AfKyTBW/eKFpOs8frOfVY41RG1LpKU62rS/hww9uv+GzPBvT26lCzGS/2qwWNlcXsbm6iE+//1Ya2wd4/XgTJy91sK22hLzsVFN4xGTRURSFHRtKqa7IpbF9kIwUJ4W5aezbtoY7dq6hOC99Qffd9GJMSpKDDz6wnaqSHL76owNcaR+YdxLX3DnE5dZ+KoqysKjLd+8riqC6LJdfffwW9mwsMyTdLoRAVQXJSQ7ee/dm6tYU8MVvvcqFpp55f/+Ex893fn6MP/61+3AuwQq9CbOO/UJAflYqH7h/K4/sN1bfUwiBABSLyprSHP78sw/yHz85wk9fOTNv7SYJ1Lf1cam5j42LGO6q6TpHzrby4qH6eUPOk1127t1Tzcffs4fczGRDY4GYWkxUFJW87FT+8BP3sKuujP/46WE6eucWmhh3+3n6zYtsWFPAurL4SsWbxlQcsVlVfvWxvVEpZ60ry+Xu3ev48Utnot73vu1r2L5h9oK+V5OW7GT7+hLeOtl8wxCgcFijpdMUoVgqOnpH+PcfvsXI+LXGs9Nh5b69NXzg/q1UFGejLMLDL4QgOz2Z99y1KSHUtlYzF5v7+O5Tx6I6z4oQVBZn8b77tnL37nWkJBnLwYlm/9Xleawry2XSsx1N10mJsUC3icl8pKe4eP99W7nQ2MPujeXs2FBKknPx6x1ZVIXdG8uQUvKP332Njt75c02PX2jnzl3rsCyT91MQecf/5kfuYEtt8YLH9bWlOfzJp+/jH77zGsfOzx3RouuS0w1dHL/Qzr7tix8+ahIdhblpfOZ9t3LnrnULzgW3Wix86vG9WK0K333qOIF5jJlJT4AjZ9sMLdbNhZSSoRE3T795gb7hucNuk112PvTANt537xbSU10LPrbVorJ/51rsNgtf+eFbtHbPLe5ypX2AN040UZKfgcsRv+ffVPOLIzUVeWyqLiLaW/ehfeuxWqK7JBmpLu7ZUx31SlNVcTY5mTeOl9d0Sd/wxKqJW050vP4Qje2D13xmURV+6aEdfPp9t1JVkrMohtQ7EfOEE5jEjj8Q4r+ePBJVwjFExoff+dhdPLxvw6IbUlcjhCA12UFG6tLX3jC5ebBZVe7etY7f/PAd3LFjLcnvqKO3mAgh2FlXyvvv2xrVxPTclR6CoaVXVJsmJcnBr3/gNrYugiEFkd9fkpfBrz62h3Vl8wtHjYx7eOtkc9T5JiaLS4rLzuc+tI+791QvmqiWRVV49M6N3La1ct5tA8Ewl9sHFu36a5rOobOt8wpOqIrg0Ts38oH7ty2KITWN1aKyZ1M5H3pgO6nzvDvDYZ2XDjfQ3T8W18XkZfNMffepYzz9xoXlOjwff3Q3t22rimv+wPb1pSQbWJkrycugpCBjXg+RACqLsqipyIu6LwW5afN6yDzeAJOeAJlpi3fTm0TPBx/Yxocf2k6S0/QeGGHU4+NfXjxI79gkv/vAbawrmD03QErJ0KSH585d4VRbN0OTXlIcNkqy0rmztpKtZYULKvL5xskmzkepaFacl8EXPn0flUXZpnS4yapACLEkid7TWFSVh27fwM9fO09Tx+Cc2/aPTDIy7iU9xbksCwrvu28LO6OIIjGCoghqK/N5eF8d3QMHcHtvrPan6ZILTb00dw6xOQ5CBCZz89FHdnL7Is83hRBkpSVzz55qzjR0MTw+t8jYwMgkPQPjVFcsbOFOSonXH+THL5+Z1yO2aV0RH3v3LlINKp9Gg81q4d5bajh2oYNXj12e0zvb1T/GobNtlBdlxU2yf9mMqb6hSfqGjEs9LhajE77ZswMXCYuqUF2eiz3KhHohBFaLSm1F/rzGlKIq7NpUbuimcNgs5GQmoyrihkpAgZDGhMdnGlPLwK1bK/nYI7vi6oZejUgpGXZ7eO7sZTyBEPdvXEdlbtZ1QhdSSs519vF/fvwSPWMTpDkd5KQm0TY8xqn2HgYm3JRmZ1AUozHl84d4+o0LeP3zyxenJjn4wqfvpap46RLiTUxWIy6Hjffdu4W//c+X5txO1yVtPcNUFi+9sEduZjLvu3drXBZNLKrKHTvWcOB0M8fOz117sr13hPrWPjasycei3pw1oJaDbbUlPLyvbk7xpViZNqirK/I4dKZ1zm3HJ330j0xSbWAR/ka8crSRlnlUd21Wld/88L55PUcLweWw8cuP7OTA6eY5DTsp4dk3L/D4PZtXnzG12snJSDYcVqOqClUl89eAURXBFoOrS9N5MxZVRdNnv+mCofC8yYwmi09eVgofeySyemNOro2hS8nhpg4cNisZSS4ONbZzT90aUtRrvXttQ6P8zveeRhGC37r/Vh7dvp5kuw0pI995g0EK01Ni7seZhi46o8jdsFpUPvLwDtZX5pvX2sRkgQgBuzaWYVGVeevT9Q5er663FLxrX13cQh6FiBhrt2yp4GJT75y1qKaLiN+zpzpuEvkm1+KwWXjsrk1x9YjmZaVQU5HHiYsdc6r7Tbj9DI3euGxGtITCOk++enZegaX7b6mlqjQn7u+5mvJcttYUc+Rc25zbtfeOUt/Sx45F9hBPY+ZMxYms9CRDai0QWWXIiaL+kcNmjUk6Ny3FgTqHmpGm6fO6bU0WF1VVuGvXOiqLs8zJdQxouuSVi83UFuZyR00FZzt6GfP6r4mNDmsaX3nlKJO+AB+9dSsf2rOZFEdkcqMogsrcTOqKYzdugiGNU/Wd84ZZAKyvymf/zjULCic0MTF5m4wUF6UFGfNuNzJH/bV4keyysbOuLOpc6FgQQnDb1qqoipNebOpldNxrChEtERvWFFBdkReXYtnTCCEoK8icd77pD4aY8PjnVX+cj4tNvbR0zR095XJYFzU/bD7uu6Umqu3eONEUtz6YxlScSE9x4jKoHKQIQVZa0rwJqoW5aVGHD15NktM+p9Z+WNPnlbg0WVzyslLYtbHMsOFtEqF7dJzGviE2FOWxq7IEXUpOt3Vfs03XyAQnW7spzkzl0e3rFz3cYmjUTWPH4LziLU67ldu2VlKYk7aoxzcxuZlRFEFx/vzGlNc/d12aeLCmNIfcLGNS0LFQmJPGhsr8eUtoDIxM0tk3t5y0yeKgqgqb1hWRlxV7xEO0FOenz5trLSW4vQGCCxQZe/low6x1Ma+mpiKP0oKMJcsH3lxdFJUY29Hz7Qs2Jm+EaUzFiZQkh+GaDkKISCVo69zWfCyFciHicp5rsNV1SdhU81tSpoVETK9UbLx2qQWrqrKjopgNxbnkpibzwvnGa9IhG/uH8IVCbCwpIN01f5kCo/QMjkclz1yYm8a29SXYrGZ0tYnJYiEEpEWRl7EcURdrSnLimjMyjaIIdm8un1fgQMpI+Yb5QiJNFk5mqot1ZTkxLXwbJSstCUcUx/H5gwua43l8Ac5f6UGfxxhfX1UQVUmgxUAIQWqSI6p58dCYm77h+IT7msZUnEhy2WJ6iBRFYJ0nObQgJ7aiq5Hir3NX2dZ0c5BdKuw2C2vLcpds0Flt6FLy4vlGMpOdbC7NJyc1mZqCHE62djPqeVuefNTjQ9d1CtIXv1ixput0D4zPO0ALAeWFmawtnV1p0MTEJDamJ1PzoS/xu00IIrVtlqi21fbakqg8AZdaTGNqKcjJTKY8hnSMWHA6rFFFXIQ0fUFzvCvtg4zOU/rDbrNQXpi5pAWiVVWJKtRX0/TrStIsFqYxFSdcdhu2GOJFFSGwWOe+LJlp88dGz7pvRcxZ80pC3FygJteT7LKzvsoUIoiVhp4BOkfGqMrNomd0gtaBEYoz05BS8srFt2Ojp89vPE6zPxCmo3dk3ufGabexeV3RksWQm6xQzOE3JtRocpKW+NymuBxkpc8ftr9YZGckRxVS1t49gqbpZqhfnMlMc5GfvfgLeLPhtFujysvSNB25gDleY/sA3jlETiDyu7Mz4h/aejWKIsjOmH9erOuSrv6xuPRh2eJNyosyyctamhttNnKzUuIyuYKIQWS3W2JKOhRCYJnHVZ8Wo2b/vL9XYr7MlxCn3UpZQeZyd2PF8tblNvyhMIca2znU+LYscFDTePVSC+/dEZGjTXc5UBSFvrHFL8XgD4To7Js/xM/psFJTaYZzmpjcLKQmO5a8rtXashw6+8bm3GZ0wsu422fm6cYRi6pQkJ26ZN4Zq8UyZz78NLqUMU/xpIwYIvOFy6YnO5c82kYRgtTk+Y8ppWRgJD4lmZbNmHrXvjoe3rdhuQ6PyxF9MV2jWFQFexzzIpLMQXBVkOS0LUly6mrE7Q9wsq2bvLQUfuOu3Vztcn3+3BXqewZoHxqlKi+Lqtws7BaV8119eAJBkuyLF3bjD4ToHhifdzuXw0pl8fxlD0xMTFYHyU47SUsU4jdNNItzEujsG6MoNz3u/blZsVlVCrKXTmhICOaMOloMfIEQAyPueUNEk1x2UpZ4jiqEiGrOrUsYHouPqueyGVNOh5WM1NVZHFZRlbiG87iWMBbVJD4IICPNtSTJqauRy31DdI2Ms7+mkndtrblmYSTJZuWPn+jiSHMHVXlZlGSmUVuYy4nWbp49e5n37axbtIWUYFhjaNQ973b5WalLPrEyWYHchI5LXZdMePyMTngZm/Th8Qbw+UN4AyECwRDBkDb1X5hAKEwwFCYYnPosrBEIhmnrnruA6HLgdFrnVVhbbApzo5vAx2t13iSCRVXJyVxdtbzGJ31MevzzbtfYPsBffO35uDoU3okuJQPDUdzTUsZN1dOcycUBVRFxqXY9jZl3sfIRUzL4JrFxvqOPoUkvd22ouu673VUlKEJwvKWb9+/aiM1i4bP37OWT33iCr792DF1KHtpUjdNmRSIZ8/jwBkOUZKYbknKVUhIIhpmY5wUjBJQUZJghfiY3JdO5ObqUMzkLl5p7aWwfpK17hM7+UXyBELou0XSJnNpOSolEImVkH5HdXPVvrv488XDYLEu+WBZtMd6Rsflr4pnEjqoqS6LiuJS4fUF8URgi424/Zy93z7vdciCBQNA0plYMihBxLdIWTWysSYIjIt5ZE+OM+/y09XjISnZRlXu9WpLDZmV3VSkdw2M09Q+zviiPDUW5/O0HHuTvn3mDLz7zJv/+8qw6uw4AAFosSURBVBEyk5x4gyHGvX4e31nHb91/KzYl+oUKKWF43DPvZE4QXTFuE5PVlLOq6xKvP8jYpI+Glj4Onm3l+Pl2hsc9IFfVT50Vq8WCbZ4yJ4tNWhR5IwDDE0tfwPhmQlUEKUmrKx3D4wvgCyx9rbbFJhiKT/kf05iKByI+ymHTqEtUCM0kvsSi9mgCnkCI/PxUags34rRZr/P4CCF4ZGsNr15qxh8Kz3y2f30llXmZvHqxmeaB4Zn8qaKMNG6vLjfsTZZIJt3zhz0gIgpHJibzsgqGdk3TGRh109g+wMHTrRw930bfUHxquyQyVkt8w/1nI1pRifkU2UwWhlAEdtvqWiz1+UPLUqttsYnXIo5pTMUBgTBDekzmRGB6GGOlMD2Fzz54+w2/V4Tg7g1ruHvDmus+L8/O4JN37FicjkgIRLnKtdS5EyYmS42UkrFJHwdOt/DWySZOXurEcxNP2hVFGAobXgyi9YSFFlC41WR+BPFN9VgOwpqOZtYnuyGmMRUPlkBZxcTEZPkJRrFSJzC9kCarGyklje2DfOvnRznd0MnoxNyFPW8GFKEsWY2paSzR1NsifqFOJhGEWH2LpdoCC/6udkxjysTExCQGJBDWo5uUxDOH0sRkOZFScvBMK//w7VfoH55EW4TC72Lm/67/RhFgt1lx2q04HBYcNitDox7G3QlmwMU53H9Wojz1ZsHe+LPaFtQ1XUc375sbYhpTJiYmJjEgAKsanccpHDZX9EyiYIXNVUJhjVePXubvv/mK4ZA+RRHYrBbsVhWb1UJ2ehIl+RkU5KSSnZFMVloSyUl2kl12khw2HA4rLrsVh82KmAqfE0S8LH//zZd57sClOPzC2NH1iCrhUhLSolvcsS2hbLXJ6kBRovO0Wi3qkhUrjoV4lSgxnygTExOTGIlmUiKBQGjlqyCZLAEraDk7HNY4eLqFf//hAUOGVEqSncKcNEoLM9lQlU9tRT7lRZlRK9G9E1XXEzJHeVrqfSkJRRm+t9QqgyYrH4uqRBVhsXNDKR9+aDuJOpglu0xjysTExCRxEOCwRzeETngCce6MicnSIaWkpXuY7z97gv5oimUSMaJ2rC9l96YyNlcXU5yXvqprJoY1bck90m5vdEZtInsOTBITq0WNSlQjPdXJ1ppiLKv42Z4N05gyMTExiQEhBKlRrKZLCSPjZl0XkyhYIWF+Hl+Qlw41UN/SF9X2VSXZfPCBbezdVE52RnJCepIWm2BIIxBaWinp+QqIT5OeapZqMDGG026Nqgj19H1vGlMmJiYmJvMigIxUF6qizKNyJOkbim713sQk0ZFS0j88yfMH6wlF4XlZW5bDb//yfjatK8KiKjeFIQUQCIaXvC7P0Kg7qu2y0pLi3BOT1UaSyxaVR9PrD+L1hW66ciCmxJSJiYlJDAghsFtV0pIdc24nJbT3jJgKWibzswLsDE3Tef1EI4NRTNyz05P4jQ/cxtbaEqwWNS6GlJSR/K1Ew+sLLnlx3N7B6IojZ6ebxpSJMVJcDlxRiDe4vQHc3psvrN00pkxMTExixGa1kJOZPO92I+MeRsa9S9AjkxXNCrC3Q2GdN080zbudEIIHblvPLVsq415vyR9MPIEXty/A5BJPKjv7R6PariQ/Pb4dMVl1pKc4ohKJGZv0MTpx873rTGPKxMTEJEYcdisl+RnzbucLhGho61+CHpmsaFaAZ2p4zENz59C826WnOHn/fVvi3h8pZUJO3ibc/iWvfdXUMTjvNilJdrIy5l8AMjG5GrvNSlFu2rxKkCPjXgbH3DddJIZpTJmYmJjEiNMRpTHlD3GhsWcJemRiEl8aOwcJa/PnSm1fX0JuZkrc+6Ppku6B6MLblhK3N8DQqBstinO1GIxMeOkdmv88lORn3FS5ayaLR3lh5rx5Ux5fgI6e0SXPF1xuTGPKxMTEJEbsNgtlhZnzqhwFQmHqW/oTcgXdJIFYAYu5nb0jUW23paY4zj2J0D88kZDPlS4lnX2jeP1Lkzd1obE3qjpTNRV5qIo59TMxTnVF/rx5U1JCQ2sf4+7olCVXC+YTZZKw3GReYpMViCIERblpFOWmzbttR+8I9S19N134g4kxEv3+GJuMbpJUVjC/x3YxOHmpM2HPWVPHEBNuf9zfZVJKjl9oR4+iSHDdmoKo6gWZmLyT8sJMSvLmf67PXO6mf2giYZ/LeGA+USZLjhBi3pUxicSXgEnFJibvpCAnlbKCzHm36x2a4Oi5drx+876+GRFCoM4ziZVE8usSmWjFHpKiUP5aKKGwxqvHrsT9OLHS1DHIwIibeLscxyZ9nLzUiT7P5DUlyU5lcTaKYob4mRhHUQS3b6+adxzz+IK8cuwKwZB20yyKm8aUyZKjKgoWy9y3nq5L3J6bT17TZOWRmeqitjJ/3lhyKeHQmRbqW/qiWkE2WV0oipi3kKWUkskoC68uF9GGiEVTg2qhXGzqpaElcYVdPP4gh8+1EoqzdPvR821RFQbfUFVARqrTzJcyiZk7tq8hM4qizy8crKe1e4QVEbu8CJjGlMmSY7WqOOaZeGqaTu/g+BL1yMQkdhRFYVddaVTJ9p39Y/z05bNMeHw3VQiECVhUFZdjbm+Nrku6+seWpkMxEm0xznjnMXl8QX780pmET3R/6XADIxPeuD3v45M+DpxqmVeGXQjYVF1Eesr8E2ETkxuRk5nMXbvXzbvd2KSP//zpIfwJ/nwuFqYxZbLkOO1WUlxzv5DDmk577wi+JUreNTFZCFWlOdStLUCNInzmwOlmvv/syZsm/MEkgt1mmbfAsy4lbd0jeJa42KsRcjOjK/gajXx6rEgpef14Iycvdcwb2rbc/P/be+/4OK7rbv+Ztn0Xi94bQYK992ZSvctqtmXJsi0rjmvsFDtx4vjNL4ljpziJ89p5U9ybJMuyiimTKlQhxd5JECRAdIDobRfbZ6f8/lgQJAiAFSwS5/l8IIiLmbkzszP33nPPOd/T2TvEi5sPX5Fjm6bJ/mNtHKo9eV5vd16mj1nlueeVtrawOB8P3jwPv/f8Nad2VzXz9O/33hCRGJYxZXHV8bhsZKadf0Du6hvieFO3tYJvcd2jyBIfuWMR7vMsEgCoSZ1nN+3nmU370DTder5vEJwOhewLqO/TFwhTdaL9un0uSi4gPxBICSJcgWswTZPqhi6ef+Mgg0NXt47TpfL8G4eoqu+c1O/UNE06e4f4/bvV9A2eP8RvRnku08tzrRA/i8umICeNh2+df96yeGpS5/k3DrNhSxWablz1Ps00U++JYZhXvG3LmLK46vjcTnKzfOfdrrN3iO0HG6/7MA4LC4BppdncvWYWFzJXUZM6P/jtDn780i4GgtGrsnJnmibRuMpQJH7dTtTfz3icdgpy/OedgPQHo7y9t+66FaKYWpKFw37uUgAAR+s7qa7vnNS2DcOkrrWXH/52B8ev41yps4nEVL7z0800nuzHMC4/lyyVW5fgpbePsONQ43m393kcrJhXdkHeBAuLcyEIAooscfuqmVSW5Zx3+8GhKD/87U5+93YV4Wjiqow9pmmS1HT6AuERz616AWUDLgfLmLK46jjsCqX56edVe9J0g3f21bHz8JVP4LWwuFwEQeCxe5YwvSz3graPJzSe3rif7/7yHfZWtxCNq5M+0JimSULVaDzZz5Z99fz05d1seKdqUtuwuDBsikxJfjoe97lD/XTdYNeRZt7ZW4eavP4Wkpx2G3OnFpx3O003+Nnv9tAzEJqUdpOazv5jrfzHL99h15HmSTnm1aShtZ//+6t3OFrfednj2eBQlOdeO8Czm84fLiwIMKMslzWLKyyvlMWkIAgCBTlpPHL7QtIvQIyidzDMfz+3jZ+8tIuapu4rVsg6qel09Q2x/1gbz79xkG/94HX+4t9fZtuBBjT9ys4hz7+8dIWIxFT6AuFr1fwITrvtqki4WpxGEGB6WQ45GV6a2vvPuW17d5Afv7SLRFLj1hUzrPoYFtc1WX4Pf/jIKr79wzfoHTx//xZPJNm8q4aapi4Wzyxhxfwy5k4rICPNdckTH1036A9GaOkYoKm9n6b2fhpP9tPc3k8wHOeuNbMu6bgWl4cgwJTCTIpy0zjeeG7Fvu7+EL/YsAdNN7hz9SwUWbxuJsKyJLJ+6TT2Vreed9t91a387OXdPHHfMvIuIBphPEwzJcqxeVcNG989TlvX4CUd51qjGwb7qlsJhuPcu242tyyfjt97ccp6mm5wrKGTl948wubdtRe02u502Hjk9gUXFFpvYXGhKLLE2kUV1DZ3s+HtoyTOs/AzFInz7KYDHDh+klXzy1k2t5TKspzzivKcj1A0TltngKb2Phra+mnuSI15XX1DVzUv+ZoZUy9sPsTb17g+hCSK3LF6Jh+6feE1PY8bkakl2Uwtyaalc+C8IU51Lb18/+mt7Dvaxr3rZw8XHby4JNpwJEHPYIjegTA+j4OK4mwrEddi0hFFgUUzi/no3Yv58Qs7CV+AkIBpQltXgJPdQbYfaiQvy8vUkmxmTsljanE2eVle/F4n4hmS1KaZEiuIJ5IEQlE6e4fo6AnS3hOgtXOQzr4hhsJxguE40VjiBhGnvf4pLchgelkuJ1p6z7s629Q+wH8/t439x9q4f/1c5lUWoJxHWv1sIlF1pN9zOhQqS3Ow2y5v2BdFgYUziyjJT6e189yGTULV2PjuMXoGwnzkjkUsmFl0wQtihmHS3hNg865ath9spKGtb9zQR0FI5XAMBKLXbWjkKXTDpKapm87eIG/srGX9kqmsWjCFolz/OWv36LrBiZYeXttRw64jzbR1DqJfYLjg/evnsHxe2SRdgYXFafxeJ4/fs5SO3iF2Hmo6b2SFYaae/8aTfby+s4aiXD+zp+YxvSyXssJMsv1uHHbbmFB5wzCJJZIEwzF6BkJ094c42RWguaOf7v4QwVCcYDhGKJq4Yl6v83HNjKmuvhBdfZPj/r9UZElk4cyia3oONyp2m8Kda2ayp6qZYPj8dVX6AhE2bavmnX115GR4mDO1gKIcPz6vA4dNQTN01KRONKYSjiQIhmMMDkXpC0ToD0aIxZPohoFhmNy3fg5PPei3jKlJwjRN9DMSPFO/Up9FYgnC0VM/KqFI/Ix/Jwid+v9Igr5AhNbzrDonkzobtx2juqELj8s+/o/Tjsdlw+NyDP+243Kc6qCFkY5aFAREUZj0FX+7Tea+dXPoGQjzwuZDFxyrbZomvYNhegfDHGvsZtO2Y8iShCQK2BQZl0PBbpMxTIjGVOKJJMZwcq1uGOi6gW6YVz3RV9eNEaGBU9+9YZrE4klC0QSRU991JEEoliAciROOqoSjp34nCIRitHQOnLetYw1dfPbvn8U7/N26nXY87rO/ezve4X+7XXbcDmV4onr6u08VDp/87/582BSZW5ZXsuNQ43Ax13MzEIzyxs4ath9sIMvvYfbUfEry0vF5HDjtNjRDJ5nUicZVQpEEQ+E4g0NR+gMR+gIRonF1pN+7eXklX3h07WUbU4IgkJ+dxm0rZ/DjF3ed91mLJZJsP9TIgeNtTC/LYf3SacyuyKMkP2PUuRiGyVAkTkvnIDVNXeypauVEczexRPKc79CMslz+7JO38J/PbuXg8ZOXdW2TRX6Wj/vXz2XT9mPjGpzBcJzDte3UNHbz05d3k5flY2pJNsW5ftJ8TuyKgq7rBMNx2roGqa7voqt/iHgiiXYRk8WZU/J48oMrsCuTP9UzTRNdNxh+5TExMUn10Wf28Wf38+HY8L8jCcLROB29Q+cNewyGYvzDD14ny+8e1a+P7fdP/7hdNhzDz5eAwKlkRUkURi1MWVweeZlevvapW/nKd17iREvPBe2jJnVOdgdo7w6w/1gbiiymxjpJxGlXcDoUFFlC0wxUTSMWT5LU9JGxzhge584ce64118yYsrixEQRYOb+c1Qsr2LTt2AVN/nTDHOmcG0+eOzzwXFzpRMQbDdM0+e4v36a2qYdwLDV5jsTU4RygSW4L6BuMXJB61ZmIooDLYTs9AXfaWTy7mKceXIkkTe6EWhAEPC47Tz6wHFXV2LTt2EWvmOvDAwVcfzkzZ/P0pn3sONhEaNg4isQSRGMq+hUQ1YjEVA7VtF/UPoKQytM8NeFyO23MKM/lkx9cTtYFqOtNJoIAi2eXsHbRVF566/AF3SPDMIeNzgGaO85vcE6EmtQm7X102GTWL5nKvupWjpxoP+9xDcMkElM5cPwkB4YNHkFILaq5HAq6bhBLaBeVIyYIAhVFWXzzS/eS5nFSWZpz3RhTBTlpfOzepaR5nfzgtzsmrLmVSGokkhrBcJza5gubiF4IAikv6F986lZ855Hjv1Sa2vv58Yu7aO8JEBlexIzEVVRVm3RPuG6YNLT1XbTcviyLqXfeZcfjtOH3Orl33RxuWzljks/wxkUQBLLTPXznKw/wd/+1icMn2i+4YLdJKs8pZUynxsj3ZhCvZUxZXENEQeAzH1pNc0c/xxq6rvXpWFwipglVdR3UNk3eZGCyMc4wxCHlEXc7bVfMgyMIAmkeJ1/46Afwuu28srWa/sDFGYDvFepaejlUe/1KeZsmxOJJYvEkvaS8QZpuXLOQMFEQePLBFTSc7ONQzfUx+b9YBEGgojibh29dQHd/iK6+oYs+hmmmcgbjl/A9SKLI7Kl5/NFj68jPSsPEpLwwE1kSL8pzcyWQJZF5lYUoisTda2cxOBTl2Vf3E4qcu6juZCEIUJqfwec+spapxVlXzPs6FIlz+EQ7vRfgYb1WaJpBIBQjEEpJ6NsUifnTC6/xWb3/OGVQ/dWn7+CHL+zg3QMNV+15v16wfJ0W15ScDA9fenw9syvyrvWpWFhMOm6njU89uJIvfvQDzKssQLyAor4W738y01x8+fF17+mJnSgKfGBxBR+/f9lVldyWJZGlc0r4o8fWMWtKHqIoIIki+Vk+Mv3XXmRBlkQWDacPOOwKj92zhCc/uIJ035W/R4IAU4qy+OyH17BiXhnyRebYWVhcKqnwXx+f+8haPnH/cgqy0671KV1VLGPK4poiCAJzp+bzpcfXs2R2yXWjWGVhMVnYbTK3rZzBnz95K4/dtdiq9WKBIAhML8vhy4+vZ/XCKYjv0X7PYVe4e+1svvrkLeRmeq94e7Ikcv9Nc/mTJ25iVkXeKNGGnEwv+ZeoGDiZuJw2ZlXkj/zbaVd46Nb5/Pknb2VaSfYVbXv53DK+9tRtrF445bJz4ywsLpZTHqqHb1vA33zuLu5YNRPpGuenZaW7KSvIuGjRsovFetssrjmSJDJnWj5/+dRt/OKVvby6/fglhX5YWFyvyJJIRXEWTz28ivXLKvn1pv28s69uWCziyrcvCKDIMnMr87l91cwr36DFeRFFkRnluXz1k7fwzKb9vLLlKJELUH+83nDYZNYtmUZRrp//em47e6qaJ70ItSBAbqaXz3xoDesWT8XpUMYsvOVkeMjL9kHtxeXUTTZzKvJxOZRRn9ltMh9YMpXi/HR+sWEvW/bXT+oY53M7+NDtC/nQ7QvweZ3vWePc4v2B064wr7KAKUWZ3LZqBr98ZS9H6zquSgiuIKSMuuK8dO5eO5ublk4lJ8N7xQXHLGPK4rpAEkUKctL48ydv5fZVM/jFhr3UNncTiU1OQqssidhtMjZFxud2WB4wi6uOIAg47QqzK/L42y/cQ1v3IC++eZjdR1oYCEbOq1p2MUhi6nl32GXSPE5WzCvj7rWzKC/KvOYrhRanEUWB3EwvX358Pbcsr+SXr+zjaH0H0ZhKYhIEIyRJxK7I2G0yPrfzioWZSqJAZWkO//DFe3hrzwmef+MQnb1DROLqJUsVS6KA02Ej0+/m5mWVfOj2BaT7Jq6/5nLYKMlLx26TSajXTrhlPBlyQRCQJIGK4iy+8dk7ue1IE89uPEB9Wy+RmHpJRXwdNpk0r5NFM4t5/N4llBdmIgpXX6HSwmI8TgkxrV5QztLZJRyqPclLb1VxrKGTcDRBXNUmRcb8VB/nsMtkprlZNKuY9UunMXdaAdJwf3c13olJN6ay070sn1dGJDp5yWeBQJS6E11oZ3Q4TqeNWbMLsV2GK1uSRMoKMy96P5/bzsp5ZUTj468iupw2cjMvLdzA7bKxbG4pQ+eQC/e67Zd07Iw0NyvmlY27+nny5ADRUAJD1TFNxuj8Xw0EISVdvGhmMfMqC6lp6mbXkSZqm3roC4QJRVIqcQlVQ9U0dD0lx31K5lgUBWyyhN2WkpB2OhTczpSE6inp2WnF2ZQVZV7RQs0Oh8L86YXnjJEXRYGygowrdg5Xi55whJqeXux+O2sWTrnWpzMhJtA8MEjHUIgpmenke73MmJJ3TSYep57z0vwMvvz4TQw9EKe6voPDte00tvczOBQlHEkQG07OT6ga+hmSsKdyRCRRQJJSkrJOu4zTYcPlSBUhz8vyMr0slxnluUwtycJuU85/YpfI9LJcYvHkdStAMR5FeX6c9it3Ty6GU8/DvMpC/vGPCzjR0sPOw03UNHXTOxAmFIkTianEVY2kpo/IAQvD0v6SKKDIEnZbymhy2pURyfjcDO9wTb8sphRm4nVfGWW3U++R22XnvvVzWb90GnuOtrK7qonWjkEC4djIM51Iahh6Sj5fHDYyJEnEblOGz91GmsdJYU4aC2cWsXROKVl+z3nHJEEQmD+9kJuWThsWmhnN9PLcSblWmyIxuyJvZKJ2NkvnlJ7zHGVJYM3CClbOK+fA8TZ2Hm6mvq2X/kCE8LASqprUUl7r4fddliUcNhm3047XbSc7PSWTv2bRFCqKsq6J1Hea28myOaUEh8Ud3gsE9B7injYG1an4bVkpyfSLQBAgPzvtvGOd3+fCcZX7l3mVBXjcNnoS7QwlB8l1FOOT/aO2qSzNueBadV2xVgaTvfiVLPKdEz/T5+JUv2C3ySyfW8byuWV09ATZV93KsYYuOnqDBEJRIjGVWDxJXE2S1AwMwxhROj013imyhKKk3gOnw4bboeB1O8jL8jGtNJvpZblMKcq87CLAl4pwngFwUkdH0zSJRBIcr26n/eQAkaiK3SaTX+Bn+swCsrLGj7muOtzK9777Gv39YWIxFTWhUVScwb/+x8fInGAfiwvHNE3++dsb2Lallg9/dAWPPbH6nAUErzaxRJLuviF6BsIMDkUJRROpugO6jqEbiKKILInIcqpGwak6E2keJxlpLjLSXCiydFUmzqZpMpRIcKi9k5bBIGE1gUNWKPH7mJefR4736koxX2l+svcA39+2i+k5Wfz00YexXeG45EvFME2+suFV3qpv4HMrl/MHyxdfdx6aU3VbegZStaaC4RhD4TiRWIKkZqQm0oZxemCRJRRZxGFT8Hoc+L1O/D4nfq8Lt8N2Q4hdmKbJO8/tIhqKsuyuhWQXvvcXKE4RTyTpHgjR0x9mIBghHEv1e6p2qt8Thvs9CaddwWW3sfeV/TgkibseXcXU6YXYlIvr9xIxlcPvHKP2QCM3fXgVhVNzL6vfNAyDgWCUjt4gvYNhhsKpOnOaZqCbp55lEZss43Hb8Q332flZPvxe5w3hZTHNVH2t9u4gfYNhBoaiw96q1ILhqagKj8tOpt9NToaXotxUncSoHqI6uJdg8sxSIQKyIOOSvWTZ8yl2TcUmXtoC7PsJ0zT5ddv3ORrcw/qcD3JzzoOIwvU5Xl0qmpHk6db/oD5Uxd0FH2NZxi2IwqWNcy+3/4Rd/a+zJOMmHi76w0k+09T3EYom6OobYjAYJRBKFd1NDBtUmqaDwMh457SnFlu8bjtpXifpPhdZfg8Ou3w1+4kJG7pqYX6madLZEeDHP3iH2poOBgcjqAkNWZZI87uYPiOfRz6yglmzC8dMAsorcviTr95NPJ6kob6b557eebVO+4bB5bKj2CRcLvt1N4A57QplhZmX5EW8mpimSctggH/fuoOqzi76ojESmoYiiWQ4XcwryOUPli1hXkHedRXTvqWhiQ3HavnWXbdhu0j1J5eiIIkCaU7HdXVN4+Gx27DLEm772HyL6wFBSK1AF+SkUZBzYykhXSp6UueHX38GAE+6h3UPL7/GZzR5OOwKpfkZlOZfmIGYiKn85GP/ic2hsHrldOxzL341WY0n2b3pEK/84E0qF02hoCLnst4VURTJSvdc9Xpe7yVOlVFI81y8ME1EG2LPwJu0RutGfS4iYZcceOQ0SlzTuDX3ETLtlmKuQ3QhCwp20XnRXqn3BgJ20YEi2rCJjuv6GgVBwOd24LtC3vKrzVUzpqKRBP/0rd9xvLqdtDQXt90+l2mVeQwORtj8+lF2bq8jGIjyp39+D0XFGaM6cI/HwcxZKQlZm03G7rg+wjPeT3zyqQ/w4UdX4PU5bogV7StBKKHylQ2vcrSrmwyXk4fnzmJmbg49oTC/O1bD5roGBqIxvn337ZT4066LCb1pmrxxooG36hvRTQO4OGPqvlkzWFNeilORka8zT8+ZCMCffWA1n1mxFP97wPCzuDBEWaR4egFD/WFyiq7vxZYrjSRLFFfmo8aTZBakX+vTsbiKiILEA4VP4VeyMDEIa0FOhI5wfGg/Bwe3EdUjPFryRZzStZeOv5bcnvcR1uXcj0vyIFyix+Z6RhIk7i34BKqRwC17r4s5xo3CVTGmTNPkt8/tofZ4J5lZXr745dtZsWra8Bdtcsttc/i3f9nIwf1NvPHqER7/xBrs10k8+42AIAh4vU68lmTzJWOaJj/cvZ/q7h7yfV6+cdtNrJtSlnrGTZP7Zs/gr1/dzO6WNl6oOsYXVi2/aC/QlSCUUKnu7kY3Li0R1GVTcF3BfJzJQhBS3rM05/tjFcwihSAI/MPLX8U0ua5Ck68Fkizyjxu/BoB4g9+LGw0BgXL3DHLsRcOfmCxOX8e+wS28dPKHtEXrqA0dYoF/9TU9z2uJIAi4ZA8u3r9eUkEQcMte3FjpL1ebq2JMBYMxdmyvwzRNVq6axqo1lWdYzAI5uWnc98FF1J3o4o3Xj3Lfg0vIyrr8OMhTOVr9fWFCoRiqqiEgYLfLpKW7yM31I8ujBx1dNzh+rB27Taa0LDsVt94VIBJRMU0Tp9NGTo4Pf7p7jAdH03QOH2rlfBJMM2cX4nTaRl2fYZgEBiMMDESIRhNomo4oCDhdNrKyvKRneMa0FwhEaG7qIz/fT3aOl96eEH19IVRVQ1EkMjI85OWnjZucmkzqtJ8coL8vNPKZIAjkFfgpmGBV0zRNao+n5C0rpuZiGCbdXUFCoRi6buBwKGRlecnM8k44sdF1g/6+EP39YeKxJIIo4Hbbycnx4Ut778bID8RivFlXD8At0ypYX1F+2vshCBT703h0/lyOd/fwYlU1H1s0nyx3SpnqZHCItkAAv8PJjJyxFevjmsbhji7sssS0rEzctrEJloFYnI6hIUKJBIZh4lAUsj0uCny+UV4Y0zTRDZO2QJBQIkFVVzc94Qi6abCzuW2UgScKAitKi8fs3xOOUNfXP6p9r93O/IJzh5EYpklfJEpfJEI4oaIZBqIg4LbZyPV6yHK7xniM+iIR6vsGKE33k+Nx0xUK0x0Kk9B1bJJEjsdNYZpvXE+Tqus0DQzSG46MuqYSfxpF/vHD6EzT5HBnF6ZpMj0nG103aB8aIhhPoBsGTkUhz+sh2+Oe0BOnGwbdoTA9kQgxNZkKZ3DYyfd68TstJcnJRBAEpOtgUeJ6wLoXNzrCqHmVACxJX8/Wng0MqN30xE+ObNkZayWsBfDbssiy548bDqaZGq2RE5iY5NqL8CipPtM0TQaTvQTUPrLt+XgUP+FkkMFkH6oRT82xRCfptuxhD9CZ44dBSAsS1gLE9Ri6qSEKIjbRSZqSjlf2j/EYmaZBb6KDQHL0mHM2HtlHvqNsVHuaodGndjKUHDjjLolk2HLItI8vSGKaJm2xegxTp8BRhoHBoNpLVA9jmgaKaCdNycCrpCONk3NlmAYhLUBYC5IYuUYJu+gkTcnAI4+OSonrUTrjrWQo2SiinZ5EO4apk27LJk3JJK5H6Em0o5s6aUom6bYsJOH01D1pqPQk2oloQyOfiYhk2wtIs53bW2+aBhEtxGCyl4QeQxQk3LKPdFv2eUMEdVMjmBwglAyQNBIIgohTcuNXsnBK7htunLsqxlRjfTfBYBRZFll388wxN1kUBYpLMikry6LqSBuN9d1kZV3e6oFpmjTUd/P6q1Ucr26no32AcDiBIIDP56S0PJt162dy+13zRikCJpM63/nHV8jI8PDwh5dx+GALe3Y30NszhG6YZGS4mTO3mIc+tJTpMwpGXUsspvLXX/s1hj6eMWWiD3/+3z96ioqpp19k0zR5d8txdmyro76ui97eIeLxJLIkkZnpYebsQu64ez4LFpaOMlKOVbfzz9/awEOPLGVKRS6vbjxM7fEOwuE4TpeNadPyuOOe+az9wAyUszT24zGV1zYd5s03jhKPacTiKrIk8tgTq3nik2snvK/f/4/XGQpG+fTnbqGxoYft79bS2TGIquqk+V3MmFnA/Q8sZuHisjEGVTKps/Xt42x55zgnajsJDEYQJZHcXB8LFpZx+13zqJye/55cYT7W1UMgHscuS9w5feqYyb0oCEzNymBKZgYH2zup6ellTXkqp2HT8RN8f/suVpeX8p8P3jvm2P2RKF966RXyvV6+fc/tzMw5XfjRME2OdHbx8tHj7Gpp4+TQEJpukO5yMis3m/tmzuDOGdOwy6ef8YFYlP/z+pt0BEP0hMPEtZSM8Bde3DCqXYcss/tLn8F2xr4mcKC9g2+9uYVoMklUTaIZBvML8nj+4x+d8P6YpsnG4yd4s76Bmu5eukJhYsnUM57jcbOosICH581iaXHRKCNlb1s7X9+0mU8vX0xFZibPHznKkc4uhhIqHpuN2Xk5fGjebG6rnIpylvhFRFX5zeGjbDxeSzSppdoTRb60ZiWfWbl0wnP929ffJqKqfGXdGqq7e3izroHWQJCkrpPhcrKgIJ/HF81neUnRGBELVdfZeLyWV2vqONrVQ380iiSKFKX5WFFazMNzZzMrN/u6E7+wsBjhxpoDva8REEi3ZdOX6CRpnFbxPT60n9e6nmVh+ho+WPgUTsk1Zt+OWDM/b/4XFNHGJ8r+fMSYApPDgR1s6fkd9xY8Qba9kN39m6kPVxHWgggI+JQM7iv8ODO9izn1QJmYHAnuojq4l45YM8FkP0kjgSRIeJV0SlyVLM24iSme2aOMFN002NH/Grv63hj3Gk0MTExm+Zbw8bKvIJwRqq4acfYNvM3BwXdRjQSqEUcUJG7JfZhbcx+Z8L693P4TolqIu/M/Rme8hergHvrVLjRDwy37KHFNZWXWHUz1zBklYmFisn9wC7VDB+mMtxBMDpA0VGRRJk3OpMwzg2UZt1DimjYiDNGX6OS51v9kScZ6EnqMfYPvkDSSzPQtYk3WXRwd2sPegbdR9QRTPDO5I++jFDrLR+aecT3Kjr5XqRk6gGrEUY0EsqBwf+GTLM+8dcJrNEyDzlgzO/pfoz5cxZA6iCwq5DqKmO9fPWIYj7nfpknSVDk0uJ2jwV20x5qIaCFkQSbdnsM0zzyWZtxErqP4ksUv3otcFWOqszNAPKYiyxJTp42/eu1Pd48o89XWdLJsRcVlt9vbE+LAvibSM9zcc/8iMjM9qKpG1ZE29u9tpLGhB3+6izUfmDFm37bWfn76o60YhsHqtdPJzU1jYCDMzu0nePutY3R3B/nH73wU5xkS2w6Hjb/6xgNjJIJNExobunnx+b2k+V24XGOVdU7UdnL4UAtz5hZx821z8HochEIxtr97gnfeOsbgQITMDDdlU3LG7Lt9ay2bXz9K5fQ8PvL4SiRR5Fj1Sba/W8vJkwNIosC6m2aN2sfpsnHXvQtYsnQKqqrx/K/3cKz65Jhjj8dgIMrTv9hOIpFkwaIy7r1/IaFQnP37mti9s47OzgDf+uePkJU1OmZ34yuH+NXP30UQBFaumpby/MWTHDncyqubDtPW1s/n/+g2yqdcXtLztaA1ECSW1FBEiRk541e5z3K7yXanYtarurpHjKnL4UhnF995ZxsH2ztZO6WMB+bMwiZL1PX181ptHce6egmrKh9dOG/EwHPbbDy+cD4Ax3t6eebgYSJqkm/fffsoNb6UWthoA0UAlhQV8k/33IGqa7xWW8+G6poLPte9be0sKSrk/jkz8dntBGJxXj9Rz4ZjNfRHo+R4PFRkjk24f7W2jkiimrn5eXxm5TJEBA60d/BGXQMtgwEkUeSO6dNG7eOx2fjogrmsrygnrmn8aM9+jnR0XdC59kYi/L8du4lrGitLi/nownkEYnG2NTXzZl0DbYEAP/rwQyPexVM8c/AI/71zD5IocvO0KUzNzCCSTLKn9STPHz5K88Agf33reioyM95zz/hkEw5E+M2//Z7Opp4Jt8nI83PnJ9dRNrt45LNgX4jXf76VuoNNI5+lZfm44xMfYOqCsnGP86tvvUh3Sx+f+ZeP0d8xyI4N+2iv60KUJSrml7D8roXklmSN2a/hcAuv/mwLc1ZNZ82DS2mv62LnK/tpr+8G0ySrKIPFt85l9srKkX1Mw6S/c5DDW4/TWNXKYPcQAiZp2T4qF09h0c1z8GWOv1jY3znIrlcO0Hy8nUggis2h4MvyUj67iFkrKskuzhwVoTDYHeS1n22hsap15LP0XD93PrmO8jPu2dnoukHj4RZ2/f4g3a192BwK05dMYcFNs8+5mBUNxdiz6RC1+xoZGghjd9oomVnI6vuXkFWYPuqZ1jWd//yTn5NTnMn9n7uNxiOt7Nt8hL6Tg0iySOG0fFbeu4jCqbljoidM0yQeVdm98SC1+xoJ9oVwuGxMmVvMynsXWzlhF8FQcgBJlEflSy1MX8O2vldojzbSFWuh3DO2kPfRwC5UI0GZeyZ5jrFjVdJUaQhXc2DwXZKmynz/KhySi7AWpDPWQpqSydmW+cloA42RY5S7Z7AofS1OyU1UD3M0uIfDge2EtQBeJZ08x+lnVxJElqbfzBT3LM5GM5O82f1bBtXeYQ/b6OfILjlYlnELld75aEaSrb0baImeuKD7FtaCvNXzAkkjQYVnDsszbyWmR0Zy0frVHp4q/0t8yui+vDVSS0v0BFPcs1iSvn7knlQFd3FgYAsxLcJ9BR8n4yzP2KHANnLtxazPeYDq4G6qg3sYSg4giwo35TxIS6SG6uA+Sl3TyXEUYhNS80in5GZN1j3M968iocfZ0vsSnbFWzoVpmoS1ABs7f0Vj5BilrkpWZt6BXXTQGW9l38BbJIw4hjl++P+23o1s63sFm+hgXtpKsuz5xPUI9ZFqdvW/Qb/axQcLPpXycN0g49xVMaaGgjGSmo7f78blGl8D3uW04fGkHo7enuBltykIAvMWlPB3//AIdoeCy21HUSRMw+SW2+fw7/+ykT27Gnjn7eOsXjt9zBc+OBjB43XwxS/fzqzZRSg2CS2pM2t2Id//j9epPd7BkUOtLF85dWQfRZFYu260YWaaJqGhOK9tOowsSzz6+Cqyc0YbGYIg8NAjy7j7noV4vA4cTgVJEtF1g7XrZvD1v/g1dSc6aWzsobR87MPZ2NjLAw8v4fGPr8HttgECN982G4/XySu/O8CrG48wd34JGRmnB3BZligpyaKkJAvTNNn6Tg3Hqi/s3saiKoFAhCefWs+qtZU4HAq6brBoSTn//Z+bqa46yYG9Tdx+17yRfRrqu3numZ3omsEX//hOli6bgt2hYBom62+eyc9+8i5vb67mnbeOk1+QPspIfS8wGIuhGTqZHs+4YXgAbrsNrz31t86h0LjbXAyBWIwXq46x72QHTy5dyKeWLsbnSKkxxpJJ5uTm8M3N7/Dc4SqWFBUyfTiE0G2zceeMlOHhsdt4seoYCU3ntsoKnMq5858EQSDb4ybbkxqYmwcCbLwAL4sgCDy1bDGPLZxHmsOB06YgCwKaYXJb5VQ+8/xLVHV2Udfbz5SM9DHPeE1PH59cspDPrlyG225DAO6bPQOv3cZvjlTzYtUxlhQVkuk+vcKqSBIVWZlUZGVimCYba05csDEVTqgMxmL82brV3FQxBacioxkmK0uL+dabWzjS2cWO5lbun336fT/W3cMPd+/DNOHrt6xjdVlKmEM3Te6eUcn/fXcnG2tOsPH4CT69Ysl57/X7naSqUXewmcYjLWP+ZpoQ6B2icGoey+9eSNns0X+MRxN0t/YR7AvR3dJHVmEGS++YN+Y4pzi85TgnDjQxa1Ulr/zvm7TVdqDGVBAEnG47uzce4lN//2GmzC0Z9ewNdAXZvfEgmqqRnuPjP//053S39JKIJQFw+5zYnfYRY8o0TXpP9vONh/6V/s4A8UgCLZny/MqyhNPrYMU9i3jqmx8h7YzFJtM0aTjcwnc//yM6GntIRBPomoEgCsiKhMPtYN0jy/n0tx7FfsZinGmaxMJxulv6CPSF6G7pJb88h+V3L5jQmDJNk12vHOB//uJXBHqGUBNJRFFk6wt7mLl8Kr5xlPdM0+RkXRc/+vqzHNtZRzQUS4WiiwJ2l52NP3qbz33nYyxYP+v0NRkmOzfsJ6c0i0QiyZbf7KL35ADJRCr01e608favd/DVH36G8jnFo+7FQHeQf//cD6nd20AsFB9py+F28M5zu/jUNz/CzOVTb5iJ2oViYo4qaHMidIh+tQuX5B5VK8gr+5mbtmJECbDEPW1U6FhQHaApUoNhGiz0r0EWx04Vk0aCquBulmXczKqsO/HKfkRBRDd1VCOOW/aNsqUEBNZm38PyzFtxSm5sogNRkDBMnTlpy/lJ07c5GWuiK9ZCrqNoxCsiCCKFrnIKXeWjr9U0ebfvFcJakCJXBWuz7xnzPEiCTI6jkBxHIaZpUhXcecHGVMKIEdaC3JH3KLPTlmIT7RimwTTPXDZ0/JyWaC0nwkdYkr5+1DXemvsI63IeGL5GO6IgoZsa070L+WXLv9EcPU6/2k26PWeU5yeqhVhXfD/5jlIybbn8quXfaY818fGyr1LunkGxaypNkRq6EydJ6LERuXtZVMh3lpBPCZqR5ODgVjo5tzEFJlXBXTSEjzLFM4u7858Y8SSpRpwDg1vZ3PU8BmOLSZ+MNbC1dwN20cF9BZ+kwjMbRbBhoDNHXc5rnc9yLLSfquAu1mTfjXT1dO6uKVflKlU1VaTP6Zx48iDJIvJwKFo4PDkFf10u24jxduZLlp7uZtnyCvbuaaS7K5jqfMbpk9fdNJM584qx2eQR2eJFS8rJy0+jqzNAY0P3KGNqPJJJnZ/8aAuHD7Zw3wOLWX/zLORx4tozhlcqzzxPWZbIy/ezYFEZm145xNDQ+IV8bTaJhx5ZStoZOUdpaS4e//hqNv3+EG2t/dTXdbNs+eQlXs6eW8yqtZW43faRe1M5PZ9plXlUV52kvq6b2+9KbWua5oh3benyKay7acaolci8fD833zKbbVtr2LOrnvsfWPyeM6biSQ3DMHEptgkHeEUURzw9ofjlPeMpGfYgO5pbKfB5eWzh/FFeEpsk8aH5c/jvXXs5GRxi/8l2pueMXXm/muQMG2Bn3h9JNCn2+1heUswLVdUE4+M/43ZZ4hNLF43KOcpwOfn8qhX8tuoY9f0D1PT0snoSvH2nWFZSxE1Tp+Cx2YaLbcL8gjxm5mZzuLOLY909I8aUaZr8rrqGgWiMm6dN4Y7p00Y8gQpQ4k/j7pmVvFFXz9v1jTy2aN4Nb0z5s3387W//FNMY7cnXNZ2NP36bH33910yZV0L5nNFGgS/Ly2Nf+yCPfvU+DMPk0wu/dkEFg+ORBD/+xq9Zec9ivvK/f0hOSSZttZ385P/8mgNvHiWrIJ1P/X3KyDmb2n2NVG2rpXxOEZ/+1kfJK8si0Bfm+K465qyZPmpbl8/JrOXT8Ga4WX7XAopnFKLGVXZuOMCz/7KBzb/cxvI757Pqg0tGGRA///vf0lR9klsfW83DX76LjLx0QoEwzUdPsn/zEWYsq8B2Vr+YnpvGE994mI99/UG0pM4fLPiL896HjsYe/v3zP0TXDO79zC3c/5nbcPtdVO84wS/+/gUOvHl0zD6DXUF+9rfPs+e1wyxYP4snvv4QJTMKCPaHePUnW9jwP5v57ud/xNd+9gVmLJ0y6h2vO9BMe10X6z+0gvs+cytZhRnUHWzm6X98mSPvHueX33qJr//iCyP5XtGhOP/2hz/g0JZjzFs7g4985T5KZxUy2DPEb/71FbY8v5tf/sOLfPG7nyD/PRjFcKWI6WEiWgjD1BlKDlATOsjOvtfQTZ0p7llM85xebJAEmYXpH2D/4FbqQkeY51+BX0kt1JqmSXO0hkG1B6+cxsy0xRO2mWMvYEnGejJtpwugK4BjnLBBAK+c8iiOGgMEiQxbDhWeOewdeIuoHp5wTnYKwzQ4PrSfHX2vYhedfKT4C/jkya8xV+6ewey0pTgkFwICkgBFrgoKneW0RGvpiDXDWU5Sn5I55hpFRLLs+ZS6Kzkc2EHciI25xix7IT4lA0mQ8duy8CnpOCUPmfZcJEHGI3nxyn5iWhjd1C7rugxMDgxuQxJlZvgWjwobdEguZvmWUhXcTWN49Aq7aZrs7X+LhBFjVtoSZvkWj+S4Scjk2IuYnbaM2tAhqoK7WJF5G5JkGVOThiCkfgxj4gHPNE/rNkxWzowgCGiaTjAYIxyKk0gk0YerKweDMTBNDN1ANwxkcbSB4/E4KC7JHKMqKMsSPp8LQRSIDq9OToSqamzccJBNvz/EsuUVPPTIUtzuiYvnqapGYDBKNJpAVTV03SCp6qiJ1Iuj6wamyZhK8IVFGbg9YxPb09PdlJRk0t0dpLdniMnCZpcpKcnC4xmtjCZJIh6vE1mRiMZOx2frmkH9iS40Tcfnc3K0amw4YVdnAIdDoaN9EFW9vI7iWiAKAghgMLEqXuoZTz3kly2uAvSGw7QFgszNz+NEbx9dobHeLp/dTm84Qsc4f7sWJDSN/miMcEIloWvohklC00hoGiagGca442hZejpe+1hDNcvjYkpGOl3hMN1nCE1cLk5ZpiIzA6999PsqiSI+hwNFFIkkT7//mmFQ3dWDbhj47A72n2wfc8z24BBOWaF5MICqX5p64vsJQRBQbKOHIC2psefVKp75p98xY2kFn/ybR/Bn+8bsJ8kSkixhGCbDgpkX0CCUziziD771KN70lGFfubicL/z7J/i7j/4Hu35/kDs/uQ5fpmfMc9ZY1co9T93MZ//lcZThMaGoEuasqhzdhCDgTnPxpe8/OeYYt3/8Awx2B3n6n17m2O56Vty7aGRRKZnQGOwOIkkiax5cSlFlAaIo4PG7yC/LYeW9iya8h6lFSAlBFC8o32nDf28mGoqz6t5FPPH1h3AO9+PL71yAO83JNx/7HoEzxgvDMDi89TgH366mcmE5f/mzz+Pxu0eu9VN//2FMTH773Y38/odvMmVO0SjvmWEYrLp/CU984yHSslLf5YL1s4iF43Q2dnPwzaPoSX3EmHr3xd3U7G2gcGouX/3hZ8jI8wOQnpPGl773JP2dAap3nODIuzXklmUjSZYxpZsa/6/+G6M+kwUFj+xjgX8V9+R/HFk8PZcRBIEMWw6VnnmcCB+mJ96BX8kCBJKmSnOkhpAWZH3OB1GEiRc285yl+JWxoknnQjOThJNB4noUzUximAaamUQzUv1pKrRsYmvKNA064y1s7d1A0lD5cPHnybBdXnHp8VAEGzn2wjFy8qIg4ZTdSIKMasTG3TdpJggnh0joseFr1EkYcXQjNbcxzLEeH5fkQRJSRbYlJBTRjlvyIgmpxXxBEJFEGR0t5YG8DHRToyvWgltOS4VHnhkphUCakoFP9o/JmdJNjdZYqqaZXXDQFBkb4h9MDiCLNnoT7eecD73fuCrGlMNhQ5REIuHEuMYApAbRU5Nor/fy5YtN06SvN8TuXfUcOthCW0s/oVDsdNJeTEXTJv6inU5l3NwmAFEafsTOYRzqusGuHXU8/YvtTKnI4YlPriUnd2IFsfq6bnbuqON4dTtdXQES8WTK4jcNQqHxV+tP4fbYJ6ybk57h5mRbP7GoOu7fLwVFkfCljS+jLqZsilGrzdFogmhMxTBMNv3+MJt+f3jCY4uigHFBM6PrC5eiIAkiobiKYZoTqsupWqoT9TkuryK9YZgMxOLopsmhjk4++9vfTbitACSS19ZANU2To109vF3fyKGOTtqHhognNUQh9X1P5JE6hc9uRxxncBWATLeLlkCAqDp5z7hNlklzjN8PicOrQ2d6Q0IJlWhSRTdNnjtcxXOHqyY8tnTWvhYpDN1IeUe++QKZ+X4+/Y8fpagy/7z7XeidlGSJ2SumjRhSkJpUpuemMf8Ds9jwP5tpq+2kcvGUMap4ik3mkT++a8SQOhcTTersThu5ZVnYnTbCwegoA9DmUJi9spKmqjZe+L+vEglEmbqwnLyyLGRl8obppKpRta0GxSaz+Na5I4YUgCAK5BZnMW1hGXtfOzLyeTySoOFwC+HBCDd/dBVOz1jV1XueupkX/u+rtB5vp6Ohh/K5p72JHr+LOaunjxhSp8gtzcKX5aX35ADRcByb04amahzdXks0FOOBB24fMaROodhllt+1gMNbjtFU3UY8HMedNr4X5EZCQGC6d+GIB0URbfiUdIpdU5nqmYsijjWI3LKX6b4FnAgfpiq4i3LPTGyCnf5ENyejDdhEO/P8K8/ZrkN0oYgXNpaZpkl7rInjQ/tpjZ5gQO1NqcAhYAomMe38i2GmaRLSgmzt2UBvooObcx5iimf2FfFOSoKCSx5fYlxATJ33mPx4k9ZoHceH9tMWrWcw2YtmJBEQMTGI6eEJ25NF5bTxIqS+U0mUr0jh3VNGniLacIhj53LisDLf2TloMT2CaiTQTY3t/ZvY3r9pwjZExBtqnLsqxlR6hgubIhONJggEIqNyd04RiaqEQykrv6Dw8pNLA4MRfvPsLl579QhZWV7WrJtBcXEGTqcNWZE4cqiV55/bPeH+gihccvFa0zQ5Vn2SZ365A0kS+cPP3sy0yollo2uOd/Cj/32b6qqTzJlXzF33LCA724tjuDjx669W8e6WiZP8DeMc6xQmpCRTL+lSxkUQBKSLuDfm8H8EAW6+bQ6zZxee6+D4/e+9wTHL40KRJMJqgsFobFTuzilCiQRDiVR4X0m6/4KPbZom2riejNS3Pr8gjzunTztn2NiMaxzid6ijk395ZxuHO7pYWlLIh+fPJc/rwSnLmMBvj1TzRl3DhPvr5vnW4iZ3wBEELlpxzyRlaN0/ewYLCiY2AgSY0FC7UTFNk9aadp7559+RiKl8/l+fYMbSyxchOhNRFMguHisVbHPYyCpMhQj1nOzH0I0xxpTH7ya3dHxhmfGIheOc2N9EU3Ubg10BoqE4mqrRVteJltTHhDYKgsCDf3QngiDw9nM7+X9/9gtKZhRSsaCUJbfNZcG6WRdkyJ2PSCBCOBhBkiXyyseKGdlddtJz/KM+S8RU+tpT0tLFlflI8tj3IiMvjbRML6HBCIO9Qco5w5hKc5ORN3YhUbErI6H9ejK1yBQZijLYM4ShGxx46yjdrX2j9jFNk47GboCRfK8buwxtClGQuDX3YbIdBQiISIKMLCjnNDIkQabYNY1cRzHVwb2sz3mADFsO3fFWuuKtVHjmkGE7dxhl6m8X1ve2RevZ1PUrmiO1lLtnsizjZtKUzJHcn30D73B0aOI5GYCBzpbeDdSEDrIkfR0L09eOayhOBoIgIF5kEfvGyDE2dvySzngrUz1zWJl5Oz45A0W0oZsaewbeojZ0cPz2zvjv6M+uJBOPqsI55o2SILMofS2Fzon7aAFh5Lu9EbgqxlR+QToOp0IsplJzvIOVIwV7TzPQH6anOxVaMH3WOSbbF4BpmrS29vPGa1V4vU6+9Cd3UjkjH4fjdOcy0B+Z0JtzuXR1BXn+17vpaB/kS392F3Pnl0y4rWEYvPPmMY4eaWPmrEK++pf3kZ7uQpZT7t6kqrF3T+M52xsKxDAnKLra1xfGZpNxTuBlu1KceWddLvtIXa2S4kzuuX/8kJVTXKoRey0pTffjVGSG4gmOdHaxvqJ8zDPeEw6PhOKdOdk+tZkxzndomiYxTSN8ltdFFAXSnU5EIfX7g7NnkuGauOjytcwr0A2Dl6trONjeyZKiAv7xrtvJcLtQRBFBEIgnNd5paDrnMQZisXFXuUygJxzBIcsTCn9cDTw2Gy4l1b9UZGbw6IK559z+SvU971WG+sP8+juv0Hy0jU998yMsvHnOBe8rcOHeKWEcA/mUyAOkJvXjLaYqDuWCZjamadJe38UPvvYMDUdaSERVPOluvOkeHG4bof7QuO85QG5JFo//1YOs//AKdr5ygK2/3UPtDxvY9uIe5q6ZwRPfeIiCKZcXzpRM6phGqs9R7GOHf1EUxnxuGibasEd9YoMutZ+hG+hnRXxIsjgmnHMitKSOMbxwdGx3Hcf31I/fmihg6MYYo/RGxi65cEoXlxedbS+g1FVJe7SJo8FdLMu4lcbIMVQjwZy05djEyVn0MUyDQ4FtNEdqKXFN48PFn8cjp42EsGlGktrQoXMewzRN9vS/yZ7+zZS7Z7A6+25cF3m9VxLD1Nndv5n2WBPTfQt4qOgPcUu+kdC9mB6hemjftT5NIJUXJQkKSUMlbkTH/N00TeLjqPk5JTeKYENAJN9RyopzSK8Pm2OTfObXL1fFmJpWmUdWtpfeniE2v3aUpcsqRuoemaaJYaRqQjU19VI+JZvS0nMXGjsfhpEK8QuF4ixcXEZpWdYoQQPDMGis70afYFC7VEzTJBpV2fDSfvbubuSxJ1azavW0cxoH8ViSnp4hNM1g6fIKcnJGh0IkNZ2m+omlgwE6OgYZGIjg9Y0Ov+jtGeJkWx+5eX5yc33nOMLkc+YQJ8silTPyOXK4lX37Gnnk0eVjctGA97RLeE5eLjkeD73hCBuO1bC6vHREZtw0TXTTpLqrh4a+AaZlZTIt6/QzbpdlJFGkMxTGME2kM4scAgfbO8eEPgpArtdDSXoaRzq7GIzFxsh0n2r7XIhCavXJBFRNvyKiCNFkks6hITTDYO2UMvJ8p0MnTNNE1TVO9J67IGPrYIC+SBTPWXlTXUMhmgcGKUn3k++7dlXfFUlkXn4eB9s72dHcypNLF42q7XWK9/IzfqVQ40me/+5Gdv3+AA996S7WPrgMWZEmfQHANE3Cg2PDbPSkRjiQCjHy+N0I4/TXF3omhm7wr5/+X+oPt7D6g0t49Kv3k1ualRoDBIE3n9nO//7F0xPu7/G7qFw8hYr5pTzyx/dw8K2j/OrbL7P1hT2IksgX/u3jlxXW5vI6kBURwzAJD44Nq9I0nXhktDiObJPxDEcLBHqGMA0T4aw8JV3XCfaFyCnOxDkmL/jCvRcOtx2bIzVWf+2nn2f5XQsm3FaSJWyT4K27kZEFhUrvfI4GU7WMZvmWUhc6Qq6jiEJnOSKTk7+uGnECyb5hVbsF+G2jIyU0M0lnbKyq5ylM06AuXMVrXb/Gp2RwZ/5jpCvXl+x2XI8RSPZhYlLpXUCacloQwzRNVCMxqnDytUQUJAqcZXTGmulNdGKYxqiaUEPaIEPJgTG5WZIgU+qeTnf8JA3halZk3j4qF+8UN+I4d1UqatntCnfePR+7XeHQgWZefmEfvb1DhMNxgoEohw4088Jv9gBwz/0Lcbnsl/WSCIKAy2VDkkV6e0IMDkYwDAPDMIlEEuzf28SunXUTFNe9dHTd4O03q/ndi/tZu34Gd9w9b8QjMxGyIg17zKC1pX84r8xE1w0CgShvvlHNsWNjk9nPxDAMfv30Tvr6QiQSSVRVo78/xC9/vg3ThNLSLCqmjV/t+0px5hULgsAtt80mJ9dHfV03zz2zi57uIJFIgng8SSSSoL8/RHNTL329offki+hUFD48fw42WWJ7cytPHzxMVyjMUDzBQDTGjuZWfrH/EIIgDCu5ySPPRZE/Da/dRn1fP9ubWwknEqi6TkRVqevr56d7D4zxZAiCQGm6n/VTygklEvzrlu009A8QjMWJJpNEVJWBaIy2QJATvX0ktPFzpjKcTuyyjG4Y7GxpJaomSeo6CU0jnFAn5buwSRJORUEAGvsHCCVSz7hmGAzEYvyuuoYjneeWLNcNg//ZtYeecIT4sGBFTzjM97fvwgSmZWVSmX3tQhkFQeCBOTPJ9Xqo6urmx3v20zkUIpxQiSWThBIJesJhTvT10x0OX2b68PuHZCLJG798l5f+8zXWPLiU+/7wFpzjiOmciwu9l7pm0HC4heQZAjemaRIOxmisakO2yRRPLxg3jO1C2+hp7ad2fyN55Tk8+MU7KZtdhNPjwO6yI0ki4cEIanxsbp9pmqPEaWQlZcCsfWgZf/fCnyIrEq01HXQ2nnth7Xy4fS7yy3PRVI3afY3oZ4QPm6ZJOBClvWH0u+jyOiibVYSsSBx8p5pkIjmqXzBNkyNba4hH4mQVppNbeunvodvnomRGATa7wvFddSh2BZfXOebH6XFgcyjjGr4WF44gCJS7Z5HjKGRA7eFg4F361R7K3bNIUzInzViRBWXYyyXQk+ggrkdTC+mmTlgb4mDgXVonkCw3TZPOeCubOn+FKIjcW/BxCpxl15UhBaCItpHaT72JduJ6bHghVSesBTkwuJWO2LkjMK4WIgKL/GvRTZ3jQ/s5Ga0fyYWKaiGOBfeOa/gJgsCKzNvwyD6aIzXs6H+NYLKfhB5DNRLE9AjB5ACd8RbCWuDqX9g15KppFt50y2xqjnew+bUqfvGzdzmwv4mCgnTCoTiHDrYQDsdZd9NMVq+dPuK1AgiH4zTW9xAKxUgmdVqaeolFVQRR4N0ttamQOEUize+ifEoObrcdURQoLMpgxowCao6384ufbmPeghJkSaStrZ9DB1qYOi1vJKxwsjhR08mPf/AOiiLh9Tg4sHf8F2f23CIKi1KF3mw2mYWLy9i7u4FtW2vwpTkpKclETWrU1XZxtOoky1ZUsHN73YTtFhRmUHWkle9+ZxMzZxUgSSK1NZ3s3llPXr6fu+5dgN9/OrLcMAw6OwK0tvaTVDWSSZ2O9sERD+Fbm6tRFAmbTaawKJ2icfIMzsfZk4/Ssmw+/uQH+PmPt/LcMzupOtzGlKk5OOwK0ZhKT3eQhrpuHv7wMu65f+GYIo7vBe6fPYPDnV1sqK7he9t2sb2plWJ/GoFYnN2tbYQTKvfNms7tldNQziiGOy8/lwWF+bxWW8/fvPYmt1dOJcvtYiAWZ2tDM26bQr53rNclzeHg4XmzaR8KsaWhibZAkCXFBaQ7nWi6QV80Sl1fP4oo8b0H78UxjtepNMPPvPxcWgNB/m3LDqq7e/A7HMQ1HVXX+OO1q0ZtPxCNcqSzG3X471Vd3WiGwWA0xsvVx7FJEjZJItvjZm5eKiTJLsusKitle1Mrr9bW43M4KM9IR9V1qjq7UgWHy0t5+xyhfmUZfna3nuT/vPYm8/LzEEWBqo4u3mlsojTdzyPzZo8Kc9QNg9ZAkKb+QVRdJ6FrtA0GMUyT6u4eNhyrwSZJOGSZ0nQ/ZRmXn6dZmZ3Fl9as5Pvbd/E/u/ayp62d6dlZOGSZiKrSPjTEse5ePrtiGQ/Pm4UoXVw8/vsNTdPZseEAP/+73zLvAzN59Kv3488ZX6RnMjAMg2O769m5YT8Lb56N2+ciNBhh54b9HN1ew/TFU8YtIHsxiLKIJEuoMZXBniBaUkeSRaJDMQ5vPc7OVw6Mu4g31B+i4XAr/lwf2YWZuLxOECA6FKOttmNE+VBxXL4n5qZHV3J46zF2/v4A89fNZMbSqdgcCv1dAba/vI/mo6MnUbIiM3tlJRXzS9n62z3MXlnJolvm4M3woMZUmqrbePaff4fT42TJbfMuu6Du6g8uYffGg7zzm11MmVfK3LUz8Gd7MQ2IR+IEeocI9oUom1VkFe+dBOxSqvBqc6SGPf1v4pI8lLorx6jYXQ6yqDDVM5faoUMcDezCJXnIsReimUnaYw00RWqZ7lvE8XHC4ML6ENv6NtIZa6XYPZWwFmTfwNtjtnPLaZS7Z+KQUuOAYRoMqN30JNrRDA3dTNKf6E6pAcaaOTi4DVmQUUQbmfY8su0Fl3WNimhjhm8RLdFaDg1uQxZsZNnzSBoJWqP1tEcbqfDMoS585PwHu0B0U6cv0Ul/ogvNTJI0EgwmezEwaI2ewC46kAQFm2gj215wRqFggTn+5dSEDlAXrmJDx8+Z5p2HXXTQp3bSEWvGq/hTMvVnke8o5ba8D/F2z0ts7v4N9eEqcu1FyIJC3IgyqPbSHmvinvyPMc+/EuEi887eq1w1Y8pul3nyD9ZRXJzJzu0nqK3pZP/eJhxOhZKSLO794EJuvnUOWWfV+OhoH+RnP95KS3MvqqqTTKYm/wD/819vYlMkFEViWmU+f/j5WyifkkoSzs/38/gn1rDhpf0cPtjCtq01uFx2ioozuPnW2dx0yyxqzuPxuViOVrURGophmrDh5f1MFNrw5T+7k4IzqsWvWlNJJBznjdeOsnHDwREJ8YppuTz16fVkZnk4uL95wnaLSzK57fY5vP3mMX734n6GQnHcbjuLlpRz970LWLZidJKgljTYsf0Ev3l294gxlUgkMU3Yse0E+/Y2oigSTqeNez+4iMc+tnpS7s+6m2bi8zl5d2sNR4+0cezYSRJxDYdTITvbx8zZhUybnj9p0vhXG4cs82cfWM3UzAzerGvkSEcX25pSoQv6cIjbZ1YuI/sscYpMl4vPr1pOutPJu43N/PLAYQQg3+dl7ZQy7plZyQ937x+30O/07Cz+7AOrmJuXwzsNzWyqqSOUSCAJIulOJxVZGdxUMWWkWPDZOBWFz65chlNR2NbUwo/3HMA0TTx2+7ienpqePr7x6mYSmoaq68S1lLx5WyDIX2/ajE1OGVMrSor5zn13joQs3jF9KhFV5eWjx3n2UBWaoeN3OJiVm8NX1q/B73Swq7Vtwns7JTOT+2fNYMOxGn5x4BBD8Theu5215WV8eP4c1pxVX0rVdd44Uc9P9x5E1YfPNZmSX3+9to4tDU3YZAmPzcZji+bz6eVLzvXVXjD3zZpOhsvJ67V17DvZwf6T7SSSGk6bjXyvh8WFBczKzUYS3pvP+GTSeLiV3/zbKwwNhBFFkdd/vnXMNnanjaV3zmfawnIglVNzYn8jDYdbiEcTxCMJwoMRTNPkrWd30HS0DbvLhsfvZvX9S0ap1cmyREFFLk//48tse2kv7rSUMXV0Ww0Ot4M7n1xHdtHlhZhn5vtZesd8dm88yNPffol9rx9BkiWCvUN0NveSluUlI98/Zr+e1n5++v/9BlESySnOxOVzIZASZGg43IIoiiy/ewF5Z3h9kqpG7d4GGqtaSURVYuE4kWCUuCyx+ent1B1owuGy483wsPK+RTjdqXux8t7FHHjzKFt+s4v/+uovmTq/DJtdYaA7wEBXkJnLp3Lw7dH1ZcpmF/HgH93JT//meX7wl88wa8U0fBkeEnGVxqpWTp7o4u6nbuKmR1dd9kLYtIVlPP5XD/CTv/kNP/z6s1TMLyU9xzdcoDjBYHcQgKe++RHLmJokZqUtZUvvBnoT7ZS5p1PkmvyCyLPTlhLXoxwY3MKe/s3o6LgkDwXOMu7Kewyv4qchPFYFNZQcpCd+EgOd1kgdbZHxF5ZL3ZXkFBeMGFO6qVEd3MvW3g1oZsqYShoqJibVwb3Uhg4jCzJ20cnyzNu4OffBy77GRelrSRoJDgW2s7PvVQwM3JKXIlcF9xR8HBOd5nHkxC+VpJHg0OA29gy8mZKXNzW04WvcP7CVw4GdyIKMS/KwNvteVtrvAFIeJo+cxl35j5He/wa1oUO83fMisqBQ4CxjecatGKbOq13Pjtvu4vT1eOV0jgZ30xytpSF0FM1MYhed+G1ZTPXMIddRPEYN8P2McJ4wnkmNRjFNk2RSp78/THi4qrkkibjddjIyPeMWao1GE6naQ4lzSzs7nAr5BemjjqFpOoMDEQKBKMmkjiyJuD12MrO82O0yDfXdiKJI+ZTTsbeGYdDY0INpmOQVpI8r037y5ABDwRiZWR5yz5A77+sL0dMVPO99yC9Ix58+Or8lkUjS2xMiEo5jmGZKftznJCvbi6qmPHJZOV4yMk7XQNmx/QT//K0NTJuWx//5+4dJJJIEBqMkkxqKnPLWZWZ5x+RspXLKhujrPU/tIUEgM9ND7rASk2maNDf1kkho5OT6xlVl7O1JHdeX5hxlMJ7ZdjgcZ3AgQjyuousGkiTicNjw+Zx4fY5xixq/V0jlAOn0hCOE4glUQ6e6q4f/7/W3mJOXw9/ecQvz8sdXdgzEYvSEI8SGZcxdNoVcjxuXzcbJQJC4pg0LXYxdnY4nk6k2EypJQ0dAwC5LeO12MlzO8+ZCDcZi9IYjxIZrJ8mihMduo8SfNuo7DMbiNA4MnPc+eOx2pmZmjNo3rml0DoUIJRIYpolNkkh3Osn1eognk9T3D5Dv9Y7K/dpUc4Kvb9rMvPxcvv/gvYTVJAPRKEldR5EkMpxOcryeMWGQumHQHQrTHZ5YihZSKbI5HjcFaamcQtM0qe3tQ9V1Cnw+ssZRZewYGqInFCHD5aT4rPsDYJgmQ/E4fZEo0WQS3TCRRRGnIuN3OvE7HcjvQc/rZPPuC3v4f1/5BQOdgREBiLPxZnj4g394lFsfXwOkVPKe/vZLbPzx2+iaga7pqPHhZ1aRkG0ykiTiy/LyT5v+ktySlPHx53d8i5q9DfzBtz+KJIm89rMtNB87iSRJzFwxlbs/dROLbpmL66z+fu9rR/jel38CgsBPq79zXkPBNE26mnt59adb2PbSXvrbB5AUmSnzSrjryfXkl2fzv3/5DEXT8vnS954cEWYIDYTZ+ON32LXxAO11XYQDURDAl+mlcmEZtzy2OuUNSj/d50aCUX7xzRd4/RfvYug6umacvhc2GVmRkGSRzPx0vrXhz0cMRdM06e8Y5M1nd/DWM9vpaOzB7rQxf90sHvzC7TQeaeV///JpvvHMl1l6x7yRa07EVBqOtPDqT7Zw4K2jBHqGcLrtVCwo5baPrWXJbfNGFTzWVI0nKv8Yl8/Fl773JPPXzRx1r9pOdPKdT/8PtXsb+VX9f4wyjLSkRlNVG28/t5P9b1TR1dyDSarQc8mMAlbdv4RV9y0eU4PsRiNpJOhLdJM04uQ5Sy9LPe2/6/+GlugJVmbezj0FTyAJ46+1m6bJkDZIQO3Fp6QP15m6sP4saagEkv3E9dQCiCzKuCQvPiUDzUzSHW8jTcnEK/tH+lXViNOf6EY1zl0+wy46ybTnjaj7GabBUHKAYPLc+bgg4FPSSbdlj1xfV7wNzVTxK1l4Ff+YPQJqH0PJAVyyj8yzalypRoKA2kfCiA1fo4J7+BoTRozeRAcZtlxcUmoul9Dj9CU6sUkOMmw5SIKEaiToS3QiC8pI0d6kodKX6EQURDJteciigmHqBNQ+QucJqRMQSbNlkKaMXiwyTYOYHmEoOYhqJIYl0T34lHSShkq/2o1ruHDw2RhmSuo9pAVJGgkM00ASJGyiA5fswSV5R+VhvU+YcIXhqhpTFpPLKWOqYmouf/sPj4wpomtxfRBOqPzJyxt5t6mZm6ZO4a9uWUfR8OT9eov7vt44ZUzNycvhvx6+/5oq9llMLklVIxFNnLOYuyAI2F22EaEB0zRJRFXUxLkLpguCgNvnRBz2cv/5Hd/i+N4GvvjdT3DLR1ejxlV0TQdSSn42hzJGDh1SBkE8mhJkcKeNFXgZD9M0Ux7/eHJYue90G4IgEI8kECQBxxm5waZpoqkaSVUbpVIniAKSkhJaOPv8TMMkHkuQPM9C49n3YqS9pI4aV4fV81JhhDanDS2pkYgkcHocSGcJgZiGiZpIkkxomIaRKpMxfG2iJI7e1jSJBKIgCDjc9jEGs64bxCNxdM3A43eNMlRPzUuSCY2kmhxR+BNEEUkSUewykjz5IiU3KgOJHr5X9zVEQebDxZ9jum/htT4lC4vrkQk7nKsW5mdhcaPitil89aY19EUjvFXfSDAe51/uvZOCa6g+Z2FxrVFs8gVLZp9CGJ6YO8Yoxl04siIhKxOXERi1rU3GcwnnaLMrEyrNuXxj2xYEAcWuXFQtKUEUcLodOC8htWUkB2ucazvXuQuigN1pwz5OFMl4bXjSJz45SRJx+8ZXJjxlJNkcCrZJyBOzmBjD1DkYeJeEEafEPY0pntnX+pQsLN5zvO98cBYW1xunag/91c3rWF5SRExN0hcZW9vBwsLCwsLiSqPqCVQ9TkyL0BA+xqHBbYiCyKrMO69YEVwLi/czlmfKwuIqIIkii4sK+fot61F1nVm511eNDAsLCwuLG4NDge20RGvRTY32aBN9ahdLM25ipm/xtT41C4v3JJYxZWFxlRBFgek5164WkoWFhYWFxUCyh+rgHhJGnHQlm5tzHmJ55i3IghVSaWFxKVgCFO9hVFUjGkmkYs89jjGqfRYW73VOFQ+WRRGf4/KKeVvcuIQGw2hJHZfXeUH5PhYW72cSepykmcA0QRREbKIdWVCs/tXC4txYan4WFhYWFhYWFhYWFhaXwITGlCVAYWFhYWFhYWFhYWFhcQlYxpSFhYWFhYWFhYWFhcUlYBlTFhYWFhYWFhYWFhYWl4BlTFlYWFhYWFhYWFhYWFwC55NGt6RdLCwsLCwsLCwsLCwsxsHyTFlYWFhYWFhYWFhYWFwCljFlYWFhYWFhYWFhYWFxCVjGlIWFhYWFhYWFhYWFxSVgGVMWFhYWFhYWFhYWFhaXgGVMWVhYWFhYWFhYWFhYXAKWMWVhYWFhYWFhYWFhYXEJ/P8N+gj6xvHfjAAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 1080x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "#convert list to string and generate\n",
    "unique_string=(\" \").join(sensitive_drugs)\n",
    "#maskArray = npy.array(Image.open(\"Downloads/shild.jpg\"))\n",
    "wordcloud = WordCloud(width = 1000, height = 500,background_color=\"white\").generate(unique_string)\n",
    "plt.figure(figsize=(15,8))\n",
    "plt.imshow(wordcloud)\n",
    "plt.axis(\"off\")\n",
    "plt.savefig(\"your_file_name\"+\".png\", bbox_inches='tight')\n",
    "plt.show()\n",
    "plt.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "snomed_senstive_info = []\n",
    "for item in sensitive_diseases:\n",
    "    info = SNOMEDCT.search(item)\n",
    "    snomed_senstive_info.append(info)\n",
    "    \n",
    "snomed_senstive_drug_info = []\n",
    "for item in sensitive_drugs :\n",
    "    info = SNOMEDCT.search(item)\n",
    "    snomed_senstive_drug_info.append(info)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[SNOMEDCT[116084008]  # Product containing abacavir (medicinal product),\n",
       " SNOMEDCT[134571004]  # Product containing abacavir and lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[324881002]  # Product containing precisely abacavir (as abacavir sulfate) 20 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[377159003]  # Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[387005008]  # Abacavir (substance),\n",
       " SNOMEDCT[412074007]  # Abacavir sulfate (substance),\n",
       " SNOMEDCT[413381000]  # Product containing abacavir and lamivudine (medicinal product),\n",
       " SNOMEDCT[713707006]  # Allergy to abacavir (finding),\n",
       " SNOMEDCT[714224008]  # Product containing abacavir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714223002]  # Product containing abacavir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714769003]  # Product containing abacavir and dolutegravir and lamivudine (medicinal product),\n",
       " SNOMEDCT[714770002]  # Product containing abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[767894003]  # Product containing abacavir and lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772187006]  # Product containing only abacavir (medicinal product),\n",
       " SNOMEDCT[772188001]  # Product containing only abacavir and lamivudine (medicinal product),\n",
       " SNOMEDCT[772196006]  # Product containing only abacavir and dolutegravir and lamivudine (medicinal product),\n",
       " SNOMEDCT[772197002]  # Product containing only abacavir and lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[772248000]  # Product containing only abacavir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772249008]  # Product containing only abacavir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772250008]  # Product containing only abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772251007]  # Product containing only abacavir and lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[783128003]  # Product containing precisely abacavir (as abacavir sulfate) 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[783301004]  # Product containing precisely abacavir (as abacavir sulfate) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[19194001]  # Product containing didanosine (medicinal product),\n",
       " SNOMEDCT[292832009]  # Didanosine adverse reaction (disorder),\n",
       " SNOMEDCT[294372006]  # Allergy to didanosine (finding),\n",
       " SNOMEDCT[324803002]  # Product containing precisely didanosine 150 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324804008]  # Product containing precisely didanosine 25 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324805009]  # Product containing precisely didanosine 100 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324811007]  # Product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule (clinical drug),\n",
       " SNOMEDCT[324812000]  # Product containing precisely didanosine 250 milligram/1 each gastro-resistant oral capsule (clinical drug),\n",
       " SNOMEDCT[324813005]  # Product containing precisely didanosine 200 milligram/1 each gastro-resistant oral capsule (clinical drug),\n",
       " SNOMEDCT[324814004]  # Product containing precisely didanosine 125 milligram/1 each gastro-resistant oral capsule (clinical drug),\n",
       " SNOMEDCT[324815003]  # Product containing precisely didanosine 200 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[376707007]  # Product containing precisely didanosine 50 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[376708002]  # Product containing precisely didanosine 125 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[376709005]  # Product containing precisely didanosine 200 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[376710000]  # Product containing precisely didanosine 250 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[387105006]  # Didanosine (substance),\n",
       " SNOMEDCT[767733002]  # Product containing didanosine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[775569007]  # Product containing only didanosine (medicinal product),\n",
       " SNOMEDCT[778996003]  # Product containing only didanosine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[784898001]  # Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[784897006]  # Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[784896002]  # Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[784899009]  # Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[404855005]  # Product containing emtricitabine (medicinal product),\n",
       " SNOMEDCT[404856006]  # Emtricitabine (substance),\n",
       " SNOMEDCT[409211007]  # Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[414090006]  # Product containing emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[414091005]  # Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[424437001]  # Product containing efavirenz and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[424646001]  # Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[709133005]  # Product containing emtricitabine and rilpivirine and tenofovir (medicinal product),\n",
       " SNOMEDCT[714261004]  # Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714403000]  # Product containing emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714864004]  # Product containing emtricitabine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[734148003]  # Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[734149006]  # Product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[734150006]  # Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[766475008]  # Product containing precisely emtricitabine 10 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[772093001]  # Product containing bictegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[772094007]  # Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[774856007]  # Product containing only bictegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775343002]  # Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775736005]  # Product containing only efavirenz and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775755005]  # Product containing only emtricitabine (medicinal product),\n",
       " SNOMEDCT[775756006]  # Product containing only emtricitabine and rilpivirine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775757002]  # Product containing only emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[778517003]  # Product containing only bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[778836000]  # Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779099001]  # Product containing only efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779112008]  # Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779113003]  # Product containing only emtricitabine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[108698001]  # Product containing lamivudine (medicinal product),\n",
       " SNOMEDCT[134571004]  # Product containing abacavir and lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[324823001]  # Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324825008]  # Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[324827000]  # Product containing precisely lamivudine 5 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[324829002]  # Product containing precisely lamivudine 100 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324859007]  # Product containing lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[324860002]  # Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[377159003]  # Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[386897000]  # Lamivudine (substance),\n",
       " SNOMEDCT[407791001]  # Product containing precisely lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[413381000]  # Product containing abacavir and lamivudine (medicinal product),\n",
       " SNOMEDCT[424990009]  # Product containing lamivudine and nevirapine and zidovudine (medicinal product),\n",
       " SNOMEDCT[422889000]  # Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[425514002]  # Product containing lamivudine and stavudine (medicinal product),\n",
       " SNOMEDCT[425922001]  # Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[428684004]  # Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[429473005]  # Product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[429606009]  # Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[428009005]  # Product containing lamivudine and nevirapine and stavudine (medicinal product),\n",
       " SNOMEDCT[443147007]  # Product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[443064007]  # Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[443188007]  # Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[714224008]  # Product containing abacavir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714530007]  # Product containing lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714405007]  # Product containing lamivudine and nevirapine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714531006]  # Product containing lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714532004]  # Product containing lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714769003]  # Product containing abacavir and dolutegravir and lamivudine (medicinal product),\n",
       " SNOMEDCT[714770002]  # Product containing abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[767894003]  # Product containing abacavir and lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772188001]  # Product containing only abacavir and lamivudine (medicinal product),\n",
       " SNOMEDCT[772196006]  # Product containing only abacavir and dolutegravir and lamivudine (medicinal product),\n",
       " SNOMEDCT[772197002]  # Product containing only abacavir and lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[772249008]  # Product containing only abacavir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772250008]  # Product containing only abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772251007]  # Product containing only abacavir and lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772548004]  # Product containing lamivudine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[776465009]  # Product containing only lamivudine (medicinal product),\n",
       " SNOMEDCT[776466005]  # Product containing only lamivudine and nevirapine and stavudine (medicinal product),\n",
       " SNOMEDCT[776467001]  # Product containing only lamivudine and nevirapine and zidovudine (medicinal product),\n",
       " SNOMEDCT[776468006]  # Product containing only lamivudine and stavudine (medicinal product),\n",
       " SNOMEDCT[776469003]  # Product containing only lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[779648009]  # Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779649001]  # Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779650001]  # Product containing only lamivudine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779651002]  # Product containing only lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779652009]  # Product containing only lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[781508002]  # Product containing only doravirine and lamivudine and tenofovir (medicinal product),\n",
       " SNOMEDCT[781506003]  # Product containing doravirine and lamivudine and tenofovir (medicinal product),\n",
       " SNOMEDCT[781511001]  # Product containing doravirine and lamivudine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[781512008]  # Product containing only doravirine and lamivudine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[783301004]  # Product containing precisely abacavir (as abacavir sulfate) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[785531009]  # Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[786234008]  # Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[787163007]  # Product containing dolutegravir and lamivudine (medicinal product),\n",
       " SNOMEDCT[787164001]  # Product containing only dolutegravir and lamivudine (medicinal product),\n",
       " SNOMEDCT[787165000]  # Product containing dolutegravir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[787166004]  # Product containing only dolutegravir and lamivudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[108690008]  # Product containing stavudine (medicinal product),\n",
       " SNOMEDCT[324831006]  # Product containing precisely stavudine 15 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324833009]  # Product containing precisely stavudine 20 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324835002]  # Product containing precisely stavudine 30 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324837005]  # Product containing precisely stavudine 40 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324839008]  # Product containing precisely stavudine 1 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[386895008]  # Stavudine (substance),\n",
       " SNOMEDCT[425514002]  # Product containing lamivudine and stavudine (medicinal product),\n",
       " SNOMEDCT[425922001]  # Product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[428684004]  # Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[429473005]  # Product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[429606009]  # Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[428009005]  # Product containing lamivudine and nevirapine and stavudine (medicinal product),\n",
       " SNOMEDCT[443064007]  # Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[443188007]  # Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[714405007]  # Product containing lamivudine and nevirapine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714404006]  # Product containing stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[772548004]  # Product containing lamivudine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[776466005]  # Product containing only lamivudine and nevirapine and stavudine (medicinal product),\n",
       " SNOMEDCT[776468006]  # Product containing only lamivudine and stavudine (medicinal product),\n",
       " SNOMEDCT[777609003]  # Product containing only stavudine (medicinal product),\n",
       " SNOMEDCT[779648009]  # Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779650001]  # Product containing only lamivudine and stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780517007]  # Product containing only stavudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[785531009]  # Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[786234008]  # Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[385556006]  # Tenofovir disoproxil fumarate (substance),\n",
       " SNOMEDCT[395264002]  # Product containing tenofovir (medicinal product),\n",
       " SNOMEDCT[407808007]  # Product containing precisely tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[414090006]  # Product containing emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[414091005]  # Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[421203005]  # Tenofovir disoproxil (substance),\n",
       " SNOMEDCT[422091007]  # Tenofovir (substance),\n",
       " SNOMEDCT[424437001]  # Product containing efavirenz and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[424646001]  # Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[709133005]  # Product containing emtricitabine and rilpivirine and tenofovir (medicinal product),\n",
       " SNOMEDCT[714261004]  # Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714403000]  # Product containing emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714402005]  # Product containing tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[715220007]  # Tenofovir alafenamide (substance),\n",
       " SNOMEDCT[734148003]  # Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[734149006]  # Product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[734150006]  # Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[734973002]  # Tenofovir alafenamide fumarate (substance),\n",
       " SNOMEDCT[772093001]  # Product containing bictegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[772094007]  # Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[774856007]  # Product containing only bictegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775343002]  # Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775736005]  # Product containing only efavirenz and emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775756006]  # Product containing only emtricitabine and rilpivirine and tenofovir (medicinal product),\n",
       " SNOMEDCT[775757002]  # Product containing only emtricitabine and tenofovir (medicinal product),\n",
       " SNOMEDCT[777706000]  # Product containing only tenofovir (medicinal product),\n",
       " SNOMEDCT[778517003]  # Product containing only bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[778836000]  # Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779099001]  # Product containing only efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779112008]  # Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780583000]  # Product containing only tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[781508002]  # Product containing only doravirine and lamivudine and tenofovir (medicinal product),\n",
       " SNOMEDCT[781506003]  # Product containing doravirine and lamivudine and tenofovir (medicinal product),\n",
       " SNOMEDCT[781511001]  # Product containing doravirine and lamivudine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[781512008]  # Product containing only doravirine and lamivudine and tenofovir in oral dose form (medicinal product form),\n",
       " SNOMEDCT[27479000]  # Product containing zidovudine (medicinal product),\n",
       " SNOMEDCT[134571004]  # Product containing abacavir and lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[292828003]  # Zidovudine adverse reaction (disorder),\n",
       " SNOMEDCT[294369004]  # Allergy to zidovudine (finding),\n",
       " SNOMEDCT[324765001]  # Product containing precisely zidovudine 100 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324767009]  # Product containing precisely zidovudine 250 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324859007]  # Product containing lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[324860002]  # Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[376938001]  # Product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[377159003]  # Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[387151007]  # Zidovudine (substance),\n",
       " SNOMEDCT[424990009]  # Product containing lamivudine and nevirapine and zidovudine (medicinal product),\n",
       " SNOMEDCT[422889000]  # Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[431071006]  # Product containing zidovudine in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[431068003]  # Product containing zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[443147007]  # Product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[443151009]  # Product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[713496008]  # Anemia caused by zidovudine (disorder),\n",
       " SNOMEDCT[714531006]  # Product containing lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714532004]  # Product containing lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[767894003]  # Product containing abacavir and lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[769137004]  # Product containing precisely zidovudine 10 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[772197002]  # Product containing only abacavir and lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[772251007]  # Product containing only abacavir and lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[776467001]  # Product containing only lamivudine and nevirapine and zidovudine (medicinal product),\n",
       " SNOMEDCT[776469003]  # Product containing only lamivudine and zidovudine (medicinal product),\n",
       " SNOMEDCT[777973001]  # Product containing only zidovudine (medicinal product),\n",
       " SNOMEDCT[779649001]  # Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779651002]  # Product containing only lamivudine and zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780794003]  # Product containing only zidovudine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780795002]  # Product containing only zidovudine in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[67933004]  # Poisoning caused by isoniazid (disorder),\n",
       " SNOMEDCT[81335000]  # Product containing isoniazid (medicinal product),\n",
       " SNOMEDCT[291679008]  # Accidental isoniazid poisoning (disorder),\n",
       " SNOMEDCT[291680006]  # Intentional isoniazid poisoning (disorder),\n",
       " SNOMEDCT[291681005]  # Isoniazid poisoning of undetermined intent (disorder),\n",
       " SNOMEDCT[293078009]  # Isoniazid adverse reaction (disorder),\n",
       " SNOMEDCT[294614007]  # Allergy to isoniazid (finding),\n",
       " SNOMEDCT[296795002]  # Isoniazid overdose (disorder),\n",
       " SNOMEDCT[296796001]  # Accidental isoniazid overdose (disorder),\n",
       " SNOMEDCT[296797005]  # Intentional isoniazid overdose (disorder),\n",
       " SNOMEDCT[296798000]  # Isoniazid overdose of undetermined intent (disorder),\n",
       " SNOMEDCT[324471006]  # Product containing precisely isoniazid 50 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324472004]  # Product containing precisely isoniazid 100 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324500006]  # Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324501005]  # Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[346670008]  # Product containing isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[346671007]  # Product containing isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[346672000]  # Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[377060006]  # Product containing precisely isoniazid 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[377513007]  # Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[387472004]  # Isoniazid (substance),\n",
       " SNOMEDCT[413046006]  # Urine isoniazid measurement (procedure),\n",
       " SNOMEDCT[414546009]  # Isoniazid resistant tuberculosis (disorder),\n",
       " SNOMEDCT[438201006]  # Product containing isoniazid in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[440247002]  # Product containing isoniazid in oral dose form (medicinal product form),\n",
       " SNOMEDCT[713450000]  # Neuropathy caused by isoniazid (disorder),\n",
       " SNOMEDCT[713918001]  # Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[713917006]  # Product containing isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714396002]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714391007]  # Product containing ethambutol and isoniazid in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714390008]  # Product containing ethambutol and isoniazid (medicinal product),\n",
       " SNOMEDCT[714392000]  # Product containing ethambutol and isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[714395003]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[714393005]  # Product containing ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[766485009]  # Product containing precisely isoniazid 10 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[775856003]  # Product containing only ethambutol and isoniazid (medicinal product),\n",
       " SNOMEDCT[775857007]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[775858002]  # Product containing only ethambutol and isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[776412002]  # Product containing only isoniazid (medicinal product),\n",
       " SNOMEDCT[776413007]  # Product containing only isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[776414001]  # Product containing only isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[779197001]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779198006]  # Product containing only ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779199003]  # Product containing only ethambutol and isoniazid in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779597007]  # Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779598002]  # Product containing only isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779599005]  # Product containing only isoniazid in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779600008]  # Product containing only isoniazid in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[781948002]  # Product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection (clinical drug),\n",
       " SNOMEDCT[29175007]  # Product containing rifampicin (medicinal product),\n",
       " SNOMEDCT[212509008]  # Rifampicin poisoning (disorder),\n",
       " SNOMEDCT[293075007]  # Rifampicin adverse reaction (disorder),\n",
       " SNOMEDCT[294611004]  # Allergy to rifampicin (finding),\n",
       " SNOMEDCT[324479008]  # Product containing precisely rifampicin 150 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324480006]  # Product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[324500006]  # Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324501005]  # Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[346670008]  # Product containing isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[346671007]  # Product containing isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[346672000]  # Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[387159009]  # Rifampicin (substance),\n",
       " SNOMEDCT[408226003]  # Urine rifampicin level (procedure),\n",
       " SNOMEDCT[415345001]  # Rifampicin resistant tuberculosis (disorder),\n",
       " SNOMEDCT[438137009]  # Product containing rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[437966009]  # Product containing rifampicin in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[713918001]  # Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[713917006]  # Product containing isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714396002]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714392000]  # Product containing ethambutol and isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[714395003]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[714393005]  # Product containing ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[377513007]  # Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[735167006]  # Rifampicin sodium (substance),\n",
       " SNOMEDCT[766163008]  # Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for injection (clinical drug),\n",
       " SNOMEDCT[769135007]  # Product containing precisely rifampicin 20 milligram/1 milliliter conventional release oral suspension (clinical drug),\n",
       " SNOMEDCT[775857007]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[775858002]  # Product containing only ethambutol and isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[776413007]  # Product containing only isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[776414001]  # Product containing only isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[777438009]  # Product containing only rifampicin (medicinal product),\n",
       " SNOMEDCT[779197001]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779198006]  # Product containing only ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779597007]  # Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779598002]  # Product containing only isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780371001]  # Product containing only rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780372008]  # Product containing only rifampicin in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[13592004]  # Product containing pyrazinamide (medicinal product),\n",
       " SNOMEDCT[121674008]  # Pyrazinamide measurement (procedure),\n",
       " SNOMEDCT[293071003]  # Pyrazinamide adverse reaction (disorder),\n",
       " SNOMEDCT[294607005]  # Allergy to pyrazinamide (finding),\n",
       " SNOMEDCT[324477005]  # Product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[346671007]  # Product containing isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[346672000]  # Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[387076005]  # Pyrazinamide (substance),\n",
       " SNOMEDCT[415222009]  # Pyrazinamide resistant tuberculosis (disorder),\n",
       " SNOMEDCT[713918001]  # Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714396002]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714437008]  # Product containing pyrazinamide in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714395003]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[775857007]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[776413007]  # Product containing only isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[777364002]  # Product containing only pyrazinamide (medicinal product),\n",
       " SNOMEDCT[779197001]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779597007]  # Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780327000]  # Product containing only pyrazinamide in oral dose form (medicinal product form),\n",
       " SNOMEDCT[14607001]  # Poisoning caused by ethambutol (disorder),\n",
       " SNOMEDCT[24450004]  # Product containing ethambutol (medicinal product),\n",
       " SNOMEDCT[26346008]  # Ethambutol hydrochloride (substance),\n",
       " SNOMEDCT[105179001]  # Ethambutol measurement (procedure),\n",
       " SNOMEDCT[291682003]  # Accidental ethambutol poisoning (disorder),\n",
       " SNOMEDCT[291683008]  # Intentional ethambutol poisoning (disorder),\n",
       " SNOMEDCT[291684002]  # Ethambutol poisoning of undetermined intent (disorder),\n",
       " SNOMEDCT[296799008]  # Ethambutol overdose (disorder),\n",
       " SNOMEDCT[296800007]  # Accidental ethambutol overdose (disorder),\n",
       " SNOMEDCT[296801006]  # Intentional ethambutol overdose (disorder),\n",
       " SNOMEDCT[296802004]  # Ethambutol overdose of undetermined intent (disorder),\n",
       " SNOMEDCT[324466004]  # Product containing precisely ethambutol hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[324467008]  # Product containing precisely ethambutol hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[387129004]  # Ethambutol (substance),\n",
       " SNOMEDCT[408225004]  # Urine ethambutol level (procedure),\n",
       " SNOMEDCT[293079001]  # Ethambutol adverse reaction (disorder),\n",
       " SNOMEDCT[414146004]  # Ethambutol resistant tuberculosis (disorder),\n",
       " SNOMEDCT[714396002]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714391007]  # Product containing ethambutol and isoniazid in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714390008]  # Product containing ethambutol and isoniazid (medicinal product),\n",
       " SNOMEDCT[714388007]  # Product containing ethambutol in oral dose form (medicinal product form),\n",
       " SNOMEDCT[714392000]  # Product containing ethambutol and isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[714395003]  # Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[714393005]  # Product containing ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[775855004]  # Product containing only ethambutol (medicinal product),\n",
       " SNOMEDCT[775856003]  # Product containing only ethambutol and isoniazid (medicinal product),\n",
       " SNOMEDCT[775857007]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product),\n",
       " SNOMEDCT[775858002]  # Product containing only ethambutol and isoniazid and rifampicin (medicinal product),\n",
       " SNOMEDCT[779197001]  # Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779198006]  # Product containing only ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779199003]  # Product containing only ethambutol and isoniazid in oral dose form (medicinal product form),\n",
       " SNOMEDCT[779200000]  # Product containing only ethambutol in oral dose form (medicinal product form),\n",
       " SNOMEDCT[294615008]  # Allergy to ethambutol (finding),\n",
       " SNOMEDCT[108386000]  # Product containing risperidone (medicinal product),\n",
       " SNOMEDCT[121681001]  # Risperidone measurement (procedure),\n",
       " SNOMEDCT[291134005]  # Risperidone poisoning (disorder),\n",
       " SNOMEDCT[291135006]  # Accidental risperidone poisoning (disorder),\n",
       " SNOMEDCT[291136007]  # Intentional risperidone poisoning (disorder),\n",
       " SNOMEDCT[291137003]  # Risperidone poisoning of undetermined intent (disorder),\n",
       " SNOMEDCT[292375007]  # Risperidone adverse reaction (disorder),\n",
       " SNOMEDCT[293917005]  # Allergy to risperidone (finding),\n",
       " SNOMEDCT[296169008]  # Risperidone overdose (disorder),\n",
       " SNOMEDCT[296170009]  # Accidental risperidone overdose (disorder),\n",
       " SNOMEDCT[296171008]  # Intentional risperidone overdose (disorder),\n",
       " SNOMEDCT[296172001]  # Risperidone overdose of undetermined intent (disorder),\n",
       " SNOMEDCT[321589009]  # Product containing precisely risperidone 1 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321590000]  # Product containing precisely risperidone 2 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321591001]  # Product containing precisely risperidone 3 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321592008]  # Product containing precisely risperidone 4 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321597002]  # Product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution (clinical drug),\n",
       " SNOMEDCT[321599004]  # Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321602009]  # Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[376595006]  # Product containing precisely risperidone 250 microgram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[386840002]  # Risperidone (substance),\n",
       " SNOMEDCT[407748006]  # Product containing risperidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[407749003]  # Product containing risperidone in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[408011009]  # Product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[408012002]  # Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[416497001]  # Product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[444736001]  # Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[444806003]  # Product containing precisely risperidone 4 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[769212002]  # Product containing precisely risperidone 12.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug),\n",
       " SNOMEDCT[769213007]  # Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug),\n",
       " SNOMEDCT[769214001]  # Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug),\n",
       " SNOMEDCT[769215000]  # Product containing precisely risperidone 50 milligram/1 vial powder for conventional release suspension for injection (clinical drug),\n",
       " SNOMEDCT[777450003]  # Product containing only risperidone (medicinal product),\n",
       " SNOMEDCT[780381002]  # Product containing only risperidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780382009]  # Product containing only risperidone in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[784240003]  # Product containing risperidone in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[784241004]  # Product containing only risperidone in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[108441004]  # Product containing olanzapine (medicinal product),\n",
       " SNOMEDCT[121414009]  # Olanzapine measurement (procedure),\n",
       " SNOMEDCT[321612002]  # Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321613007]  # Product containing precisely olanzapine 7.5 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321614001]  # Product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321618003]  # Product containing precisely olanzapine 2.5 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321622008]  # Product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[321623003]  # Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[374054003]  # Product containing precisely olanzapine 20 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[376807001]  # Product containing precisely olanzapine 15 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[386213008]  # Product containing precisely olanzapine 20 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[386849001]  # Olanzapine (substance),\n",
       " SNOMEDCT[407922008]  # Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug),\n",
       " SNOMEDCT[409170007]  # Product containing fluoxetine and olanzapine (medicinal product),\n",
       " SNOMEDCT[409171006]  # Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[409172004]  # Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[409173009]  # Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[409174003]  # Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[410934006]  # Product containing olanzapine in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[424274004]  # Product containing olanzapine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[430084007]  # Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[725800004]  # Olanzapine embonate (substance),\n",
       " SNOMEDCT[725801000]  # Olanzapine embonate monohydrate (substance),\n",
       " SNOMEDCT[735189005]  # Olanzapine pamoate (substance),\n",
       " SNOMEDCT[772468008]  # Product containing fluoxetine and olanzapine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[776004002]  # Product containing only fluoxetine and olanzapine (medicinal product),\n",
       " SNOMEDCT[776977006]  # Product containing only olanzapine (medicinal product),\n",
       " SNOMEDCT[779294001]  # Product containing only fluoxetine and olanzapine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780053004]  # Product containing only olanzapine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780054005]  # Product containing only olanzapine in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[785554000]  # Product containing olanzapine in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[786259004]  # Product containing only olanzapine in oromucosal dose form (medicinal product form),\n",
       " SNOMEDCT[108383008]  # Quetiapine fumarate (substance),\n",
       " SNOMEDCT[108443001]  # Product containing quetiapine (medicinal product),\n",
       " SNOMEDCT[321624009]  # Product containing precisely quetiapine (as quetiapine fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321625005]  # Product containing precisely quetiapine (as quetiapine fumarate) 100 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[321626006]  # Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[386850001]  # Quetiapine (substance),\n",
       " SNOMEDCT[426802009]  # Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet (clinical drug),\n",
       " SNOMEDCT[426401009]  # Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each prolonged-release oral tablet (clinical drug),\n",
       " SNOMEDCT[426954000]  # Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet (clinical drug),\n",
       " SNOMEDCT[428990002]  # Measurement of quetiapine (procedure),\n",
       " SNOMEDCT[429830008]  # Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[429826005]  # Product containing precisely quetiapine fumarate 400 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[441607005]  # Product containing precisely quetiapine fumarate 50 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[767770006]  # Product containing quetiapine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[777377006]  # Product containing only quetiapine (medicinal product),\n",
       " SNOMEDCT[780334003]  # Product containing only quetiapine in oral dose form (medicinal product form),\n",
       " SNOMEDCT[783585006]  # Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug),\n",
       " SNOMEDCT[129479007]  # Ziprasidone hydrochloride (substance),\n",
       " SNOMEDCT[373389002]  # Product containing ziprasidone (medicinal product),\n",
       " SNOMEDCT[375160007]  # Product containing precisely ziprasidone (as ziprasidone hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[375161006]  # Product containing precisely ziprasidone hydrochloride 40 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[375162004]  # Product containing precisely ziprasidone (as ziprasidone hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[375163009]  # Product containing precisely ziprasidone hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug),\n",
       " SNOMEDCT[409356003]  # Ziprasidone (substance),\n",
       " SNOMEDCT[409357007]  # Ziprasidone mesilate (substance),\n",
       " SNOMEDCT[428082004]  # Product containing ziprasidone in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[428081006]  # Product containing ziprasidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[777985009]  # Product containing only ziprasidone (medicinal product),\n",
       " SNOMEDCT[780806001]  # Product containing only ziprasidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[780807005]  # Product containing only ziprasidone in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[785103009]  # Product containing precisely ziprasidone (as ziprasidone mesilate) 20 milligram/1 milliliter conventional release solution for injection (clinical drug),\n",
       " SNOMEDCT[426276000]  # Paliperidone (substance),\n",
       " SNOMEDCT[425483000]  # Product containing paliperidone (medicinal product),\n",
       " SNOMEDCT[426125007]  # Product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet (clinical drug),\n",
       " SNOMEDCT[426782001]  # Product containing precisely paliperidone 6 milligram/1 each prolonged-release oral tablet (clinical drug),\n",
       " SNOMEDCT[427321002]  # Product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet (clinical drug),\n",
       " SNOMEDCT[441502006]  # Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug),\n",
       " SNOMEDCT[706896003]  # Paliperidone palmitate (substance),\n",
       " SNOMEDCT[777049007]  # Product containing only paliperidone (medicinal product),\n",
       " SNOMEDCT[784242006]  # Product containing paliperidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[784244007]  # Product containing only paliperidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[703116009]  # Lurasidone hydrochloride (substance),\n",
       " SNOMEDCT[703115008]  # Lurasidone (substance),\n",
       " SNOMEDCT[715585000]  # Product containing lurasidone (medicinal product),\n",
       " SNOMEDCT[715586004]  # Product containing lurasidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[776588007]  # Product containing only lurasidone (medicinal product),\n",
       " SNOMEDCT[779756002]  # Product containing only lurasidone in oral dose form (medicinal product form),\n",
       " SNOMEDCT[409405006]  # Product containing bevacizumab (medicinal product),\n",
       " SNOMEDCT[409406007]  # Bevacizumab (substance),\n",
       " SNOMEDCT[714213006]  # Product containing bevacizumab in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[774850001]  # Product containing only bevacizumab (medicinal product),\n",
       " SNOMEDCT[778511002]  # Product containing only bevacizumab in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[781788003]  # Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug),\n",
       " SNOMEDCT[51326002]  # Product containing carmustine (medicinal product),\n",
       " SNOMEDCT[290623001]  # Carmustine poisoning (disorder),\n",
       " SNOMEDCT[290624007]  # Accidental carmustine poisoning (disorder),\n",
       " SNOMEDCT[290625008]  # Intentional carmustine poisoning (disorder),\n",
       " SNOMEDCT[290626009]  # Carmustine poisoning of undetermined intent (disorder),\n",
       " SNOMEDCT[292212004]  # Carmustine adverse reaction (disorder),\n",
       " SNOMEDCT[293755005]  # Allergy to carmustine (finding),\n",
       " SNOMEDCT[295645003]  # Carmustine overdose (disorder),\n",
       " SNOMEDCT[295646002]  # Accidental carmustine overdose (disorder),\n",
       " SNOMEDCT[295647006]  # Intentional carmustine overdose (disorder),\n",
       " SNOMEDCT[295648001]  # Carmustine overdose of undetermined intent (disorder),\n",
       " SNOMEDCT[387281007]  # Carmustine (substance),\n",
       " SNOMEDCT[428740009]  # Implantation of carmustine wafer into cerebrum (procedure),\n",
       " SNOMEDCT[766102001]  # Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug),\n",
       " SNOMEDCT[772375005]  # Product containing carmustine in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[775073000]  # Product containing only carmustine (medicinal product),\n",
       " SNOMEDCT[778655003]  # Product containing only carmustine in parenteral dose form (medicinal product form),\n",
       " SNOMEDCT[785911000]  # Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug),\n",
       " SNOMEDCT[786790001]  # Product containing carmustine in prolonged-release intralesional implant (medicinal product form),\n",
       " SNOMEDCT[786927003]  # Product containing only carmustine in prolonged-release intralesional implant (medicinal product form),\n",
       " SNOMEDCT[32514002]  # Clotting factor V assay (procedure),\n",
       " SNOMEDCT[60208008]  # Coagulation factor V (substance),\n",
       " SNOMEDCT[61630008]  # Chondroitin AC lyase (substance),\n",
       " SNOMEDCT[81929006]  # Hemoglobin Raleigh (substance),\n",
       " SNOMEDCT[88776002]  # Hereditary factor V deficiency disease (disorder),\n",
       " SNOMEDCT[246985000]  # Anterior chamber finding (finding),\n",
       " SNOMEDCT[251781009]  # Ocular accommodation convergence/accommodation ratio (observable entity),\n",
       " SNOMEDCT[252578003]  # Air conduction pure tone audiometry, manual with ear phones (procedure),\n",
       " SNOMEDCT[256207005]  # Ethyleneurea,melamineformaldehyde (Fix.Ac) (substance),\n",
       " SNOMEDCT[256240001]  # Alternating current (physical force),\n",
       " SNOMEDCT[307165006]  # Before meal (qualifier value),\n",
       " SNOMEDCT[39845007]  # Anterior colporrhaphy (procedure),\n",
       " SNOMEDCT[251326000]  # Index of orthodontic treatment need - esthetic component (observable entity),\n",
       " SNOMEDCT[34536000]  # Amniocentesis (procedure),\n",
       " SNOMEDCT[9077000]  # Air conduction, function (observable entity),\n",
       " SNOMEDCT[400926009]  # Measurement of ratio of accommodative convergence to accommodation (procedure),\n",
       " SNOMEDCT[411508001]  # Ethyleneurea,melamineformaldehyde (Fix.Ac) (product),\n",
       " SNOMEDCT[417973009]  # Computed tomography of acromioclavicular joint (procedure),\n",
       " SNOMEDCT[246986004]  # Shallow anterior chamber of eye (finding),\n",
       " SNOMEDCT[246990002]  # Medium depth anterior chamber of eye (finding),\n",
       " SNOMEDCT[246991003]  # Deep anterior chamber of eye (finding),\n",
       " SNOMEDCT[301936006]  # Anterior chamber of eye normal (finding),\n",
       " SNOMEDCT[31636006]  # Anterior chamber of eye structure (body structure),\n",
       " SNOMEDCT[34174003]  # Actinium-224 (substance),\n",
       " SNOMEDCT[67098008]  # Actinium-226 (substance),\n",
       " SNOMEDCT[32059002]  # Actinium-225 (substance),\n",
       " SNOMEDCT[32922001]  # Actinium-227 (substance),\n",
       " SNOMEDCT[18743009]  # Actinium-228 (substance),\n",
       " SNOMEDCT[38758005]  # Actinium-229 (substance)]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_snomed_senstive_info=[]\n",
    "for term in snomed_senstive_info:\n",
    "    for term1 in term:\n",
    "        all_snomed_senstive_info.append(term1)\n",
    "#all_snomed_senstive_info     \n",
    "\n",
    "all_snomed_senstive_drug_info=[]\n",
    "for term in snomed_senstive_drug_info:\n",
    "    for term1 in term:\n",
    "        all_snomed_senstive_drug_info.append(term1)\n",
    "all_snomed_senstive_drug_info  \n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['human immunodeficiency virus',\n",
       " 'human immunodeficiency virus infection with infectious mononucleosis-like syndrome',\n",
       " 'feline immunodeficiency virus',\n",
       " 'acquired immune deficiency syndrome',\n",
       " 'simian immunodeficiency virus',\n",
       " 'human immunodeficiency virus infection with acute lymphadenitis',\n",
       " 'fear of contracting human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a3',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b3',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c1',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c2',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c3',\n",
       " 'human immunodeficiency virus world health organization class iv',\n",
       " 'bovine immunodeficiency virus',\n",
       " 'audiovisual aids operator',\n",
       " 'fully mobile',\n",
       " 'human immunodeficiency virus antibody test',\n",
       " 'notification of acquired immune deficiency syndrome',\n",
       " 'human immunodeficiency virus screening',\n",
       " 'mobility aid',\n",
       " 'use of aids for daily life',\n",
       " 'use of kitchen aids',\n",
       " 'use of bathroom aids',\n",
       " 'use of work aids',\n",
       " 'use of indoor mobility aids',\n",
       " 'human aid to communication',\n",
       " 'provision of aids to daily living',\n",
       " 'sharing of sex aids',\n",
       " 'acquired immune deficiency syndrome-related nephropathy',\n",
       " 'aids for severely handicapped',\n",
       " 'human immunodeficiency virus risk lifestyle',\n",
       " 'acquired immunodeficiency syndrome risk behavior knowledge test',\n",
       " 'fear of acquired immunodeficiency syndrome scale',\n",
       " 'learning development aids - handwriting assessment',\n",
       " 'congenital acquired immune deficiency syndrome',\n",
       " 'use of memory retrieval aids',\n",
       " 'ability to mobilize using mobility aids',\n",
       " 'able to mobilize using mobility aids',\n",
       " 'unable to mobilize using mobility aids',\n",
       " 'does mobilize using aids',\n",
       " 'does not mobilize using mobility aids',\n",
       " 'difficulty mobilizing using mobility aids',\n",
       " 'handicapped aids',\n",
       " 'external memory aids training',\n",
       " 'aids to daily living',\n",
       " 'finding related to ability to mobilize using mobility aids',\n",
       " 'finding of use of memory retrieval aids',\n",
       " 'human immunodeficiency virus infection with aseptic meningitis',\n",
       " 'acquired immunodeficiency syndrome clinical trial group',\n",
       " 'pediatric acquired immunodeficiency syndrome clinical trial group',\n",
       " 'leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'hairy leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'neutropenia associated with acquired immunodeficiency syndrome',\n",
       " 'assistive device education',\n",
       " 'acquired immunodeficiency syndrome-associated disorder',\n",
       " 'abnormal weight loss associated with acquired immunodeficiency syndrome',\n",
       " 'acute endocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'myocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'agranulocytosis associated with acquired immunodeficiency syndrome',\n",
       " 'anemia associated with acquired immunodeficiency syndrome',\n",
       " 'acquired hemolytic anemia associated with acquired immunodeficiency syndrome',\n",
       " 'aplastic anemia associated with acquired immunodeficiency syndrome',\n",
       " 'retinopathy associated with acquired immunodeficiency syndrome',\n",
       " 'blindness associated with acquired immunodeficiency syndrome',\n",
       " 'cachexia associated with acquired immunodeficiency syndrome',\n",
       " 'candidiasis of mouth associated with acquired immunodeficiency syndrome',\n",
       " 'central nervous disorder associated with acquired immunodeficiency syndrome',\n",
       " 'central nervous system demyelinating disease associated with acquired immunodeficiency syndrome',\n",
       " 'myelopathy associated with acquired immunodeficiency syndrome',\n",
       " 'coccidioidomycosis associated with acquired immunodeficiency syndrome',\n",
       " 'cryptococcosis associated with acquired immunodeficiency syndrome',\n",
       " 'disseminated candidiasis associated with acquired immunodeficiency syndrome',\n",
       " 'encephalopathy associated with acquired immunodeficiency syndrome',\n",
       " 'dementia associated with acquired immunodeficiency syndrome',\n",
       " 'encephalitis associated with acquired immunodeficiency syndrome',\n",
       " 'encephalomyelitis associated with acquired immunodeficiency syndrome',\n",
       " 'organic brain syndrome associated with acquired immunodeficiency syndrome',\n",
       " 'organic dementia associated with acquired immunodeficiency syndrome',\n",
       " 'presenile dementia associated with acquired immunodeficiency syndrome',\n",
       " 'primary lymphoma of brain associated with acquired immunodeficiency syndrome',\n",
       " 'progressive multifocal leukoencephalopathy associated with acquired immunodeficiency syndrome',\n",
       " 'subacute adenoviral encephalitis associated with acquired immunodeficiency syndrome',\n",
       " 'failure to thrive in infant associated with acquired immunodeficiency syndrome',\n",
       " 'fatigue associated with acquired immunodeficiency syndrome',\n",
       " 'hematopoietic system disease associated with acquired immunodeficiency syndrome',\n",
       " 'hepatomegaly associated with acquired immunodeficiency syndrome',\n",
       " 'herpes zoster associated with acquired immunodeficiency syndrome',\n",
       " 'histoplasmosis associated with acquired immunodeficiency syndrome',\n",
       " 'ill-defined intestinal infection associated with acquired immunodeficiency syndrome',\n",
       " 'infectious gastroenteritis associated with acquired immunodeficiency syndrome',\n",
       " 'noninfectious gastroenteritis associated with acquired immunodeficiency syndrome',\n",
       " 'infective arthritis associated with acquired immunodeficiency syndrome',\n",
       " 'intestinal malabsorption associated with acquired immunodeficiency syndrome',\n",
       " 'low vision associated with acquired immunodeficiency syndrome',\n",
       " 'malaise associated with acquired immunodeficiency syndrome',\n",
       " 'malignant neoplasm associated with acquired immunodeficiency syndrome',\n",
       " \"kaposi's sarcoma associated with acquired immunodeficiency syndrome\",\n",
       " 'reticulosarcoma associated with acquired immunodeficiency syndrome',\n",
       " 'microsporidiosis associated with acquired immunodeficiency syndrome',\n",
       " 'mycobacteriosis associated with acquired immunodeficiency syndrome',\n",
       " 'tuberculosis associated with acquired immunodeficiency syndrome',\n",
       " 'myelitis associated with acquired immunodeficiency syndrome',\n",
       " 'neuralgia associated with acquired immunodeficiency syndrome',\n",
       " 'neuritis associated with acquired immunodeficiency syndrome',\n",
       " 'radiculitis associated with acquired immunodeficiency syndrome',\n",
       " 'nocardiosis associated with acquired immunodeficiency syndrome',\n",
       " 'nutritional deficiency associated with acquired immunodeficiency syndrome',\n",
       " 'pneumocystosis associated with acquired immunodeficiency syndrome',\n",
       " 'pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'bacterial pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'pneumococcal pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'candidiasis of lung associated with acquired immunodeficiency syndrome',\n",
       " 'viral pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'polyneuropathy associated with acquired immunodeficiency syndrome',\n",
       " 'respiratory disorder associated with acquired immunodeficiency syndrome',\n",
       " 'dyspnea associated with acquired immunodeficiency syndrome',\n",
       " 'retinal vascular changes associated with acquired immunodeficiency syndrome',\n",
       " 'salivary gland disease associated with acquired immunodeficiency syndrome',\n",
       " 'salmonella infection associated with acquired immunodeficiency syndrome',\n",
       " 'skin disorder associated with acquired immunodeficiency syndrome',\n",
       " 'dermatomycosis associated with acquired immunodeficiency syndrome',\n",
       " 'hyperhidrosis associated with acquired immunodeficiency syndrome',\n",
       " 'skin rash associated with acquired immunodeficiency syndrome',\n",
       " 'strongyloidiasis associated with acquired immunodeficiency syndrome',\n",
       " 'subacute endocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'subacute myocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'thrombocytopenia associated with acquired immunodeficiency syndrome',\n",
       " 'family history of acquired immune deficiency syndrome',\n",
       " 'cholangitis associated with acquired immunodeficiency syndrome',\n",
       " 'acquired immune deficiency syndrome complicating childbirth',\n",
       " 'kaposi sarcoma not associated with acquired immunodeficiency syndrome',\n",
       " 'assessment using assessment of intelligibility of dysarthric speech',\n",
       " 'assessment of intelligibility of dysarthric speech',\n",
       " 'assessment of intelligibility of dysarthric speech score',\n",
       " 'infection caused by coccidia co-occurrent with acquired immunodeficiency syndrome',\n",
       " 'infection caused by toxoplasma gondii co-occurrent with acquired immunodeficiency syndrome',\n",
       " 'infection caused by isospora co-occurrent with acquired immunodeficiency syndrome',\n",
       " 'assessment using acquired immunodeficiency syndrome risk behavior knowledge test',\n",
       " 'acquired immunodeficiency syndrome risk behavior knowledge test total score',\n",
       " 'human immunodeficiency virus receptor',\n",
       " 'human immunodeficiency virus type 1 dot blot immunobinding assay',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus type 1 passive hemagglutination assay',\n",
       " 'measurement of human immunodeficiency virus 2 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 antibody',\n",
       " 'human immunodeficiency virus antigen test',\n",
       " 'human immunodeficiency virus-2 antigen assay',\n",
       " 'human immunodeficiency virus type 2',\n",
       " 'human immunodeficiency virus type 1 western blot assay',\n",
       " 'human immunodeficiency virus infection with infectious mononucleosis-like syndrome',\n",
       " 'human immunodeficiency virus type 1 radioimmunoprecipitation assay',\n",
       " 'human immunodeficiency virus type 1 antibody confirmatory test',\n",
       " 'congenital human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus type 2 confirmatory assay',\n",
       " 'human immunodeficiency virus 1 enzyme linked immunosorbent assay',\n",
       " 'human immunodeficiency virus-1 indirect immunofluorescence assay',\n",
       " 'human immunodeficiency virus-1 rapid latex agglutination assay',\n",
       " 'human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus infection with acute lymphadenitis',\n",
       " 'human immunodeficiency virus type i',\n",
       " 'asymptomatic human immunodeficiency virus infection',\n",
       " 'asymptomatic human immunodeficiency virus infection in pregnancy',\n",
       " 'antigen of human immunodeficiency virus protein 24',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a1',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a2',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a3',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b1',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b2',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b3',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c1',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c2',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c3',\n",
       " 'human immunodeficiency virus world health organization class i',\n",
       " 'human immunodeficiency virus world health organization class ii',\n",
       " 'human immunodeficiency virus world health organization class iii',\n",
       " 'human immunodeficiency virus world health organization class iv',\n",
       " 'human immunodeficiency virus p24 antigen test',\n",
       " 'antigen of human immunodeficiency virus 1 glycoprotein 120',\n",
       " 'antigen of human immunodeficiency virus 1 glycoprotein 160',\n",
       " 'antigen of human immunodeficiency virus 2 protein 41',\n",
       " 'acute human immunodeficiency virus infection',\n",
       " 'antigen of human immunodeficiency virus 1',\n",
       " 'human immunodeficiency virus deoxyribonucleic acid assay',\n",
       " 'human immunodeficiency virus 1 deoxyribonucleic acid assay',\n",
       " 'human immunodeficiency virus 1 ribonucleic acid assay',\n",
       " 'human immunodeficiency virus culture',\n",
       " 'human immunodeficiency virus type 1 identification',\n",
       " 'human immunodeficiency virus 1 antibody band pattern determination',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 105 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 120 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 120 and glycoprotein 160 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 160 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 34 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 41 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 41 and glycoprotein 43 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 15 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 15 antibody and protein 18 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 17 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 18 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 23 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 24 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 26 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 28 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 31 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 32 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 51 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 53 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 55 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 58 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 64 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 65 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 66 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 68 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 105 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 120 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 125 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 15 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 34 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 36 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 80 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 26 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 31 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 41 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 53 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 55 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 56 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 58 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 68 antibody',\n",
       " 'human immunodeficiency virus 1 antigen assay',\n",
       " 'human immunodeficiency virus 1 p24 antigen assay',\n",
       " 'antigen of human immunodeficiency virus 1 protein 24',\n",
       " 'human immunodeficiency virus, type ii glycoprotein 125 antibody',\n",
       " 'human immunodeficiency virus, type ii glycoprotein 36 antibody',\n",
       " 'human immunodeficiency virus, type i protein 23 antibody',\n",
       " 'human immunodeficiency virus, type i protein 32 antibody',\n",
       " 'human immunodeficiency virus, type i protein 28 antibody',\n",
       " 'human immunodeficiency virus, type i protein 65 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 68 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 56 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 26 antibody',\n",
       " 'human immunodeficiency virus, type ii glycoprotein 80 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 105 antibody',\n",
       " 'human immunodeficiency virus, type i protein 58 antibody',\n",
       " 'human immunodeficiency virus, type i protein 51 antibody',\n",
       " 'human immunodeficiency virus, type i protein 66 antibody',\n",
       " 'human immunodeficiency virus, type i protein 55 antibody',\n",
       " 'human immunodeficiency virus, type i protein 31 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 24 antibody',\n",
       " 'human immunodeficiency virus, type i protein 17 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 41 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 120 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 160 antibody',\n",
       " 'human immunodeficiency virus, type i protein 64 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 41 antibody',\n",
       " 'human immunodeficiency virus, type i protein 53 antibody',\n",
       " 'human immunodeficiency virus, type i protein 18 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 34 antibody',\n",
       " 'human immunodeficiency virus, type i protein 26 antibody',\n",
       " 'human immunodeficiency virus, type i protein 15 antibody',\n",
       " 'fear of contracting human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus antibody test',\n",
       " 'human immunodeficiency virus negative',\n",
       " 'human immunodeficiency virus positive',\n",
       " 'human immunodeficiency virus screening',\n",
       " 'patient advised about the risks of human immunodeficiency virus',\n",
       " 'human immunodeficiency virus infection constitutional disease',\n",
       " 'human immunodeficiency virus leukoencephalopathy',\n",
       " 'neuropathy caused by human immunodeficiency virus',\n",
       " 'human immunodeficiency virus enteropathy',\n",
       " 'human immunodeficiency virus myopathy',\n",
       " 'human immunodeficiency virus infection classification systems',\n",
       " 'human immunodeficiency virus antibody',\n",
       " 'human immunodeficiency virus risk lifestyle',\n",
       " 'congenital human immunodeficiency virus positive status syndrome',\n",
       " 'human immunodeficiency virus status',\n",
       " 'human immunodeficiency virus-related sclerosing cholangitis',\n",
       " 'human immunodeficiency virus counseling',\n",
       " 'human immunodeficiency virus prevention education',\n",
       " 'human immunodeficiency virus infection with aseptic meningitis',\n",
       " 'human immunodeficiency virus viral load',\n",
       " 'measurement of both human immunodeficiency virus 1 antibody and human immunodeficiency virus 2 antibody',\n",
       " 'finding of human immunodeficiency virus status',\n",
       " 'human immunodeficiency virus antibody titer measurement',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category',\n",
       " 'human immunodeficiency virus world health organization class',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category finding',\n",
       " 'human immunodeficiency virus world health organization class finding',\n",
       " 'antenatal screening for human immunodeficiency virus',\n",
       " 'human immunodeficiency virus-1 nucleic acid assay',\n",
       " 'polymerase chain reaction test for human immunodeficiency virus type 1',\n",
       " 'oral hairy leukoplakia associated with human immunodeficiency virus disease',\n",
       " 'human immunodeficiency virus encephalitis',\n",
       " 'pediatric human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus enzyme-linked immunosorbent assay test negative',\n",
       " 'human immunodeficiency virus enzyme-linked immunosorbent assay test positive',\n",
       " 'antenatal human immunodeficiency virus blood screening test status',\n",
       " 'antenatal human immunodeficiency virus blood screening test sent',\n",
       " 'antenatal human immunodeficiency virus blood screening test requested',\n",
       " 'rapid human immunodeficiency virus type 1 antibody test',\n",
       " 'human immunodeficiency virus type 1 antibody',\n",
       " 'leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'hairy leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'retinopathy associated with acquired immunodeficiency syndrome',\n",
       " 'cachexia associated with acquired immunodeficiency syndrome',\n",
       " 'family history of human immunodeficiency virus infection',\n",
       " 'copies of human immunodeficiency virus ribonucleic acid above reference range',\n",
       " 'human immunodeficiency virus, type ii antibody',\n",
       " 'determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using genotypic technique',\n",
       " 'determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using phenotypic technique',\n",
       " 'determination of coreceptor tropism of human immunodeficiency virus 1',\n",
       " 'pulmonary arterial hypertension associated with human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus carrier',\n",
       " 'human immunodeficiency virus in mother complicating childbirth',\n",
       " 'symptomatic human immunodeficiency virus i infection',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus ii infection',\n",
       " 'ribonucleic acid of human immunodeficiency virus 2',\n",
       " 'deoxyribonucleic acid of human immunodeficiency virus 2',\n",
       " 'human immunodeficiency virus 1 and virus 2 antibodies and human immunodeficiency virus 1 p24 antigen combination immunoassay',\n",
       " 'immunoglobulin g antibody to human immunodeficiency virus type 1',\n",
       " 'immunoglobulin g antibody to human immunodeficiency virus type 2',\n",
       " 'proviral deoxyribonucleic acid of human immunodeficiency virus 1',\n",
       " 'proviral deoxyribonucleic acid of human immunodeficiency virus 2',\n",
       " 'human immunodeficiency virus 1 antibody indeterminate',\n",
       " 'human immunodeficiency virus 2 antibody indeterminate',\n",
       " 'human immunodeficiency virus 2 antibody positive and human immunodeficiency virus 1 antibody cross-reactivity',\n",
       " 'human immunodeficiency virus screening declined',\n",
       " 'invasive carcinoma of uterine cervix co-occurrent with human immunodeficiency virus infection',\n",
       " 'extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 1',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 2',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 3',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 4',\n",
       " 'human immunodeficiency virus fusion inhibitor',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus entry inhibitor',\n",
       " 'symptomatic human immunodeficiency virus infection',\n",
       " 'ribonucleic acid of human immunodeficiency virus 1',\n",
       " 'deoxyribonucleic acid of human immunodeficiency virus',\n",
       " 'deoxyribonucleic acid of human immunodeficiency virus 1',\n",
       " 'human immunodeficiency virus social work service',\n",
       " 'human immunodeficiency virus nurse practitioner service',\n",
       " 'human immunodeficiency virus nursing specialty',\n",
       " 'human immunodeficiency virus social work specialty',\n",
       " 'bacterial infection due to human immunodeficiency virus infection',\n",
       " 'encephalitis caused by human immunodeficiency virus type 1',\n",
       " 'esophagitis due to human immunodeficiency virus disease',\n",
       " 'transmitted by',\n",
       " 'mycobacterium, non-tuberculosis',\n",
       " 'notification of tuberculosis',\n",
       " 'tuberculosis screening',\n",
       " 'examination for suspected tuberculosis',\n",
       " 'tuberculosis chemotherapy',\n",
       " 'acute tuberculous pericarditis',\n",
       " 'genital tuberculosis',\n",
       " 'tuberculosis',\n",
       " 'tuberculosis of meninges',\n",
       " 'tuberculosis of urinary organs',\n",
       " 'entire terminal bronchiole',\n",
       " 'tuberculosis of bladder',\n",
       " 'mycobacterium tuberculosis hominis',\n",
       " 'tuberculosis of kidney',\n",
       " 'tuberculosis of genitourinary system',\n",
       " 'tuberculosis of ureter',\n",
       " 'pulmonary tuberculosis',\n",
       " 'atypical mycobacterial infection',\n",
       " 'tuberculosis, extrapulmonary',\n",
       " 'tuberculosis in mother complicating childbirth',\n",
       " 'tuberculous laryngitis',\n",
       " 'tuberculous peritonitis',\n",
       " 'primary tuberculosis',\n",
       " 'tuberculous salpingitis',\n",
       " 'tuberculous erythema nodosum',\n",
       " 'tuberculous cervicitis',\n",
       " 'extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection',\n",
       " 'screening for cancer',\n",
       " 'laparotomy for staging of ovarian cancer',\n",
       " 'fear of getting cancer',\n",
       " 'prescription for alteration of hormonal balance for cancer',\n",
       " 'cancer hospital',\n",
       " 'pleurodesis with cancer chemotherapy substance',\n",
       " 'no microscopic confirmation - clinically metastatic tumor',\n",
       " 'immunotherapy for cancer',\n",
       " 'no microscopic confirmation - clinically malignant tumor',\n",
       " 'hyperthermia treatment of cancer',\n",
       " 'malignant neoplasm, primary',\n",
       " 'intra-arterial infusion of antineoplastic agent',\n",
       " 'cancer antigen 125',\n",
       " 'cancer antigen 19-5',\n",
       " 'cancer antigen 19-9',\n",
       " 'cancer antigen 242',\n",
       " 'cancer antigen 27-29',\n",
       " 'cancer antigen 50',\n",
       " 'cancer antigen 549',\n",
       " 'cancer antigen 72-4',\n",
       " 'cancer antigen 15-3',\n",
       " 'gleason grading system for prostatic cancer',\n",
       " 'walter reed staging of prostatic cancer',\n",
       " 'cancer antigen dm /70k',\n",
       " \"howel-evans' syndrome\",\n",
       " 'cancer procoagulant',\n",
       " 'suspected breast cancer',\n",
       " 'suspected lung cancer',\n",
       " 'malignant tumor of nasopharynx',\n",
       " 'malignant tumor of undescended testis',\n",
       " 'malignant tumor of ectopic testis',\n",
       " 'malignant tumor of body of penis',\n",
       " 'secondary malignant neoplasm of cervix uteri',\n",
       " 'cancer education',\n",
       " \"united kingdom children's cancer study group central nervous system tumor staging system\",\n",
       " 'american urological association staging system for prostate cancer',\n",
       " 'squamous cell carcinoma of bronchus',\n",
       " 'small cell carcinoma of lung',\n",
       " 'non-small cell lung cancer',\n",
       " 'malignant neoplasm of breast',\n",
       " 'cancer en cuirasse',\n",
       " 'familial cancer of breast',\n",
       " 'malignant tumor of skin of penis',\n",
       " 'malignant neoplasm of unknown origin',\n",
       " 'malignant tumor of salivary gland',\n",
       " 'malignant tumor of exocrine pancreas',\n",
       " 'cancer staging',\n",
       " 'history of malignant neoplasm',\n",
       " 'family history: stomach cancer',\n",
       " 'family history: bowel cancer',\n",
       " 'family history: bronchus cancer',\n",
       " 'family history of cancer',\n",
       " 'early gastric cancer',\n",
       " 'late gastric cancer',\n",
       " 'cancer attitude inventory',\n",
       " 'mental adjustment to cancer scale',\n",
       " 'family history of cancer of colon',\n",
       " 'hereditary nonpolyposis colon cancer',\n",
       " 'suspected cervical cancer',\n",
       " 'suspected endometrial cancer',\n",
       " 'suspected prostate cancer',\n",
       " 'suspected bladder cancer',\n",
       " 'suspected kidney cancer',\n",
       " 'suspected urothelial cancer',\n",
       " 'suspected testicular cancer',\n",
       " 'suspected upper gastrointestinal cancer',\n",
       " 'suspected lower gastrointestinal cancer',\n",
       " 'suspected skin cancer',\n",
       " 'suspected head and neck cancer',\n",
       " 'secondary malignant neoplastic disease',\n",
       " 't3',\n",
       " 'malignant neoplasm of liver',\n",
       " 'secondary malignant neoplasm of liver',\n",
       " 'secondary malignant neoplasm of ovary',\n",
       " 'secondary malignant neoplasm of skin',\n",
       " 'secondary malignant neoplasm of vertebral column',\n",
       " 'secondary malignant neoplasm of vulva',\n",
       " 'cancer protocol observable',\n",
       " 'cancer dataset administrative items',\n",
       " 'basis of cancer diagnosis',\n",
       " 'cancer diagnosis based on death certificate',\n",
       " 'cancer diagnosis based on clinical evidence',\n",
       " 'cancer diagnosis based on investigations, without a tissue diagnosis',\n",
       " 'cancer diagnosis based on specific tumor markers',\n",
       " 'cancer diagnosis based on cytological evidence',\n",
       " 'cancer diagnosis based on metastatic histological evidence',\n",
       " 'cancer diagnosis based on primary site histological evidence',\n",
       " 'reason for no specific anti-cancer treatment',\n",
       " 'no anti-cancer treatment - poor performance status',\n",
       " 'no anti-cancer treatment - advanced stage cancer',\n",
       " 'patient died before anti-cancer treatment',\n",
       " 'no anti-cancer treatment - significant co-morbidity',\n",
       " 'no anti-cancer treatment available',\n",
       " 'no anti-cancer treatment - watchful waiting',\n",
       " 'cancer treatment related morbidity',\n",
       " 'malignant tumor of cecum',\n",
       " 'malignant tumor of esophagus',\n",
       " 'malignant neoplastic disease',\n",
       " 'malignant tumor of lip',\n",
       " 'malignant tumor of stomach',\n",
       " 'malignant tumor of rectum',\n",
       " 'malignant tumor of anal canal',\n",
       " 'malignant tumor of cervix',\n",
       " 'malignant tumor of adrenal gland',\n",
       " 'malignant neoplasm of ill-defined site',\n",
       " 'malignant tumor of lung',\n",
       " 'malignant tumor of vulva',\n",
       " 'malignant tumor of tongue',\n",
       " 'malignant tumor of parotid gland',\n",
       " 'malignant tumor of gum',\n",
       " 'malignant tumor of floor of mouth',\n",
       " 'malignant tumor of buccal mucosa',\n",
       " 'malignant tumor of palate',\n",
       " 'malignant tumor of oropharynx',\n",
       " 'malignant tumor of tonsil',\n",
       " 'malignant tumor of duodenum',\n",
       " 'malignant neoplasm of colon',\n",
       " 'malignant tumor of pancreas',\n",
       " 'malignant neoplasm of omentum',\n",
       " 'malignant tumor of larynx',\n",
       " 'malignant tumor of trachea',\n",
       " 'malignant tumor of pleura',\n",
       " 'malignant tumor of vertebral column',\n",
       " 'malignant tumor of ovary',\n",
       " 'malignant tumor of vagina',\n",
       " 'malignant tumor of foreskin',\n",
       " 'malignant tumor of glans penis',\n",
       " 'malignant tumor of scrotum',\n",
       " 'malignant tumor of ureter',\n",
       " 'malignant tumor of urethra',\n",
       " 'malignant tumor of thyroid gland',\n",
       " 'malignant tumor of parathyroid gland',\n",
       " 'malignant tumor of pituitary gland',\n",
       " 'malignant tumor of vocal cord',\n",
       " 'malignant tumor of peritoneum',\n",
       " 'malignant tumor of bronchus',\n",
       " 'malignant tumor of muscle',\n",
       " 'multiple malignancy',\n",
       " 'malignant tumor of oral cavity',\n",
       " 'malignant neoplasm of pharynx',\n",
       " 'malignant tumor of intestine',\n",
       " 'malignant tumor of large intestine',\n",
       " 'malignant tumor of penis',\n",
       " 'malignant tumor of kidney',\n",
       " 'malignant neoplasm of uterus',\n",
       " 'primary malignant neoplasm of bronchus',\n",
       " 'secondary malignant neoplasm of bone',\n",
       " 'secondary malignant neoplasm of brain',\n",
       " 'secondary malignant neoplasm of kidney',\n",
       " 'secondary malignant neoplasm of lung',\n",
       " 'secondary malignant neoplasm of lymph node',\n",
       " 'gleason grade finding for prostatic cancer',\n",
       " 'cancer registrar',\n",
       " 'cancer pagurus specific immunoglobulin e',\n",
       " 'cancer pagurus specific immunoglobulin e antibody measurement',\n",
       " 'cancer treatment started',\n",
       " 'cancer diagnosis discussed',\n",
       " 'cancer confirmed',\n",
       " 'no evidence of cancer found',\n",
       " 'cancer primary healthcare multidisciplinary team',\n",
       " 'cancer diagnosis discussed with partner in relationship',\n",
       " 'cancer diagnosis discussed with patient',\n",
       " 'cancer care plan discussed with patient',\n",
       " 'cancer care plan discussed with partner in relationship',\n",
       " 'pt3a',\n",
       " 'suspected central nervous system cancer',\n",
       " 'suspected urological cancer',\n",
       " 'suspected gynecological cancer',\n",
       " \"suspected children's cancer\",\n",
       " 'multidisciplinary care conference for cancer care planning',\n",
       " 'monitoring of patient with cancer',\n",
       " 'no anti-cancer treatment due to unknown primary',\n",
       " 'cancer supportive care worker',\n",
       " 'phobic fear of skin cancer',\n",
       " 'suspected hematological malignancy',\n",
       " 'suspected malignancy',\n",
       " 'malignant tumor of prostate',\n",
       " 'malignant tumor of urinary bladder',\n",
       " 'risk control behavior: cancer',\n",
       " 'breast cancer type 1 susceptibility protein',\n",
       " 'breast cancer type 2 susceptibility protein',\n",
       " 'college of american pathologists cancer checklist; adrenal gland: resection',\n",
       " 'college of american pathologists cancer checklist; ampulla of vater: ampullectomy',\n",
       " 'college of american pathologists cancer checklist; ampulla of vater: pancreaticoduodenectomy',\n",
       " 'college of american pathologists cancer checklist; anus: excisional biopsy',\n",
       " 'college of american pathologists cancer checklist; anus: local excision',\n",
       " 'college of american pathologists cancer checklist; anus: resection',\n",
       " 'college of american pathologists cancer checklist; urinary bladder, ureter, renal pelvis: biopsy',\n",
       " 'college of american pathologists cancer checklist; urinary bladder: cystectomy, partial, total, or radical; anterior exenteration',\n",
       " 'college of american pathologists cancer checklist; renal pelvis: resection/nephroureterectomy, partial or complete',\n",
       " 'college of american pathologists cancer checklist; ureter: resection',\n",
       " 'college of american pathologists cancer checklist; bone marrow: blood film, aspirate, cell block, trephine biopsy, touch imprint',\n",
       " 'college of american pathologists cancer checklist; brain/spinal cord: biopsy/resection',\n",
       " 'college of american pathologists cancer checklist; breast: excision less than total mastectomy',\n",
       " 'college of american pathologists cancer checklist; colon and rectum: excisional biopsy',\n",
       " 'college of american pathologists cancer checklist; rectum: local excision',\n",
       " 'college of american pathologists cancer checklist; colon and rectum: resection',\n",
       " 'college of american pathologists cancer checklist; endometrium: biopsy',\n",
       " 'college of american pathologists cancer checklist; endometrium: hysterectomy, with or without other organs or tissues',\n",
       " 'college of american pathologists cancer checklist; esophagus: biopsy',\n",
       " 'college of american pathologists cancer checklist; esophagus: resection',\n",
       " 'college of american pathologists cancer checklist; extrahepatic bile ducts: resection',\n",
       " 'college of american pathologists cancer checklist; uveal melanoma: resection',\n",
       " 'college of american pathologists cancer checklist; vulva: excisional biopsy/resection',\n",
       " 'college of american pathologists cancer checklist; vagina: biopsy',\n",
       " 'college of american pathologists cancer checklist; vagina: excisional biopsy, resection',\n",
       " 'college of american pathologists cancer checklist; uterine cervix: cone biopsy',\n",
       " 'college of american pathologists cancer checklist; uterine cervix: colpectomy, hysterectomy, pelvic exenteration',\n",
       " 'college of american pathologists cancer checklist; upper aerodigestive tract and minor salivary glands: incisional and excisional biopsy/resection',\n",
       " 'college of american pathologists cancer checklist; major salivary glands: resection',\n",
       " 'college of american pathologists cancer checklist; trophoblast: dilation and curettage/resection',\n",
       " 'college of american pathologists cancer checklist; thyroid: resection',\n",
       " 'college of american pathologists cancer checklist; thymoma and thymic carcinoma: biopsy',\n",
       " 'college of american pathologists cancer checklist; thymoma and thymic carcinoma: thymectomy, other procedure',\n",
       " 'college of american pathologists cancer checklist; pleura/pericardium: resection',\n",
       " 'college of american pathologists cancer checklist; pleura/pericardium: biopsy',\n",
       " 'college of american pathologists cancer checklist; testis: radical orchiectomy',\n",
       " 'college of american pathologists cancer checklist; testis: retroperitoneal lymphadenectomy',\n",
       " 'college of american pathologists cancer checklist; stomach: biopsy',\n",
       " 'college of american pathologists cancer checklist; stomach: resection',\n",
       " 'college of american pathologists cancer checklist; small intestine: polypectomy, segmental resection, pancreaticoduodenectomy, partial or complete, with or without partial gastrectomy',\n",
       " 'college of american pathologists cancer checklist; melanoma of the skin: excision; re-excision',\n",
       " 'college of american pathologists cancer checklist; fallopian tube: unilateral salpingectomy, salpingo-oophorectomy, or hysterectomy with salpingo-oophorectomy',\n",
       " 'college of american pathologists cancer checklist; gallbladder: resection/cholecystectomy',\n",
       " 'college of american pathologists cancer checklist; gastrointestinal lymphoma: resection',\n",
       " 'college of american pathologists cancer checklist; heart: resection',\n",
       " 'college of american pathologists cancer checklist; hodgkin lymphoma: biopsy/staging procedure',\n",
       " 'college of american pathologists cancer checklist; kidney: biopsy',\n",
       " 'college of american pathologists cancer checklist; kidney: nephrectomy, partial or radical',\n",
       " 'college of american pathologists cancer checklist; liver: resection',\n",
       " 'college of american pathologists cancer checklist; lung: biopsy',\n",
       " 'college of american pathologists cancer checklist; lung: resection',\n",
       " 'college of american pathologists cancer checklist; non-hodgkin lymphoma: biopsy, resection',\n",
       " 'college of american pathologists cancer checklist; ovary: oophorectomy, salpingo-oophorectomy, subtotal oophorectomy or removal of tumor in fragments, hysterectomy with salpingo-oophorectomy',\n",
       " 'college of american pathologists cancer checklist; pancreas',\n",
       " 'college of american pathologists cancer checklist; pancreas',\n",
       " 'college of american pathologists cancer checklist; peritoneum: resection',\n",
       " 'college of american pathologists cancer checklist; prostate gland: needle biopsy, transurethral prostatic resection, enucleation specimen',\n",
       " 'college of american pathologists cancer checklist; prostate gland: radical prostatectomy',\n",
       " 'college of american pathologists cancer checklist; retinoblastoma: enucleation, partial or complete exenteration',\n",
       " 'college of american pathologists cancer checklist; carcinoma of the skin: resection',\n",
       " 'college of american pathologists cancer checklist; rhabdomyosarcoma and related neoplasms: excision, local or wide; compartmentectomy; excision, radical; amputation; other',\n",
       " 'college of american pathologists cancer checklist; kidney: resection for wilms tumor',\n",
       " 'seen by breast cancer nurse',\n",
       " 'widespread metastatic malignant neoplastic disease',\n",
       " 'college of american pathologists cancer checklist; neuroblastoma: resection',\n",
       " 'college of american pathologists cancer checklist; primitive neuroectodermal tumor / ewing sarcoma: resection',\n",
       " 'cancer pagurus diagnostic allergen extract',\n",
       " 'family history of prostate cancer',\n",
       " 'cancer monitoring third letter',\n",
       " 'cancer monitoring second letter',\n",
       " 'cancer monitoring first letter',\n",
       " 'cancer monitoring invitation',\n",
       " 'cancer hospital treatment completed',\n",
       " 'cancer emotional and psychosocial support and education',\n",
       " 'cancer screening follow up',\n",
       " 'no evidence of recurrence of cancer',\n",
       " 'cancer short term health assessment',\n",
       " 'cancer rehabilitation and readaption',\n",
       " 'cancer pain and symptom management',\n",
       " 'carcinoma-associated retinopathy',\n",
       " 'malignant neoplasm of skin',\n",
       " 'cancer shared care medication card',\n",
       " 'cancer monitoring verbal invitation',\n",
       " 'cancer home care pack given',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage i',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ib',\n",
       " 'international union against cancer',\n",
       " 'american joint committee on cancer',\n",
       " 'international union against cancer stage grouping',\n",
       " 'european organization for research and treatment of cancer - quality of life questionnaire',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage ii',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iv',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ia',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage i a',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage i',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage iii',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ii',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage i b',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage iv',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iii',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ib occ',\n",
       " 'college of american pathologists cancer checklist; appendix: resection',\n",
       " 'college of american pathologists cancer checklist; prostate gland: needle biopsy',\n",
       " 'college of american pathologists cancer checklist; prostate gland: transurethral prostatic resection, enucleation specimen',\n",
       " 'college of american pathologists cancer checklist; bone: resection',\n",
       " 'college of american pathologists cancer checklist; bone: biopsy',\n",
       " 'college of american pathologists cancer checklist; soft tissue: resection',\n",
       " 'college of american pathologists cancer checklist; soft tissue: biopsy',\n",
       " 'primary malignant neoplasm of thyroid gland, metastatic to bone',\n",
       " 'primary malignant neoplasm of ovary, with widespread metastatic disease',\n",
       " 'primary malignant neoplasm of vulva, with widespread metastatic disease',\n",
       " 'hormone refractory prostate cancer',\n",
       " 'non-small cell lung cancer, negative for epidermal growth factor receptor expression',\n",
       " 'french federation of cancer centers sarcoma group grading system',\n",
       " 'national cancer institute histologic grading system',\n",
       " 'non-small cell lung cancer, positive for epidermal growth factor receptor expression',\n",
       " 'psychosocial counseling about cancer',\n",
       " 'family history of cancer of the esophagus',\n",
       " 'family history of breast cancer 1 gene mutation',\n",
       " 'family history of breast cancer 2 gene mutation',\n",
       " 'increased cancer antigen 125',\n",
       " 'family history of malignant neoplasm of liver',\n",
       " 'family history of malignant neoplasm of pancreas',\n",
       " 'family history of malignant neoplasm of lung',\n",
       " 'family history of malignant neoplasm of skin',\n",
       " 'knowledge level about cancer prevention and early detection',\n",
       " 'knowledge level about cancer management',\n",
       " 'measurement of cancer antigen 72-4',\n",
       " 'american joint commission on cancer, cancer staging manual, 6th edition neoplasm staging system',\n",
       " 'american joint commission on cancer, cancer staging manual, 7th edition neoplasm staging system',\n",
       " 'edition of american joint commission on cancer, cancer staging manual used for tnm staging',\n",
       " 'cancer antigen 27-29 above reference range',\n",
       " 'residual cancer burden index',\n",
       " 'breast cancer genetic marker of susceptibility negative',\n",
       " 'measurement of cancer antigen 27-29',\n",
       " 'residual cancer burden class',\n",
       " 'residual cancer burden score',\n",
       " 'residual cancer burden index',\n",
       " 'breast cancer genetic marker of susceptibility positive',\n",
       " 'malignant neoplasm detection during interval between recommended screening examinations',\n",
       " 'brca1 mutation carrier detection test',\n",
       " 'brca1 gene mutation negative',\n",
       " 'brca1 gene mutation positive',\n",
       " 'brca2 gene mutation positive',\n",
       " 'brca2 mutation carrier detection test',\n",
       " 'brca2 gene mutation negative',\n",
       " 'malignant neoplasm of urinary organ',\n",
       " 'malignant neoplasm of respiratory system',\n",
       " 'malignant neoplasm of cerebellum',\n",
       " 'malignant neoplasm of carotid body',\n",
       " 'malignant neoplasm of cerebellopontine angle',\n",
       " 'malignant neoplasm of pelvic peritoneum',\n",
       " 'transglottic malignant neoplasm of larynx',\n",
       " 'malignant neoplasm of visceral pleura',\n",
       " 'malignant neoplasm of skin of scrotum',\n",
       " 'malignant neoplasm of upper respiratory tract',\n",
       " 'malignant neoplasm of parietal pleura',\n",
       " 'malignant neoplasm of intraabdominal organ',\n",
       " 'malignant neoplasm of mandible',\n",
       " 'malignant neoplasm of soft tissue of orbit',\n",
       " 'malignant neoplasm of posterior mediastinum',\n",
       " 'nottingham histologic grading system',\n",
       " 'malignant neoplasm of lateral wall of oropharynx',\n",
       " 'malignant neoplasm of alveolus of maxilla',\n",
       " 'malignant neoplasm of anterior mediastinum',\n",
       " 'malignant neoplasm of parametrium',\n",
       " 'malignant neoplasm of digestive system',\n",
       " 'malignant neoplasm of anterior and lateral floor of mouth',\n",
       " 'malignant neoplasm of alveolus of mandible',\n",
       " 'malignant neoplasm of broad ligament of uterus',\n",
       " 'malignant neoplasm of alveolus dentalis',\n",
       " 'verrucous carcinoma of oral cavity',\n",
       " 'electro cancer therapy system',\n",
       " 'educated about screening for malignant neoplasm of prostate',\n",
       " 'family history of colorectal cancer',\n",
       " 'patient advised about prostate cancer screening',\n",
       " 'pt4: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition',\n",
       " 'pt3: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition',\n",
       " 'pt4: tumor of lung as per american joint committee on cancer 6th edition definition',\n",
       " 'pt4: extraocular tumor extension which includes sites as per american joint committee on cancer 6th edition definition',\n",
       " 'pt2: tumor of lung as per american joint committee on cancer 6th edition definition',\n",
       " 'pn3b: tumor of breast with metastasis as per american joint committee on cancer 6th edition definition',\n",
       " 'hereditary cancer-predisposing syndrome',\n",
       " 'cancer antigen 19-9 measurement',\n",
       " 'cancer antigen 15-3 measurement',\n",
       " 'alternating electric field antimitotic cancer treatment system',\n",
       " 'alternating electric field antimitotic cancer treatment system transducer array',\n",
       " 'alternating electric field antimitotic cancer treatment system generator',\n",
       " 'screening for malignant neoplasm of vagina done',\n",
       " 'history of malignant neoplasm of vulva',\n",
       " 'malignant neoplastic disease in mother complicating childbirth',\n",
       " 'screening for malignant neoplasm of vagina',\n",
       " 'sampling of vagina for papanicolaou smear after hysterectomy for malignant disease done',\n",
       " 'anemia in malignant neoplastic disease',\n",
       " 'non-small cell lung cancer without mutation in epidermal growth factor receptor',\n",
       " 'non-small cell lung cancer with mutation in epidermal growth factor receptor',\n",
       " 'primary malignant neoplasm of endocervix',\n",
       " 'primary malignant neoplasm of endometrium',\n",
       " 'secondary malignant neoplasm of vagina',\n",
       " 'carcinoma of ovary, stage 3',\n",
       " 'history of malignant neoplasm of ovary',\n",
       " 'carcinoma of ovary, stage 1',\n",
       " 'carcinoma of ovary, stage 2',\n",
       " 'carcinoma of ovary, stage 4',\n",
       " 'primary malignant neoplasm of clitoris',\n",
       " 'history of malignant neoplasm of uterine adnexa',\n",
       " 'history of malignant neoplasm of cervix',\n",
       " 'history of malignant neoplasm of uterine body',\n",
       " 'history of malignant neoplasm of vagina',\n",
       " 'undifferentiated carcinoma of ovary',\n",
       " 'at risk of breast cancer',\n",
       " 'triple negative malignant neoplasm of breast',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iiib',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iiic1',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iiic2',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer',\n",
       " 'malignant neoplasm of exocervix',\n",
       " 'history of non-small cell malignant neoplasm of lung',\n",
       " 'family history of malignant neoplasm of male breast',\n",
       " 'family history of malignant neoplasm of cervix uteri',\n",
       " 'family history of malignant neoplasm of ileum',\n",
       " 'family history of malignant neoplasm of vagina',\n",
       " 'family history of malignant neoplasm of brain',\n",
       " 'history of malignant neoplasm of esophagus',\n",
       " 'history of malignant neoplasm of neck',\n",
       " 'history of malignant neoplasm of bone',\n",
       " 'secondary malignant neoplasm of central nervous system',\n",
       " 'secondary malignant neoplasm of cerebral meninges',\n",
       " 'secondary malignant neoplasm of bone marrow',\n",
       " 'family history of malignant neoplasm of uterus',\n",
       " 'family history of malignant neoplasm of bone',\n",
       " 'secondary malignant neoplasm of bladder',\n",
       " 'history of malignant neoplasm of endocrine gland',\n",
       " 'history of malignant neoplasm of tongue',\n",
       " 'secondary malignant neoplasm of adrenal gland',\n",
       " 'history of malignant neoplasm of spinal cord',\n",
       " 'history of malignant neoplasm of nervous system',\n",
       " 'carcinoma in situ of ileum',\n",
       " 'secondary malignant neoplasm of intercostal lymph nodes',\n",
       " 'secondary malignant neoplasm of lymph nodes of face',\n",
       " 'overlapping malignant neoplasm of small intestine',\n",
       " 'carcinoma in situ of tongue',\n",
       " 'secondary malignant neoplasm of intrapelvic lymph nodes',\n",
       " 'secondary malignant neoplasm of tracheobronchial lymph nodes',\n",
       " 'carcinoma in situ of eye',\n",
       " 'carcinoma in situ of vulva',\n",
       " 'squamous cell carcinoma of penis',\n",
       " 'squamous cell carcinoma of tip of nose',\n",
       " 'squamous cell carcinoma of forehead',\n",
       " 'malignant neoplasm of cerebral meninges',\n",
       " 'carcinoma in situ of small intestine',\n",
       " 'carcinoma of uterine cervix, invasive',\n",
       " 'secondary malignant neoplasm of intra-abdominal organs',\n",
       " 'malignant mesothelioma of peritoneum',\n",
       " 'secondary malignant neoplasm of chest wall',\n",
       " 'carcinoma of colon, stage i',\n",
       " 'malignant neoplasm of female breast',\n",
       " 'carcinoma in situ of prostate',\n",
       " 'secondary malignant neoplasm of prostate',\n",
       " 'malignant tumor of spinal cord, intramedullary',\n",
       " 'secondary malignant neoplasm of left ovary',\n",
       " 'secondary malignant neoplasm of thyroid gland',\n",
       " 'secondary malignant neoplasm of male genital organ',\n",
       " 'malignant mixed tumor of salivary gland',\n",
       " 'secondary malignant neoplasm of peritoneum',\n",
       " 'squamous cell carcinoma of scalp',\n",
       " 'squamous cell carcinoma of nasolabial fold',\n",
       " 'overlapping malignant neoplasm of eye and adnexa, primary',\n",
       " 'secondary malignant neoplasm of mediastinum',\n",
       " 'secondary malignant neoplasm of lymph nodes of upper limb',\n",
       " 'secondary malignant neoplasm of duodenum',\n",
       " 'overlapping malignant neoplasm of penis',\n",
       " 'overlapping malignant neoplasm of stomach',\n",
       " 'secondary malignant neoplasm of spleen',\n",
       " 'carcinoma in situ of common bile duct',\n",
       " 'squamous cell carcinoma of back',\n",
       " 'carcinoma in situ of skin',\n",
       " 'carcinoma in situ of rectum',\n",
       " 'malignant tumor of spinal cord, extramedullary',\n",
       " 'secondary malignant neoplasm of choroid',\n",
       " 'carcinoma in situ of gum',\n",
       " 'secondary malignant neoplasm of uterus',\n",
       " 'carcinoma in situ of mouth',\n",
       " 'overlapping malignant neoplasm of floor of mouth',\n",
       " 'secondary malignant neoplasm of inguinal lymph nodes',\n",
       " 'squamous cell carcinoma of temple',\n",
       " 'carcinoma in situ of pylorus',\n",
       " 'overlapping malignant neoplasm of brain',\n",
       " 'basal cell carcinoma of auricle of ear',\n",
       " 'secondary malignant neoplasm of rectosigmoid junction',\n",
       " 'secondary malignant neoplasm of tibial lymph nodes',\n",
       " 'malignant tumor of extrahepatic bile duct',\n",
       " 'carcinoma in situ of duodenum',\n",
       " 'carcinoma in situ of thyroid gland',\n",
       " 'secondary malignant neoplasm of hypogastric lymph nodes',\n",
       " 'secondary malignant neoplasm of female genital organ',\n",
       " 'malignant tumor of pineal gland',\n",
       " 'secondary malignant neoplasm of lymph nodes of lower limb',\n",
       " 'carcinoma in situ of oropharynx',\n",
       " 'carcinoma in situ of colon',\n",
       " 'secondary malignant neoplasm of lymph nodes of neck',\n",
       " 'carcinoma in situ of hypopharynx',\n",
       " 'squamous cell carcinoma of larynx',\n",
       " 'mesothelioma',\n",
       " 'stool dna-based colorectal cancer screening positive',\n",
       " 'overlapping malignant neoplasm of colon',\n",
       " 'carcinoma in situ of spleen',\n",
       " 'carcinoma in situ of cystic duct',\n",
       " 'secondary malignant neoplasm of intrathoracic lymph nodes',\n",
       " 'carcinoma in situ of bladder',\n",
       " 'carcinoma in situ',\n",
       " 'carcinoma in situ of penis',\n",
       " 'secondary malignant neoplasm of lymph nodes of head',\n",
       " 'carcinoma of urinary bladder, superficial',\n",
       " 'secondary malignant neoplasm of mesenteric lymph nodes',\n",
       " 'secondary malignant neoplasm of spinal meninges',\n",
       " 'carcinoma in situ of esophagus',\n",
       " 'metastasis from malignant tumor of prostate',\n",
       " 'secondary malignant neoplasm of esophagus',\n",
       " 'carcinoma in situ of lung',\n",
       " 'secondary malignant neoplasm of small intestine',\n",
       " 'secondary malignant neoplasm of respiratory tract',\n",
       " 'carcinoma in situ of pharynx',\n",
       " 'history of malignant neoplasm of penis',\n",
       " 'carcinoma in situ of vagina',\n",
       " 'carcinoma in situ of anal canal',\n",
       " 'secondary malignant neoplasm of iliac lymph nodes',\n",
       " 'malignant neoplasm of peripheral nerve of thorax',\n",
       " 'secondary malignant neoplasm of omentum',\n",
       " 'secondary malignant neoplasm of popliteal lymph nodes',\n",
       " 'secondary malignant neoplasm of pituitary gland',\n",
       " 'secondary malignant neoplasm of soft tissues of pelvis',\n",
       " 'secondary malignant neoplasm of lymph nodes of multiple sites',\n",
       " 'secondary malignant neoplasm of heart',\n",
       " 'secondary malignant neoplasm of pancreas',\n",
       " 'carcinoma in situ of jejunum',\n",
       " 'secondary malignant neoplasm of trachea',\n",
       " 'overlapping malignant neoplasm of major salivary gland',\n",
       " 'secondary malignant neoplasm of gallbladder',\n",
       " 'carcinoma of urinary bladder, invasive',\n",
       " 'secondary malignant neoplasm of pleura',\n",
       " 'squamous cell carcinoma of pharynx',\n",
       " 'secondary malignant neoplasm of urinary system',\n",
       " 'carcinoma in situ of larynx',\n",
       " 'malignant neoplasm of intrahepatic gall duct',\n",
       " 'carcinoma in situ of uterus',\n",
       " 'overlapping malignant neoplasm of palate',\n",
       " 'secondary malignant neoplasm of large intestine',\n",
       " 'secondary malignant neoplasm of retroperitoneal lymph nodes',\n",
       " 'squamous cell carcinoma of bridge of nose',\n",
       " 'squamous cell carcinoma in situ of skin',\n",
       " 'carcinoma in situ of urinary system',\n",
       " 'carcinoma in situ of gastrointestinal tract',\n",
       " 'secondary malignant neoplasm of stomach',\n",
       " 'secondary malignant neoplasm of nervous system',\n",
       " 'secondary malignant neoplasm of rectum',\n",
       " 'carcinoma in situ of pancreas',\n",
       " 'secondary malignant neoplasm of right ovary',\n",
       " 'overlapping malignant neoplasm of pancreas',\n",
       " 'malignant melanoma of anus',\n",
       " 'carcinoma in situ of salivary gland duct',\n",
       " 'carcinoma in situ of endocrine gland',\n",
       " 'malignant melanoma of rectum',\n",
       " 'secondary malignant neoplasm of pararectal lymph nodes',\n",
       " 'secondary malignant neoplasm of intestinal lymph nodes',\n",
       " 'malignant tumor of peripheral nerve',\n",
       " 'carcinoma of colon, stage iii',\n",
       " 'carcinoma of colon, stage ii',\n",
       " \"paget's disease of vulva\",\n",
       " 'carcinoma of prostate',\n",
       " 'carcinoma of the rectosigmoid junction',\n",
       " 'secondary malignant neoplasm of obturator lymph nodes',\n",
       " 'basal cell carcinoma of chest wall',\n",
       " 'carcinoma of nasal meatus',\n",
       " 'malignant neoplasm of anorectum',\n",
       " 'hurthle cell carcinoma of thyroid',\n",
       " 'basal cell carcinoma of back',\n",
       " 'mucoepidermoid carcinoma of parotid gland',\n",
       " 'adenoid cystic carcinoma of submandibular gland',\n",
       " 'squamous cell carcinoma of skin of neck',\n",
       " 'metastasis to peripheral nerve',\n",
       " 'carcinoma of colon, stage iv',\n",
       " 'carcinoma of tip of nose',\n",
       " 'squamous cell carcinoma of oropharynx',\n",
       " 'metastasis to digestive organs',\n",
       " 'mucoepidermoid carcinoma of submandibular gland',\n",
       " 'family history of malignant neoplasm of trachea',\n",
       " 'basal cell carcinoma of scalp',\n",
       " 'basal cell carcinoma of upper extremity',\n",
       " 'carcinoma in situ of skin of scalp',\n",
       " 'carcinoma in situ of skin of eyelid',\n",
       " 'basal cell carcinoma of hand',\n",
       " 'history of cancer of unknown primary site',\n",
       " 'history of cancer metastatic to liver',\n",
       " 'history of cancer of gall bladder',\n",
       " 'basal cell carcinoma of truncal skin',\n",
       " 'history of cancer of ampulla of duodenum',\n",
       " 'history of cancer metastatic to lung',\n",
       " 'carcinoma in situ of skin of trunk',\n",
       " 'history of cancer of floor of mouth',\n",
       " 'carcinoma in situ of skin of upper limb',\n",
       " 'history of cancer metastatic to lymph nodes',\n",
       " 'carcinoma in situ of body of stomach',\n",
       " 'basal cell carcinoma of lower extremity',\n",
       " 'history of malignant neoplasm of eye',\n",
       " 'basal cell carcinoma of neck',\n",
       " 'history of cancer metastatic to skin',\n",
       " 'history of cancer metastatic to brain',\n",
       " 'family history of malignant neoplasm of genital structure',\n",
       " 'basal cell carcinoma of forehead',\n",
       " 'family history of malignant neoplasm of urinary bladder',\n",
       " 'basal cell carcinoma of upper eyelid',\n",
       " 'basal cell carcinoma of chin',\n",
       " 'history of cancer of urethra',\n",
       " 'history of cancer metastatic to bone',\n",
       " 'basal cell carcinoma of ear',\n",
       " 'carcinoma in situ of fundus of stomach',\n",
       " 'basal cell carcinoma of skin',\n",
       " 'carcinoma in situ of skin of face',\n",
       " 'basal cell carcinoma of skin of lip',\n",
       " 'carcinoma in situ of skin of neck',\n",
       " ...]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "string = ' '.join([str(elem) for elem in all_snomed_senstive_info])\n",
    "#type(result1)\n",
    "result1 = re.split(r\"#|\\n\",string.lower())\n",
    "#result1.group(0)\n",
    "result1\n",
    "result2=[]\n",
    "for i in result1:\n",
    "    res=re.findall(r\"^ snomedct\\[[0-9]+\\]  |^snomedct\\[[0-9]+\\]  \",i)#mached snomedct word\n",
    "    result2.append(res)\n",
    "result2\n",
    "result3=[ele for ele in result2 if ele!=[]]#remove empty list\n",
    "result4=[]\n",
    "for i in result3:\n",
    "    for item in i:\n",
    "        result4.append(item)#make ito a sinle list\n",
    "\n",
    "result4\n",
    "result5=[]\n",
    "for j in result1:\n",
    "    if j not in result4:\n",
    "        result5.append(j.strip())\n",
    "#result5\n",
    "result5=' '.join([str(elem) for elem in result5])\n",
    "result6=re.split(r\"\\(|\\)\", result5)\n",
    "result6\n",
    "\n",
    "result7 = re.split(r\"\\(|\\)\",string)\n",
    "#result1.group(0)\n",
    "result1\n",
    "result8=set()\n",
    "for i in result7:\n",
    "    if '\\n' not in i:\n",
    "        result8.add(str(i).lower())\n",
    "\n",
    "result9=[]\n",
    "for i in result8:\n",
    "    res=re.findall(r\"^(?!snomedct*).+\",i)#mached snomedct word\n",
    "    result9.append(res)\n",
    "\n",
    "result10=[]\n",
    "for i in result9:\n",
    "    for j in i:\n",
    "        if j !=[''] and j !=' ' and j!='':\n",
    "            result10.append(j)\n",
    "\n",
    "\n",
    "snomed_reduced_final_res=[]\n",
    "for i in result6:\n",
    "    if i not in result10 and i != '':\n",
    "        snomed_reduced_final_res.append(i.strip())\n",
    "snomed_reduced_final_result = []\n",
    "for i in snomed_reduced_final_res:\n",
    "    if i != '':\n",
    "        snomed_reduced_final_result.append(i.strip())\n",
    "snomed_reduced_final_result        \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['product containing abacavir',\n",
       " 'product containing abacavir and lamivudine and zidovudine',\n",
       " 'product containing precisely abacavir',\n",
       " 'product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'abacavir',\n",
       " 'abacavir sulfate',\n",
       " 'product containing abacavir and lamivudine',\n",
       " 'allergy to abacavir',\n",
       " 'product containing abacavir and lamivudine in oral dose form',\n",
       " 'product containing abacavir in oral dose form',\n",
       " 'product containing abacavir and dolutegravir and lamivudine',\n",
       " 'product containing abacavir and dolutegravir and lamivudine in oral dose form',\n",
       " 'product containing abacavir and lamivudine and zidovudine in oral dose form',\n",
       " 'product containing only abacavir',\n",
       " 'product containing only abacavir and lamivudine',\n",
       " 'product containing only abacavir and dolutegravir and lamivudine',\n",
       " 'product containing only abacavir and lamivudine and zidovudine',\n",
       " 'product containing only abacavir in oral dose form',\n",
       " 'product containing only abacavir and lamivudine in oral dose form',\n",
       " 'product containing only abacavir and dolutegravir and lamivudine in oral dose form',\n",
       " 'product containing only abacavir and lamivudine and zidovudine in oral dose form',\n",
       " 'product containing precisely abacavir',\n",
       " 'product containing precisely abacavir',\n",
       " 'product containing didanosine',\n",
       " 'didanosine adverse reaction',\n",
       " 'allergy to didanosine',\n",
       " 'product containing precisely didanosine 150 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely didanosine 25 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely didanosine 100 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule',\n",
       " 'product containing precisely didanosine 250 milligram/1 each gastro-resistant oral capsule',\n",
       " 'product containing precisely didanosine 200 milligram/1 each gastro-resistant oral capsule',\n",
       " 'product containing precisely didanosine 125 milligram/1 each gastro-resistant oral capsule',\n",
       " 'product containing precisely didanosine 200 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely didanosine 50 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely didanosine 125 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely didanosine 200 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely didanosine 250 milligram/1 each conventional release oral capsule',\n",
       " 'didanosine',\n",
       " 'product containing didanosine in oral dose form',\n",
       " 'product containing only didanosine',\n",
       " 'product containing only didanosine in oral dose form',\n",
       " 'product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing emtricitabine',\n",
       " 'emtricitabine',\n",
       " 'product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule',\n",
       " 'product containing emtricitabine and tenofovir',\n",
       " 'product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet',\n",
       " 'product containing efavirenz and emtricitabine and tenofovir',\n",
       " 'product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing emtricitabine and rilpivirine and tenofovir',\n",
       " 'product containing efavirenz and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing emtricitabine in oral dose form',\n",
       " 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir',\n",
       " 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely emtricitabine 10 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing bictegravir and emtricitabine and tenofovir',\n",
       " 'product containing bictegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only bictegravir and emtricitabine and tenofovir',\n",
       " 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir',\n",
       " 'product containing only efavirenz and emtricitabine and tenofovir',\n",
       " 'product containing only emtricitabine',\n",
       " 'product containing only emtricitabine and rilpivirine and tenofovir',\n",
       " 'product containing only emtricitabine and tenofovir',\n",
       " 'product containing only bictegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only efavirenz and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only emtricitabine in oral dose form',\n",
       " 'product containing lamivudine',\n",
       " 'product containing abacavir and lamivudine and zidovudine',\n",
       " 'product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing precisely lamivudine 5 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing precisely lamivudine 100 milligram/1 each conventional release oral tablet',\n",
       " 'product containing lamivudine and zidovudine',\n",
       " 'product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'lamivudine',\n",
       " 'product containing precisely lamivudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing abacavir and lamivudine',\n",
       " 'product containing lamivudine and nevirapine and zidovudine',\n",
       " 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing lamivudine and stavudine',\n",
       " 'product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing lamivudine and nevirapine and stavudine',\n",
       " 'product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet',\n",
       " 'product containing abacavir and lamivudine in oral dose form',\n",
       " 'product containing lamivudine in oral dose form',\n",
       " 'product containing lamivudine and nevirapine and stavudine in oral dose form',\n",
       " 'product containing lamivudine and nevirapine and zidovudine in oral dose form',\n",
       " 'product containing lamivudine and zidovudine in oral dose form',\n",
       " 'product containing abacavir and dolutegravir and lamivudine',\n",
       " 'product containing abacavir and dolutegravir and lamivudine in oral dose form',\n",
       " 'product containing abacavir and lamivudine and zidovudine in oral dose form',\n",
       " 'product containing only abacavir and lamivudine',\n",
       " 'product containing only abacavir and dolutegravir and lamivudine',\n",
       " 'product containing only abacavir and lamivudine and zidovudine',\n",
       " 'product containing only abacavir and lamivudine in oral dose form',\n",
       " 'product containing only abacavir and dolutegravir and lamivudine in oral dose form',\n",
       " 'product containing only abacavir and lamivudine and zidovudine in oral dose form',\n",
       " 'product containing lamivudine and stavudine in oral dose form',\n",
       " 'product containing only lamivudine',\n",
       " 'product containing only lamivudine and nevirapine and stavudine',\n",
       " 'product containing only lamivudine and nevirapine and zidovudine',\n",
       " 'product containing only lamivudine and stavudine',\n",
       " 'product containing only lamivudine and zidovudine',\n",
       " 'product containing only lamivudine and nevirapine and stavudine in oral dose form',\n",
       " 'product containing only lamivudine and nevirapine and zidovudine in oral dose form',\n",
       " 'product containing only lamivudine and stavudine in oral dose form',\n",
       " 'product containing only lamivudine and zidovudine in oral dose form',\n",
       " 'product containing only lamivudine in oral dose form',\n",
       " 'product containing only doravirine and lamivudine and tenofovir',\n",
       " 'product containing doravirine and lamivudine and tenofovir',\n",
       " 'product containing doravirine and lamivudine and tenofovir in oral dose form',\n",
       " 'product containing only doravirine and lamivudine and tenofovir in oral dose form',\n",
       " 'product containing precisely abacavir',\n",
       " 'product containing lamivudine and nevirapine and stavudine in oromucosal dose form',\n",
       " 'product containing only lamivudine and nevirapine and stavudine in oromucosal dose form',\n",
       " 'product containing dolutegravir and lamivudine',\n",
       " 'product containing only dolutegravir and lamivudine',\n",
       " 'product containing dolutegravir and lamivudine in oral dose form',\n",
       " 'product containing only dolutegravir and lamivudine in oral dose form',\n",
       " 'product containing stavudine',\n",
       " 'product containing precisely stavudine 15 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely stavudine 20 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely stavudine 30 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely stavudine 40 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely stavudine 1 milligram/1 milliliter conventional release oral solution',\n",
       " 'stavudine',\n",
       " 'product containing lamivudine and stavudine',\n",
       " 'product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing lamivudine and nevirapine and stavudine',\n",
       " 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet',\n",
       " 'product containing lamivudine and nevirapine and stavudine in oral dose form',\n",
       " 'product containing stavudine in oral dose form',\n",
       " 'product containing lamivudine and stavudine in oral dose form',\n",
       " 'product containing only lamivudine and nevirapine and stavudine',\n",
       " 'product containing only lamivudine and stavudine',\n",
       " 'product containing only stavudine',\n",
       " 'product containing only lamivudine and nevirapine and stavudine in oral dose form',\n",
       " 'product containing only lamivudine and stavudine in oral dose form',\n",
       " 'product containing only stavudine in oral dose form',\n",
       " 'product containing lamivudine and nevirapine and stavudine in oromucosal dose form',\n",
       " 'product containing only lamivudine and nevirapine and stavudine in oromucosal dose form',\n",
       " 'tenofovir disoproxil fumarate',\n",
       " 'product containing tenofovir',\n",
       " 'product containing precisely tenofovir disoproxil',\n",
       " 'product containing emtricitabine and tenofovir',\n",
       " 'product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet',\n",
       " 'tenofovir disoproxil',\n",
       " 'tenofovir',\n",
       " 'product containing efavirenz and emtricitabine and tenofovir',\n",
       " 'product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing emtricitabine and rilpivirine and tenofovir',\n",
       " 'product containing efavirenz and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing tenofovir in oral dose form',\n",
       " 'tenofovir alafenamide',\n",
       " 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir',\n",
       " 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet',\n",
       " 'tenofovir alafenamide fumarate',\n",
       " 'product containing bictegravir and emtricitabine and tenofovir',\n",
       " 'product containing bictegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only bictegravir and emtricitabine and tenofovir',\n",
       " 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir',\n",
       " 'product containing only efavirenz and emtricitabine and tenofovir',\n",
       " 'product containing only emtricitabine and rilpivirine and tenofovir',\n",
       " 'product containing only emtricitabine and tenofovir',\n",
       " 'product containing only tenofovir',\n",
       " 'product containing only bictegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only efavirenz and emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only emtricitabine and tenofovir in oral dose form',\n",
       " 'product containing only tenofovir in oral dose form',\n",
       " 'product containing only doravirine and lamivudine and tenofovir',\n",
       " 'product containing doravirine and lamivudine and tenofovir',\n",
       " 'product containing doravirine and lamivudine and tenofovir in oral dose form',\n",
       " 'product containing only doravirine and lamivudine and tenofovir in oral dose form',\n",
       " 'product containing zidovudine',\n",
       " 'product containing abacavir and lamivudine and zidovudine',\n",
       " 'zidovudine adverse reaction',\n",
       " 'allergy to zidovudine',\n",
       " 'product containing precisely zidovudine 100 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely zidovudine 250 milligram/1 each conventional release oral capsule',\n",
       " 'product containing lamivudine and zidovudine',\n",
       " 'product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'zidovudine',\n",
       " 'product containing lamivudine and nevirapine and zidovudine',\n",
       " 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing zidovudine in parenteral dose form',\n",
       " 'product containing zidovudine in oral dose form',\n",
       " 'product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet',\n",
       " 'anemia caused by zidovudine',\n",
       " 'product containing lamivudine and nevirapine and zidovudine in oral dose form',\n",
       " 'product containing lamivudine and zidovudine in oral dose form',\n",
       " 'product containing abacavir and lamivudine and zidovudine in oral dose form',\n",
       " 'product containing precisely zidovudine 10 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing only abacavir and lamivudine and zidovudine',\n",
       " 'product containing only abacavir and lamivudine and zidovudine in oral dose form',\n",
       " 'product containing only lamivudine and nevirapine and zidovudine',\n",
       " 'product containing only lamivudine and zidovudine',\n",
       " 'product containing only zidovudine',\n",
       " 'product containing only lamivudine and nevirapine and zidovudine in oral dose form',\n",
       " 'product containing only lamivudine and zidovudine in oral dose form',\n",
       " 'product containing only zidovudine in oral dose form',\n",
       " 'product containing only zidovudine in parenteral dose form',\n",
       " 'poisoning caused by isoniazid',\n",
       " 'product containing isoniazid',\n",
       " 'accidental isoniazid poisoning',\n",
       " 'intentional isoniazid poisoning',\n",
       " 'isoniazid poisoning of undetermined intent',\n",
       " 'isoniazid adverse reaction',\n",
       " 'allergy to isoniazid',\n",
       " 'isoniazid overdose',\n",
       " 'accidental isoniazid overdose',\n",
       " 'intentional isoniazid overdose',\n",
       " 'isoniazid overdose of undetermined intent',\n",
       " 'product containing precisely isoniazid 50 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely isoniazid 100 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing isoniazid and rifampicin',\n",
       " 'product containing isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely isoniazid 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule',\n",
       " 'isoniazid',\n",
       " 'urine isoniazid measurement',\n",
       " 'isoniazid resistant tuberculosis',\n",
       " 'product containing isoniazid in parenteral dose form',\n",
       " 'product containing isoniazid in oral dose form',\n",
       " 'neuropathy caused by isoniazid',\n",
       " 'product containing isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing isoniazid and rifampicin in oral dose form',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing ethambutol and isoniazid in oral dose form',\n",
       " 'product containing ethambutol and isoniazid',\n",
       " 'product containing ethambutol and isoniazid and rifampicin',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing ethambutol and isoniazid and rifampicin in oral dose form',\n",
       " 'product containing precisely isoniazid 10 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing only ethambutol and isoniazid',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only ethambutol and isoniazid and rifampicin',\n",
       " 'product containing only isoniazid',\n",
       " 'product containing only isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only isoniazid and rifampicin',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing only ethambutol and isoniazid and rifampicin in oral dose form',\n",
       " 'product containing only ethambutol and isoniazid in oral dose form',\n",
       " 'product containing only isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing only isoniazid and rifampicin in oral dose form',\n",
       " 'product containing only isoniazid in oral dose form',\n",
       " 'product containing only isoniazid in parenteral dose form',\n",
       " 'product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection',\n",
       " 'product containing rifampicin',\n",
       " 'rifampicin poisoning',\n",
       " 'rifampicin adverse reaction',\n",
       " 'allergy to rifampicin',\n",
       " 'product containing precisely rifampicin 150 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet',\n",
       " 'product containing isoniazid and rifampicin',\n",
       " 'product containing isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet',\n",
       " 'rifampicin',\n",
       " 'urine rifampicin level',\n",
       " 'rifampicin resistant tuberculosis',\n",
       " 'product containing rifampicin in oral dose form',\n",
       " 'product containing rifampicin in parenteral dose form',\n",
       " 'product containing isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing isoniazid and rifampicin in oral dose form',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing ethambutol and isoniazid and rifampicin',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing ethambutol and isoniazid and rifampicin in oral dose form',\n",
       " 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule',\n",
       " 'rifampicin sodium',\n",
       " 'product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for injection',\n",
       " 'product containing precisely rifampicin 20 milligram/1 milliliter conventional release oral suspension',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only ethambutol and isoniazid and rifampicin',\n",
       " 'product containing only isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only isoniazid and rifampicin',\n",
       " 'product containing only rifampicin',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing only ethambutol and isoniazid and rifampicin in oral dose form',\n",
       " 'product containing only isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing only isoniazid and rifampicin in oral dose form',\n",
       " 'product containing only rifampicin in oral dose form',\n",
       " 'product containing only rifampicin in parenteral dose form',\n",
       " 'product containing pyrazinamide',\n",
       " 'pyrazinamide measurement',\n",
       " 'pyrazinamide adverse reaction',\n",
       " 'allergy to pyrazinamide',\n",
       " 'product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet',\n",
       " 'product containing isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet',\n",
       " 'pyrazinamide',\n",
       " 'pyrazinamide resistant tuberculosis',\n",
       " 'product containing isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing pyrazinamide in oral dose form',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only pyrazinamide',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing only isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing only pyrazinamide in oral dose form',\n",
       " 'poisoning caused by ethambutol',\n",
       " 'product containing ethambutol',\n",
       " 'ethambutol hydrochloride',\n",
       " 'ethambutol measurement',\n",
       " 'accidental ethambutol poisoning',\n",
       " 'intentional ethambutol poisoning',\n",
       " 'ethambutol poisoning of undetermined intent',\n",
       " 'ethambutol overdose',\n",
       " 'accidental ethambutol overdose',\n",
       " 'intentional ethambutol overdose',\n",
       " 'ethambutol overdose of undetermined intent',\n",
       " 'product containing precisely ethambutol hydrochloride 100 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely ethambutol hydrochloride 400 milligram/1 each conventional release oral tablet',\n",
       " 'ethambutol',\n",
       " 'urine ethambutol level',\n",
       " 'ethambutol adverse reaction',\n",
       " 'ethambutol resistant tuberculosis',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing ethambutol and isoniazid in oral dose form',\n",
       " 'product containing ethambutol and isoniazid',\n",
       " 'product containing ethambutol in oral dose form',\n",
       " 'product containing ethambutol and isoniazid and rifampicin',\n",
       " 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing ethambutol and isoniazid and rifampicin in oral dose form',\n",
       " 'product containing only ethambutol',\n",
       " 'product containing only ethambutol and isoniazid',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin',\n",
       " 'product containing only ethambutol and isoniazid and rifampicin',\n",
       " 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form',\n",
       " 'product containing only ethambutol and isoniazid and rifampicin in oral dose form',\n",
       " 'product containing only ethambutol and isoniazid in oral dose form',\n",
       " 'product containing only ethambutol in oral dose form',\n",
       " 'allergy to ethambutol',\n",
       " 'product containing risperidone',\n",
       " 'risperidone measurement',\n",
       " 'risperidone poisoning',\n",
       " 'accidental risperidone poisoning',\n",
       " 'intentional risperidone poisoning',\n",
       " 'risperidone poisoning of undetermined intent',\n",
       " 'risperidone adverse reaction',\n",
       " 'allergy to risperidone',\n",
       " 'risperidone overdose',\n",
       " 'accidental risperidone overdose',\n",
       " 'intentional risperidone overdose',\n",
       " 'risperidone overdose of undetermined intent',\n",
       " 'product containing precisely risperidone 1 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely risperidone 2 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely risperidone 3 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely risperidone 4 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution',\n",
       " 'product containing precisely risperidone 6 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely risperidone 500 microgram/1 each conventional release oral tablet',\n",
       " 'product containing precisely risperidone 250 microgram/1 each conventional release oral tablet',\n",
       " 'risperidone',\n",
       " 'product containing risperidone in oral dose form',\n",
       " 'product containing risperidone in parenteral dose form',\n",
       " 'product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely risperidone 4 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely risperidone 12.5 milligram/1 vial powder for conventional release suspension for injection',\n",
       " 'product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection',\n",
       " 'product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection',\n",
       " 'product containing precisely risperidone 50 milligram/1 vial powder for conventional release suspension for injection',\n",
       " 'product containing only risperidone',\n",
       " 'product containing only risperidone in oral dose form',\n",
       " 'product containing only risperidone in parenteral dose form',\n",
       " 'product containing risperidone in oromucosal dose form',\n",
       " 'product containing only risperidone in oromucosal dose form',\n",
       " 'product containing olanzapine',\n",
       " 'olanzapine measurement',\n",
       " 'product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely olanzapine 7.5 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely olanzapine 2.5 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing precisely olanzapine 20 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely olanzapine 15 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely olanzapine 20 milligram/1 each conventional release orodispersible tablet',\n",
       " 'olanzapine',\n",
       " 'product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet',\n",
       " 'product containing fluoxetine and olanzapine',\n",
       " 'product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule',\n",
       " 'product containing olanzapine in parenteral dose form',\n",
       " 'product containing olanzapine in oral dose form',\n",
       " 'product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule',\n",
       " 'olanzapine embonate',\n",
       " 'olanzapine embonate monohydrate',\n",
       " 'olanzapine pamoate',\n",
       " 'product containing fluoxetine and olanzapine in oral dose form',\n",
       " 'product containing only fluoxetine and olanzapine',\n",
       " 'product containing only olanzapine',\n",
       " 'product containing only fluoxetine and olanzapine in oral dose form',\n",
       " 'product containing only olanzapine in oral dose form',\n",
       " 'product containing only olanzapine in parenteral dose form',\n",
       " 'product containing olanzapine in oromucosal dose form',\n",
       " 'product containing only olanzapine in oromucosal dose form',\n",
       " 'quetiapine fumarate',\n",
       " 'product containing quetiapine',\n",
       " 'product containing precisely quetiapine',\n",
       " 'product containing precisely quetiapine',\n",
       " 'product containing precisely quetiapine',\n",
       " 'quetiapine',\n",
       " 'product containing precisely quetiapine',\n",
       " 'product containing precisely quetiapine',\n",
       " 'product containing precisely quetiapine',\n",
       " 'measurement of quetiapine',\n",
       " 'product containing precisely quetiapine',\n",
       " 'product containing precisely quetiapine fumarate 400 milligram/1 each conventional release oral tablet',\n",
       " 'product containing precisely quetiapine fumarate 50 milligram/1 each conventional release oral tablet',\n",
       " 'product containing quetiapine in oral dose form',\n",
       " 'product containing only quetiapine',\n",
       " 'product containing only quetiapine in oral dose form',\n",
       " 'product containing precisely quetiapine',\n",
       " 'ziprasidone hydrochloride',\n",
       " 'product containing ziprasidone',\n",
       " 'product containing precisely ziprasidone',\n",
       " 'product containing precisely ziprasidone hydrochloride 40 milligram/1 each conventional release oral capsule',\n",
       " 'product containing precisely ziprasidone',\n",
       " 'product containing precisely ziprasidone hydrochloride 80 milligram/1 each conventional release oral capsule',\n",
       " 'ziprasidone',\n",
       " 'ziprasidone mesilate',\n",
       " 'product containing ziprasidone in parenteral dose form',\n",
       " 'product containing ziprasidone in oral dose form',\n",
       " 'product containing only ziprasidone',\n",
       " 'product containing only ziprasidone in oral dose form',\n",
       " 'product containing only ziprasidone in parenteral dose form',\n",
       " 'product containing precisely ziprasidone',\n",
       " 'paliperidone',\n",
       " 'product containing paliperidone',\n",
       " 'product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet',\n",
       " 'product containing precisely paliperidone 6 milligram/1 each prolonged-release oral tablet',\n",
       " 'product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet',\n",
       " 'product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet',\n",
       " 'paliperidone palmitate',\n",
       " 'product containing only paliperidone',\n",
       " 'product containing paliperidone in oral dose form',\n",
       " 'product containing only paliperidone in oral dose form',\n",
       " 'lurasidone hydrochloride',\n",
       " 'lurasidone',\n",
       " 'product containing lurasidone',\n",
       " 'product containing lurasidone in oral dose form',\n",
       " 'product containing only lurasidone',\n",
       " 'product containing only lurasidone in oral dose form',\n",
       " 'product containing bevacizumab',\n",
       " 'bevacizumab',\n",
       " 'product containing bevacizumab in parenteral dose form',\n",
       " 'product containing only bevacizumab',\n",
       " 'product containing only bevacizumab in parenteral dose form',\n",
       " 'product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection',\n",
       " 'product containing carmustine',\n",
       " 'carmustine poisoning',\n",
       " 'accidental carmustine poisoning',\n",
       " 'intentional carmustine poisoning',\n",
       " 'carmustine poisoning of undetermined intent',\n",
       " 'carmustine adverse reaction',\n",
       " 'allergy to carmustine',\n",
       " 'carmustine overdose',\n",
       " 'accidental carmustine overdose',\n",
       " 'intentional carmustine overdose',\n",
       " 'carmustine overdose of undetermined intent',\n",
       " 'carmustine',\n",
       " 'implantation of carmustine wafer into cerebrum',\n",
       " 'product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection',\n",
       " 'product containing carmustine in parenteral dose form',\n",
       " 'product containing only carmustine',\n",
       " 'product containing only carmustine in parenteral dose form',\n",
       " 'product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant',\n",
       " 'product containing carmustine in prolonged-release intralesional implant',\n",
       " 'product containing only carmustine in prolonged-release intralesional implant',\n",
       " 'clotting factor v assay',\n",
       " 'coagulation factor v',\n",
       " 'chondroitin ac lyase',\n",
       " 'hemoglobin raleigh',\n",
       " 'hereditary factor v deficiency disease',\n",
       " 'anterior chamber finding',\n",
       " 'ocular accommodation convergence/accommodation ratio',\n",
       " 'air conduction pure tone audiometry, manual with ear phones',\n",
       " 'ethyleneurea,melamineformaldehyde',\n",
       " '',\n",
       " 'alternating current',\n",
       " 'before meal',\n",
       " 'anterior colporrhaphy',\n",
       " 'index of orthodontic treatment need - esthetic component',\n",
       " 'amniocentesis',\n",
       " 'air conduction, function',\n",
       " 'measurement of ratio of accommodative convergence to accommodation',\n",
       " 'ethyleneurea,melamineformaldehyde',\n",
       " '',\n",
       " 'computed tomography of acromioclavicular joint',\n",
       " 'shallow anterior chamber of eye',\n",
       " 'medium depth anterior chamber of eye',\n",
       " 'deep anterior chamber of eye',\n",
       " 'anterior chamber of eye normal',\n",
       " 'anterior chamber of eye structure',\n",
       " 'actinium-224',\n",
       " 'actinium-226',\n",
       " 'actinium-225',\n",
       " 'actinium-227',\n",
       " 'actinium-228',\n",
       " 'actinium-229',\n",
       " '']"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "string = ' '.join([str(elem) for elem in all_snomed_senstive_drug_info])\n",
    "#type(result1)\n",
    "result1 = re.split(r\"#|\\n\",string.lower())\n",
    "#result1.group(0)\n",
    "result1\n",
    "result2=[]\n",
    "for i in result1:\n",
    "    res=re.findall(r\"^ snomedct\\[[0-9]+\\]  |^snomedct\\[[0-9]+\\]  \",i)#mached snomedct word\n",
    "    result2.append(res)\n",
    "result2\n",
    "result3=[ele for ele in result2 if ele!=[]]#remove empty list\n",
    "result4=[]\n",
    "for i in result3:\n",
    "    for item in i:\n",
    "        result4.append(item)#make ito a sinle list\n",
    "\n",
    "result4\n",
    "result5=[]\n",
    "for j in result1:\n",
    "    if j not in result4:\n",
    "        result5.append(j.strip())\n",
    "#result5\n",
    "result5=' '.join([str(elem) for elem in result5])\n",
    "result6=re.split(r\"\\(|\\)\", result5)\n",
    "result6\n",
    "\n",
    "result7 = re.split(r\"\\(|\\)\",string)\n",
    "#result1.group(0)\n",
    "result1\n",
    "result8=set()\n",
    "for i in result7:\n",
    "    if '\\n' not in i:\n",
    "        result8.add(str(i).lower())\n",
    "\n",
    "result9=[]\n",
    "for i in result8:\n",
    "    res=re.findall(r\"^(?!snomedct*).+\",i)#mached snomedct word\n",
    "    result9.append(res)\n",
    "\n",
    "result10=[]\n",
    "for i in result9:\n",
    "    for j in i:\n",
    "        if j !=[''] and j !=' ' and j!='':\n",
    "            result10.append(j)\n",
    "\n",
    "\n",
    "snomed_reduced_final_drug_result=[]\n",
    "for i in result6:\n",
    "    if i not in result10:\n",
    "        snomed_reduced_final_drug_result.append(i.strip())\n",
    "snomed_reduced_final_drug_result\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['Abacavir',\n",
       "  'Abacavir/dolutegravir/lamivudine',\n",
       "  'Abacavir/lamivudine',\n",
       "  'Abacavir/lamivudine/zidovudine',\n",
       "  'Lamivudine',\n",
       "  'Guanosine',\n",
       "  'ViiV Healthcare',\n",
       "  'Zidovudine',\n",
       "  'Schedule H',\n",
       "  'Morbilliform'],\n",
       " ['Didanosine',\n",
       "  'Bioretrosynthesis',\n",
       "  'Allopurinol',\n",
       "  'Emtricitabine/tenofovir',\n",
       "  'DDI',\n",
       "  'Bristol Myers Squibb',\n",
       "  'Fanconi syndrome',\n",
       "  'Reverse-transcriptase inhibitor',\n",
       "  'Tenofovir disoproxil',\n",
       "  'Ciprofloxacin'],\n",
       " ['Emtricitabine',\n",
       "  'Emtricitabine/tenofovir',\n",
       "  'Tenofovir alafenamide',\n",
       "  'Bictegravir/emtricitabine/tenofovir alafenamide',\n",
       "  'Efavirenz/emtricitabine/tenofovir',\n",
       "  'Tenofovir disoproxil',\n",
       "  'Elvitegravir/cobicistat/emtricitabine/tenofovir',\n",
       "  'Bictegravir',\n",
       "  'Pre-exposure prophylaxis',\n",
       "  'ATC code J05'],\n",
       " ['Lamivudine',\n",
       "  'Lamivudine/zidovudine',\n",
       "  'Dolutegravir/lamivudine/tenofovir',\n",
       "  'Abacavir/lamivudine',\n",
       "  'Dolutegravir/lamivudine',\n",
       "  'Efavirenz/lamivudine/tenofovir',\n",
       "  'Lamivudine/raltegravir',\n",
       "  'Abacavir/dolutegravir/lamivudine',\n",
       "  'WHO Model List of Essential Medicines',\n",
       "  'Lamivudine/tenofovir'],\n",
       " ['Stavudine',\n",
       "  'Organic anion transporter 1',\n",
       "  'Lamivudine/nevirapine/stavudine',\n",
       "  'Nucleoside analogue',\n",
       "  'Adverse effect',\n",
       "  'Metaxalone',\n",
       "  'Lipodystrophy',\n",
       "  'Reverse-transcriptase inhibitor',\n",
       "  'List of medical abbreviations: D',\n",
       "  'Stampidine'],\n",
       " ['Tenofovir disoproxil',\n",
       "  'Emtricitabine/tenofovir',\n",
       "  'Tenofovir alafenamide',\n",
       "  'Efavirenz/emtricitabine/tenofovir',\n",
       "  'Dolutegravir/lamivudine/tenofovir',\n",
       "  'Bictegravir/emtricitabine/tenofovir alafenamide',\n",
       "  'Pre-exposure prophylaxis',\n",
       "  'Lamivudine/tenofovir',\n",
       "  'Elvitegravir/cobicistat/emtricitabine/tenofovir',\n",
       "  'Emtricitabine'],\n",
       " ['Zidovudine',\n",
       "  'Lamivudine/zidovudine',\n",
       "  'Lamivudine',\n",
       "  'Abacavir/lamivudine/zidovudine',\n",
       "  'WHO Model List of Essential Medicines',\n",
       "  'Lamivudine/nevirapine/zidovudine',\n",
       "  'Glucuronidation',\n",
       "  'List of antiviral drugs',\n",
       "  'Reverse transcriptase',\n",
       "  'Nevirapine'],\n",
       " ['Isoniazid',\n",
       "  'Isoniazid/rifampicin',\n",
       "  'Tuberculosis management',\n",
       "  'WHO Model List of Essential Medicines',\n",
       "  'Rifampicin/isoniazid/pyrazinamide',\n",
       "  'Latent tuberculosis',\n",
       "  'Tuberculosis',\n",
       "  'Isopar',\n",
       "  'Ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       "  'Ethambutol/isoniazid'],\n",
       " ['Rifampicin',\n",
       "  'Isoniazid/rifampicin',\n",
       "  'WHO Model List of Essential Medicines',\n",
       "  'Tuberculosis management',\n",
       "  'Leprosy',\n",
       "  'Ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       "  'Tuberculosis',\n",
       "  'Isoniazid',\n",
       "  'Rifampicin/isoniazid/pyrazinamide',\n",
       "  'Epiglottitis'],\n",
       " ['Pyrazinamide',\n",
       "  'WHO Model List of Essential Medicines',\n",
       "  'Ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       "  'Tuberculosis management',\n",
       "  'Streptomycin',\n",
       "  'Rifampicin/isoniazid/pyrazinamide',\n",
       "  'Isoniazid',\n",
       "  'Uricosuric',\n",
       "  'Tuberculosis',\n",
       "  'Rifampicin'],\n",
       " ['Ethambutol',\n",
       "  'WHO Model List of Essential Medicines',\n",
       "  'Tuberculosis management',\n",
       "  'Ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       "  'Ethambutol/isoniazid',\n",
       "  'Ethambutol/isoniazid/rifampicin',\n",
       "  'Enantiopure drug',\n",
       "  'Isoniazid',\n",
       "  'Tuberculosis',\n",
       "  'Bacteriostatic agent'],\n",
       " ['Risperidone',\n",
       "  'Olanzapine',\n",
       "  'List of adverse effects of risperidone',\n",
       "  'Paliperidone',\n",
       "  'Quetiapine',\n",
       "  'Bupropion',\n",
       "  'Fluoxetine',\n",
       "  'Potency (pharmacology)',\n",
       "  'Tizanidine',\n",
       "  'Amitriptyline'],\n",
       " ['Olanzapine',\n",
       "  'Olanzapine/fluoxetine',\n",
       "  'Olanzapine/samidorphan',\n",
       "  'List of adverse effects of olanzapine',\n",
       "  'Atypical antipsychotic',\n",
       "  'Psychotic depression',\n",
       "  'Lurasidone',\n",
       "  'Antipsychotic',\n",
       "  'Quetiapine',\n",
       "  'Mirtazapine'],\n",
       " ['Quetiapine',\n",
       "  'Antipsychotic',\n",
       "  'Atypical antipsychotic',\n",
       "  'Olanzapine',\n",
       "  'Lurasidone',\n",
       "  'Appetite stimulant',\n",
       "  'Psychotic depression',\n",
       "  'Quell',\n",
       "  'Alpha-2 adrenergic receptor',\n",
       "  'Mirtazapine'],\n",
       " ['Ziprasidone',\n",
       "  'Atypical antipsychotic',\n",
       "  'Potency (pharmacology)',\n",
       "  'Quetiapine',\n",
       "  'Psychomotor agitation',\n",
       "  'Amisulpride',\n",
       "  'Lurasidone',\n",
       "  'Aripiprazole',\n",
       "  'Antipsychotic',\n",
       "  'Nikki McKibbin'],\n",
       " ['Paliperidone',\n",
       "  'Risperidone',\n",
       "  'List of antipsychotics',\n",
       "  'Antipsychotic',\n",
       "  'Atypical antipsychotic',\n",
       "  'Lurasidone',\n",
       "  'Neuroleptic-induced deficit syndrome',\n",
       "  'Amisulpride',\n",
       "  'Palmitic acid',\n",
       "  'List of psychotropic medications'],\n",
       " ['Lurasidone',\n",
       "  'Cycloserine/lurasidone',\n",
       "  'List of adverse effects of lurasidone',\n",
       "  'Atypical antipsychotic',\n",
       "  'Extrapyramidal symptoms',\n",
       "  'Antipsychotic',\n",
       "  'Akathisia',\n",
       "  'Amisulpride',\n",
       "  'Oculogyric crisis',\n",
       "  'Paliperidone'],\n",
       " ['Everolimus',\n",
       "  'Novartis',\n",
       "  'Anticonvulsant',\n",
       "  'Pancreatic neuroendocrine tumor',\n",
       "  'Neuroendocrine tumor',\n",
       "  'List of largest selling pharmaceutical products',\n",
       "  'Targeted therapy',\n",
       "  'Tuberous sclerosis',\n",
       "  'Exemestane',\n",
       "  'Sunitinib'],\n",
       " ['Bevacizumab',\n",
       "  'Genentech',\n",
       "  'Sue Desmond-Hellmann',\n",
       "  'Novartis',\n",
       "  'Antivascular endothelial growth factor therapy',\n",
       "  'Biosimilar',\n",
       "  'Side effect',\n",
       "  'Chemotherapy',\n",
       "  'Retinal haemorrhage',\n",
       "  'Follicle-stimulating hormone'],\n",
       " ['Bevacizumab',\n",
       "  'Ranibizumab',\n",
       "  'Antivascular endothelial growth factor therapy',\n",
       "  'FOLFOXIRI',\n",
       "  'Macular degeneration',\n",
       "  'Angiogenesis inhibitor',\n",
       "  'FOLFIRI',\n",
       "  'Corneal neovascularization',\n",
       "  'Nasal septum perforation',\n",
       "  'Atezolizumab'],\n",
       " ['Carmustine', 'Nitrosourea', 'Bristol Myers Squibb', 'List of drugs: Bi-Bo'],\n",
       " ['Carmustine',\n",
       "  'Eisai (company)',\n",
       "  'Lomustine',\n",
       "  'Nitrosourea',\n",
       "  'Beam',\n",
       "  'Interstitial lung disease',\n",
       "  'Diffuse intrinsic pontine glioma',\n",
       "  'Methotrexate',\n",
       "  'Ground-glass opacity',\n",
       "  'Alkylating antineoplastic agent'],\n",
       " [],\n",
       " [],\n",
       " ['T.N.T. (album)',\n",
       "  'AC-to-AC converter',\n",
       "  'AC/DC',\n",
       "  'AC-T (disambiguation)',\n",
       "  'Alternating current',\n",
       "  'AC/DC discography',\n",
       "  '.ac',\n",
       "  'AC Cobra',\n",
       "  'A.C.T',\n",
       "  'Power Up (album)']]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import wikipedia\n",
    "wikipedia_senstive_info = []\n",
    "for item in sensitive_diseases:\n",
    "    info = wikipedia.search(item)\n",
    "    wikipedia_senstive_info.append(info)\n",
    "#wikipedia_senstive_info\n",
    "\n",
    "wikipedia_senstive_drug_info = []\n",
    "for item in sensitive_drugs:\n",
    "    info = wikipedia.search(item)\n",
    "    wikipedia_senstive_drug_info.append(info)\n",
    "wikipedia_senstive_drug_info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['abacavir',\n",
       " 'abacavir/dolutegravir/lamivudine',\n",
       " 'abacavir/lamivudine',\n",
       " 'abacavir/lamivudine/zidovudine',\n",
       " 'lamivudine',\n",
       " 'guanosine',\n",
       " 'viiv healthcare',\n",
       " 'zidovudine',\n",
       " 'schedule h',\n",
       " 'morbilliform',\n",
       " 'didanosine',\n",
       " 'bioretrosynthesis',\n",
       " 'allopurinol',\n",
       " 'emtricitabine/tenofovir',\n",
       " 'ddi',\n",
       " 'bristol myers squibb',\n",
       " 'fanconi syndrome',\n",
       " 'reverse-transcriptase inhibitor',\n",
       " 'tenofovir disoproxil',\n",
       " 'ciprofloxacin',\n",
       " 'emtricitabine',\n",
       " 'emtricitabine/tenofovir',\n",
       " 'tenofovir alafenamide',\n",
       " 'bictegravir/emtricitabine/tenofovir alafenamide',\n",
       " 'efavirenz/emtricitabine/tenofovir',\n",
       " 'tenofovir disoproxil',\n",
       " 'elvitegravir/cobicistat/emtricitabine/tenofovir',\n",
       " 'bictegravir',\n",
       " 'pre-exposure prophylaxis',\n",
       " 'atc code j05',\n",
       " 'lamivudine',\n",
       " 'lamivudine/zidovudine',\n",
       " 'dolutegravir/lamivudine/tenofovir',\n",
       " 'abacavir/lamivudine',\n",
       " 'dolutegravir/lamivudine',\n",
       " 'efavirenz/lamivudine/tenofovir',\n",
       " 'lamivudine/raltegravir',\n",
       " 'abacavir/dolutegravir/lamivudine',\n",
       " 'who model list of essential medicines',\n",
       " 'lamivudine/tenofovir',\n",
       " 'stavudine',\n",
       " 'organic anion transporter 1',\n",
       " 'lamivudine/nevirapine/stavudine',\n",
       " 'nucleoside analogue',\n",
       " 'adverse effect',\n",
       " 'metaxalone',\n",
       " 'lipodystrophy',\n",
       " 'reverse-transcriptase inhibitor',\n",
       " 'list of medical abbreviations: d',\n",
       " 'stampidine',\n",
       " 'tenofovir disoproxil',\n",
       " 'emtricitabine/tenofovir',\n",
       " 'tenofovir alafenamide',\n",
       " 'efavirenz/emtricitabine/tenofovir',\n",
       " 'dolutegravir/lamivudine/tenofovir',\n",
       " 'bictegravir/emtricitabine/tenofovir alafenamide',\n",
       " 'pre-exposure prophylaxis',\n",
       " 'lamivudine/tenofovir',\n",
       " 'elvitegravir/cobicistat/emtricitabine/tenofovir',\n",
       " 'emtricitabine',\n",
       " 'zidovudine',\n",
       " 'lamivudine/zidovudine',\n",
       " 'lamivudine',\n",
       " 'abacavir/lamivudine/zidovudine',\n",
       " 'who model list of essential medicines',\n",
       " 'lamivudine/nevirapine/zidovudine',\n",
       " 'glucuronidation',\n",
       " 'list of antiviral drugs',\n",
       " 'reverse transcriptase',\n",
       " 'nevirapine',\n",
       " 'isoniazid',\n",
       " 'isoniazid/rifampicin',\n",
       " 'tuberculosis management',\n",
       " 'who model list of essential medicines',\n",
       " 'rifampicin/isoniazid/pyrazinamide',\n",
       " 'latent tuberculosis',\n",
       " 'tuberculosis',\n",
       " 'isopar',\n",
       " 'ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       " 'ethambutol/isoniazid',\n",
       " 'rifampicin',\n",
       " 'isoniazid/rifampicin',\n",
       " 'who model list of essential medicines',\n",
       " 'tuberculosis management',\n",
       " 'leprosy',\n",
       " 'ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       " 'tuberculosis',\n",
       " 'isoniazid',\n",
       " 'rifampicin/isoniazid/pyrazinamide',\n",
       " 'epiglottitis',\n",
       " 'pyrazinamide',\n",
       " 'who model list of essential medicines',\n",
       " 'ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       " 'tuberculosis management',\n",
       " 'streptomycin',\n",
       " 'rifampicin/isoniazid/pyrazinamide',\n",
       " 'isoniazid',\n",
       " 'uricosuric',\n",
       " 'tuberculosis',\n",
       " 'rifampicin',\n",
       " 'ethambutol',\n",
       " 'who model list of essential medicines',\n",
       " 'tuberculosis management',\n",
       " 'ethambutol/isoniazid/pyrazinamide/rifampicin',\n",
       " 'ethambutol/isoniazid',\n",
       " 'ethambutol/isoniazid/rifampicin',\n",
       " 'enantiopure drug',\n",
       " 'isoniazid',\n",
       " 'tuberculosis',\n",
       " 'bacteriostatic agent',\n",
       " 'risperidone',\n",
       " 'olanzapine',\n",
       " 'list of adverse effects of risperidone',\n",
       " 'paliperidone',\n",
       " 'quetiapine',\n",
       " 'bupropion',\n",
       " 'fluoxetine',\n",
       " 'potency (pharmacology)',\n",
       " 'tizanidine',\n",
       " 'amitriptyline',\n",
       " 'olanzapine',\n",
       " 'olanzapine/fluoxetine',\n",
       " 'olanzapine/samidorphan',\n",
       " 'list of adverse effects of olanzapine',\n",
       " 'atypical antipsychotic',\n",
       " 'psychotic depression',\n",
       " 'lurasidone',\n",
       " 'antipsychotic',\n",
       " 'quetiapine',\n",
       " 'mirtazapine',\n",
       " 'quetiapine',\n",
       " 'antipsychotic',\n",
       " 'atypical antipsychotic',\n",
       " 'olanzapine',\n",
       " 'lurasidone',\n",
       " 'appetite stimulant',\n",
       " 'psychotic depression',\n",
       " 'quell',\n",
       " 'alpha-2 adrenergic receptor',\n",
       " 'mirtazapine',\n",
       " 'ziprasidone',\n",
       " 'atypical antipsychotic',\n",
       " 'potency (pharmacology)',\n",
       " 'quetiapine',\n",
       " 'psychomotor agitation',\n",
       " 'amisulpride',\n",
       " 'lurasidone',\n",
       " 'aripiprazole',\n",
       " 'antipsychotic',\n",
       " 'nikki mckibbin',\n",
       " 'paliperidone',\n",
       " 'risperidone',\n",
       " 'list of antipsychotics',\n",
       " 'antipsychotic',\n",
       " 'atypical antipsychotic',\n",
       " 'lurasidone',\n",
       " 'neuroleptic-induced deficit syndrome',\n",
       " 'amisulpride',\n",
       " 'palmitic acid',\n",
       " 'list of psychotropic medications',\n",
       " 'lurasidone',\n",
       " 'cycloserine/lurasidone',\n",
       " 'list of adverse effects of lurasidone',\n",
       " 'atypical antipsychotic',\n",
       " 'extrapyramidal symptoms',\n",
       " 'antipsychotic',\n",
       " 'akathisia',\n",
       " 'amisulpride',\n",
       " 'oculogyric crisis',\n",
       " 'paliperidone',\n",
       " 'everolimus',\n",
       " 'novartis',\n",
       " 'anticonvulsant',\n",
       " 'pancreatic neuroendocrine tumor',\n",
       " 'neuroendocrine tumor',\n",
       " 'list of largest selling pharmaceutical products',\n",
       " 'targeted therapy',\n",
       " 'tuberous sclerosis',\n",
       " 'exemestane',\n",
       " 'sunitinib',\n",
       " 'bevacizumab',\n",
       " 'genentech',\n",
       " 'sue desmond-hellmann',\n",
       " 'novartis',\n",
       " 'antivascular endothelial growth factor therapy',\n",
       " 'biosimilar',\n",
       " 'side effect',\n",
       " 'chemotherapy',\n",
       " 'retinal haemorrhage',\n",
       " 'follicle-stimulating hormone',\n",
       " 'bevacizumab',\n",
       " 'ranibizumab',\n",
       " 'antivascular endothelial growth factor therapy',\n",
       " 'folfoxiri',\n",
       " 'macular degeneration',\n",
       " 'angiogenesis inhibitor',\n",
       " 'folfiri',\n",
       " 'corneal neovascularization',\n",
       " 'nasal septum perforation',\n",
       " 'atezolizumab',\n",
       " 'carmustine',\n",
       " 'nitrosourea',\n",
       " 'bristol myers squibb',\n",
       " 'list of drugs: bi-bo',\n",
       " 'carmustine',\n",
       " 'eisai (company)',\n",
       " 'lomustine',\n",
       " 'nitrosourea',\n",
       " 'beam',\n",
       " 'interstitial lung disease',\n",
       " 'diffuse intrinsic pontine glioma',\n",
       " 'methotrexate',\n",
       " 'ground-glass opacity',\n",
       " 'alkylating antineoplastic agent',\n",
       " 't.n.t. (album)',\n",
       " 'ac-to-ac converter',\n",
       " 'ac/dc',\n",
       " 'ac-t (disambiguation)',\n",
       " 'alternating current',\n",
       " 'ac/dc discography',\n",
       " '.ac',\n",
       " 'ac cobra',\n",
       " 'a.c.t',\n",
       " 'power up (album)']"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_wikipedia_senstive_info=[]\n",
    "for term in wikipedia_senstive_info:\n",
    "    for term1 in term:\n",
    "        all_wikipedia_senstive_info.append(term1)\n",
    "all_wikipedia_senstive_info\n",
    "for i in range(len(all_wikipedia_senstive_info)):\n",
    "    all_wikipedia_senstive_info[i] = all_wikipedia_senstive_info[i].lower()\n",
    "\n",
    "#all_wikipedia_senstive_info\n",
    "\n",
    "all_wikipedia_senstive_drug_info=[]\n",
    "for term in wikipedia_senstive_drug_info:\n",
    "    for term1 in term:\n",
    "        all_wikipedia_senstive_drug_info.append(term1)\n",
    "all_wikipedia_senstive_drug_info\n",
    "for i in range(len(all_wikipedia_senstive_drug_info)):\n",
    "    all_wikipedia_senstive_drug_info[i] = all_wikipedia_senstive_drug_info[i].lower()\n",
    "\n",
    "all_wikipedia_senstive_drug_info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "final_sensitive_info_list = all_wikipedia_senstive_info + snomed_reduced_final_result\n",
    "final_drug_list = all_wikipedia_senstive_drug_info + snomed_reduced_final_drug_result\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "final_sensitive_list = final_sensitive_info_list + final_drug_list\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2516"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(final_sensitive_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "%%time\n",
    "import nltk\n",
    "import re\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem import SnowballStemmer\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "from string import punctuation\n",
    "from autocorrect import spell\n",
    "\n",
    "snowball_stemmer = SnowballStemmer('english')\n",
    "wordnet_lemmatizer = WordNetLemmatizer()\n",
    "\n",
    "class Preprocess:\n",
    "    def __int__(self):\n",
    "        pass\n",
    "\n",
    "    def autospell(self,text):\n",
    "       \n",
    "        #correct the spelling of the word.\n",
    "       \n",
    "        spells = [spell(w) for w in (nltk.word_tokenize(text))]\n",
    "        return \" \".join(spells)\n",
    "\n",
    "    def to_lower(self,text):\n",
    "        \n",
    "       # :param text:\n",
    "        #:return:\n",
    "         #   Converted text to lower case as in, converting \"Hello\" to \"hello\" or \"HELLO\" to \"hello\".\n",
    "        \n",
    "        return text.lower()\n",
    "\n",
    "    def remove_numbers(self,text):\n",
    "        \n",
    "        #take string input and return a clean text without numbers.\n",
    "       # Use regex to discard the numbers.\n",
    "        \n",
    "        output = ''.join(c for c in text if not c.isdigit())\n",
    "        return output\n",
    "\n",
    "    def remove_punct(self,text):\n",
    "      \n",
    "        #take string input and clean string without punctuations.\n",
    "        #use regex to remove the punctuations.\n",
    "       \n",
    "        return ''.join(c for c in text if c not in punctuation)\n",
    "\n",
    "    def remove_Tags(self,text):\n",
    "        \n",
    "        #take string input and clean string without tags.\n",
    "        #use regex to remove the html tags.\n",
    "        \n",
    "        cleaned_text = re.sub('<[^<]+?>', '', text)\n",
    "        return cleaned_text\n",
    "\n",
    "    def sentence_tokenize(self,text):\n",
    "       \n",
    "        #take string input and return list of sentences.\n",
    "       # use nltk.sent_tokenize() to split the sentences.\n",
    "        \n",
    "        sent_list = []\n",
    "        for w in nltk.sent_tokenize(text):\n",
    "            sent_list.append(w)\n",
    "        return sent_list\n",
    "\n",
    "    def word_tokenize(self,text):\n",
    "        \n",
    "        #:param text:\n",
    "        #:return: list of words\n",
    "       \n",
    "        return [w for sent in nltk.sent_tokenize(text) for w in nltk.word_tokenize(sent)]\n",
    "\n",
    "    def remove_stopwords(self,sentence):\n",
    "    \n",
    "        #removes all the stop words like \"is,the,a, etc.\"\n",
    "      \n",
    "        stop_words = stopwords.words('english')\n",
    "        return ' '.join([w for w in nltk.word_tokenize(sentence) if not w in stop_words])\n",
    "\n",
    "    def stem(self,text):\n",
    "       \n",
    "        #:param word_tokens:\n",
    "        #:return: list of words\n",
    "        \n",
    "        stemmed_word = [snowball_stemmer.stem(word) for sent in nltk.sent_tokenize(text)for word in nltk.word_tokenize(sent)]\n",
    "        return \" \".join(stemmed_word)\n",
    "\n",
    "    def lemmatize(self,text):\n",
    "        lemmatized_word = [wordnet_lemmatizer.lemmatize(word)for sent in nltk.sent_tokenize(text)for word in nltk.word_tokenize(sent)]\n",
    "        return \" \".join(lemmatized_word)\n",
    "\n",
    "\n",
    "    def preprocess(self,text):\n",
    "        lower_text = self.to_lower(text)\n",
    "        sentence_tokens = self.sentence_tokenize(lower_text)\n",
    "        word_list = []\n",
    "        for each_sent in sentence_tokens:\n",
    "            lemmatizzed_sent = self.lemmatize(each_sent)\n",
    "            clean_text = self.remove_numbers(lemmatizzed_sent)\n",
    "            clean_text = self.remove_punct(clean_text)\n",
    "            clean_text = self.remove_Tags(clean_text)\n",
    "            clean_text = self.remove_stopwords(clean_text)\n",
    "            word_tokens = self.word_tokenize(clean_text)\n",
    "            for i in word_tokens:\n",
    "                word_list.append(i)\n",
    "        return word_list\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 0 ns, sys: 1.97 ms, total: 1.97 ms\n",
      "Wall time: 1.5 ms\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['hiv/aids',\n",
       " 'epidemiology of hiv/aids',\n",
       " 'timeline of hiv/aids',\n",
       " 'hiv/aids in the united states',\n",
       " 'aids (disambiguation)',\n",
       " 'list of countries by hiv/aids adult prevalence rate',\n",
       " 'hiv/aids in africa',\n",
       " 'hiv/aids denialism',\n",
       " 'aids (computer virus)',\n",
       " 'hiv/aids research',\n",
       " 'hiv',\n",
       " 'hiv/aids',\n",
       " 'epidemiology of hiv/aids',\n",
       " 'subtypes of hiv',\n",
       " 'history of hiv/aids',\n",
       " 'hiv (disambiguation)',\n",
       " 'diagnosis of hiv/aids',\n",
       " 'list of countries by hiv/aids adult prevalence rate',\n",
       " 'hiv/aids in africa',\n",
       " 'management of hiv/aids',\n",
       " 'tb',\n",
       " 'tuberculosis',\n",
       " 'tampa bay rays',\n",
       " 'terabyte',\n",
       " 'socata tb family',\n",
       " 'multi-drug-resistant tuberculosis',\n",
       " 'tuberculosis radiology',\n",
       " 'tuberculosis in india',\n",
       " 'directly observed treatment, short-course',\n",
       " 'tb alert',\n",
       " 'cancer',\n",
       " 'breast cancer',\n",
       " 'colorectal cancer',\n",
       " 'lung cancer',\n",
       " 'pancreatic cancer',\n",
       " 'not cancer',\n",
       " 'cancer (astrology)',\n",
       " 'prostate cancer',\n",
       " 'esophageal cancer',\n",
       " 'stomach cancer',\n",
       " 'bipolar disorder',\n",
       " 'bipolar',\n",
       " 'bipolar ii disorder',\n",
       " 'bipolarity',\n",
       " 'bipolar i disorder',\n",
       " 'bipolar junction transistor',\n",
       " 'list of people with bipolar disorder',\n",
       " 'bipolar neuron',\n",
       " 'schizoaffective disorder',\n",
       " 'retina bipolar cell',\n",
       " 'mental disorder',\n",
       " 'list of mental disorders',\n",
       " 'causes of mental disorders',\n",
       " 'classification of mental disorders',\n",
       " 'bipolar disorder',\n",
       " 'history of mental disorders',\n",
       " 'mental disorders and gender',\n",
       " 'diagnostic and statistical manual of mental disorders',\n",
       " 'personality disorder',\n",
       " 'treatment of mental disorders',\n",
       " 'brain tumor',\n",
       " 'list of people with brain tumors',\n",
       " 'cerebral edema',\n",
       " 'canine brain tumors',\n",
       " 'glioblastoma',\n",
       " 'meningioma',\n",
       " 'neurosurgery',\n",
       " 'griffith r. harsh',\n",
       " 'barrow neurological institute',\n",
       " 'atypical teratoid rhabdoid tumor',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus infection with infectious mononucleosis-like syndrome',\n",
       " 'feline immunodeficiency virus',\n",
       " 'acquired immune deficiency syndrome',\n",
       " 'simian immunodeficiency virus',\n",
       " 'human immunodeficiency virus infection with acute lymphadenitis',\n",
       " 'fear of contracting human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a3',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b3',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c1',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c2',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c3',\n",
       " '',\n",
       " 'human immunodeficiency virus world health organization class iv',\n",
       " '',\n",
       " 'bovine immunodeficiency virus',\n",
       " 'audiovisual aids operator',\n",
       " 'fully mobile',\n",
       " 'human immunodeficiency virus antibody test',\n",
       " 'notification of acquired immune deficiency syndrome',\n",
       " 'human immunodeficiency virus screening',\n",
       " 'mobility aid',\n",
       " 'use of aids for daily life',\n",
       " 'use of kitchen aids',\n",
       " 'use of bathroom aids',\n",
       " 'use of work aids',\n",
       " 'use of indoor mobility aids',\n",
       " 'human aid to communication',\n",
       " 'provision of aids to daily living',\n",
       " 'sharing of sex aids',\n",
       " 'acquired immune deficiency syndrome-related nephropathy',\n",
       " 'aids for severely handicapped',\n",
       " 'human immunodeficiency virus risk lifestyle',\n",
       " 'acquired immunodeficiency syndrome risk behavior knowledge test',\n",
       " 'fear of acquired immunodeficiency syndrome scale',\n",
       " 'learning development aids - handwriting assessment',\n",
       " 'congenital acquired immune deficiency syndrome',\n",
       " 'use of memory retrieval aids',\n",
       " 'ability to mobilize using mobility aids',\n",
       " 'able to mobilize using mobility aids',\n",
       " 'unable to mobilize using mobility aids',\n",
       " 'does mobilize using aids',\n",
       " 'does not mobilize using mobility aids',\n",
       " 'difficulty mobilizing using mobility aids',\n",
       " 'handicapped aids',\n",
       " 'external memory aids training',\n",
       " 'aids to daily living',\n",
       " 'finding related to ability to mobilize using mobility aids',\n",
       " 'finding of use of memory retrieval aids',\n",
       " 'human immunodeficiency virus infection with aseptic meningitis',\n",
       " 'acquired immunodeficiency syndrome clinical trial group',\n",
       " 'pediatric acquired immunodeficiency syndrome clinical trial group',\n",
       " 'leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'hairy leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'neutropenia associated with acquired immunodeficiency syndrome',\n",
       " 'assistive device education',\n",
       " 'acquired immunodeficiency syndrome-associated disorder',\n",
       " 'abnormal weight loss associated with acquired immunodeficiency syndrome',\n",
       " 'acute endocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'myocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'agranulocytosis associated with acquired immunodeficiency syndrome',\n",
       " 'anemia associated with acquired immunodeficiency syndrome',\n",
       " 'acquired hemolytic anemia associated with acquired immunodeficiency syndrome',\n",
       " 'aplastic anemia associated with acquired immunodeficiency syndrome',\n",
       " 'retinopathy associated with acquired immunodeficiency syndrome',\n",
       " 'blindness associated with acquired immunodeficiency syndrome',\n",
       " 'cachexia associated with acquired immunodeficiency syndrome',\n",
       " 'candidiasis of mouth associated with acquired immunodeficiency syndrome',\n",
       " 'central nervous disorder associated with acquired immunodeficiency syndrome',\n",
       " 'central nervous system demyelinating disease associated with acquired immunodeficiency syndrome',\n",
       " 'myelopathy associated with acquired immunodeficiency syndrome',\n",
       " 'coccidioidomycosis associated with acquired immunodeficiency syndrome',\n",
       " 'cryptococcosis associated with acquired immunodeficiency syndrome',\n",
       " 'disseminated candidiasis associated with acquired immunodeficiency syndrome',\n",
       " 'encephalopathy associated with acquired immunodeficiency syndrome',\n",
       " 'dementia associated with acquired immunodeficiency syndrome',\n",
       " 'encephalitis associated with acquired immunodeficiency syndrome',\n",
       " 'encephalomyelitis associated with acquired immunodeficiency syndrome',\n",
       " 'organic brain syndrome associated with acquired immunodeficiency syndrome',\n",
       " 'organic dementia associated with acquired immunodeficiency syndrome',\n",
       " 'presenile dementia associated with acquired immunodeficiency syndrome',\n",
       " 'primary lymphoma of brain associated with acquired immunodeficiency syndrome',\n",
       " 'progressive multifocal leukoencephalopathy associated with acquired immunodeficiency syndrome',\n",
       " 'subacute adenoviral encephalitis associated with acquired immunodeficiency syndrome',\n",
       " 'failure to thrive in infant associated with acquired immunodeficiency syndrome',\n",
       " 'fatigue associated with acquired immunodeficiency syndrome',\n",
       " 'hematopoietic system disease associated with acquired immunodeficiency syndrome',\n",
       " 'hepatomegaly associated with acquired immunodeficiency syndrome',\n",
       " 'herpes zoster associated with acquired immunodeficiency syndrome',\n",
       " 'histoplasmosis associated with acquired immunodeficiency syndrome',\n",
       " 'ill-defined intestinal infection associated with acquired immunodeficiency syndrome',\n",
       " 'infectious gastroenteritis associated with acquired immunodeficiency syndrome',\n",
       " 'noninfectious gastroenteritis associated with acquired immunodeficiency syndrome',\n",
       " 'infective arthritis associated with acquired immunodeficiency syndrome',\n",
       " 'intestinal malabsorption associated with acquired immunodeficiency syndrome',\n",
       " 'low vision associated with acquired immunodeficiency syndrome',\n",
       " 'malaise associated with acquired immunodeficiency syndrome',\n",
       " 'malignant neoplasm associated with acquired immunodeficiency syndrome',\n",
       " \"kaposi's sarcoma associated with acquired immunodeficiency syndrome\",\n",
       " 'reticulosarcoma associated with acquired immunodeficiency syndrome',\n",
       " 'microsporidiosis associated with acquired immunodeficiency syndrome',\n",
       " 'mycobacteriosis associated with acquired immunodeficiency syndrome',\n",
       " 'tuberculosis associated with acquired immunodeficiency syndrome',\n",
       " 'myelitis associated with acquired immunodeficiency syndrome',\n",
       " 'neuralgia associated with acquired immunodeficiency syndrome',\n",
       " 'neuritis associated with acquired immunodeficiency syndrome',\n",
       " 'radiculitis associated with acquired immunodeficiency syndrome',\n",
       " 'nocardiosis associated with acquired immunodeficiency syndrome',\n",
       " 'nutritional deficiency associated with acquired immunodeficiency syndrome',\n",
       " 'pneumocystosis associated with acquired immunodeficiency syndrome',\n",
       " 'pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'bacterial pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'pneumococcal pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'candidiasis of lung associated with acquired immunodeficiency syndrome',\n",
       " 'viral pneumonia associated with acquired immunodeficiency syndrome',\n",
       " 'polyneuropathy associated with acquired immunodeficiency syndrome',\n",
       " 'respiratory disorder associated with acquired immunodeficiency syndrome',\n",
       " 'dyspnea associated with acquired immunodeficiency syndrome',\n",
       " 'retinal vascular changes associated with acquired immunodeficiency syndrome',\n",
       " 'salivary gland disease associated with acquired immunodeficiency syndrome',\n",
       " 'salmonella infection associated with acquired immunodeficiency syndrome',\n",
       " 'skin disorder associated with acquired immunodeficiency syndrome',\n",
       " 'dermatomycosis associated with acquired immunodeficiency syndrome',\n",
       " 'hyperhidrosis associated with acquired immunodeficiency syndrome',\n",
       " 'skin rash associated with acquired immunodeficiency syndrome',\n",
       " 'strongyloidiasis associated with acquired immunodeficiency syndrome',\n",
       " 'subacute endocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'subacute myocarditis associated with acquired immunodeficiency syndrome',\n",
       " 'thrombocytopenia associated with acquired immunodeficiency syndrome',\n",
       " 'family history of acquired immune deficiency syndrome',\n",
       " 'cholangitis associated with acquired immunodeficiency syndrome',\n",
       " 'acquired immune deficiency syndrome complicating childbirth',\n",
       " 'kaposi sarcoma not associated with acquired immunodeficiency syndrome',\n",
       " 'assessment using assessment of intelligibility of dysarthric speech',\n",
       " 'assessment of intelligibility of dysarthric speech',\n",
       " 'assessment of intelligibility of dysarthric speech score',\n",
       " 'infection caused by coccidia co-occurrent with acquired immunodeficiency syndrome',\n",
       " 'infection caused by toxoplasma gondii co-occurrent with acquired immunodeficiency syndrome',\n",
       " 'infection caused by isospora co-occurrent with acquired immunodeficiency syndrome',\n",
       " 'assessment using acquired immunodeficiency syndrome risk behavior knowledge test',\n",
       " 'acquired immunodeficiency syndrome risk behavior knowledge test total score',\n",
       " 'human immunodeficiency virus receptor',\n",
       " 'human immunodeficiency virus type 1 dot blot immunobinding assay',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus type 1 passive hemagglutination assay',\n",
       " 'measurement of human immunodeficiency virus 2 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 antibody',\n",
       " 'human immunodeficiency virus antigen test',\n",
       " 'human immunodeficiency virus-2 antigen assay',\n",
       " 'human immunodeficiency virus type 2',\n",
       " 'human immunodeficiency virus type 1 western blot assay',\n",
       " 'human immunodeficiency virus infection with infectious mononucleosis-like syndrome',\n",
       " 'human immunodeficiency virus type 1 radioimmunoprecipitation assay',\n",
       " 'human immunodeficiency virus type 1 antibody confirmatory test',\n",
       " 'congenital human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus type 2 confirmatory assay',\n",
       " 'human immunodeficiency virus 1 enzyme linked immunosorbent assay',\n",
       " 'human immunodeficiency virus-1 indirect immunofluorescence assay',\n",
       " 'human immunodeficiency virus-1 rapid latex agglutination assay',\n",
       " 'human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus infection with acute lymphadenitis',\n",
       " 'human immunodeficiency virus type i',\n",
       " 'asymptomatic human immunodeficiency virus infection',\n",
       " 'asymptomatic human immunodeficiency virus infection in pregnancy',\n",
       " 'antigen of human immunodeficiency virus protein 24',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a1',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a2',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category a3',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b1',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b2',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category b3',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c1',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c2',\n",
       " '',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category c3',\n",
       " '',\n",
       " 'human immunodeficiency virus world health organization class i',\n",
       " 'human immunodeficiency virus world health organization class ii',\n",
       " 'human immunodeficiency virus world health organization class iii',\n",
       " 'human immunodeficiency virus world health organization class iv',\n",
       " '',\n",
       " 'human immunodeficiency virus p24 antigen test',\n",
       " 'antigen of human immunodeficiency virus 1 glycoprotein 120',\n",
       " 'antigen of human immunodeficiency virus 1 glycoprotein 160',\n",
       " 'antigen of human immunodeficiency virus 2 protein 41',\n",
       " 'acute human immunodeficiency virus infection',\n",
       " 'antigen of human immunodeficiency virus 1',\n",
       " 'human immunodeficiency virus deoxyribonucleic acid assay',\n",
       " 'human immunodeficiency virus 1 deoxyribonucleic acid assay',\n",
       " 'human immunodeficiency virus 1 ribonucleic acid assay',\n",
       " 'human immunodeficiency virus culture',\n",
       " 'human immunodeficiency virus type 1 identification',\n",
       " 'human immunodeficiency virus 1 antibody band pattern determination',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 105 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 120 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 120 and glycoprotein 160 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 160 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 34 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 41 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 glycoprotein 41 and glycoprotein 43 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 15 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 15 antibody and protein 18 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 17 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 18 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 23 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 24 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 26 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 28 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 31 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 32 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 51 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 53 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 55 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 58 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 64 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 65 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 66 antibody',\n",
       " 'measurement of human immunodeficiency virus 1 protein 68 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 105 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 120 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 125 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 15 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 34 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 36 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 glycoprotein 80 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 26 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 31 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 41 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 53 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 55 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 56 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 58 antibody',\n",
       " 'measurement of human immunodeficiency virus 2 protein 68 antibody',\n",
       " 'human immunodeficiency virus 1 antigen assay',\n",
       " 'human immunodeficiency virus 1 p24 antigen assay',\n",
       " 'antigen of human immunodeficiency virus 1 protein 24',\n",
       " 'human immunodeficiency virus, type ii glycoprotein 125 antibody',\n",
       " 'human immunodeficiency virus, type ii glycoprotein 36 antibody',\n",
       " 'human immunodeficiency virus, type i protein 23 antibody',\n",
       " 'human immunodeficiency virus, type i protein 32 antibody',\n",
       " 'human immunodeficiency virus, type i protein 28 antibody',\n",
       " 'human immunodeficiency virus, type i protein 65 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 68 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 56 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 26 antibody',\n",
       " 'human immunodeficiency virus, type ii glycoprotein 80 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 105 antibody',\n",
       " 'human immunodeficiency virus, type i protein 58 antibody',\n",
       " 'human immunodeficiency virus, type i protein 51 antibody',\n",
       " 'human immunodeficiency virus, type i protein 66 antibody',\n",
       " 'human immunodeficiency virus, type i protein 55 antibody',\n",
       " 'human immunodeficiency virus, type i protein 31 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 24 antibody',\n",
       " 'human immunodeficiency virus, type i protein 17 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 41 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 120 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 160 antibody',\n",
       " 'human immunodeficiency virus, type i protein 64 antibody',\n",
       " 'human immunodeficiency virus, type ii protein 41 antibody',\n",
       " 'human immunodeficiency virus, type i protein 53 antibody',\n",
       " 'human immunodeficiency virus, type i protein 18 antibody',\n",
       " 'human immunodeficiency virus, type i glycoprotein 34 antibody',\n",
       " 'human immunodeficiency virus, type i protein 26 antibody',\n",
       " 'human immunodeficiency virus, type i protein 15 antibody',\n",
       " 'fear of contracting human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus antibody test',\n",
       " 'human immunodeficiency virus negative',\n",
       " 'human immunodeficiency virus positive',\n",
       " 'human immunodeficiency virus screening',\n",
       " 'patient advised about the risks of human immunodeficiency virus',\n",
       " 'human immunodeficiency virus infection constitutional disease',\n",
       " 'human immunodeficiency virus leukoencephalopathy',\n",
       " 'neuropathy caused by human immunodeficiency virus',\n",
       " 'human immunodeficiency virus enteropathy',\n",
       " 'human immunodeficiency virus myopathy',\n",
       " 'human immunodeficiency virus infection classification systems',\n",
       " 'human immunodeficiency virus antibody',\n",
       " 'human immunodeficiency virus risk lifestyle',\n",
       " 'congenital human immunodeficiency virus positive status syndrome',\n",
       " 'human immunodeficiency virus status',\n",
       " 'human immunodeficiency virus-related sclerosing cholangitis',\n",
       " 'human immunodeficiency virus counseling',\n",
       " 'human immunodeficiency virus prevention education',\n",
       " 'human immunodeficiency virus infection with aseptic meningitis',\n",
       " 'human immunodeficiency virus viral load',\n",
       " 'measurement of both human immunodeficiency virus 1 antibody and human immunodeficiency virus 2 antibody',\n",
       " 'finding of human immunodeficiency virus status',\n",
       " 'human immunodeficiency virus antibody titer measurement',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category',\n",
       " 'human immunodeficiency virus world health organization class',\n",
       " 'human immunodeficiency virus centers for disease control and prevention category finding',\n",
       " 'human immunodeficiency virus world health organization class finding',\n",
       " 'antenatal screening for human immunodeficiency virus',\n",
       " 'human immunodeficiency virus-1 nucleic acid assay',\n",
       " 'polymerase chain reaction test for human immunodeficiency virus type 1',\n",
       " 'oral hairy leukoplakia associated with human immunodeficiency virus disease',\n",
       " 'human immunodeficiency virus encephalitis',\n",
       " 'pediatric human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus enzyme-linked immunosorbent assay test negative',\n",
       " 'human immunodeficiency virus enzyme-linked immunosorbent assay test positive',\n",
       " 'antenatal human immunodeficiency virus blood screening test status',\n",
       " 'antenatal human immunodeficiency virus blood screening test sent',\n",
       " 'antenatal human immunodeficiency virus blood screening test requested',\n",
       " 'rapid human immunodeficiency virus type 1 antibody test',\n",
       " 'human immunodeficiency virus type 1 antibody',\n",
       " 'leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'hairy leukoplakia of tongue associated with human immunodeficiency virus disease',\n",
       " 'retinopathy associated with acquired immunodeficiency syndrome',\n",
       " 'cachexia associated with acquired immunodeficiency syndrome',\n",
       " 'family history of human immunodeficiency virus infection',\n",
       " 'copies of human immunodeficiency virus ribonucleic acid above reference range',\n",
       " 'human immunodeficiency virus, type ii antibody',\n",
       " 'determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using genotypic technique',\n",
       " 'determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using phenotypic technique',\n",
       " 'determination of coreceptor tropism of human immunodeficiency virus 1',\n",
       " 'pulmonary arterial hypertension associated with human immunodeficiency virus infection',\n",
       " 'human immunodeficiency virus carrier',\n",
       " 'human immunodeficiency virus in mother complicating childbirth',\n",
       " 'symptomatic human immunodeficiency virus i infection',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus',\n",
       " 'human immunodeficiency virus ii infection',\n",
       " 'ribonucleic acid of human immunodeficiency virus 2',\n",
       " 'deoxyribonucleic acid of human immunodeficiency virus 2',\n",
       " 'human immunodeficiency virus 1 and virus 2 antibodies and human immunodeficiency virus 1 p24 antigen combination immunoassay',\n",
       " 'immunoglobulin g antibody to human immunodeficiency virus type 1',\n",
       " 'immunoglobulin g antibody to human immunodeficiency virus type 2',\n",
       " 'proviral deoxyribonucleic acid of human immunodeficiency virus 1',\n",
       " 'proviral deoxyribonucleic acid of human immunodeficiency virus 2',\n",
       " 'human immunodeficiency virus 1 antibody indeterminate',\n",
       " 'human immunodeficiency virus 2 antibody indeterminate',\n",
       " 'human immunodeficiency virus 2 antibody positive and human immunodeficiency virus 1 antibody cross-reactivity',\n",
       " 'human immunodeficiency virus screening declined',\n",
       " 'invasive carcinoma of uterine cervix co-occurrent with human immunodeficiency virus infection',\n",
       " 'extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 1',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 2',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 3',\n",
       " 'world health organization 2007 human immunodeficiency virus infection clinical stage 4',\n",
       " 'human immunodeficiency virus fusion inhibitor',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with malaria',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with tuberculosis',\n",
       " 'human immunodeficiency virus entry inhibitor',\n",
       " 'symptomatic human immunodeficiency virus infection',\n",
       " 'ribonucleic acid of human immunodeficiency virus 1',\n",
       " 'deoxyribonucleic acid of human immunodeficiency virus',\n",
       " 'deoxyribonucleic acid of human immunodeficiency virus 1',\n",
       " 'human immunodeficiency virus social work service',\n",
       " 'human immunodeficiency virus nurse practitioner service',\n",
       " 'human immunodeficiency virus nursing specialty',\n",
       " 'human immunodeficiency virus social work specialty',\n",
       " 'bacterial infection due to human immunodeficiency virus infection',\n",
       " 'encephalitis caused by human immunodeficiency virus type 1',\n",
       " 'esophagitis due to human immunodeficiency virus disease',\n",
       " 'transmitted by',\n",
       " 'mycobacterium, non-tuberculosis',\n",
       " 'notification of tuberculosis',\n",
       " 'tuberculosis screening',\n",
       " 'examination for suspected tuberculosis',\n",
       " 'tuberculosis chemotherapy',\n",
       " 'acute tuberculous pericarditis',\n",
       " 'genital tuberculosis',\n",
       " 'tuberculosis',\n",
       " 'tuberculosis of meninges',\n",
       " 'tuberculosis of urinary organs',\n",
       " 'entire terminal bronchiole',\n",
       " 'tuberculosis of bladder',\n",
       " 'mycobacterium tuberculosis hominis',\n",
       " 'tuberculosis of kidney',\n",
       " 'tuberculosis of genitourinary system',\n",
       " 'tuberculosis of ureter',\n",
       " 'pulmonary tuberculosis',\n",
       " 'atypical mycobacterial infection',\n",
       " 'tuberculosis, extrapulmonary',\n",
       " 'tuberculosis in mother complicating childbirth',\n",
       " 'tuberculous laryngitis',\n",
       " 'tuberculous peritonitis',\n",
       " 'primary tuberculosis',\n",
       " 'tuberculous salpingitis',\n",
       " 'tuberculous erythema nodosum',\n",
       " 'tuberculous cervicitis',\n",
       " 'extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection',\n",
       " 'screening for cancer',\n",
       " 'laparotomy for staging of ovarian cancer',\n",
       " 'fear of getting cancer',\n",
       " 'prescription for alteration of hormonal balance for cancer',\n",
       " 'cancer hospital',\n",
       " 'pleurodesis with cancer chemotherapy substance',\n",
       " 'no microscopic confirmation - clinically metastatic tumor',\n",
       " '',\n",
       " 'immunotherapy for cancer',\n",
       " 'no microscopic confirmation - clinically malignant tumor',\n",
       " '',\n",
       " 'hyperthermia treatment of cancer',\n",
       " 'malignant neoplasm, primary',\n",
       " 'intra-arterial infusion of antineoplastic agent',\n",
       " 'cancer antigen 125',\n",
       " 'cancer antigen 19-5',\n",
       " 'cancer antigen 19-9',\n",
       " 'cancer antigen 242',\n",
       " 'cancer antigen 27-29',\n",
       " 'cancer antigen 50',\n",
       " 'cancer antigen 549',\n",
       " 'cancer antigen 72-4',\n",
       " 'cancer antigen 15-3',\n",
       " 'gleason grading system for prostatic cancer',\n",
       " 'walter reed staging of prostatic cancer',\n",
       " 'cancer antigen dm /70k',\n",
       " \"howel-evans' syndrome\",\n",
       " 'cancer procoagulant',\n",
       " 'suspected breast cancer',\n",
       " 'suspected lung cancer',\n",
       " 'malignant tumor of nasopharynx',\n",
       " 'malignant tumor of undescended testis',\n",
       " 'malignant tumor of ectopic testis',\n",
       " 'malignant tumor of body of penis',\n",
       " 'secondary malignant neoplasm of cervix uteri',\n",
       " 'cancer education',\n",
       " \"united kingdom children's cancer study group central nervous system tumor staging system\",\n",
       " 'american urological association staging system for prostate cancer',\n",
       " 'squamous cell carcinoma of bronchus',\n",
       " 'small cell carcinoma of lung',\n",
       " 'non-small cell lung cancer',\n",
       " 'malignant neoplasm of breast',\n",
       " 'cancer en cuirasse',\n",
       " 'familial cancer of breast',\n",
       " 'malignant tumor of skin of penis',\n",
       " 'malignant neoplasm of unknown origin',\n",
       " 'malignant tumor of salivary gland',\n",
       " 'malignant tumor of exocrine pancreas',\n",
       " 'cancer staging',\n",
       " 'history of malignant neoplasm',\n",
       " 'family history: stomach cancer',\n",
       " 'family history: bowel cancer',\n",
       " 'family history: bronchus cancer',\n",
       " 'family history of cancer',\n",
       " 'early gastric cancer',\n",
       " 'late gastric cancer',\n",
       " 'cancer attitude inventory',\n",
       " 'mental adjustment to cancer scale',\n",
       " 'family history of cancer of colon',\n",
       " 'hereditary nonpolyposis colon cancer',\n",
       " 'suspected cervical cancer',\n",
       " 'suspected endometrial cancer',\n",
       " 'suspected prostate cancer',\n",
       " 'suspected bladder cancer',\n",
       " 'suspected kidney cancer',\n",
       " 'suspected urothelial cancer',\n",
       " 'suspected testicular cancer',\n",
       " 'suspected upper gastrointestinal cancer',\n",
       " 'suspected lower gastrointestinal cancer',\n",
       " 'suspected skin cancer',\n",
       " 'suspected head and neck cancer',\n",
       " 'secondary malignant neoplastic disease',\n",
       " 't3',\n",
       " 'malignant neoplasm of liver',\n",
       " 'secondary malignant neoplasm of liver',\n",
       " 'secondary malignant neoplasm of ovary',\n",
       " 'secondary malignant neoplasm of skin',\n",
       " 'secondary malignant neoplasm of vertebral column',\n",
       " 'secondary malignant neoplasm of vulva',\n",
       " 'cancer protocol observable',\n",
       " 'cancer dataset administrative items',\n",
       " 'basis of cancer diagnosis',\n",
       " 'cancer diagnosis based on death certificate',\n",
       " 'cancer diagnosis based on clinical evidence',\n",
       " 'cancer diagnosis based on investigations, without a tissue diagnosis',\n",
       " 'cancer diagnosis based on specific tumor markers',\n",
       " 'cancer diagnosis based on cytological evidence',\n",
       " 'cancer diagnosis based on metastatic histological evidence',\n",
       " 'cancer diagnosis based on primary site histological evidence',\n",
       " 'reason for no specific anti-cancer treatment',\n",
       " 'no anti-cancer treatment - poor performance status',\n",
       " 'no anti-cancer treatment - advanced stage cancer',\n",
       " 'patient died before anti-cancer treatment',\n",
       " 'no anti-cancer treatment - significant co-morbidity',\n",
       " 'no anti-cancer treatment available',\n",
       " 'no anti-cancer treatment - watchful waiting',\n",
       " 'cancer treatment related morbidity',\n",
       " 'malignant tumor of cecum',\n",
       " 'malignant tumor of esophagus',\n",
       " 'malignant neoplastic disease',\n",
       " 'malignant tumor of lip',\n",
       " 'malignant tumor of stomach',\n",
       " 'malignant tumor of rectum',\n",
       " 'malignant tumor of anal canal',\n",
       " 'malignant tumor of cervix',\n",
       " 'malignant tumor of adrenal gland',\n",
       " 'malignant neoplasm of ill-defined site',\n",
       " 'malignant tumor of lung',\n",
       " 'malignant tumor of vulva',\n",
       " 'malignant tumor of tongue',\n",
       " 'malignant tumor of parotid gland',\n",
       " 'malignant tumor of gum',\n",
       " 'malignant tumor of floor of mouth',\n",
       " 'malignant tumor of buccal mucosa',\n",
       " 'malignant tumor of palate',\n",
       " 'malignant tumor of oropharynx',\n",
       " 'malignant tumor of tonsil',\n",
       " 'malignant tumor of duodenum',\n",
       " 'malignant neoplasm of colon',\n",
       " 'malignant tumor of pancreas',\n",
       " 'malignant neoplasm of omentum',\n",
       " 'malignant tumor of larynx',\n",
       " 'malignant tumor of trachea',\n",
       " 'malignant tumor of pleura',\n",
       " 'malignant tumor of vertebral column',\n",
       " 'malignant tumor of ovary',\n",
       " 'malignant tumor of vagina',\n",
       " 'malignant tumor of foreskin',\n",
       " 'malignant tumor of glans penis',\n",
       " 'malignant tumor of scrotum',\n",
       " 'malignant tumor of ureter',\n",
       " 'malignant tumor of urethra',\n",
       " 'malignant tumor of thyroid gland',\n",
       " 'malignant tumor of parathyroid gland',\n",
       " 'malignant tumor of pituitary gland',\n",
       " 'malignant tumor of vocal cord',\n",
       " 'malignant tumor of peritoneum',\n",
       " 'malignant tumor of bronchus',\n",
       " 'malignant tumor of muscle',\n",
       " 'multiple malignancy',\n",
       " 'malignant tumor of oral cavity',\n",
       " 'malignant neoplasm of pharynx',\n",
       " 'malignant tumor of intestine',\n",
       " 'malignant tumor of large intestine',\n",
       " 'malignant tumor of penis',\n",
       " 'malignant tumor of kidney',\n",
       " 'malignant neoplasm of uterus',\n",
       " 'primary malignant neoplasm of bronchus',\n",
       " 'secondary malignant neoplasm of bone',\n",
       " 'secondary malignant neoplasm of brain',\n",
       " 'secondary malignant neoplasm of kidney',\n",
       " 'secondary malignant neoplasm of lung',\n",
       " 'secondary malignant neoplasm of lymph node',\n",
       " 'gleason grade finding for prostatic cancer',\n",
       " 'cancer registrar',\n",
       " 'cancer pagurus specific immunoglobulin e',\n",
       " 'cancer pagurus specific immunoglobulin e antibody measurement',\n",
       " 'cancer treatment started',\n",
       " 'cancer diagnosis discussed',\n",
       " 'cancer confirmed',\n",
       " 'no evidence of cancer found',\n",
       " 'cancer primary healthcare multidisciplinary team',\n",
       " 'cancer diagnosis discussed with partner in relationship',\n",
       " 'cancer diagnosis discussed with patient',\n",
       " 'cancer care plan discussed with patient',\n",
       " 'cancer care plan discussed with partner in relationship',\n",
       " 'pt3a',\n",
       " '',\n",
       " '',\n",
       " 'suspected central nervous system cancer',\n",
       " 'suspected urological cancer',\n",
       " 'suspected gynecological cancer',\n",
       " \"suspected children's cancer\",\n",
       " 'multidisciplinary care conference for cancer care planning',\n",
       " 'monitoring of patient with cancer',\n",
       " 'no anti-cancer treatment due to unknown primary',\n",
       " 'cancer supportive care worker',\n",
       " 'phobic fear of skin cancer',\n",
       " 'suspected hematological malignancy',\n",
       " 'suspected malignancy',\n",
       " 'malignant tumor of prostate',\n",
       " 'malignant tumor of urinary bladder',\n",
       " 'risk control behavior: cancer',\n",
       " 'breast cancer type 1 susceptibility protein',\n",
       " 'breast cancer type 2 susceptibility protein',\n",
       " 'college of american pathologists cancer checklist; adrenal gland: resection',\n",
       " 'college of american pathologists cancer checklist; ampulla of vater: ampullectomy',\n",
       " 'college of american pathologists cancer checklist; ampulla of vater: pancreaticoduodenectomy',\n",
       " 'college of american pathologists cancer checklist; anus: excisional biopsy',\n",
       " 'college of american pathologists cancer checklist; anus: local excision',\n",
       " '',\n",
       " 'college of american pathologists cancer checklist; anus: resection',\n",
       " 'college of american pathologists cancer checklist; urinary bladder, ureter, renal pelvis: biopsy',\n",
       " 'college of american pathologists cancer checklist; urinary bladder: cystectomy, partial, total, or radical; anterior exenteration',\n",
       " 'college of american pathologists cancer checklist; renal pelvis: resection/nephroureterectomy, partial or complete',\n",
       " 'college of american pathologists cancer checklist; ureter: resection',\n",
       " 'college of american pathologists cancer checklist; bone marrow: blood film, aspirate, cell block, trephine biopsy, touch imprint',\n",
       " 'college of american pathologists cancer checklist; brain/spinal cord: biopsy/resection',\n",
       " 'college of american pathologists cancer checklist; breast: excision less than total mastectomy',\n",
       " 'college of american pathologists cancer checklist; colon and rectum: excisional biopsy',\n",
       " '',\n",
       " 'college of american pathologists cancer checklist; rectum: local excision',\n",
       " '',\n",
       " 'college of american pathologists cancer checklist; colon and rectum: resection',\n",
       " 'college of american pathologists cancer checklist; endometrium: biopsy',\n",
       " 'college of american pathologists cancer checklist; endometrium: hysterectomy, with or without other organs or tissues',\n",
       " 'college of american pathologists cancer checklist; esophagus: biopsy',\n",
       " 'college of american pathologists cancer checklist; esophagus: resection',\n",
       " 'college of american pathologists cancer checklist; extrahepatic bile ducts: resection',\n",
       " 'college of american pathologists cancer checklist; uveal melanoma: resection',\n",
       " 'college of american pathologists cancer checklist; vulva: excisional biopsy/resection',\n",
       " 'college of american pathologists cancer checklist; vagina: biopsy',\n",
       " 'college of american pathologists cancer checklist; vagina: excisional biopsy, resection',\n",
       " 'college of american pathologists cancer checklist; uterine cervix: cone biopsy',\n",
       " 'college of american pathologists cancer checklist; uterine cervix: colpectomy, hysterectomy, pelvic exenteration',\n",
       " 'college of american pathologists cancer checklist; upper aerodigestive tract and minor salivary glands: incisional and excisional biopsy/resection',\n",
       " 'college of american pathologists cancer checklist; major salivary glands: resection',\n",
       " 'college of american pathologists cancer checklist; trophoblast: dilation and curettage/resection',\n",
       " 'college of american pathologists cancer checklist; thyroid: resection',\n",
       " 'college of american pathologists cancer checklist; thymoma and thymic carcinoma: biopsy',\n",
       " 'college of american pathologists cancer checklist; thymoma and thymic carcinoma: thymectomy, other procedure',\n",
       " 'college of american pathologists cancer checklist; pleura/pericardium: resection',\n",
       " 'college of american pathologists cancer checklist; pleura/pericardium: biopsy',\n",
       " 'college of american pathologists cancer checklist; testis: radical orchiectomy',\n",
       " 'college of american pathologists cancer checklist; testis: retroperitoneal lymphadenectomy',\n",
       " 'college of american pathologists cancer checklist; stomach: biopsy',\n",
       " 'college of american pathologists cancer checklist; stomach: resection',\n",
       " 'college of american pathologists cancer checklist; small intestine: polypectomy, segmental resection, pancreaticoduodenectomy, partial or complete, with or without partial gastrectomy',\n",
       " '',\n",
       " 'college of american pathologists cancer checklist; melanoma of the skin: excision; re-excision',\n",
       " 'college of american pathologists cancer checklist; fallopian tube: unilateral salpingectomy, salpingo-oophorectomy, or hysterectomy with salpingo-oophorectomy',\n",
       " 'college of american pathologists cancer checklist; gallbladder: resection/cholecystectomy',\n",
       " 'college of american pathologists cancer checklist; gastrointestinal lymphoma: resection',\n",
       " 'college of american pathologists cancer checklist; heart: resection',\n",
       " 'college of american pathologists cancer checklist; hodgkin lymphoma: biopsy/staging procedure',\n",
       " 'college of american pathologists cancer checklist; kidney: biopsy',\n",
       " 'college of american pathologists cancer checklist; kidney: nephrectomy, partial or radical',\n",
       " 'college of american pathologists cancer checklist; liver: resection',\n",
       " 'college of american pathologists cancer checklist; lung: biopsy',\n",
       " 'college of american pathologists cancer checklist; lung: resection',\n",
       " 'college of american pathologists cancer checklist; non-hodgkin lymphoma: biopsy, resection',\n",
       " 'college of american pathologists cancer checklist; ovary: oophorectomy, salpingo-oophorectomy, subtotal oophorectomy or removal of tumor in fragments, hysterectomy with salpingo-oophorectomy',\n",
       " 'college of american pathologists cancer checklist; pancreas',\n",
       " 'college of american pathologists cancer checklist; pancreas',\n",
       " 'college of american pathologists cancer checklist; peritoneum: resection',\n",
       " 'college of american pathologists cancer checklist; prostate gland: needle biopsy, transurethral prostatic resection, enucleation specimen',\n",
       " 'college of american pathologists cancer checklist; prostate gland: radical prostatectomy',\n",
       " 'college of american pathologists cancer checklist; retinoblastoma: enucleation, partial or complete exenteration',\n",
       " 'college of american pathologists cancer checklist; carcinoma of the skin: resection',\n",
       " 'college of american pathologists cancer checklist; rhabdomyosarcoma and related neoplasms: excision, local or wide; compartmentectomy; excision, radical; amputation; other',\n",
       " 'college of american pathologists cancer checklist; kidney: resection for wilms tumor',\n",
       " 'seen by breast cancer nurse',\n",
       " 'widespread metastatic malignant neoplastic disease',\n",
       " 'college of american pathologists cancer checklist; neuroblastoma: resection',\n",
       " 'college of american pathologists cancer checklist; primitive neuroectodermal tumor / ewing sarcoma: resection',\n",
       " 'cancer pagurus diagnostic allergen extract',\n",
       " 'family history of prostate cancer',\n",
       " 'cancer monitoring third letter',\n",
       " 'cancer monitoring second letter',\n",
       " 'cancer monitoring first letter',\n",
       " 'cancer monitoring invitation',\n",
       " 'cancer hospital treatment completed',\n",
       " 'cancer emotional and psychosocial support and education',\n",
       " 'cancer screening follow up',\n",
       " 'no evidence of recurrence of cancer',\n",
       " 'cancer short term health assessment',\n",
       " 'cancer rehabilitation and readaption',\n",
       " 'cancer pain and symptom management',\n",
       " 'carcinoma-associated retinopathy',\n",
       " 'malignant neoplasm of skin',\n",
       " 'cancer shared care medication card',\n",
       " 'cancer monitoring verbal invitation',\n",
       " 'cancer home care pack given',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage i',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ib',\n",
       " 'international union against cancer',\n",
       " 'american joint committee on cancer',\n",
       " 'international union against cancer stage grouping',\n",
       " 'european organization for research and treatment of cancer - quality of life questionnaire',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage ii',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iv',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ia',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage i a',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage i',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage iii',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ii',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage i b',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage iv',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iii',\n",
       " 'international federation of gynecology and obstetrics cervical cancer stage ib occ',\n",
       " 'college of american pathologists cancer checklist; appendix: resection',\n",
       " 'college of american pathologists cancer checklist; prostate gland: needle biopsy',\n",
       " 'college of american pathologists cancer checklist; prostate gland: transurethral prostatic resection, enucleation specimen',\n",
       " 'college of american pathologists cancer checklist; bone: resection',\n",
       " 'college of american pathologists cancer checklist; bone: biopsy',\n",
       " 'college of american pathologists cancer checklist; soft tissue: resection',\n",
       " 'college of american pathologists cancer checklist; soft tissue: biopsy',\n",
       " 'primary malignant neoplasm of thyroid gland, metastatic to bone',\n",
       " 'primary malignant neoplasm of ovary, with widespread metastatic disease',\n",
       " 'primary malignant neoplasm of vulva, with widespread metastatic disease',\n",
       " 'hormone refractory prostate cancer',\n",
       " 'non-small cell lung cancer, negative for epidermal growth factor receptor expression',\n",
       " 'french federation of cancer centers sarcoma group grading system',\n",
       " 'national cancer institute histologic grading system',\n",
       " 'non-small cell lung cancer, positive for epidermal growth factor receptor expression',\n",
       " 'psychosocial counseling about cancer',\n",
       " 'family history of cancer of the esophagus',\n",
       " 'family history of breast cancer 1 gene mutation',\n",
       " 'family history of breast cancer 2 gene mutation',\n",
       " 'increased cancer antigen 125',\n",
       " 'family history of malignant neoplasm of liver',\n",
       " 'family history of malignant neoplasm of pancreas',\n",
       " 'family history of malignant neoplasm of lung',\n",
       " 'family history of malignant neoplasm of skin',\n",
       " 'knowledge level about cancer prevention and early detection',\n",
       " 'knowledge level about cancer management',\n",
       " 'measurement of cancer antigen 72-4',\n",
       " 'american joint commission on cancer, cancer staging manual, 6th edition neoplasm staging system',\n",
       " 'american joint commission on cancer, cancer staging manual, 7th edition neoplasm staging system',\n",
       " 'edition of american joint commission on cancer, cancer staging manual used for tnm staging',\n",
       " 'cancer antigen 27-29 above reference range',\n",
       " 'residual cancer burden index',\n",
       " 'breast cancer genetic marker of susceptibility negative',\n",
       " 'measurement of cancer antigen 27-29',\n",
       " 'residual cancer burden class',\n",
       " 'residual cancer burden score',\n",
       " 'residual cancer burden index',\n",
       " 'breast cancer genetic marker of susceptibility positive',\n",
       " 'malignant neoplasm detection during interval between recommended screening examinations',\n",
       " 'brca1 mutation carrier detection test',\n",
       " 'brca1 gene mutation negative',\n",
       " 'brca1 gene mutation positive',\n",
       " 'brca2 gene mutation positive',\n",
       " 'brca2 mutation carrier detection test',\n",
       " 'brca2 gene mutation negative',\n",
       " 'malignant neoplasm of urinary organ',\n",
       " 'malignant neoplasm of respiratory system',\n",
       " 'malignant neoplasm of cerebellum',\n",
       " 'malignant neoplasm of carotid body',\n",
       " 'malignant neoplasm of cerebellopontine angle',\n",
       " 'malignant neoplasm of pelvic peritoneum',\n",
       " 'transglottic malignant neoplasm of larynx',\n",
       " 'malignant neoplasm of visceral pleura',\n",
       " 'malignant neoplasm of skin of scrotum',\n",
       " 'malignant neoplasm of upper respiratory tract',\n",
       " 'malignant neoplasm of parietal pleura',\n",
       " 'malignant neoplasm of intraabdominal organ',\n",
       " 'malignant neoplasm of mandible',\n",
       " 'malignant neoplasm of soft tissue of orbit',\n",
       " 'malignant neoplasm of posterior mediastinum',\n",
       " 'nottingham histologic grading system',\n",
       " 'malignant neoplasm of lateral wall of oropharynx',\n",
       " 'malignant neoplasm of alveolus of maxilla',\n",
       " 'malignant neoplasm of anterior mediastinum',\n",
       " 'malignant neoplasm of parametrium',\n",
       " 'malignant neoplasm of digestive system',\n",
       " 'malignant neoplasm of anterior and lateral floor of mouth',\n",
       " 'malignant neoplasm of alveolus of mandible',\n",
       " 'malignant neoplasm of broad ligament of uterus',\n",
       " 'malignant neoplasm of alveolus dentalis',\n",
       " 'verrucous carcinoma of oral cavity',\n",
       " 'electro cancer therapy system',\n",
       " 'educated about screening for malignant neoplasm of prostate',\n",
       " 'family history of colorectal cancer',\n",
       " 'patient advised about prostate cancer screening',\n",
       " 'pt4: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition',\n",
       " '',\n",
       " 'pt3: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition',\n",
       " '',\n",
       " 'pt4: tumor of lung as per american joint committee on cancer 6th edition definition',\n",
       " '',\n",
       " 'pt4: extraocular tumor extension which includes sites as per american joint committee on cancer 6th edition definition',\n",
       " '',\n",
       " 'pt2: tumor of lung as per american joint committee on cancer 6th edition definition',\n",
       " '',\n",
       " 'pn3b: tumor of breast with metastasis as per american joint committee on cancer 6th edition definition',\n",
       " '',\n",
       " 'hereditary cancer-predisposing syndrome',\n",
       " 'cancer antigen 19-9 measurement',\n",
       " 'cancer antigen 15-3 measurement',\n",
       " 'alternating electric field antimitotic cancer treatment system',\n",
       " 'alternating electric field antimitotic cancer treatment system transducer array',\n",
       " 'alternating electric field antimitotic cancer treatment system generator',\n",
       " 'screening for malignant neoplasm of vagina done',\n",
       " 'history of malignant neoplasm of vulva',\n",
       " 'malignant neoplastic disease in mother complicating childbirth',\n",
       " 'screening for malignant neoplasm of vagina',\n",
       " 'sampling of vagina for papanicolaou smear after hysterectomy for malignant disease done',\n",
       " 'anemia in malignant neoplastic disease',\n",
       " 'non-small cell lung cancer without mutation in epidermal growth factor receptor',\n",
       " 'non-small cell lung cancer with mutation in epidermal growth factor receptor',\n",
       " 'primary malignant neoplasm of endocervix',\n",
       " 'primary malignant neoplasm of endometrium',\n",
       " 'secondary malignant neoplasm of vagina',\n",
       " 'carcinoma of ovary, stage 3',\n",
       " 'history of malignant neoplasm of ovary',\n",
       " 'carcinoma of ovary, stage 1',\n",
       " 'carcinoma of ovary, stage 2',\n",
       " 'carcinoma of ovary, stage 4',\n",
       " 'primary malignant neoplasm of clitoris',\n",
       " 'history of malignant neoplasm of uterine adnexa',\n",
       " 'history of malignant neoplasm of cervix',\n",
       " 'history of malignant neoplasm of uterine body',\n",
       " 'history of malignant neoplasm of vagina',\n",
       " 'undifferentiated carcinoma of ovary',\n",
       " 'at risk of breast cancer',\n",
       " 'triple negative malignant neoplasm of breast',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iiib',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iiic1',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics cervical cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer stage iiic2',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer',\n",
       " 'international federation of gynecology and obstetrics endometrial cancer',\n",
       " 'malignant neoplasm of exocervix',\n",
       " 'history of non-small cell malignant neoplasm of lung',\n",
       " 'family history of malignant neoplasm of male breast',\n",
       " 'family history of malignant neoplasm of cervix uteri',\n",
       " 'family history of malignant neoplasm of ileum',\n",
       " 'family history of malignant neoplasm of vagina',\n",
       " 'family history of malignant neoplasm of brain',\n",
       " 'history of malignant neoplasm of esophagus',\n",
       " 'history of malignant neoplasm of neck',\n",
       " 'history of malignant neoplasm of bone',\n",
       " 'secondary malignant neoplasm of central nervous system',\n",
       " 'secondary malignant neoplasm of cerebral meninges',\n",
       " 'secondary malignant neoplasm of bone marrow',\n",
       " 'family history of malignant neoplasm of uterus',\n",
       " 'family history of malignant neoplasm of bone',\n",
       " 'secondary malignant neoplasm of bladder',\n",
       " 'history of malignant neoplasm of endocrine gland',\n",
       " 'history of malignant neoplasm of tongue',\n",
       " 'secondary malignant neoplasm of adrenal gland',\n",
       " 'history of malignant neoplasm of spinal cord',\n",
       " 'history of malignant neoplasm of nervous system',\n",
       " 'carcinoma in situ of ileum',\n",
       " 'secondary malignant neoplasm of intercostal lymph nodes',\n",
       " 'secondary malignant neoplasm of lymph nodes of face',\n",
       " 'overlapping malignant neoplasm of small intestine',\n",
       " 'carcinoma in situ of tongue',\n",
       " 'secondary malignant neoplasm of intrapelvic lymph nodes',\n",
       " 'secondary malignant neoplasm of tracheobronchial lymph nodes',\n",
       " 'carcinoma in situ of eye',\n",
       " 'carcinoma in situ of vulva',\n",
       " 'squamous cell carcinoma of penis',\n",
       " 'squamous cell carcinoma of tip of nose',\n",
       " 'squamous cell carcinoma of forehead',\n",
       " 'malignant neoplasm of cerebral meninges',\n",
       " 'carcinoma in situ of small intestine',\n",
       " 'carcinoma of uterine cervix, invasive',\n",
       " 'secondary malignant neoplasm of intra-abdominal organs',\n",
       " 'malignant mesothelioma of peritoneum',\n",
       " 'secondary malignant neoplasm of chest wall',\n",
       " 'carcinoma of colon, stage i',\n",
       " 'malignant neoplasm of female breast',\n",
       " 'carcinoma in situ of prostate',\n",
       " 'secondary malignant neoplasm of prostate',\n",
       " 'malignant tumor of spinal cord, intramedullary',\n",
       " 'secondary malignant neoplasm of left ovary',\n",
       " 'secondary malignant neoplasm of thyroid gland',\n",
       " 'secondary malignant neoplasm of male genital organ',\n",
       " 'malignant mixed tumor of salivary gland',\n",
       " 'secondary malignant neoplasm of peritoneum',\n",
       " 'squamous cell carcinoma of scalp',\n",
       " 'squamous cell carcinoma of nasolabial fold',\n",
       " 'overlapping malignant neoplasm of eye and adnexa, primary',\n",
       " 'secondary malignant neoplasm of mediastinum',\n",
       " 'secondary malignant neoplasm of lymph nodes of upper limb',\n",
       " 'secondary malignant neoplasm of duodenum',\n",
       " 'overlapping malignant neoplasm of penis',\n",
       " 'overlapping malignant neoplasm of stomach',\n",
       " 'secondary malignant neoplasm of spleen',\n",
       " 'carcinoma in situ of common bile duct',\n",
       " 'squamous cell carcinoma of back',\n",
       " 'carcinoma in situ of skin',\n",
       " 'carcinoma in situ of rectum',\n",
       " 'malignant tumor of spinal cord, extramedullary',\n",
       " 'secondary malignant neoplasm of choroid',\n",
       " 'carcinoma in situ of gum',\n",
       " 'secondary malignant neoplasm of uterus',\n",
       " 'carcinoma in situ of mouth',\n",
       " 'overlapping malignant neoplasm of floor of mouth',\n",
       " 'secondary malignant neoplasm of inguinal lymph nodes',\n",
       " 'squamous cell carcinoma of temple',\n",
       " 'carcinoma in situ of pylorus',\n",
       " 'overlapping malignant neoplasm of brain',\n",
       " 'basal cell carcinoma of auricle of ear',\n",
       " 'secondary malignant neoplasm of rectosigmoid junction',\n",
       " 'secondary malignant neoplasm of tibial lymph nodes',\n",
       " 'malignant tumor of extrahepatic bile duct',\n",
       " 'carcinoma in situ of duodenum',\n",
       " 'carcinoma in situ of thyroid gland',\n",
       " 'secondary malignant neoplasm of hypogastric lymph nodes',\n",
       " 'secondary malignant neoplasm of female genital organ',\n",
       " 'malignant tumor of pineal gland',\n",
       " 'secondary malignant neoplasm of lymph nodes of lower limb',\n",
       " 'carcinoma in situ of oropharynx',\n",
       " 'carcinoma in situ of colon',\n",
       " 'secondary malignant neoplasm of lymph nodes of neck',\n",
       " 'carcinoma in situ of hypopharynx',\n",
       " 'squamous cell carcinoma of larynx',\n",
       " 'mesothelioma',\n",
       " '',\n",
       " 'stool dna-based colorectal cancer screening positive',\n",
       " 'overlapping malignant neoplasm of colon',\n",
       " 'carcinoma in situ of spleen',\n",
       " 'carcinoma in situ of cystic duct',\n",
       " 'secondary malignant neoplasm of intrathoracic lymph nodes',\n",
       " 'carcinoma in situ of bladder',\n",
       " 'carcinoma in situ',\n",
       " 'carcinoma in situ of penis',\n",
       " 'secondary malignant neoplasm of lymph nodes of head',\n",
       " 'carcinoma of urinary bladder, superficial',\n",
       " 'secondary malignant neoplasm of mesenteric lymph nodes',\n",
       " 'secondary malignant neoplasm of spinal meninges',\n",
       " 'carcinoma in situ of esophagus',\n",
       " 'metastasis from malignant tumor of prostate',\n",
       " 'secondary malignant neoplasm of esophagus',\n",
       " 'carcinoma in situ of lung',\n",
       " 'secondary malignant neoplasm of small intestine',\n",
       " 'secondary malignant neoplasm of respiratory tract',\n",
       " 'carcinoma in situ of pharynx',\n",
       " 'history of malignant neoplasm of penis',\n",
       " ...]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%%time\n",
    "file = open(\"snomed.txt\",'r')\n",
    "final_sensitive_list = []\n",
    "\n",
    "for line in file:\n",
    "    strip_line = line.strip()\n",
    "    final_sensitive_list.append(strip_line)\n",
    "file.close()\n",
    "final_sensitive_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 1.2 s, sys: 137 ms, total: 1.34 s\n",
      "Wall time: 5.61 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import tkinter as tk\n",
    "\n",
    "import pandas as pd\n",
    "import pickle\n",
    "import spacy\n",
    "\n",
    "from spacy import displacy\n",
    "from scispacy.abbreviation import AbbreviationDetector\n",
    "\n",
    "import en_ner_bc5cdr_md\n",
    "import en_ner_bionlp13cg_md\n",
    "import pdfkit \n",
    "from IPython.core.display import HTML\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 0 ns, sys: 201 s, total: 201 s\n",
      "Wall time: 214 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import re\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem import SnowballStemmer\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "from string import punctuation\n",
    "from autocorrect import spell\n",
    "\n",
    "snowball_stemmer = SnowballStemmer('english')\n",
    "wordnet_lemmatizer = WordNetLemmatizer()\n",
    "\n",
    "class Preprocess:\n",
    "    def __int__(self):\n",
    "        pass\n",
    "\n",
    "    def autospell(self,text):\n",
    "       \n",
    "        #correct the spelling of the word.\n",
    "       \n",
    "        spells = [spell(w) for w in (nltk.word_tokenize(text))]\n",
    "        return \" \".join(spells)\n",
    "\n",
    "    def to_lower(self,text):\n",
    "        \n",
    "       # :param text:\n",
    "        #:return:\n",
    "         #   Converted text to lower case as in, converting \"Hello\" to \"hello\" or \"HELLO\" to \"hello\".\n",
    "        \n",
    "        return text.lower()\n",
    "\n",
    "    def remove_numbers(self,text):\n",
    "        \n",
    "        #take string input and return a clean text without numbers.\n",
    "       # Use regex to discard the numbers.\n",
    "        \n",
    "        output = ''.join(c for c in text if not c.isdigit())\n",
    "        return output\n",
    "\n",
    "    def remove_punct(self,text):\n",
    "      \n",
    "        #take string input and clean string without punctuations.\n",
    "        #use regex to remove the punctuations.\n",
    "       \n",
    "        return ''.join(c for c in text if c not in punctuation)\n",
    "\n",
    "    def remove_Tags(self,text):\n",
    "        \n",
    "        #take string input and clean string without tags.\n",
    "        #use regex to remove the html tags.\n",
    "        \n",
    "        cleaned_text = re.sub('<[^<]+?>', '', text)\n",
    "        return cleaned_text\n",
    "\n",
    "    def sentence_tokenize(self,text):\n",
    "       \n",
    "        #take string input and return list of sentences.\n",
    "       # use nltk.sent_tokenize() to split the sentences.\n",
    "        \n",
    "        sent_list = []\n",
    "        for w in nltk.sent_tokenize(text):\n",
    "            sent_list.append(w)\n",
    "        return sent_list\n",
    "\n",
    "    def word_tokenize(self,text):\n",
    "        \n",
    "        #:param text:\n",
    "        #:return: list of words\n",
    "       \n",
    "        return [w for sent in nltk.sent_tokenize(text) for w in nltk.word_tokenize(sent)]\n",
    "\n",
    "    def remove_stopwords(self,sentence):\n",
    "    \n",
    "        #removes all the stop words like \"is,the,a, etc.\"\n",
    "      \n",
    "        stop_words = stopwords.words('english')\n",
    "        return ' '.join([w for w in nltk.word_tokenize(sentence) if not w in stop_words])\n",
    "\n",
    "    def stem(self,text):\n",
    "       \n",
    "        #:param word_tokens:\n",
    "        #:return: list of words\n",
    "        \n",
    "        stemmed_word = [snowball_stemmer.stem(word) for sent in nltk.sent_tokenize(text)for word in nltk.word_tokenize(sent)]\n",
    "        return \" \".join(stemmed_word)\n",
    "\n",
    "    def lemmatize(self,text):\n",
    "        lemmatized_word = [wordnet_lemmatizer.lemmatize(word)for sent in nltk.sent_tokenize(text)for word in nltk.word_tokenize(sent)]\n",
    "        return \" \".join(lemmatized_word)\n",
    "\n",
    "\n",
    "    def preprocess(self,text):\n",
    "        lower_text = self.to_lower(text)\n",
    "        sentence_tokens = self.sentence_tokenize(lower_text)\n",
    "        word_list = []\n",
    "        for each_sent in sentence_tokens:\n",
    "            lemmatizzed_sent = self.lemmatize(each_sent)\n",
    "            clean_text = self.remove_numbers(lemmatizzed_sent)\n",
    "            clean_text = self.remove_punct(clean_text)\n",
    "            clean_text = self.remove_Tags(clean_text)\n",
    "            clean_text = self.remove_stopwords(clean_text)\n",
    "            word_tokens = self.word_tokenize(clean_text)\n",
    "            for i in word_tokens:\n",
    "                word_list.append(i)\n",
    "        return word_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RECORD #####\n",
      "* * * * * * * * * * * * * * * * * * * * * * Admission Date: [DATE] Report Status: Signed\n",
      "Discharge Date: [DATE]\n",
      "ATTENDING: [PERSONS] \n",
      "CODE STATUS: Full code.\n",
      "The patient was admitted to the Renal Transplant PA Service.\n",
      "ADMITTING DIAGNOSES:\n",
      "1. Acute renal failure.\n",
      "2. Congestive heart failure.\n",
      "3. End-stage renal disease , status post renal transplant.\n",
      "PRINCIPAL DISCHARGE DIAGNOSES:\n",
      "1. Acute renal failure requiring dialysis initiation.\n",
      "2. CHF -improved.\n",
      "3. End-stage renal disease , status post failed renal transplant.\n",
      "OTHER DIAGNOSES AND CONDITIONS AFFECTING TREATMENT OR STAY:\n",
      "Hypertension , congestive heart failure , chronic renal\n",
      "dysfunction , renal transplant , CVA and pulmonary hypertension.\n",
      "OPERATIONS AND PROCEDURE: Not applicable.\n",
      "OTHER TREATMENTS AND PROCEDURES: Initiation of dialysis , IV\n",
      "diuretics.\n",
      "BRIEF SUMMARY OF HOSPITAL COURSE:\n",
      "CHIEF COMPLAINT: Shortness of breath.\n",
      "HISTORY OF PRESENT ILLNESS: [PERSON] is a [51-60]yearsold male\n",
      "with history of end-stage renal disease secondary to diabetes\n",
      "mellitus , status post living related transplant [DATE]\n",
      "complicated by delayed graft function , severe ATN and CVA with\n",
      "resultant hemiplegia , multiple reexplorations of transplant site\n",
      "for wound infection , transplant artery stenosis , multiple renal\n",
      "biopsies for delayed graft function , most recent on March of 2006\n",
      "consistent with ATN. [PERSON] presented to the ER from Rehab\n",
      "with worsening shortness of breath. Upon arrival , he was found\n",
      "to have moderate bibasilar crackles , elevated BNP and bilateral\n",
      "pedal edema. He was given Lasix 20 mg IV x2 , aspirin and nitro\n",
      "paste. He denied any chest pain at that time and his troponin\n",
      "was 0.17. His BP upon arrival to the ED was 195/86 , oxygen\n",
      "saturation 96% on 5 liters. EKG showed no acute changes.\n",
      "Creatinine upon admission was 3.6 and potassium 4.8. [PERSON]\n",
      "has had several admissions over the past few months for several\n",
      "complaints and congestive heart failure. He has been at a Rehab\n",
      "Facility where he had been doing okay , although without much\n",
      "improvement in functional status. He persistently complains of\n",
      "pain over the coccyx area. He denied any fevers , cough , chest\n",
      "pain or abdominal pain. He reports voiding regularly. The\n",
      "patient denies any pruritus or metallic taste in his mouth.\n",
      "Reports good appetite.\n",
      "REVIEW OF SYSTEMS: As above , otherwise negative in detail.\n",
      "PAST MEDICAL HISTORY: The patient has ESRD secondary to diabetes\n",
      "type 2 , status post living related transplant [DATE] , CKD\n",
      "baseline creatinine about 2.5 , history of CVA x3 including one\n",
      "posttransplant resulting in dense left hemiplegia , congestive\n",
      "heart failure. The patient had transthoracic echocardiogram in\n",
      "[DATE] , ejection fraction 55% , LVH , mild tricuspid\n",
      "regurgitation , has a history of hypertension , has a history of\n",
      "lumbar fracture , status post fusion with a history of C. diff ,\n",
      "history of lower GI bleed , which has been stable off Plavix ,\n",
      "history of depression , anxiety , history of BPH with urinary\n",
      "retention during the last hospitalization.\n",
      "MEDICATIONS: On admission include CellCept 500 mg p.o. b.i.d. ,\n",
      "Decadron 1 mg p.o. daily , Bactrim one tab p.o. every other day ,\n",
      "aspirin 81 mg p.o. daily , torsemide 50 mg p.o. b.i.d. ,\n",
      "hydralazine 25 mg p.o. t.i.d. , labetolol 400 mg p.o. b.i.d. ,\n",
      "Aranesp 40 mcg subcu every week , iron 324 mg p.o. b.i.d. , NPH 10\n",
      "units subcu q.a.m. , Aspart sliding scale q.a.c. and at bedtime ,\n",
      "Neurontin 300 mg p.o. t.i.d. , Remeron 30 mg p.o. at bedtime ,\n",
      "trazodone 50 mg p.o. at bedtime , Flomax 0.4 mg p.o. daily , Xanax\n",
      "0.25 mg p.o. at bedtime , Percocet 5/325 mg q. 6 h. p.r.n. pain ,\n",
      "heparin 5000 units subcu b.i.d. , Nexium 40 mg p.o. daily , Colace\n",
      "100 mg p.o. b.i.d. , lactulose 30 mg p.o. q.a.m.\n",
      "PHYSICAL EXAM ON ADMISSION: Temperature 97.2 , pulse 61 , BP\n",
      "172/80 , respirations 20 , O2 sat 98% on 5 liters. Generally , the\n",
      "patient is a well-developed , obese white male in moderate\n",
      "distress. HEENT , normocephalic , EOMI. PERRLA. No\n",
      "lymphadenopathy. No jugular venous distention. Oropharynx\n",
      "clear. Lungs with bibasilar rales. Heart , regular rate and\n",
      "rhythm. S1 , split S2. Abdomen , soft , nontender and mildly\n",
      "distended , normoactive bowel sounds , allograft nontender.\n",
      "Musculoskeletal , 1+ edema in the lower extremities bilaterally ,\n",
      "stage 2 coccyx decubitus ulcer. Neuro , alert and oriented x3.\n",
      "No tremor. Mood okay.\n",
      "HOSPITAL COURSE:\n",
      "Renal: Creatinine elevated to 4.0. The patient exhibiting\n",
      "uremic symptoms. The patient was started on dialysis on [DATE]\n",
      "to improve his uremic symptoms as well as his volume overload\n",
      "status and CHF. He has a left upper extremity AV fistula for\n",
      "access , which is functioning well.\n",
      "Immunosuppression: The patient's CellCept was decreased to 250\n",
      "mg b.i.d. secondary to graft failure and initiation of dialysis.\n",
      "Cardiovascular: The patient was admiited with congestive heart failure ,\n",
      "hypovolemia. BP has been fairly well controlled. Volume\n",
      "status- the patient is euvolemic , status post dialysis. The\n",
      "patient will continue on torsemide 100 mg p.o. b.i.d. and\n",
      "metolazone 10 mg daily.\n",
      "Musculoskeletal: The patient should be using an air mattress to\n",
      "alleviate pressure sores. His fentanyl patch 0.25 mcg q. 72\n",
      "hours and oxycodone 5 mg p.o. q. 6 h. p.r.n. for breakthrough\n",
      "pain. His pain is well controlled on this regimen. Please hold\n",
      "both for sedation.\n",
      "Fluid and Electrolytes: The patient is on a 1 liter fluid\n",
      "restriction , strict Is and Os , daily weight , renal diet.\n",
      "Psych: The patient is on trazodone , Remeron , Xanax and Zyprexa\n",
      "p.r.n. 2.5 mg p.r.n. agitation. Hold if sedated. [PERSON] was\n",
      "discharged home in stable condition with VNA Services today.\n",
      "ADDITIONAL COMMENTS: The patient was instructed to call the\n",
      "Renal Transplant Nursing Line at [PHONE NUMBER] if he had any\n",
      "questions or concerns. He was also instructed if it was an\n",
      "emergency during the night or in the weekend to have the renal\n",
      "fellow on-call paged. He was also instructed to return to the\n",
      "hospital if he developed any worsening shortness of breath , chest\n",
      "pain , fever or abdominal pain.\n",
      "DISCHARGE MEDICATIONS:\n",
      "1. Aspirin 81 mg p.o. daily.\n",
      "2. Xanax 0.25 mg p.o. at bedtime.\n",
      "3. Calcium acetate 667 mg p.o. q.a.c. Instructions to be given\n",
      "with meals.\n",
      "4. Decadron 1 mg p.o. daily.\n",
      "5. Colace 100 mg p.o. b.i.d.\n",
      "6. Nexium 40 mg p.o. daily.\n",
      "7. Fentanyl 25 mcg transdermal , q. 72 h.\n",
      "8. Neurontin 100 mg p.o. daily.\n",
      "9. NovoLog sliding scale q.a.c. and at bedtime.\n",
      "10. Insulin NPH Human 10 units subcu q.a.m.\n",
      "11. Labetalol 50 mg p.o. b.i.d.\n",
      "12. Metolazone 10 mg p.o. daily.\n",
      "13. Miconazole nitrate 2% powder topical b.i.d.\n",
      "14. Remeron 30 mg p.o. at bedtime.\n",
      "15. CellCept 250 mg p.o. b.i.d.\n",
      "16. Nephrocaps one tab p.o. daily.\n",
      "17. Zyprexa 2.5 mg p.o. q. 12 h. p.r.n. agitation.\n",
      "18. Oxycodone 5 mg p.o. at bedtime. p.r.n. pain , hold if the\n",
      "patient sedated.\n",
      "19. Flomax 0.4 mg p.o. daily.\n",
      "20. Torsemide 100 mg p.o. b.i.d.\n",
      "21. Trazodone 50 mg p.o. at bedtime.\n",
      "22. Bactrim single strength one tab p.o. every other day.\n",
      "eScription document: 2-2973099 CSSten Tel\n",
      "Dictated By: [DOCTORS]\n",
      "Attending: [PERSONS] \n",
      "Dictation ID: ********\n",
      "D: [DATE]\n",
      "T: [DATE]\n",
      "[report_end]\n",
      "\n",
      "CPU times: user 106 ms, sys: 0 ns, total: 106 ms\n",
      "Wall time: 133 ms\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import re\n",
    "import datefinder as df\n",
    "import datetime as dt\n",
    "\n",
    "#function to find the range of age\n",
    "def range_age(s):\n",
    "        ag=s\n",
    "        i=1\n",
    "        j=10\n",
    "        x=''\n",
    "        while i<j and j<150:\n",
    "            if ag in range(i,j+1):\n",
    "                x='['+str(i)+'-'+str(j)+']'\n",
    "                return x\n",
    "           \n",
    "            i+=10\n",
    "            j+=10\n",
    "    \n",
    "\n",
    "#main function to extract and replace\n",
    "def Generalization(file):\n",
    "    s1=re.findall(r'(?:\\d{1,2}[a-z]* )?(?:Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)[a-z]* (?:\\d{1,2}[a-z]*, )?\\d{4}',file)\n",
    "    s=re.findall(r'\\d{1,2}[/-]\\d{1,2}[/-]\\d{2,4}',file)\n",
    "     #replace date\n",
    "    for i in range(len(s)):\n",
    "        file=file.replace(s[i],'[DATE]')\n",
    "    if len(s1)>0:\n",
    "       for i in range(len(s1)):\n",
    "         file=file.replace(s1[i],'[DATE]') \n",
    "    \n",
    "    #extract and replace Record Number\n",
    "    r=file.split()\n",
    "    file=file.replace(r[1],'#####')\n",
    "    \n",
    "    #extract and replace patient and doctor name\n",
    "    name=re.findall(r'Mr\\. \\w[A-Za-z]+|Mrs\\. \\w[A-Za-z]+',file)\n",
    "    for i in range(len(name)):\n",
    "        file=file.replace(name[i],'[PERSON]')\n",
    "    \n",
    "    name=re.findall(r'DR\\. \\w[A-Za-z]+|Mrs\\. \\w[A-Za-z]+',file)\n",
    "    for i in range(len(name)):\n",
    "        file=file.replace(name[i],'[DOCTOR]')\n",
    "        \n",
    "    #extract and replace Phone number\n",
    "    phno=re.findall(r'\\d{3}[-\\s]+\\d{3}[-\\s]+\\d{4}',file)\n",
    "    for i in range(len(phno)):\n",
    "        file=file.replace(phno[i],'[PHONE NUMBER]')\n",
    "    \n",
    "    #extract age\n",
    "    age=re.findall(r'[0-9]+[-\\s]year[-\\s]|[0-9]+[-\\s]years[-\\s]',file)\n",
    "    for i in range(len(age)):\n",
    "        a=str(age[i])\n",
    "        a1=list(a)\n",
    "        age_years=\"\".join(a1[0:2])\n",
    "        dob=range_age(float(age_years))\n",
    "        file=file.replace(age[i],dob+'years')\n",
    "    \n",
    "    #extract and remove unwanted data\n",
    "    i=2\n",
    "    while(r[i]!='Admission'):\n",
    "        file=file.replace(r[i],'*',1)\n",
    "        i+=1\n",
    "        \n",
    "    #extract and replace dictated fields and attending fields\n",
    "    d=re.findall(r'Dictated By:\\s[A-Za-z]*\\s.*| Dictated By:\\s[A-Za-z]*\\s.',file)\n",
    "    for i in range(len(d)):\n",
    "        file=file.replace(d[0],'Dictated By: [DOCTORS]')\n",
    "        \n",
    "    a=re.findall(r'Attending:\\s[A-Za-z]*\\s.*| ATTENDING:\\s[A-Za-z]*\\s.*',file)\n",
    "    for i in range(len(a)):\n",
    "        file=file.replace(a[0],'Attending: [PERSONS] ')\n",
    "        \n",
    "    a1=re.findall(r'ATTENDING:\\s[A-Za-z]*\\s.*',file)\n",
    "    for i in range(len(a1)):\n",
    "        file=file.replace(a1[0],'ATTENDING: [PERSONS] ')\n",
    "    \n",
    "    e=re.findall(r'ENTERED BY:\\s[A-Za-z]*\\s.*',file)\n",
    "    for i in range(len(e)):\n",
    "        file=file.replace(e[0],'ENTERED BY: [PERSONS] ')\n",
    "    \n",
    "    id=re.findall(r'Dictation ID\\s.*',file)\n",
    "    for i in range (len(id)):\n",
    "        file=file.replace(id[i],'Dictation ID: ********')\n",
    "        \n",
    "    #extract and replace Batch and Index Number\n",
    "    batch=re.findall(r'Batch:\\s[0-9]+\\sIndex No\\.[-\\s][A-Za-z0-9]+',file)\n",
    "    for i in range(len(batch)):\n",
    "        file=file.replace(batch[i],'batch:''****'+'\\tIndex No.'' *********')\n",
    "  \n",
    "    return(file)\n",
    "\n",
    "f=open(r\"finaldocuments/6637\",'r')\n",
    "file=f.read()\n",
    "\n",
    "General_data=Generalization(file)#the modified data is stored in General data....\n",
    "print(General_data) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RECORD #####\n",
      "* * * * * * * * * * * * * * * * * * * * Admission Date: [1995] Report Status: Signed\n",
      "Discharge Date: [1995]\n",
      "PRINCIPAL DIAGNOSIS: DEEP VENOUS THROMBOSIS\n",
      "SECONDARY DIAGNOSIS: HEREDITARY ANGIOEDEMA\n",
      "HISTORY OF PRESENT ILLNESS: This is a [75.5] years old white female with\n",
      "hereditary angioedema with recent\n",
      "abdominal surgery presents with 30 hours of severe abdominal pain\n",
      "and tightness , typical of her hereditary angioedema attacks. The\n",
      "patient has had HAE since childhood and recalls having a ring cut\n",
      "off her finger as a child during an attack. She has had three\n",
      "tracheostomies , the last one over [15.5] years ago for laryngeal edema.\n",
      "Symptoms include throat tightness , difficulty talking and\n",
      "swallowing and abdominal pain. She often has attacks at local\n",
      "trauma sites. Over the past several years she has received Human\n",
      "C1 esterase inhibitor as part of a study conducted at CTMC by [DOCTOR] Gendusa She has done very well with these treatments for acute\n",
      "attacks until recently when she states the inhibitor has stopped\n",
      "working as well as previously. [DOCTOR] Toomsen has told her she\n",
      "may have an antibody to the inhibitor and her recent events include\n",
      "3/0 admitted with severe abdominal pain , flare of HAE , apparently\n",
      "became hypotensive and acidemic and went to laparotomy emergently ,\n",
      "on pressors without bowel preparation. Colostomy was done for bowel\n",
      "wall edema and was complicated by postoperative abscess requiring\n",
      "drainage. One month ago she had her colostomy taken down which has\n",
      "been complicated by incontinence of stool requiring Depends. At\n",
      "baseline , C4 is 6-10 , normal being 16-34 , C1 inhibitor 5-9 , normal\n",
      "being 25-83. On [1995]at 1:30 p.m. she developed the onset of\n",
      "typical HAE attack with crescendo abdominal pain and throat\n",
      "tightness. She took extra stanozolol but the abdominal pain\n",
      "persisted to where it was intolerable and she presented to the EW\n",
      "with nausea and vomiting. Last bowel movement was [1995],\n",
      "slightly loose , normal urine. In the EW she was given Demerol ,\n",
      "Solu Medrol , Zantac and Benadryl. PAST MEDICAL HISTORY: Includes\n",
      "cholecystectomy , appendectomy , hysterectomy for fibroid , but not\n",
      "bilateral salpingo-oophorectomy. She has a history of renal\n",
      "calculi , history of abnormal liver function tests , unknown cause ,\n",
      "history of AF , now controlled with DIG and Verapamil. She is\n",
      "status post subdural hematoma on Coumadin at therapeutic levels ,\n",
      "hypothyroid on replacement , history of right deep venous\n",
      "thrombosis , history of carpal tunnel syndrome , severe\n",
      "osteoarthritis with cervical spine , lumbosacral spine and right\n",
      "knee involvement. History of cerebrovascular accident , right\n",
      "hemiparesis , now at 90% of baseline , left iridectomy , left drop\n",
      "foot , left thigh numbness and tingling , dizziness and\n",
      "disequilibrium. FAMILY/SOCIAL HISTORY: She has a son and two\n",
      "grandchildren with HAE , three daughterse not effected , lives with\n",
      "husband , daughter , lives upstairs. She uses no tobacco , rare ETOH.\n",
      "MEDICATIONS: Digoxin .125 mg q day , Verapamil 60 mg b.i.d. ,\n",
      "Coumadin 1 mg q day , aspirin 80 mg q day , Synthroid 0.05 mg q day ,\n",
      "Stanozolol 2 mg q day with increased dose as needed. ALLERGIES:\n",
      "Quinidine causes nausea; IV contrast causes rash; propafenone ,\n",
      "migraines; penicillin rash; sulfa rash; novocaine throat swelling.\n",
      "Food allergies are wheat , dairy , chocolate , walnuts and\n",
      "strawberries.\n",
      "PHYSICAL EXAMINATION: On admission this is an ill-appearing woman\n",
      "with a raspy voice. Vital signs , 99.1 , heart\n",
      "rate 116 in atrial fibrillation , blood pressure 132/84 , respiratory\n",
      "rate 18. Head and neck examination , normocephalic , atraumatic ,\n",
      "status post iridectomy on left. The oropharynx is clear , no\n",
      "stridor. Neck , supple , carotids 2+ , stigmata of old thyroid\n",
      "tracheostomy. Lungs , clear to auscultation. Heart , irregularly\n",
      "irregular , tachycardia , I/VI early systolic murmur at left lower\n",
      "sternal border without radiation. Abdomen , recent midline incision ,\n",
      "healing , normal bowel sounds , soft but exquisitely tender to\n",
      "palpation or percussion. There is positive rebound tenderness ,\n",
      "positive shake tenderness. Rectal , guaiac positive per EW.\n",
      "Extremities , no clubbing , cyanosis or edema , pulses are 2+\n",
      "peripherally. She has positive pain to passive motion right knee ,\n",
      "neck not examined. Neuro , alert and oriented x 3 , cranial nerves\n",
      "are intact. Motor is 5/5 throughout except left foot without\n",
      "extension. Sensory , decreased light touch on the left lateral\n",
      "thigh , deep tendon reflexes 2+ throughout , toes right upgoing , left\n",
      "downgoing.\n",
      "LABORATORY DATA: White count 10.2 , hematocrit 41.3 , platelets\n",
      "377 , sodium 140 , potassium 3.8 , chloride 100 ,\n",
      "bicarb 30 , BUN 14 , creatinine 1.5 , glucose 140 , liver function\n",
      "tests normal. PT 13.5 , PTT 24.5. Chest x-ray and KUB without\n",
      "infiltrates , no free air , no ileus , no obstruction. EKG , atrial\n",
      "fibrillation at 117 , normal QRS and QT , unchanged from 10/14 , DIG\n",
      "effect is present.\n",
      "HOSPITAL COURSE: The patient improved dramatically over the first\n",
      "day of admission with decreased abdominal pain ,\n",
      "improving appetite and was started on clear liquids on [1995]late\n",
      "in the day. Initial treatment included Solu Medrol 125 mg IV bolus\n",
      "in the emergency room and Stanozolol 2 mg q.i.d. when first sent to\n",
      "the floor. She also had IV Zantac 50 mg q8 for the first three days\n",
      "of admission. The patient's symptoms continued to improve and diet\n",
      "was advanced over the next several days. Further concerns on this\n",
      "hospitalization were whether or not she would ever be a candidate\n",
      "for further C1 esterase inhibitor replacement , the question being\n",
      "was her hypotension during the last treatment leading to bowel\n",
      "surgery caused by the disease itself or as a response to the\n",
      "inhibitor. As of discharge this question has yet to be settled with\n",
      "[DOCTOR] The patient developed left pedal edema by [1995]and\n",
      "although on low dose Coumadin , note is made of past subdurals on\n",
      "therapeutic Coumadin. The patient had a lower extremity noninvasive\n",
      "revealing a left leg deep venous thrombosis located at the\n",
      "bifurcation of the left common and superficial femorals. Given the\n",
      "patient's complications on Coumadin in the past and risk of\n",
      "pulmonary embolus , she was sent for filter placement which was done\n",
      "on 6/19/95. The patient also had the complication of bright red\n",
      "blood per rectum , she said this happens occasionally at home and on\n",
      "examination had moderate external hemorrhoids , no sign of recent\n",
      "bleeding , no internal hemorrhoids , no gross blood on examination.\n",
      "At this point she had normal coagulation studies and her hematocrit\n",
      "was 29.8 on 9/10/95. The patient was kept overnight with stable\n",
      "hematocrit and discharged on 11/5/95.\n",
      "DISPOSITION: The patient was discharged to home. MEDICATIONS:\n",
      "Aspirin 81 mg p.o. q day; Digoxin .125 mg p.o. q day;\n",
      "Synthroid 50 micrograms p.o. q day; Verapamil 60 mg p.o. t.i.d.;\n",
      "Coumadin 1 mg p.o. q day; Stanozolol 2 mg p.o. b.i.d. The patient\n",
      "will followup by telephone with [DOCTOR] Manoso CONDITION ON\n",
      "DISCHARGE: Good.\n",
      "Dictated By: [DOCTORS]\n",
      "Attending: [PERSONS]\n",
      "QA950/9889\n",
      "Batch:******\tIndex No. ***** D: [1995]T: [1995][report_end]\n",
      "\n",
      "CPU times: user 15.6 ms, sys: 0 ns, total: 15.6 ms\n",
      "Wall time: 24 ms\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import re\n",
    "import datefinder as df\n",
    "import datetime as dt\n",
    "#import time\n",
    "#function to replace age as bin_avg of age\n",
    "def bin_avg(s):\n",
    "    ag=s\n",
    "    i=1\n",
    "    j=10\n",
    "    while i<j and j<150:\n",
    "        if ag in range(i,j+1):\n",
    "            return str((i+j)/2)\n",
    "           \n",
    "        i+=10\n",
    "        j+=10\n",
    "\n",
    "#main function to extract and replace\n",
    "def sanitization(file):\n",
    "    #extract date\n",
    "    s1=re.findall(r'(?:\\d{1,2}[a-z]* )?(?:Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)[a-z]* (?:\\d{1,2}[a-z]*, )?\\d{4}',file)\n",
    "    s=re.findall(r'\\d{1,2}[/]\\d{1,2}[/]\\d{2}\\s|\\d{1,2}[/]\\d{1,2}[/]\\d{4}',file)\n",
    "    mon=re.findall(r'(?:\\d{1,2} of )?(?:Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)[a-z]*',file)\n",
    "    #print(s1)\n",
    "    #print(s)\n",
    "    #print(mon)\n",
    "    month=['4/30','6/30','9/30','11/30']\n",
    "    month1=['4/31','6/31','9/31','11/31']\n",
    "    #replace date\n",
    "    for i in range(len(s)):\n",
    "        y=\"\".join(s[i])\n",
    "        y_1=y\n",
    "        for i in range(len(month)):\n",
    "            if month[i] in y:\n",
    "                y=y.replace(month[i],'5/30')\n",
    "        y=y.replace('0/','1/')\n",
    "        for i in range(len(month1)):\n",
    "            if month1[i] in y:\n",
    "                y=y.replace(month1[i],'5/30')\n",
    "        mat=list(df.find_dates(y))\n",
    "        rep=str(dt.datetime.date(mat[0]).year)\n",
    "        rep='['+rep+']'\n",
    "        file=file.replace(y_1,rep)\n",
    "    if len(s1)>0:    \n",
    "        for i in range(len(s1)):\n",
    "            y1=\"\".join(s1[i])\n",
    "            mat1=list(df.find_dates(s1[i]))\n",
    "            #print(mat)\n",
    "            rep1=str(dt.datetime.date(mat1[0]).year)\n",
    "            rep1='['+rep1+']'\n",
    "            file=file.replace(y1,rep1)\n",
    "    if len(mon)>0:\n",
    "        for i in range(len(mon)):\n",
    "            file=file.replace(mon[i],\"[MONTH] \")\n",
    "   \n",
    "    #extract and replace Record Number\n",
    "    r=file.split()\n",
    "    file=file.replace(r[1],'#####')\n",
    "    \n",
    "    #extract and replace patient and doctor name\n",
    "    name=re.findall(r'Mr\\. \\w[A-Za-z]+|Mrs\\. \\w[A-Za-z]+|Ms\\. \\w[A-Za-z]+',file)\n",
    "    #print(name)\n",
    "    for i in range(len(name)):\n",
    "        file=file.replace(name[i],\"[PERSON]\")\n",
    "    doctor=re.findall(r'Dr\\.\\s\\w[A-Za-z]+|DR\\.\\s\\w[A-Za-z]+|Dr\\.\\s\\w[A-Za-z]+[A-Z][a-z]*',file)\n",
    "    #print(doctor)\n",
    "    for i in range(len(doctor)):\n",
    "        file=file.replace(doctor[i],\"[DOCTOR]\")\n",
    "    \n",
    "    #extract and remove unwanted data\n",
    "    i=2\n",
    "    while(r[i]!='Admission'):\n",
    "        #print(r[i])\n",
    "        file=file.replace(r[i],'*',1)\n",
    "        i+=1\n",
    "    #extract and replce Hospital name\n",
    "    hosp=re.findall(r'[A-Za-z]* Hospital|[A-Za-z]* Hospital [A-Za-z]*',file)\n",
    "    for i in range(len(hosp)):\n",
    "        file=file.replace(hosp[i],\"[HOSPITAL]\")\n",
    "    \n",
    "    #extract and replace dictated fields and attending fields\n",
    "    d=re.findall(r'Dictated By:\\s[A-Za-z]*\\s.*|DICTATED By:\\s[A-Za-z]*\\s.*',file)\n",
    "    #print(d)\n",
    "    for i in range(len(d)):\n",
    "        file=file.replace(d[i],'Dictated By: [DOCTORS]')\n",
    "    a=re.findall(r'Attending:\\s[A-Za-z]*\\s.*|ATTENDING:\\s[A-Za-z]*\\s.*|ENTERED BY:\\s[A-Za-z]*\\s.*',file)\n",
    "    #print(a)\n",
    "    for i in range(len(a)):\n",
    "        file=file.replace(a[i],'Attending: [PERSONS]')\n",
    "\n",
    "\n",
    "    id=re.findall(r'Dictation ID\\s.*',file)\n",
    "    for i in range(len(id)):\n",
    "        file=file.replace(id[i],'Dictation ID ********')\n",
    "    \n",
    "    #extract age\n",
    "    age=re.findall(r'[0-9]+[-\\s]year[-\\s]|[0-9]+[-\\s]years[-\\s]',file)\n",
    "    #print(age)\n",
    "    for i in range(len(age)):\n",
    "        a=str(age[i])\n",
    "        a1=list(age[i])\n",
    "        age_years=\"\".join(a1[0:2])\n",
    "        dob=bin_avg(float(age_years))\n",
    "        years='['+dob+']'\n",
    "        file=file.replace(age[i],years+' years ')\n",
    "        \n",
    "    #extract and replace Phone number\n",
    "    phno=re.findall(r'\\d{3}[-\\s]+\\d{3}[-\\s]+\\d{4}',file)\n",
    "    #print(phno)\n",
    "    for i in range(len(phno)):\n",
    "        file=file.replace(phno[i],\"[PHONE NUMBER]\")\n",
    "        \n",
    "    #extract and replace Batch and Index Number\n",
    "    batch=re.findall(r'Batch:\\s[0-9]+\\sIndex No\\.[-\\s][A-Za-z0-9]+',file)\n",
    "    #print(batch)\n",
    "    for i in range(len(batch)):\n",
    "        file=file.replace(batch[i],'Batch:******\\tIndex No. *****')\n",
    "    \n",
    "    #extract and replace eScription document\n",
    "    doc=re.findall(r'eScription document:\\s.*',file)\n",
    "    for i in range(len(doc)):\n",
    "        file=file.replace(doc[i],\"eScription document: ******\")\n",
    "   \n",
    "    return(file)\n",
    "\n",
    "#read and write the file \n",
    "f=open(r\"finaldocuments/741398\",'r')\n",
    "file=f.read()\n",
    "#st=time.time()\n",
    "#call the sanitization function\n",
    "synthetic_data=sanitization(file)#the modified data is stored in synthetic data....\n",
    "#end=time.time()\n",
    "#print(\"Time taken:\",end-st)\n",
    "print(synthetic_data)    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def summarization(filename):\n",
    "    text=''\n",
    "    with open(filename,\"r\") as a_file:\n",
    "        for line in a_file:\n",
    "            stripped_line = line.replace(\"\\n\",\" \")\n",
    "            text+=stripped_line\n",
    "    def content(pattern):\n",
    "    #pattern='PRINCIPAL DIAGNOSIS:(.*?)(:)'\n",
    "        principal_diagnosis = re.search(pattern,text).group(0)\n",
    "#print(res)\n",
    "#Identifying the last label\n",
    "        result = re.search('[ a-zA-Z]+\\:$',principal_diagnosis).group(0)\n",
    "#res1\n",
    "#splitting each sentence based on full stop\n",
    "        result_1=principal_diagnosis.split(\".\")\n",
    "#result_1\n",
    "#creating a list having only principal diagnosis\n",
    "        text_list=[]\n",
    "        for i in result_1:\n",
    "            if i != result:\n",
    "                text_list.append(i)\n",
    "#text_list\n",
    "        final_result = '.'.join(text_list)\n",
    "        final= final_result+'.'\n",
    "        return final\n",
    "    \n",
    "    \n",
    "    from IPython.display import Markdown, display\n",
    "    def printmd(string):\n",
    "        display(Markdown(string))\n",
    "        \n",
    "    import re\n",
    "    d1 = re.findall(r\"Admission Date: [\\d]{1,2}/[\\d]{1,2}/[\\d]{2,4}\", text)\n",
    "    for s in d1:\n",
    "        printmd(s)\n",
    "    d2 = re.findall(r\"Discharge Date: [\\d]{1,2}/[\\d]{1,2}/[\\d]{2,4}\", text)\n",
    "    for s in d2:\n",
    "        printmd(s) \n",
    "    p_d=\"\"\n",
    "    h_p_i=\"\"\n",
    "    p_m_h=\"\"\n",
    "    m_o_a=\"\"\n",
    "    allergies=\"\"\n",
    "    p_e_a=\"\"\n",
    "    if 'PRINCIPAL DIAGNOSIS ON DISCHARGE:' in text:\n",
    "        p_d = 'PRINCIPAL DIAGNOSIS ON DISCHARGE:(.*?)([a-bA-Z]:)'\n",
    "        p_d = content(p_d)\n",
    "    if 'HISTORY OF PRESENT ILLNESS:' in text:\n",
    "        h_p_i='HISTORY OF PRESENT ILLNESS:(.*?)([a-bA-Z]:)'\n",
    "        h_p_i=content(h_p_i)\n",
    "    if 'PAST MEDICAL HISTORY:' in text:\n",
    "        p_m_h='PAST MEDICAL HISTORY:(.*?)([a-bA-Z]:)'\n",
    "        p_m_h=content(p_m_h)\n",
    "    if 'MEDICATIONS ON ADMISSION:' in text:\n",
    "        m_o_a='MEDICATIONS ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        m_o_a=content(m_o_a)\n",
    "    if 'ALLERGIES' in text:\n",
    "        allergies='ALLERGIES:(.*?)([a-bA-Z]:)'\n",
    "        allergies=content(allergies)\n",
    "    if 'PHYSICAL EXAMINATION ON ADMISSION:' in text:\n",
    "        p_e_a='PHYSICAL EXAMINATION ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        p_e_a=content(p_e_a)\n",
    "    res = str(d1)+\"\\n\"+str(d2)+\"\\n\"+p_d+\"\\n\"+h_p_i+\"\\n\"+p_m_h+\"\\n\"+m_o_a+\"\\n\"+allergies+\"\\n\"+p_e_a\n",
    "    res1 = res.split('\\n')\n",
    "    with open('summerization.txt',\"w\") as f:\n",
    "        for lis in res1:\n",
    "            \n",
    "            if lis != \"\":\n",
    "                f.write('%s\\n'%lis)\n",
    "    return res1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp_bc = en_ner_bc5cdr_md.load()\n",
    "nlp_bi = en_ner_bionlp13cg_md.load()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 4 s, sys: 0 ns, total: 4 s\n",
      "Wall time: 6.91 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "def check_sensitive(file):\n",
    "        f=open(file)\n",
    "        y=f.read()\n",
    "\n",
    "        pr = Preprocess()\n",
    "        res=pr.preprocess(y)\n",
    "        y=\" \".join(res)\n",
    "        \n",
    "       \n",
    "        doc_bio = nlp_bi(y)\n",
    "        doc_bc = nlp_bc(y)\n",
    "    \n",
    "        doc_bc_list = [item for i in doc_bc.ents for item in i]\n",
    "    \n",
    "    #spacy.displacy.render(doc, style='ent', jupyter=True)\n",
    "        doc_list_bc = [item for i in doc_bio.ents for item in i]\n",
    "    \n",
    "        sen_list =  doc_bc_list+doc_list_bc#doc_med7_list \n",
    "        sensitive = False\n",
    "        sen=[]\n",
    "        for item in sen_list:\n",
    "            term1 =  str(item)\n",
    "            if  term1 in final_sensitive_list:\n",
    "                sensitive=True\n",
    "                sen.append(term1)\n",
    "                \n",
    "            \n",
    "        if sensitive is True:\n",
    "            \n",
    "            return True\n",
    "        else:\n",
    "            return False\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " * Serving Flask app \"__main__\" (lazy loading)\n",
      " * Environment: production\n",
      "\u001b[31m   WARNING: This is a development server. Do not use it in a production deployment.\u001b[0m\n",
      "\u001b[2m   Use a production WSGI server instead.\u001b[0m\n",
      " * Debug mode: on\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " * Running on http://127.0.0.1:5001/ (Press CTRL+C to quit)\n"
     ]
    },
    {
     "ename": "NameError",
     "evalue": "name 'file_nam' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<timed exec>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'file_nam' is not defined"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "from flask import *  \n",
    "import spacy\n",
    "\n",
    "\n",
    "\n",
    "app = Flask(__name__)  \n",
    "#app.secret_key =\"abc\"\n",
    "app.config['CLIENT_PDF'] = 'static/files'\n",
    "\n",
    "@app.route('/')  \n",
    "def upload():  \n",
    "    return render_template(\"file_upload_form.html\")  \n",
    " \n",
    "@app.route('/anonimization', methods=['POST'])\n",
    "def analymaization():\n",
    "    if request.method == 'POST':\n",
    "        if request.form.get('Generalization') == 'Generalization':\n",
    "            print(\"Generalization\")\n",
    "            f=open(file_nam,'r')\n",
    "            file1=f.read()\n",
    "            generalige = Generalization(file1)\n",
    "            generalige = generalige.split('\\n')\n",
    "            \n",
    "            with open('static/files/generalization.txt',\"w\") as f:\n",
    "                for lis in generalige:\n",
    "                    f.write('%s\\n'%lis)\n",
    "                    \n",
    "            summarize = summarization('static/files/generalization.txt')\n",
    "            doc = ' '.join([str(elem+'\\n') for elem in summarize])\n",
    "            doc =nlp_bc(doc)\n",
    "            html =  displacy.render(doc, style='ent', page=True,jupyter = False)\n",
    "            with open(\"output.html\", 'w+', encoding=\"utf-8\") as fp:\n",
    "                fp.write(html)\n",
    "            final_output_file_path = 'static/files/'+fname+'_sen.pdf'\n",
    "            pdfkit.from_file('output.html', final_output_file_path) \n",
    "            fp.close()\n",
    "            \n",
    "                        \n",
    "            return render_template(\"download_sen.html\",name = file_nam)\n",
    "      \n",
    "        elif  request.form.get('Sanitization') == 'Sanitization':\n",
    "            print(\"Sanitization\")\n",
    "            f=open(file_nam,'r')\n",
    "            file1=f.read()\n",
    "            sanitize = sanitization(file1)\n",
    "            sanitize = sanitize.split('\\n')\n",
    "            \n",
    "            with open('static/files/sanitization.txt',\"w\") as f:\n",
    "                for lis in sanitize:\n",
    "                    f.write('%s\\n'%lis)\n",
    "                    \n",
    "            summarize = summarization('static/files/sanitization.txt')\n",
    "            doc = ' '.join([str(elem+'\\n') for elem in summarize ])\n",
    "            doc =nlp_bc(doc)\n",
    "            html =  displacy.render(doc, style='ent', page=True,jupyter = False)\n",
    "            with open(\"output.html\", 'w+', encoding=\"utf-8\") as fp:\n",
    "                fp.write(html)\n",
    "            final_output_file_path = 'static/files/'+fname+'_sen.pdf'\n",
    "            pdfkit.from_file('output.html', final_output_file_path) \n",
    "            fp.close()\n",
    "            \n",
    "                        \n",
    "            return render_template(\"download_sen.html\",name = file_nam)\n",
    "    return render_template(\"ananimization.html\")\n",
    "      \n",
    "@app.route('/success', methods = ['POST'])  \n",
    "def success():  \n",
    "    if request.method == 'POST':  \n",
    "        f = request.files['file']  \n",
    "        #file = f.filename+str(f) \n",
    "        print('file uploaded successfully')\n",
    "        global fname\n",
    "        fname = str(f.filename)\n",
    "        global file_nam\n",
    "        file_nam = \"finaldocuments/\"+fname\n",
    "        #session['file_name']=file\n",
    "        global res\n",
    "        res = check_sensitive(file_nam)\n",
    "        if res == True:\n",
    "            return render_template(\"ananimization.html\", name = file_nam)\n",
    "        else:\n",
    "            res = summarization(file_nam)\n",
    "            doc = ' '.join([str(elem+'\\n') for elem in res])\n",
    "            doc =nlp_bc(doc)\n",
    "            html =  displacy.render(doc, style='ent', page=True,jupyter = False)\n",
    "            with open(\"output.html\", 'w+', encoding=\"utf-8\") as fp:\n",
    "                fp.write(html)\n",
    "            final_output_file_path = 'static/files/'+fname+'_nonsen.pdf'\n",
    "            pdfkit.from_file('output.html', final_output_file_path) \n",
    "            fp.close()\n",
    "            #print('mohith')\n",
    "            return render_template(\"download_nonsen.html\",name = file_nam)  \n",
    "  \n",
    "@app.route('/return-sen_files')\n",
    "def return_files_tut():\n",
    "    \n",
    "        file_path = fname+'_sen.pdf'\n",
    "        \n",
    "        return send_from_directory(app.config['CLIENT_PDF'],filename= file_path,as_attachment=True,cache_timeout=0)\n",
    "\n",
    "@app.route('/return-nonsen_file')\n",
    "def return_files_tut1():\n",
    "    \n",
    "        file_path = fname+'_nonsen.pdf'\n",
    "        #print(file_path)\n",
    "        return send_from_directory(app.config['CLIENT_PDF'],filename= file_path,as_attachment=True,cache_timeout=0)\n",
    "    \n",
    "if __name__ == '__main__':  \n",
    "    app.run(debug = True, port=\"5001\" , use_reloader=False)\n",
    "      \n",
    "del file_nam\n",
    "del fname\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "ename": "OSError",
     "evalue": "Database /home/likhith/anaconda3/lib/python3.8/site-packages/pymedtermino/snomedct.sqlite3 not available. Please build, or set pymedtermino.DATA_DIR correctly",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mOSError\u001b[0m                                   Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-13-47b1f5c9abc7>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0;32mimport\u001b[0m \u001b[0mpymedtermino\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msnomedct\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;32m~/anaconda3/lib/python3.8/site-packages/pymedtermino/snomedct.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m     38\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     39\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 40\u001b[0;31m \u001b[0mdb\u001b[0m        \u001b[0;34m=\u001b[0m \u001b[0mpymedtermino\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mconnect_sqlite3\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"snomedct\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     41\u001b[0m \u001b[0mdb_cursor\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mdb\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mcursor\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     42\u001b[0m \u001b[0mdb_cursor\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mexecute\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"PRAGMA synchronous  = OFF;\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;32m~/anaconda3/lib/python3.8/site-packages/pymedtermino/__init__.py\u001b[0m in \u001b[0;36mconnect_sqlite3\u001b[0;34m(base_filename, read_only)\u001b[0m\n\u001b[1;32m    788\u001b[0m     \u001b[0mpath\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m'%s.sqlite3'\u001b[0m \u001b[0;34m%\u001b[0m \u001b[0mos\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mjoin\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mDATA_DIR\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mbase_filename\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    789\u001b[0m     \u001b[0;32mif\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0mos\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mexists\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpath\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 790\u001b[0;31m       \u001b[0;32mraise\u001b[0m \u001b[0mIOError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'Database %s not available. Please build, or set pymedtermino.DATA_DIR correctly'\u001b[0m \u001b[0;34m%\u001b[0m \u001b[0mpath\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    791\u001b[0m     \u001b[0mdb\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0msql_module\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mconnect\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpath\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    792\u001b[0m     \u001b[0;32mif\u001b[0m \u001b[0mREAD_ONLY_DATABASE\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0mread_only\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mOSError\u001b[0m: Database /home/likhith/anaconda3/lib/python3.8/site-packages/pymedtermino/snomedct.sqlite3 not available. Please build, or set pymedtermino.DATA_DIR correctly"
     ]
    }
   ],
   "source": [
    "import pymedtermino.snomedct"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['/home/likhith/finalyearprojectwork-main',\n",
       " '/home/likhith/anaconda3/lib/python38.zip',\n",
       " '/home/likhith/anaconda3/lib/python3.8',\n",
       " '/home/likhith/anaconda3/lib/python3.8/lib-dynload',\n",
       " '',\n",
       " '/home/likhith/anaconda3/lib/python3.8/site-packages',\n",
       " '/home/likhith/anaconda3/lib/python3.8/site-packages/IPython/extensions',\n",
       " '/home/likhith/.ipython']"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import sys\n",
    "sys.path"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pymedtermino.snomedct\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
